data_1cmg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cmg _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 84' ' ' GLU . 1.3 mt-10 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -43.7 -33.85 1.34 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 109.65 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.459 ' HA ' ' HE1' ' A' ' 145' ' ' MET . 2.1 mp -93.17 -34.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.198 -0.939 . . . . 0.0 109.929 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.462 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 2.0 mmt85 -48.58 -37.91 19.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.641 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.7 mt-10 -87.01 -51.89 5.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.762 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.477 ' HA ' HG22 ' A' ' 91' ' ' VAL . . . -45.94 -25.06 0.48 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.994 -1.066 . . . . 0.0 109.11 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 77.6 t80 -66.5 -56.31 11.5 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.413 -0.804 . . . . 0.0 109.45 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -63.14 -27.51 69.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.295 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 88' ' ' ALA . 41.2 t -50.34 -28.99 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.463 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 62.4 m-85 -100.96 -36.19 9.12 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.94 82.58 8.28 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.581 -0.7 . . . . 0.0 109.254 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.447 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 4.7 mmtt -80.61 -20.43 43.25 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.301 -0.875 . . . . 0.0 110.157 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' GLY . 2.6 m-20 -78.12 1.56 20.82 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.98 48.15 1.96 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -109.09 -18.28 13.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -1.196 . . . . 0.0 109.812 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.461 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 120.09 -36.65 3.35 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.577 ' CD1' ' OE1' ' A' ' 135' ' ' GLN . 54.7 m-85 -116.38 142.08 47.32 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.374 -1.074 . . . . 0.0 109.59 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 97.0 mt -90.25 123.78 42.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 108.962 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.4 p -82.05 173.5 12.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.14 -0.975 . . . . 0.0 109.427 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.486 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -63.4 -42.1 98.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.414 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.462 ' HA ' ' NH2' ' A' ' 106' ' ' ARG . . . -63.46 -30.23 71.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 56.1 mm-40 -72.15 -22.51 61.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.149 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 109' ' ' MET . 4.1 tp -88.71 -31.83 18.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.6 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.462 ' NH2' ' HA ' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -88.16 -9.59 52.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.164 -0.96 . . . . 0.0 109.175 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -88.31 -39.31 14.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.098 -1.001 . . . . 0.0 109.669 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 92' ' ' PHE . 57.3 t -88.62 -28.42 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 109.795 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 4.5 mtt -68.16 -20.98 64.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.238 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.518 ' CB ' ' O ' ' A' ' 114' ' ' GLU . 8.5 t -100.05 1.19 42.15 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.578 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 45.9 p-10 -57.51 -16.17 9.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 0.0 109.601 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.468 ' N ' ' OD1' ' A' ' 111' ' ' ASN . 1.2 mt -107.46 -20.93 13.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 109.641 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.6 -32.35 1.73 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 110' ' ' THR . 10.6 mt-10 -50.62 137.45 19.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.254 -1.145 . . . . 0.0 109.488 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 81.68 1.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.105 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.473 ' HB3' HG21 ' A' ' 121' ' ' VAL . 4.8 mp -63.91 136.29 57.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.0 t -90.81 -178.15 5.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 108.78 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -67.08 -54.98 16.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.892 -1.13 . . . . 0.0 110.178 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -60.73 -12.09 9.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.251 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 124' ' ' MET . 5.1 tp10 -97.46 -32.6 11.76 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.239 -0.913 . . . . 0.0 109.606 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 116' ' ' LEU . 25.3 t -72.64 -54.43 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 0.0 109.787 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.69 -34.83 62.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.119 -0.988 . . . . 0.0 109.689 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 1.0 OUTLIER -76.08 -35.71 59.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.095 -1.003 . . . . 0.0 109.243 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.402 ' CG ' ' O ' ' A' ' 120' ' ' GLU . 1.4 mmt -70.56 -21.05 62.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 108.716 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 102' ' ' ALA . 2.0 mt -84.87 -42.77 16.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -48.79 -31.61 7.32 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 109.898 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.84 -24.62 20.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.022 -1.049 . . . . 0.0 110.394 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.81 -44.98 54.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 109.838 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' A' ' 135' ' ' GLN . 12.9 p-10 -86.39 177.06 7.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.349 -0.845 . . . . 0.0 109.668 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.0 mt -85.9 -66.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.414 -0.804 . . . . 0.0 109.567 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -177.47 57.83 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.512 -0.742 . . . . 0.0 109.49 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.22 -87.15 1.78 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.4 p-10 -139.11 -24.51 0.88 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.999 -0.707 . . . . 0.0 110.249 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 125' ' ' ILE . . . 141.06 29.48 0.17 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.577 ' OE1' ' CD1' ' A' ' 99' ' ' TYR . 3.0 pt20 -119.63 166.85 12.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.263 . . . . 0.0 108.914 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 69.9 t -119.41 162.87 17.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.501 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 5.2 t-20 -141.29 -164.38 1.75 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.975 -1.078 . . . . 0.0 108.372 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.462 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 60.9 t80 -77.31 -49.5 14.85 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.686 -1.259 . . . . 0.0 110.15 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.29 -29.06 69.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.967 -1.083 . . . . 0.0 109.593 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.476 ' HB3' ' HA ' ' A' ' 129' ' ' ASP . 19.6 mt-10 -84.65 -32.87 23.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.107 -0.995 . . . . 0.0 108.856 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.42 ' CE2' ' HA ' ' A' ' 89' ' ' PHE . 42.8 t80 -71.66 -25.81 62.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.535 -0.728 . . . . 0.0 109.087 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.0 t -60.53 -47.07 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.444 -0.785 . . . . 0.0 109.511 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -64.42 -35.54 81.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 109.782 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.417 ' O ' ' HG2' ' A' ' 144' ' ' MET . 6.0 tmm? -83.34 -12.54 56.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.781 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.459 ' HE1' ' HA ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -81.88 -67.84 0.75 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.299 -0.876 . . . . 0.0 109.247 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.412 -0.805 . . . . 0.0 109.285 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -47.83 84.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 142' ' ' VAL . 5.1 mt -75.3 -37.35 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.614 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.589 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -52.52 -30.71 31.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.193 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 23.1 mm-40 -90.93 -52.11 5.02 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.377 -0.827 . . . . 0.0 109.473 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -47.19 -24.86 0.78 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.989 . . . . 0.0 109.159 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 92.6 t80 -67.51 -56.46 9.43 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -63.76 -24.31 67.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.4 t -52.73 -32.72 17.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.4 ' CE1' HG13 ' A' ' 108' ' ' VAL . 53.9 m-85 -95.32 -36.56 11.35 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.474 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 27.6 t0 -84.26 112.78 20.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.544 -0.722 . . . . 0.0 109.483 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.478 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -89.31 -24.42 22.03 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.095 -1.003 . . . . 0.0 109.825 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 97' ' ' ASN . 60.2 m-20 -78.6 1.41 22.77 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.571 -0.852 . . . . 0.0 108.748 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 36.32 31.41 0.04 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -88.16 -28.36 21.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.076 -1.249 . . . . 0.0 109.529 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.48 -19.76 5.03 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 2.0 m-30 -118.45 152.41 35.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -1.156 . . . . 0.0 109.562 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.474 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 52.3 mt -118.25 105.36 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.145 -0.972 . . . . 0.0 109.491 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 102' ' ' ALA . 2.3 p -74.17 151.79 39.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 0.0 109.258 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.79 -36.4 2.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.95 . . . . 0.0 109.771 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.34 -45.81 82.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.083 -1.011 . . . . 0.0 109.58 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.478 ' OE2' ' HB2' ' A' ' 94' ' ' LYS . 3.8 mm-40 -65.95 -21.44 66.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.118 -0.989 . . . . 0.0 108.785 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.536 ' O ' ' CG ' ' A' ' 109' ' ' MET . 10.6 tp -84.53 -25.14 28.99 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.459 -0.776 . . . . 0.0 109.581 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -77.79 -54.81 5.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.516 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.458 ' O ' HG23 ' A' ' 110' ' ' THR . 15.2 t60 -45.05 -45.4 10.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.954 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 91' ' ' VAL . 98.2 t -82.88 -24.4 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 110.107 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' A' ' 105' ' ' LEU . 8.8 mmt -70.59 -14.06 62.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.071 -1.018 . . . . 0.0 109.256 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 107' ' ' HIS . 15.3 t -100.55 -6.32 25.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 109.686 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.442 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 1.2 t-20 -44.3 -51.97 7.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.228 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.442 ' HG ' ' C ' ' A' ' 111' ' ' ASN . 28.7 mt -145.83 13.46 1.32 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -129.11 22.6 5.06 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 2.8 mm-40 62.05 153.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.405 -1.056 . . . . 0.0 109.278 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 126.81 31.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 0.0 109.668 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' ' 109' ' ' MET . 10.2 mp -70.29 171.56 9.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.445 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.83 -170.23 2.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.301 -0.874 . . . . 0.0 108.835 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.03 -49.83 8.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.182 -0.949 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.81 -12.04 57.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.816 . . . . 0.0 109.41 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -99.52 -41.64 7.28 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.362 -0.836 . . . . 0.0 109.75 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 117' ' ' THR . 29.4 t -56.51 -51.78 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.588 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.18 -27.42 54.41 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.183 -0.948 . . . . 0.0 109.733 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 85.4 mt-10 -79.12 -29.13 43.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.375 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.46 ' SD ' HD22 ' A' ' 116' ' ' LEU . 2.1 mtt -78.52 -24.85 45.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 108.542 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.531 HG22 ' CG2' ' A' ' 136' ' ' VAL . 5.7 mt -83.59 -39.27 14.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.563 0.697 . . . . 0.0 109.378 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.8 ptm180 -42.37 -21.87 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.735 -0.603 . . . . 0.0 111.494 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' ILE . 1.6 mt-10 -86.18 -42.51 13.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.579 -1.326 . . . . 0.0 108.918 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.442 ' HB2' HG23 ' A' ' 136' ' ' VAL . . . -92.36 7.56 42.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.444 ' CG ' HG21 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -69.0 132.71 47.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.548 0.69 . . . . 0.0 110.455 -179.008 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.526 ' HA ' ' HG3' ' A' ' 140' ' ' GLU . 12.3 mt -49.11 -43.6 15.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.565 -0.709 . . . . 0.0 109.645 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -156.67 -36.29 0.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.355 -0.841 . . . . 0.0 109.971 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 155.82 40.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -101.46 -23.35 14.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -1.153 . . . . 0.0 109.358 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.467 ' O ' HG23 ' A' ' 125' ' ' ILE . . . 109.76 -17.44 30.28 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.462 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -103.05 169.13 8.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.076 -1.249 . . . . 0.0 109.728 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.531 ' CG2' HG22 ' A' ' 125' ' ' ILE . 54.3 t -128.07 167.21 23.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.587 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 5.3 p-10 -138.4 -173.89 3.66 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.589 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 55.3 t80 -72.7 -43.02 63.59 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.682 -1.261 . . . . 0.0 111.657 -178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -66.4 -32.42 73.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.785 -1.197 . . . . 0.0 110.743 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.564 ' CG ' ' OD1' ' A' ' 137' ' ' ASN . 41.5 mm-40 -86.4 -28.93 23.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.0 109.161 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.434 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 20.6 t80 -75.1 -24.09 58.05 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.453 ' HA ' HG22 ' A' ' 85' ' ' ILE . 42.3 t -69.33 -44.89 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.515 -0.741 . . . . 0.0 109.996 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -51.77 -38.29 54.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.082 -1.012 . . . . 0.0 109.946 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.42 -42.67 24.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.192 -0.943 . . . . 0.0 109.842 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.405 ' SD ' HG12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -68.36 -10.02 52.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.255 -0.903 . . . . 0.0 109.919 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.475 ' O ' HG21 ' A' ' 146' ' ' THR . 2.6 m . . . . . 0 C--N 1.303 -1.422 0 O-C-N 121.164 -0.96 . . . . 0.0 109.299 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -59.96 -18.3 44.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.5 mm -71.94 -34.21 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.447 -0.783 . . . . 0.0 109.641 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.574 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -50.7 -39.34 51.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 109.304 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' PHE . 20.7 mt-10 -85.58 -50.68 7.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.181 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.86 -25.57 0.31 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.216 -0.927 . . . . 0.0 108.893 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 78.6 t80 -65.55 -56.65 11.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.283 -0.886 . . . . 0.0 109.2 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 5.3 mtp180 -61.23 -29.26 69.72 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 38.2 t -47.63 -35.02 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.571 ' CE2' HG13 ' A' ' 108' ' ' VAL . 61.3 m-85 -91.54 -37.84 12.88 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.474 ' OD1' ' OE2' ' A' ' 104' ' ' GLU . 44.1 t0 -89.78 90.12 8.06 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -78.58 -25.13 45.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 110.492 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.475 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 1.2 m-20 -79.84 7.07 9.45 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.165 -0.959 . . . . 0.0 109.33 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 40.21 38.9 1.43 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -87.92 -1.42 57.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.61 -21.94 23.43 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.656 ' CE1' ' CB ' ' A' ' 137' ' ' ASN . 1.5 m-85 -125.26 145.61 49.92 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.325 -1.103 . . . . 0.0 109.382 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 88.5 mt -103.04 101.16 11.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 109.592 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 p -73.29 -179.53 3.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -0.987 . . . . 0.0 109.223 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.16 90.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.59 -28.09 66.63 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.222 -0.924 . . . . 0.0 109.277 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.475 ' OE2' ' HB2' ' A' ' 95' ' ' ASP . 5.2 mm-40 -72.94 -31.6 64.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.112 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 109' ' ' MET . 16.2 tp -83.12 -27.57 30.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.313 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.421 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 2.2 ttt180 -65.26 -18.62 65.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.858 . . . . 0.0 108.82 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.505 ' CD2' HG21 ' A' ' 108' ' ' VAL . 33.9 t60 -82.76 -34.48 27.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.472 -0.767 . . . . 0.0 109.926 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.571 HG13 ' CE2' ' A' ' 92' ' ' PHE . 74.1 t -123.38 26.37 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.012 -1.055 . . . . 0.0 110.155 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.472 ' HB3' ' O ' ' A' ' 105' ' ' LEU . 9.2 ptt? -71.41 -21.58 61.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.067 -1.021 . . . . 0.0 108.815 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -88.84 -8.7 53.84 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.422 -0.799 . . . . 0.0 110.171 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.534 ' HB2' ' CG1' ' A' ' 108' ' ' VAL . 4.5 t-20 -36.44 -46.73 0.57 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.477 -0.764 . . . . 0.0 109.619 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.407 HD11 ' O ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER 174.92 35.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.49 -0.756 . . . . 0.0 109.071 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -116.12 36.1 3.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 22.8 mt-10 72.31 -160.72 0.11 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -1.019 . . . . 0.0 109.071 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.406 ' HB2' ' HE3' ' A' ' 115' ' ' LYS . 26.8 mtmt -120.93 89.81 3.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 109.691 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.478 ' HB2' ' HG2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -84.16 170.94 13.28 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.353 -0.842 . . . . 0.0 109.905 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.482 ' O ' HG21 ' A' ' 121' ' ' VAL . 5.4 t -112.1 -155.92 0.58 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.379 -0.826 . . . . 0.0 109.345 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.433 ' N ' HG22 ' A' ' 117' ' ' THR . 2.9 m-20 -84.44 -58.7 2.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.958 -1.089 . . . . 0.0 109.671 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -54.58 -18.86 4.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' A' ' 116' ' ' LEU . 3.2 tt0 -91.13 -37.0 13.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.357 -0.839 . . . . 0.0 109.764 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 117' ' ' THR . 2.9 t -41.85 -53.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.33 -0.856 . . . . 0.0 109.99 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -37.42 77.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.073 -1.017 . . . . 0.0 109.795 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -72.09 -19.06 61.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 0.0 109.377 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.5 mmm -85.73 -23.23 27.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.976 . . . . 0.0 108.424 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 134' ' ' GLY . 6.1 mt -84.32 -41.74 16.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.692 0.758 . . . . 0.0 109.164 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -61.44 -19.58 62.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 110.153 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -88.93 -31.77 18.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.01 . . . . 0.0 109.089 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.12 -5.83 51.96 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.608 -0.682 . . . . 0.0 109.394 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.465 ' OD2' ' OE1' ' A' ' 140' ' ' GLU . 1.2 t70 -100.23 166.59 10.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.451 ' N ' ' CG ' ' A' ' 129' ' ' ASP . 38.9 mm -86.78 -71.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.37 -0.831 . . . . 0.0 109.285 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 179.62 58.1 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.612 -0.68 . . . . 0.0 109.211 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.08 -89.5 1.92 Allowed Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -127.92 -25.84 3.0 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.69 0.757 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 125' ' ' ILE . . . 136.55 30.01 0.3 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 5.9 pt20 -128.74 -170.62 2.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.293 . . . . 0.0 108.938 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.486 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 92.8 t -127.33 169.82 18.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.994 -1.066 . . . . 0.0 109.604 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.656 ' CB ' ' CE1' ' A' ' 99' ' ' TYR . 7.7 p30 -149.37 -168.02 2.99 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.574 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 55.3 t80 -66.12 -55.24 17.43 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.44 -1.412 . . . . 0.0 110.461 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.507 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -53.66 -57.9 9.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.102 -0.999 . . . . 0.0 110.373 -179.322 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.527 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 19.6 mt-10 -57.68 -39.22 76.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.058 -1.026 . . . . 0.0 109.883 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.582 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 59.9 t80 -63.58 -28.05 69.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.538 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 139' ' ' GLU . 35.7 t -65.91 -53.12 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.421 -0.799 . . . . 0.0 109.722 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -58.43 -30.21 66.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 0.0 110.051 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.449 ' O ' ' HG2' ' A' ' 144' ' ' MET . 0.6 OUTLIER -86.92 -20.68 27.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.963 . . . . 0.0 109.958 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.582 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -96.31 -7.54 35.06 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.16 -0.963 . . . . 0.0 109.977 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.087 -1.008 . . . . 0.0 110.029 -179.619 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.97 -19.59 61.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.895 . . . . 0.0 109.086 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 mt -116.71 -48.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.308 -0.87 . . . . 0.0 109.328 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.502 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.2 OUTLIER -56.33 -43.25 78.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.275 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -82.63 -31.99 28.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.341 -0.849 . . . . 0.0 109.491 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 91' ' ' VAL . . . -61.5 -26.51 67.96 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.414 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 85.5 t80 -66.06 -56.89 9.27 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.507 -0.746 . . . . 0.0 109.417 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -64.03 -25.54 68.16 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 88' ' ' ALA . 17.6 t -53.13 -30.34 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.579 ' CE1' HG13 ' A' ' 108' ' ' VAL . 68.7 m-85 -97.22 -32.36 11.96 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.459 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 11.7 t70 -99.08 94.18 6.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -75.58 -23.4 56.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.056 -1.028 . . . . 0.0 109.671 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 97' ' ' ASN . 51.4 m-20 -78.5 0.92 24.12 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.339 -0.851 . . . . 0.0 108.943 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 31.26 37.46 0.03 OUTLIER Glycine 0 N--CA 1.498 2.826 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.6 OUTLIER -84.14 -32.93 24.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.26 . . . . 0.0 109.708 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.49 -34.08 2.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.7 m-85 -114.58 145.53 41.86 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.36 -1.082 . . . . 0.0 109.096 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.459 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 27.9 mt -100.07 122.6 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.171 -0.956 . . . . 0.0 109.469 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.59 -178.1 5.74 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.291 -0.881 . . . . 0.0 109.114 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.462 ' HB3' HG13 ' A' ' 121' ' ' VAL . . . -72.36 -36.19 68.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.131 -0.981 . . . . 0.0 109.303 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.45 -30.29 71.06 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.329 -0.857 . . . . 0.0 109.747 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 33.6 mm-40 -75.95 -22.7 55.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.168 -0.958 . . . . 0.0 109.189 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 63.5 tp -95.61 -11.02 27.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -0.764 . . . . 0.0 109.339 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -87.73 -43.26 12.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.314 -0.866 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.462 ' O ' HG21 ' A' ' 110' ' ' THR . 3.2 t60 -61.69 -41.84 98.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.952 . . . . 0.0 109.431 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 92' ' ' PHE . 1.3 t -73.05 -40.0 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.156 -0.965 . . . . 0.0 109.161 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.463 ' HB3' HD11 ' A' ' 116' ' ' LEU . 2.4 mmt -68.1 -16.79 64.16 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 2.3 t -96.07 -20.95 18.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.845 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.478 ' OD1' ' O ' ' A' ' 108' ' ' VAL . 0.6 OUTLIER -52.18 -44.99 64.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 108.845 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 111' ' ' ASN . 33.1 mt -152.62 18.14 0.61 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.473 -0.767 . . . . 0.0 109.474 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -114.61 34.9 4.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 110' ' ' THR . 13.1 mm-40 62.09 -169.12 0.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.418 -1.048 . . . . 0.0 109.627 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.32 89.88 4.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.824 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -57.39 131.31 49.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.497 HG21 ' HB3' ' A' ' 120' ' ' GLU . 1.1 t -79.47 177.75 8.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.09 -1.006 . . . . 0.0 108.839 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.85 -63.09 1.26 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.92 -1.113 . . . . 0.0 109.994 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 14.4 pt-20 -47.07 -44.39 20.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.948 . . . . 0.0 109.934 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.514 ' N ' ' CG ' ' A' ' 119' ' ' GLU . 39.8 tp10 -62.02 -41.15 97.78 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.757 -0.589 . . . . 0.0 110.454 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 102' ' ' ALA . 46.9 t -65.89 -62.65 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.13 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -31.42 52.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.974 -1.079 . . . . 0.0 109.196 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 30.3 mt-10 -71.06 -34.65 71.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.0 108.955 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.9 mmt -70.89 -28.15 64.33 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.342 -0.849 . . . . 0.0 108.842 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.447 HG22 HG22 ' A' ' 136' ' ' VAL . 2.7 mt -75.75 -42.08 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.424 -0.798 . . . . 0.0 109.15 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -14.63 3.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.673 -0.642 . . . . 0.0 110.165 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.2 -32.37 21.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 108.981 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.64 -7.25 50.54 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.467 -0.77 . . . . 0.0 109.348 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 0.3 OUTLIER -76.99 145.14 38.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.867 . . . . 0.0 109.808 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.502 ' CG1' ' OE1' ' A' ' 140' ' ' GLU . 32.0 mm -81.68 -39.38 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.155 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.18 -43.62 3.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.704 -0.622 . . . . 0.0 109.618 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.84 39.0 0.67 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.412 ' CG ' ' OE1' ' A' ' 135' ' ' GLN . 1.5 p30 -78.62 -25.03 45.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.294 -1.121 . . . . 0.0 108.771 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.21 26.95 4.12 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.65 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.587 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -156.86 170.36 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.935 -1.332 . . . . 0.0 109.369 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 137' ' ' ASN . 85.5 t -130.74 168.2 24.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.18 -0.95 . . . . 0.0 109.572 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.604 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -140.27 -165.57 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.502 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 57.9 t80 -80.96 -40.07 25.05 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.04 -1.037 . . . . 0.0 109.768 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -33.0 73.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.089 -1.007 . . . . 0.0 109.378 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.57 ' CG ' ' ND2' ' A' ' 137' ' ' ASN . 2.1 mm-40 -82.18 -38.92 23.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.045 -1.034 . . . . 0.0 108.98 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.578 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 31.3 t80 -67.41 -25.42 65.93 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 108.978 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 138' ' ' TYR . 40.0 t -70.71 -43.67 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.862 . . . . 0.0 109.713 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -61.58 -23.89 66.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 109.697 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -31.47 16.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.638 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.578 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -93.03 -2.67 55.43 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.261 -0.9 . . . . 0.0 109.917 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.303 -1.446 0 O-C-N 121.263 -0.898 . . . . 0.0 108.992 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.472 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 22.8 tt0 -47.25 -24.58 0.76 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.57 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 mp -80.39 -43.39 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.321 -0.862 . . . . 0.0 109.667 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -39.0 57.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 109.355 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 17.7 pt-20 -81.03 -47.8 13.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.516 ' N ' ' HG3' ' A' ' 87' ' ' GLU . . . -45.47 -32.06 2.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 108.805 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.4 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 90.4 t80 -58.96 -56.29 24.22 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.393 -0.817 . . . . 0.0 109.582 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -63.42 -30.0 71.2 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.693 -0.629 . . . . 0.0 109.453 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 74.5 t -49.23 -28.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -102.14 -32.18 10.23 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD1' ' OE1' ' A' ' 104' ' ' GLU . 30.6 t70 -91.05 80.14 5.73 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.64 -0.663 . . . . 0.0 109.624 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -21.0 59.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.845 . . . . 0.0 109.817 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -78.58 1.9 21.08 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.72 -0.792 . . . . 0.0 108.994 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 34.62 39.44 0.15 Allowed Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -94.42 -17.8 22.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.277 . . . . 0.0 109.686 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.98 -38.19 2.94 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.581 ' CE2' ' HB2' ' A' ' 137' ' ' ASN . 36.6 m-85 -115.36 140.47 49.1 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.291 -1.123 . . . . 0.0 109.32 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.501 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 72.1 mt -89.49 117.12 32.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.19 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.3 p -83.74 164.86 19.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.427 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -58.71 -35.3 72.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.522 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.44 -31.65 71.12 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.228 -0.92 . . . . 0.0 109.381 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' OE1' ' OD1' ' A' ' 93' ' ' ASP . 34.5 mt-10 -71.94 -24.22 61.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.202 -0.936 . . . . 0.0 108.948 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.5 tp -85.05 -33.96 22.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.259 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -61.25 -28.49 69.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 108.657 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -65.89 -49.25 68.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.544 -0.722 . . . . 0.0 109.451 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.468 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 23.8 t -103.16 41.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.497 ' HB2' ' CD1' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -92.39 -23.06 19.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.804 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.8 OUTLIER -100.55 -12.48 19.24 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.211 -0.931 . . . . 0.0 109.573 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.533 ' O ' ' CD2' ' A' ' 112' ' ' LEU . 19.7 p-10 -45.55 -44.87 13.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.044 -1.035 . . . . 0.0 108.915 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -159.5 22.69 0.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.306 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -123.72 45.02 1.22 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.5 mm-40 56.84 -141.18 0.81 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -1.234 . . . . 0.0 109.125 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -126.18 83.62 2.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.977 -1.077 . . . . 0.0 109.459 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.497 ' CD1' ' HB2' ' A' ' 109' ' ' MET . 35.2 mt -59.31 -160.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.138 -0.976 . . . . 0.0 109.587 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.524 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 17.9 p -153.78 -161.58 1.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.39 -48.6 9.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.192 -0.943 . . . . 0.0 109.072 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.42 -16.18 60.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.285 -0.884 . . . . 0.0 108.796 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -88.81 -37.31 15.5 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 117' ' ' THR . 9.1 t -55.98 -52.54 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.418 -0.801 . . . . 0.0 109.014 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 3.5 m-20 -57.82 -23.35 52.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.173 -0.954 . . . . 0.0 109.327 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -81.37 -29.96 33.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.428 -0.795 . . . . 0.0 109.046 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.432 ' HE1' ' HA ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -77.82 -25.85 49.14 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 134' ' ' GLY . 6.8 mt -84.65 -38.73 13.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.738 0.78 . . . . 0.0 109.031 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.2 ptm85 -54.33 -33.49 59.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.703 -0.623 . . . . 0.0 109.897 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 5.7 mt-10 -89.62 -18.09 27.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.064 -1.022 . . . . 0.0 109.336 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.35 -5.37 43.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.387 -0.821 . . . . 0.0 109.751 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.464 ' OD2' ' O ' ' A' ' 126' ' ' ARG . 3.0 p30 -81.99 177.78 8.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.88 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.503 ' CD1' ' OE2' ' A' ' 140' ' ' GLU . 36.0 mt -81.13 -50.31 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.497 -0.752 . . . . 0.0 109.78 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -133.09 -24.32 1.88 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.32 -0.862 . . . . 0.0 110.55 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 137.78 40.79 0.11 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -78.97 -24.15 44.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -1.11 . . . . 0.0 108.74 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 125' ' ' ILE . . . 102.06 -26.58 23.83 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -103.58 173.71 6.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -1.229 . . . . 0.0 109.451 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.505 HG13 ' N ' ' A' ' 137' ' ' ASN . 55.6 t -124.26 162.62 25.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.581 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 4.6 t-20 -141.54 -165.55 2.01 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.867 -1.146 . . . . 0.0 108.215 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.452 ' O ' ' CG2' ' A' ' 142' ' ' VAL . 72.1 t80 -75.99 -39.22 56.28 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.844 -1.16 . . . . 0.0 109.843 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -70.56 -34.12 71.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.235 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.503 ' OE2' ' CD1' ' A' ' 130' ' ' ILE . 7.8 mt-10 -80.2 -28.91 38.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 108.778 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.4 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 43.1 t80 -78.88 -25.12 43.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.433 -0.792 . . . . 0.0 109.3 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 48.1 t -58.86 -48.53 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 109.822 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -66.64 -26.37 67.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.001 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.2 ttp -81.93 -21.95 37.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.468 ' HG3' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -87.67 -65.51 1.01 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.245 -0.909 . . . . 0.0 109.756 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.333 -0.854 . . . . 0.0 109.657 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.376 0.608 . . . . 0.0 109.413 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -55.73 24.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.943 . . . . 0.0 109.495 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.81 -41.64 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.536 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.577 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 4.2 ttp180 -49.86 -31.35 11.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.066 -1.021 . . . . 0.0 109.03 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 77.9 mt-10 -86.15 -57.54 2.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 110.105 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.514 ' CB ' ' SD ' ' A' ' 145' ' ' MET . . . -41.07 -32.98 0.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 109.031 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.456 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 89.9 t80 -59.76 -56.96 15.35 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.493 -0.754 . . . . 0.0 109.194 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.448 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -59.94 -35.85 75.82 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.759 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 88' ' ' ALA . 66.1 t -42.93 -32.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -98.57 -31.7 11.82 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 13.2 t70 -95.6 81.68 3.55 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.607 -0.683 . . . . 0.0 109.316 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -22.35 55.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 110.296 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 97' ' ' ASN . 59.1 m-20 -78.51 2.15 20.02 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.281 -0.887 . . . . 0.0 109.21 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.09 29.83 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 95' ' ' ASP . 1.9 t30 -78.51 -36.44 44.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.101 -1.235 . . . . 0.0 109.551 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.71 -52.73 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 11.8 m-30 -106.42 156.52 18.44 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.352 -1.087 . . . . 0.0 109.003 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.2 mt -97.24 108.33 21.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.453 -0.779 . . . . 0.0 109.273 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -78.19 -177.56 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.759 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.65 -45.14 88.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -0.856 . . . . 0.0 109.17 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.97 -23.9 67.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.434 -0.791 . . . . 0.0 109.698 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -76.99 -31.89 56.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.023 -1.048 . . . . 0.0 108.892 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.53 ' CD2' ' HG3' ' A' ' 109' ' ' MET . 0.7 OUTLIER -89.27 -13.23 38.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -0.842 . . . . 0.0 108.899 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.498 ' O ' ' CG2' ' A' ' 110' ' ' THR . 10.1 ttt180 -90.15 -14.03 34.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.377 -0.827 . . . . 0.0 108.793 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -77.79 -26.47 49.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 110.172 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.8 t -106.67 -50.86 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 110.492 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.53 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 2.4 mmt -56.2 -19.55 14.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 109.858 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 106' ' ' ARG . 12.9 t -88.26 -28.94 20.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.119 -0.988 . . . . 0.0 109.645 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -52.93 -47.09 68.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.37 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pp -132.85 -3.72 3.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 110.131 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 109' ' ' MET . . . -103.79 20.05 42.52 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 16.3 mt-10 63.49 141.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -1.124 . . . . 0.0 109.186 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.469 ' HA ' ' OG1' ' A' ' 110' ' ' THR . 0.6 OUTLIER -50.39 100.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.752 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' A' ' 109' ' ' MET . 29.0 mt -59.57 133.18 55.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 109.264 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.519 HG21 ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -71.16 178.97 3.02 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.109 -0.994 . . . . 0.0 108.332 179.201 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.412 ' N ' ' OG1' ' A' ' 117' ' ' THR . 10.0 m-20 -60.52 -63.45 1.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.87 -1.144 . . . . 0.0 109.914 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -50.4 -42.19 53.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 109.947 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.519 ' CB ' HG21 ' A' ' 117' ' ' THR . 12.7 tp10 -63.04 -34.99 78.75 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.586 -0.696 . . . . 0.0 110.156 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.464 HG21 ' HB2' ' A' ' 116' ' ' LEU . 28.7 t -71.65 -65.37 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.276 -0.89 . . . . 0.0 109.638 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -48.82 -30.66 6.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.087 -1.008 . . . . 0.0 109.158 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.09 -38.94 61.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.166 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.534 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 3.7 mmt -65.32 -23.89 67.13 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.524 HG21 ' CG2' ' A' ' 136' ' ' VAL . 3.2 mt -81.76 -38.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -47.97 -28.76 2.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.955 -0.466 . . . . 0.0 110.099 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 124' ' ' MET . 7.2 pt-20 -80.2 -37.39 33.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.887 -1.133 . . . . 0.0 108.589 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.405 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -78.47 -7.98 58.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.65 143.3 30.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.822 . . . . 0.0 109.255 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 130' ' ' ILE . 54.9 mt -94.8 -39.47 10.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 109.665 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.11 -44.81 7.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.455 -0.778 . . . . 0.0 109.956 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.19 39.94 1.09 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -79.08 -24.54 43.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -1.073 . . . . 0.0 108.776 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.492 ' O ' HG22 ' A' ' 125' ' ' ILE . . . 117.22 -36.77 3.58 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -98.75 170.07 9.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.061 -1.258 . . . . 0.0 109.118 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.524 ' CG2' HG21 ' A' ' 125' ' ' ILE . 52.0 t -127.9 162.79 33.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.176 -0.952 . . . . 0.0 108.556 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.507 ' N ' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -137.99 -169.76 2.63 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 109.094 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.577 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 78.7 t80 -77.62 -34.9 53.19 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.701 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -49.62 70.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.262 -0.899 . . . . 0.0 109.322 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -69.3 -39.79 78.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.331 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.456 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 47.7 t80 -66.38 -24.34 66.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.812 . . . . 0.0 109.793 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 40.8 t -70.29 -46.95 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.94 . . . . 0.0 109.963 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -70.28 -23.96 62.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 109.866 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -85.12 -23.77 28.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.514 ' SD ' ' CB ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -83.34 -51.63 7.25 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.0 109.994 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -58.42 -27.28 64.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.112 -0.993 . . . . 0.0 109.191 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.501 HG13 ' CG2' ' A' ' 146' ' ' THR . 4.5 mm -76.07 -39.86 36.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.371 -0.83 . . . . 0.0 109.262 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.56 -43.66 68.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 109.584 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 9.9 pt-20 -78.8 -41.59 29.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.991 . . . . 0.0 109.607 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.496 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -52.16 -30.37 26.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.104 -0.998 . . . . 0.0 108.648 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.446 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 90.4 t80 -64.39 -52.95 55.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.0 109.622 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -64.51 -24.21 67.53 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 52.7 t -56.35 -22.8 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -104.97 -36.27 7.38 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.41 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 39.4 t0 -83.99 108.29 16.86 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -84.28 -26.49 28.55 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.079 -1.013 . . . . 0.0 110.088 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.485 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -79.46 3.04 19.74 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 108.903 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 36.32 36.74 0.16 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 95' ' ' ASP . 14.5 p-10 -93.71 -42.87 8.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -1.187 . . . . 0.0 109.875 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.42 -20.71 1.52 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.641 ' CE1' ' CB ' ' A' ' 137' ' ' ASN . 1.7 m-85 -120.72 144.44 48.24 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.216 -1.167 . . . . 0.0 109.71 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.41 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 68.5 mt -108.54 110.21 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.547 -0.721 . . . . 0.0 109.537 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.75 162.92 28.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.245 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.06 -36.85 66.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.975 . . . . 0.0 109.38 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.44 78.59 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.375 -0.828 . . . . 0.0 109.343 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -72.24 -22.54 61.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.339 -0.851 . . . . 0.0 108.895 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 109' ' ' MET . 17.8 tp -90.03 -23.16 21.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.378 -0.826 . . . . 0.0 109.512 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.44 -34.33 23.49 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.16 -0.962 . . . . 0.0 109.882 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.423 ' O ' HG21 ' A' ' 110' ' ' THR . 35.0 t60 -61.12 -41.53 96.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.033 -1.042 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 91' ' ' VAL . 46.9 t -86.64 -23.86 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.816 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.492 ' CG ' ' O ' ' A' ' 105' ' ' LEU . 4.4 mmt -73.25 -21.33 60.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 9.3 t -89.55 -26.03 21.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.34 -0.85 . . . . 0.0 109.63 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.454 ' HB3' ' CD1' ' A' ' 112' ' ' LEU . 1.6 t30 -48.18 -57.49 5.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.445 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' A' ' 111' ' ' ASN . 1.8 mp -125.22 3.63 7.84 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.354 -0.841 . . . . 0.0 109.64 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . -108.86 56.4 0.47 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.9 mt-10 45.45 -134.53 0.78 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -1.15 . . . . 0.0 108.861 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -148.44 78.1 1.41 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.76 -1.212 . . . . 0.0 109.564 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.53 HD11 ' N ' ' A' ' 121' ' ' VAL . 1.4 pt? -67.85 144.81 55.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.095 -1.003 . . . . 0.0 109.0 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 120' ' ' GLU . 21.9 p -77.55 -159.73 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.9 . . . . 0.0 109.956 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.21 -48.37 13.21 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.422 -0.799 . . . . 0.0 109.49 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.68 -21.96 20.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.137 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 23.6 mm-40 -87.5 -47.88 8.38 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.53 ' N ' HD11 ' A' ' 116' ' ' LEU . 49.0 t -46.96 -49.99 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.445 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.45 -38.16 68.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.832 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 15.6 mt-10 -67.45 -38.26 84.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.935 . . . . 0.0 109.629 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 21.9 mmm -68.51 -30.38 69.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.103 -0.998 . . . . 0.0 108.893 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.462 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 3.0 mt -71.96 -40.36 67.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.419 -0.801 . . . . 0.0 108.849 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -61.28 -18.93 60.89 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.558 -0.714 . . . . 0.0 109.189 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 7.1 mm-40 -90.4 -21.48 21.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.337 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 144' ' ' MET . . . -92.59 -65.18 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 30.4 p-10 -76.16 177.47 7.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.462 -0.774 . . . . 0.0 109.069 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.492 HG12 ' OE2' ' A' ' 140' ' ' GLU . 7.4 mm -85.89 -66.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -0.908 . . . . 0.0 109.721 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 130' ' ' ILE . 1.0 OUTLIER 173.46 65.01 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.92 -87.51 1.77 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.93 -17.61 7.26 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.765 -0.844 . . . . 0.0 109.327 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.436 ' O ' HD11 ' A' ' 125' ' ' ILE . . . 125.08 18.32 2.59 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.488 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 1.3 pt20 -118.68 171.37 8.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -1.184 . . . . 0.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 137' ' ' ASN . 84.1 t -125.43 169.41 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.141 -0.974 . . . . 0.0 109.862 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.641 ' CB ' ' CE1' ' A' ' 99' ' ' TYR . 1.8 p-10 -145.23 -173.21 4.04 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.498 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 49.9 t80 -69.81 -45.21 68.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.392 -1.443 . . . . 0.0 111.671 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -47.82 83.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.902 -1.124 . . . . 0.0 110.651 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.493 ' CG ' ' OD1' ' A' ' 137' ' ' ASN . 0.8 OUTLIER -70.41 -36.52 74.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.892 -1.13 . . . . 0.0 109.78 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.595 ' CZ ' ' HG2' ' A' ' 145' ' ' MET . 6.2 t80 -67.66 -27.71 67.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.19 -0.943 . . . . 0.0 109.159 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.498 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 75.8 t -79.32 -62.62 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.369 -0.832 . . . . 0.0 109.662 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.44 ' C ' ' O ' ' A' ' 142' ' ' VAL . 7.8 mm100 -39.38 -34.65 0.22 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.473 -0.767 . . . . 0.0 110.73 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 128' ' ' ALA . 29.6 mmt -90.45 -45.75 8.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.871 -1.143 . . . . 0.0 110.624 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -71.61 -0.61 11.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 0.0 110.549 -178.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.501 ' CG2' HG13 ' A' ' 85' ' ' ILE . 7.8 p . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.104 -0.997 . . . . 0.0 110.008 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -52.95 -23.15 6.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.474 -0.766 . . . . 0.0 109.401 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -81.81 -38.12 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.326 -0.859 . . . . 0.0 109.058 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.461 ' HG2' ' CZ ' ' A' ' 138' ' ' TYR . 9.9 mtt180 -61.19 -31.92 71.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.437 -0.79 . . . . 0.0 109.143 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.474 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -89.74 -34.99 16.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 109.136 179.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.481 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.56 -23.12 67.25 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.418 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 82.6 t80 -69.68 -54.31 14.46 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.4 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -63.54 -27.62 69.38 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 4.9 t -48.17 -31.11 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.489 ' CE1' ' HB ' ' A' ' 108' ' ' VAL . 83.3 m-85 -98.29 -37.59 9.59 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.457 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 43.2 t0 -87.39 92.32 9.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -84.0 -24.8 30.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.26 -0.9 . . . . 0.0 110.223 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -79.18 4.18 15.57 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.245 -0.91 . . . . 0.0 109.101 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 39.57 29.3 0.14 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 95' ' ' ASP . 15.4 p-10 -73.93 -39.0 64.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.116 . . . . 0.0 109.658 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.26 -48.34 0.68 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.484 ' CD2' ' HG3' ' A' ' 135' ' ' GLN . 8.7 m-30 -108.92 176.29 5.16 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.335 -1.097 . . . . 0.0 109.465 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.7 mt -119.31 115.3 47.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.643 -0.66 . . . . 0.0 109.424 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.5 p -80.29 159.11 25.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.651 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.484 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -51.93 -35.89 47.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 0.0 109.514 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.56 -41.21 88.99 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.152 -0.968 . . . . 0.0 109.117 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 13.6 mt-10 -65.84 -22.69 66.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.227 -0.921 . . . . 0.0 109.103 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 109' ' ' MET . 9.4 tp -85.54 -32.25 22.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.422 -0.799 . . . . 0.0 109.644 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -34.79 77.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.289 -0.882 . . . . 0.0 109.177 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -59.55 -27.15 65.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 109.985 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.489 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 17.5 t -102.33 -12.73 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.078 -1.014 . . . . 0.0 110.44 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.524 ' CG ' ' O ' ' A' ' 105' ' ' LEU . 0.5 OUTLIER -78.24 -11.18 59.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.909 -1.12 . . . . 0.0 109.618 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.444 HG21 ' N ' ' A' ' 111' ' ' ASN . 2.1 t -99.93 -30.72 11.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.07 -1.019 . . . . 0.0 110.123 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.444 ' N ' HG21 ' A' ' 110' ' ' THR . 0.8 OUTLIER -43.92 -45.49 7.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 109.221 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.8 23.48 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.648 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -115.04 19.76 15.0 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 2.2 mm-40 67.8 146.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -1.095 . . . . 0.0 109.223 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.42 81.5 1.42 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -0.963 . . . . 0.0 110.053 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.55 HD13 ' N ' ' A' ' 121' ' ' VAL . 2.7 pt? -63.33 151.75 39.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 109.008 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.482 ' OG1' ' HG2' ' A' ' 120' ' ' GLU . 44.4 p -84.45 -165.61 1.22 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.296 -0.877 . . . . 0.0 109.447 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -75.11 -46.57 33.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.712 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.439 ' O ' ' OE1' ' A' ' 123' ' ' GLU . 30.9 mt-10 -57.2 -16.42 8.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.763 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.482 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 5.2 mm-40 -95.17 -45.08 7.34 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.342 -0.849 . . . . 0.0 108.961 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.55 ' N ' HD13 ' A' ' 116' ' ' LEU . 41.8 t -49.42 -55.72 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.89 -0.507 . . . . 0.0 110.599 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.34 -36.54 84.05 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.852 -1.155 . . . . 0.0 109.042 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 119' ' ' GLU . 87.0 mt-10 -70.79 -15.56 62.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.179 -0.951 . . . . 0.0 108.56 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.434 ' SD ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -85.32 -30.94 23.31 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 102' ' ' ALA . 3.3 mt -74.42 -41.31 49.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.99 -15.23 3.23 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.706 -0.621 . . . . 0.0 110.007 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -87.33 -30.94 20.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.923 -1.111 . . . . 0.0 109.797 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.7 -58.48 2.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.337 -0.852 . . . . 0.0 109.506 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.435 ' OD2' HG21 ' A' ' 125' ' ' ILE . 8.6 p30 -53.05 155.49 2.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.713 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.8 mt -111.79 -44.39 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.295 -0.878 . . . . 0.0 109.703 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -72.51 -38.14 68.18 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.473 -0.767 . . . . 0.0 109.63 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.66 33.46 6.42 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -78.94 -26.28 43.6 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.318 -1.107 . . . . 0.0 108.681 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 124.22 -42.19 1.6 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.484 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -90.07 165.25 14.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.059 -1.26 . . . . 0.0 109.49 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 53.1 t -118.23 161.49 17.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.481 ' ND2' ' HG3' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -134.16 -164.62 1.53 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.714 -1.241 . . . . 0.0 108.659 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.5 ' O ' ' CG2' ' A' ' 142' ' ' VAL . 64.9 t80 -78.49 -38.48 40.8 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.205 -0.934 . . . . 0.0 110.206 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -70.45 -33.08 70.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.995 -1.066 . . . . 0.0 109.417 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.481 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 15.5 mt-10 -82.12 -34.07 29.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.159 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.417 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 38.5 t80 -75.47 -25.65 57.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.519 -0.738 . . . . 0.0 109.671 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.5 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 26.8 t -55.38 -48.98 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.786 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -65.9 -27.3 68.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.041 -1.037 . . . . 0.0 109.627 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -19.33 46.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.198 -0.939 . . . . 0.0 109.691 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.47 -39.13 47.62 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.095 -1.003 . . . . 0.0 109.36 179.826 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 121.349 0.595 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -47.09 -26.94 1.2 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.312 -0.868 . . . . 0.0 110.116 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 mt -72.45 -44.67 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.042 -1.036 . . . . 0.0 109.641 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.573 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -46.24 -33.4 3.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.059 -1.025 . . . . 0.0 109.441 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 88' ' ' ALA . 1.9 mt-10 -87.17 -55.44 3.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 109.977 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.449 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -42.69 -28.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 108.901 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 87' ' ' GLU . 79.6 t80 -62.61 -57.52 10.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.481 -0.762 . . . . 0.0 109.419 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.442 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 6.0 mtp180 -61.1 -32.99 72.65 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.67 -0.644 . . . . 0.0 109.302 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 39.1 t -45.31 -32.45 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.483 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 85.8 m-85 -94.47 -49.79 5.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.468 ' CA ' HG12 ' A' ' 100' ' ' ILE . 65.7 t0 -65.36 91.37 0.11 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -90.32 -21.01 22.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 111.238 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.46 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 10.5 p-10 -78.2 7.53 6.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.938 -1.101 . . . . 0.0 109.876 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.75 49.66 1.92 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.403 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 1.8 t30 -110.17 -64.58 1.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -1.114 . . . . 0.0 109.207 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.19 -47.27 0.11 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.593 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 7.6 m-30 -110.06 150.38 28.64 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.53 -0.982 . . . . 0.0 109.204 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.52 HG21 ' N ' ' A' ' 101' ' ' SER . 55.6 mt -85.43 152.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.419 -0.801 . . . . 0.0 109.511 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.52 ' N ' HG21 ' A' ' 100' ' ' ILE . 18.7 p -110.48 172.63 6.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.183 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.47 ' O ' HG12 ' A' ' 121' ' ' VAL . . . -62.96 -53.7 49.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.828 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.24 62.72 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 71.4 mt-10 -75.24 -30.0 60.39 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.123 -0.986 . . . . 0.0 108.561 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.442 ' HG ' ' HG3' ' A' ' 109' ' ' MET . 12.2 tp -81.18 -21.93 39.29 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.478 ' O ' ' HB ' ' A' ' 110' ' ' THR . 35.9 ttt-85 -78.86 -22.64 45.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.41 -0.806 . . . . 0.0 108.968 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -67.76 -38.49 83.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.468 -0.77 . . . . 0.0 110.427 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.439 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 92.4 t -99.17 -38.07 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.255 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.505 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . 16.3 mmt -61.14 -13.34 16.88 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.32 -0.862 . . . . 0.0 109.615 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -94.73 -29.41 14.8 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.22 -0.925 . . . . 0.0 108.849 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -68.12 0.39 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.905 . . . . 0.0 109.258 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.7 mt -114.33 15.19 18.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 109.328 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 109' ' ' MET . . . -111.04 51.35 0.7 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 48.29 -145.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -1.083 . . . . 0.0 109.545 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.56 101.01 9.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.02 . . . . 0.0 109.788 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.505 ' CD1' ' HB3' ' A' ' 109' ' ' MET . 0.1 OUTLIER -102.6 111.5 23.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.41 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.55 ' CG2' ' HG2' ' A' ' 120' ' ' GLU . 6.3 t -82.71 -146.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 108.735 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.487 ' N ' HG21 ' A' ' 117' ' ' THR . 2.9 m-20 -90.11 -48.45 7.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.023 -1.048 . . . . 0.0 109.884 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -60.23 -17.83 44.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.869 . . . . 0.0 109.586 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.55 ' HG2' ' CG2' ' A' ' 117' ' ' THR . 11.9 mm-40 -94.1 -47.76 6.53 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 117' ' ' THR . 47.7 t -47.49 -62.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.599 -0.688 . . . . 0.0 109.905 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -31.68 11.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.982 -1.074 . . . . 0.0 109.646 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -68.49 -40.18 81.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.224 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.464 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 36.2 mmm -63.39 -32.68 74.18 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mt -71.03 -39.25 74.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.567 -0.708 . . . . 0.0 109.463 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -55.06 -27.55 45.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 110.263 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -89.33 -21.56 23.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.126 -0.984 . . . . 0.0 109.663 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.507 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -97.19 -5.82 36.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.824 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 135' ' ' GLN . 1.0 OUTLIER -97.45 133.32 42.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.7 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 57.0 mt -85.34 -50.23 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.358 -0.839 . . . . 0.0 109.426 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.1 -49.86 7.91 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.604 -0.685 . . . . 0.0 109.726 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.08 37.75 2.45 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -78.78 -25.19 44.33 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.317 -1.108 . . . . 0.0 108.821 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.19 28.96 1.88 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.485 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.593 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -159.18 165.85 32.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.068 -1.254 . . . . 0.0 109.256 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 55.8 t -122.6 162.86 21.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.12 -0.987 . . . . 0.0 108.654 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.516 ' ND2' ' HG3' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -132.44 -164.01 1.41 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.908 -1.12 . . . . 0.0 108.517 179.424 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 67.2 t80 -78.58 -49.59 13.01 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 110.323 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -59.84 -39.65 85.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.0 109.536 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.516 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 7.5 mt-10 -74.68 -38.96 62.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.049 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 39.0 t80 -65.64 -22.52 66.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.422 -0.798 . . . . 0.0 109.059 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 89.7 t -70.68 -40.66 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.552 -0.718 . . . . 0.0 110.079 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -65.98 -27.82 68.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.068 -1.02 . . . . 0.0 110.188 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.6 ttp -90.34 -26.54 19.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.094 -1.004 . . . . 0.0 110.058 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -97.68 -62.69 1.21 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.005 -1.06 . . . . 0.0 109.99 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.475 ' HB ' HG11 ' A' ' 142' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.159 -0.963 . . . . 0.0 109.348 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 121.033 0.444 . . . . 0.0 109.849 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.443 ' OE1' ' HE2' ' A' ' 145' ' ' MET . 0.0 OUTLIER -47.41 -39.42 15.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.961 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.502 HG21 ' CB ' ' A' ' 145' ' ' MET . 2.6 mt -91.72 -37.17 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.178 -0.952 . . . . 0.0 110.243 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.561 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 34.8 mtt180 -49.61 -28.91 6.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.005 . . . . 0.0 109.772 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -92.68 -54.02 3.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.078 -1.014 . . . . 0.0 109.478 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.453 ' HA ' HG22 ' A' ' 91' ' ' VAL . . . -44.51 -26.74 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.189 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 75.7 t80 -64.77 -55.9 16.94 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.111 -0.993 . . . . 0.0 109.403 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.411 ' CZ ' ' CB ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -62.88 -31.68 72.78 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.307 -179.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 88' ' ' ALA . 41.0 t -47.41 -28.24 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 64.7 m-85 -102.74 -31.69 10.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.463 ' HB2' HG12 ' A' ' 100' ' ' ILE . 34.3 t0 -93.62 92.83 7.72 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.583 -0.698 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.553 ' NZ ' ' CD2' ' A' ' 107' ' ' HIS . 1.6 mmmm -90.28 -23.13 21.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.222 -0.924 . . . . 0.0 109.927 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.492 ' O ' ' C ' ' A' ' 96' ' ' GLY . 15.8 t0 -78.79 1.95 21.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 109.186 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 33.55 37.8 0.07 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 95' ' ' ASP . 12.9 p-10 -88.0 -28.53 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -1.178 . . . . 0.0 109.768 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 143.37 -54.27 0.59 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 14.6 m-30 -109.59 157.28 19.2 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.486 -1.008 . . . . 0.0 109.124 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.469 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 84.3 mt -90.28 117.4 33.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 109.026 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.0 p -74.48 159.86 31.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.168 -0.958 . . . . 0.0 109.265 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.79 -31.12 66.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.418 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.78 -35.34 62.54 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.168 -0.958 . . . . 0.0 109.042 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 50.7 mm-40 -73.3 -22.8 60.27 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.276 -0.89 . . . . 0.0 108.967 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.517 ' CD2' ' SD ' ' A' ' 109' ' ' MET . 5.3 tp -90.78 -25.16 20.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 0.0 109.032 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.496 ' O ' ' OG1' ' A' ' 110' ' ' THR . 2.0 ttt180 -77.4 -30.4 53.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.271 -0.893 . . . . 0.0 109.01 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.553 ' CD2' ' NZ ' ' A' ' 94' ' ' LYS . 71.3 t60 -58.03 -45.11 87.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.906 . . . . 0.0 110.057 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 25.9 t -91.65 -26.46 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.06 -1.025 . . . . 0.0 110.392 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.517 ' SD ' ' CD2' ' A' ' 105' ' ' LEU . 13.7 mtm -61.29 -42.63 98.98 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.102 -0.999 . . . . 0.0 109.038 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -59.31 -26.67 65.2 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.207 -0.933 . . . . 0.0 109.253 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 110' ' ' THR . 7.9 t-20 39.02 -93.03 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.662 -0.648 . . . . 0.0 110.088 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 110' ' ' THR . 1.3 pp -148.71 68.34 1.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.143 -0.973 . . . . 0.0 109.226 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.56 -17.55 11.14 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -83.75 43.41 0.91 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.228 -1.16 . . . . 0.0 109.826 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.481 ' CA ' HG21 ' A' ' 110' ' ' THR . 13.7 ttpp -64.98 126.52 28.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 0.0 109.344 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.513 ' CD1' ' SD ' ' A' ' 109' ' ' MET . 45.5 mt -104.08 140.6 37.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.48 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.419 ' O ' HG21 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -66.98 -169.17 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.91 . . . . 0.0 108.71 179.33 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.47 -50.53 12.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.011 -1.055 . . . . 0.0 109.269 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -30.6 70.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.18 -0.95 . . . . 0.0 108.5 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 116' ' ' LEU . 9.8 tp10 -70.56 -41.88 71.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 117' ' ' THR . 34.6 t -61.5 -36.63 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.14 -25.53 67.02 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -75.01 -45.86 38.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.481 -0.762 . . . . 0.0 109.017 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 7.6 mmt -60.66 -28.28 68.47 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.21 -0.931 . . . . 0.0 108.76 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.471 HG12 HD21 ' A' ' 105' ' ' LEU . 2.4 mt -82.09 -35.24 13.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.519 -0.738 . . . . 0.0 109.475 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -59.69 -31.24 69.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 110.35 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.42 -5.24 56.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.029 -1.045 . . . . 0.0 110.509 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.06 -29.85 11.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.986 -1.071 . . . . 0.0 109.747 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.33 149.87 23.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.287 -0.883 . . . . 0.0 109.641 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mt -113.38 -29.02 2.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.18 -0.95 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.401 ' HB3' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -61.73 -33.6 74.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.88 21.39 55.83 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' A' ' 131' ' ' ASP . 0.7 OUTLIER -83.51 -27.56 29.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -1.169 . . . . 0.0 109.609 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.84 28.03 4.65 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.457 ' CD ' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -146.61 163.07 37.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -1.204 . . . . 0.0 109.391 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 94.2 t -117.78 168.2 9.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.327 -0.858 . . . . 0.0 109.188 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.538 ' C ' ' CE1' ' A' ' 89' ' ' PHE . 47.0 t30 -148.25 -166.29 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 60.2 t80 -80.62 -41.79 23.31 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.583 -1.323 . . . . 0.0 110.117 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.49 -29.99 66.67 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.104 -0.998 . . . . 0.0 109.303 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.427 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 6.1 mm-40 -85.26 -35.41 21.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 26.1 t80 -71.22 -26.87 63.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.536 -0.727 . . . . 0.0 109.16 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 138' ' ' TYR . 20.3 t -55.37 -44.31 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.189 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -57.94 -31.59 66.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.708 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.47 ' HE1' ' CE1' ' A' ' 141' ' ' PHE . 34.5 ttp -75.98 -39.57 55.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.454 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.502 ' CB ' HG21 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -69.77 -20.17 63.49 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.2 p . . . . . 0 N--CA 1.488 1.44 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.053 0.454 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.01 -19.46 4.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.064 -1.022 . . . . 0.0 109.338 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.412 HG23 ' HA ' ' A' ' 142' ' ' VAL . 5.8 mt -74.92 -39.72 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.282 -0.886 . . . . 0.0 109.548 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.576 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -46.52 -31.79 2.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.934 -1.103 . . . . 0.0 109.214 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 88' ' ' ALA . 15.5 mt-10 -91.88 -50.28 5.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.454 -0.779 . . . . 0.0 109.168 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.78 -25.87 0.34 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -0.906 . . . . 0.0 108.761 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' N ' ' C ' ' A' ' 87' ' ' GLU . 82.9 t80 -63.51 -55.61 22.59 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.284 -0.885 . . . . 0.0 109.004 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -60.86 -36.13 78.37 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 34.4 t -43.32 -28.35 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 90' ' ' ARG . 92.0 m-85 -106.36 -31.37 8.62 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.427 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 10.8 t0 -89.34 79.7 6.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.602 -0.686 . . . . 0.0 109.369 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -89.19 -16.97 30.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.386 -0.821 . . . . 0.0 109.745 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.459 ' O ' ' C ' ' A' ' 96' ' ' GLY . 12.6 t70 -77.19 0.39 21.98 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.397 -0.815 . . . . 0.0 108.988 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.96 50.3 2.07 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -108.12 -31.83 7.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -1.176 . . . . 0.0 109.587 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.39 -50.02 0.82 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.636 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 10.9 m-30 -114.03 146.04 40.73 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.339 -1.095 . . . . 0.0 109.217 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 81.9 mt -81.96 132.56 31.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.398 -0.814 . . . . 0.0 109.389 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.6 p -98.26 178.04 5.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 121' ' ' VAL . . . -65.7 -40.54 92.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 109.341 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.73 -31.1 70.8 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.267 -0.896 . . . . 0.0 109.407 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.53 -26.23 59.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.877 . . . . 0.0 108.667 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.549 ' CD2' ' CG ' ' A' ' 109' ' ' MET . 3.6 tt -82.11 -26.2 33.77 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.494 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 0.0 OUTLIER -73.03 -47.33 45.84 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 106' ' ' ARG . 28.0 t60 -40.93 -38.4 0.95 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.48 -0.762 . . . . 0.0 110.347 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.432 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 36.2 t -97.97 -28.11 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.972 -1.08 . . . . 0.0 110.297 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.549 ' CG ' ' CD2' ' A' ' 105' ' ' LEU . 3.9 mmt -64.33 -17.34 63.6 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.725 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 t -88.7 -18.55 27.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.455 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.432 ' OD1' ' HA ' ' A' ' 108' ' ' VAL . 7.3 m120 -58.48 97.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.875 . . . . 0.0 109.552 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt 61.32 13.45 4.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -117.96 41.91 1.95 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 52.89 -125.76 2.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.236 -1.155 . . . . 0.0 109.12 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 135.67 32.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.634 -1.292 . . . . 0.0 109.991 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.534 ' HG ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -103.94 116.46 32.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.297 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.541 HG21 ' CB ' ' A' ' 120' ' ' GLU . 5.6 t -75.45 165.78 24.6 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.64 -52.67 63.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.845 -1.16 . . . . 0.0 110.237 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -59.41 -17.96 34.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.244 -0.91 . . . . 0.0 109.998 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.541 ' CB ' HG21 ' A' ' 117' ' ' THR . 7.7 tp10 -87.18 -40.16 14.83 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 116' ' ' LEU . 21.9 t -61.41 -46.74 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.304 -0.872 . . . . 0.0 109.079 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -46.92 -28.82 1.74 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.383 -0.823 . . . . 0.0 109.751 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -75.54 -51.41 12.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.142 -0.974 . . . . 0.0 109.426 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.502 ' SD ' ' CD2' ' A' ' 116' ' ' LEU . 1.2 mpt? -59.91 -21.14 60.71 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.222 -0.924 . . . . 0.0 109.559 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.482 HG12 ' CD1' ' A' ' 105' ' ' LEU . 2.3 mt -84.85 -42.97 16.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.3 -0.875 . . . . 0.0 109.659 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -22.68 1.02 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.38 -0.825 . . . . 0.0 110.588 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -90.87 -30.37 16.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.919 -1.113 . . . . 0.0 110.379 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.464 ' HB2' HG23 ' A' ' 136' ' ' VAL . . . -76.19 -49.65 16.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.838 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.418 ' OD2' HG21 ' A' ' 125' ' ' ILE . 1.9 p30 -80.44 150.91 29.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.5 mt -117.69 -34.48 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.334 -0.854 . . . . 0.0 109.214 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -61.75 -39.88 93.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.536 -0.727 . . . . 0.0 109.286 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.56 29.44 29.8 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.18 -25.64 39.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.386 -1.067 . . . . 0.0 108.77 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 115.3 26.54 3.42 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.636 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -160.27 162.54 33.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.045 -1.268 . . . . 0.0 109.517 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.465 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 70.0 t -113.8 161.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.418 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 0.3 OUTLIER -135.79 -166.46 1.86 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.97 -1.081 . . . . 0.0 108.619 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.576 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 52.3 t80 -78.87 -37.44 40.27 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.415 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.423 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 5.2 tp10 -67.77 -38.99 84.15 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -77.09 -38.47 52.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.175 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 38.6 t80 -69.47 -23.49 63.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.394 -0.816 . . . . 0.0 109.456 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 138' ' ' TYR . 23.1 t -75.7 -54.01 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 109.84 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.423 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 2.8 mt-30 -63.34 -21.9 66.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.0 110.044 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -90.24 -32.82 16.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.076 -1.015 . . . . 0.0 109.941 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -93.25 -4.4 51.95 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.201 -0.937 . . . . 0.0 110.143 -179.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 142' ' ' VAL . 12.5 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.044 -1.035 . . . . 0.0 109.587 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.351 0.596 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.406 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -72.87 -23.74 60.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.206 -0.934 . . . . 0.0 109.709 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.416 HG23 HG21 ' A' ' 142' ' ' VAL . 3.5 mp -82.64 -37.85 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.142 -0.974 . . . . 0.0 109.929 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -42.05 95.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.56 -30.14 41.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.148 -0.97 . . . . 0.0 109.442 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 91' ' ' VAL . . . -67.38 -27.02 66.76 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 82.0 t80 -68.44 -54.61 15.93 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.652 0.739 . . . . 0.0 109.247 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -63.78 -27.91 69.51 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 88' ' ' ALA . 8.5 t -50.09 -30.1 6.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.469 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 87.1 m-85 -98.02 -35.42 10.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -90.13 95.71 10.33 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -89.98 -26.02 20.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.207 -0.933 . . . . 0.0 110.841 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -78.99 5.26 12.12 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.062 -1.024 . . . . 0.0 109.055 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 40.94 33.12 0.62 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -75.81 -70.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -1.117 . . . . 0.0 109.081 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.19 -53.98 0.09 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.629 ' CE2' ' NE2' ' A' ' 135' ' ' GLN . 9.7 m-30 -107.95 152.15 24.84 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.488 -1.007 . . . . 0.0 109.047 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.469 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 86.0 mt -88.63 128.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 109.911 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.9 p -90.36 -176.58 4.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.327 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.51 -50.71 57.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.74 -29.52 69.43 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.382 -0.824 . . . . 0.0 109.526 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 28.5 mt-10 -73.64 -30.79 63.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.16 -0.962 . . . . 0.0 108.953 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 2.2 tp -91.06 -9.21 46.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.46 -0.775 . . . . 0.0 109.211 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -91.53 -40.24 11.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.383 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.469 ' HA ' HG23 ' A' ' 110' ' ' THR . 24.4 t60 -54.83 -35.22 63.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.627 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 91' ' ' VAL . 71.1 t -88.85 -44.64 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.118 -0.989 . . . . 0.0 110.056 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.474 ' HE1' ' CE ' ' A' ' 124' ' ' MET . 97.1 mmm -68.13 -7.65 31.64 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 109.188 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.472 HG21 ' N ' ' A' ' 111' ' ' ASN . 6.6 t -98.86 -19.54 17.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.125 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 112' ' ' LEU . 3.3 m120 -89.23 31.3 0.9 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.129 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.505 ' CB ' ' O ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER 161.03 -19.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.585 -0.697 . . . . 0.0 109.725 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -85.83 20.86 17.38 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.506 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.529 ' O ' ' O ' ' A' ' 115' ' ' LYS . 13.3 mt-10 62.08 40.61 11.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.112 -1.228 . . . . 0.0 110.125 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 114' ' ' GLU . 3.1 ttpp 50.0 115.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.767 0.794 . . . . 0.0 111.45 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.435 ' HB3' HG21 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -95.36 159.26 15.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 109.356 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 120' ' ' GLU . 21.7 p -92.41 -171.64 2.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 109.774 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.87 -47.82 8.3 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.465 -0.772 . . . . 0.0 109.025 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.42 -13.18 62.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 108.838 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.475 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 23.9 tp10 -93.46 -42.23 9.37 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.475 -0.766 . . . . 0.0 109.137 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 117' ' ' THR . 6.9 t -53.87 -61.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.422 -0.798 . . . . 0.0 109.775 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -48.1 -27.73 2.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.987 . . . . 0.0 109.952 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -77.33 -39.74 46.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.196 -0.94 . . . . 0.0 109.326 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.474 ' CE ' ' HE1' ' A' ' 109' ' ' MET . 25.1 mmm -66.38 -22.3 66.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.872 -1.142 . . . . 0.0 108.586 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.493 HG21 HG21 ' A' ' 136' ' ' VAL . 3.2 mt -86.91 -38.3 12.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -55.88 -22.82 27.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.636 -0.665 . . . . 0.0 110.062 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.458 ' N ' ' HG3' ' A' ' 126' ' ' ARG . 3.1 mt-10 -90.41 -34.57 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 0.0 109.75 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.24 -13.49 60.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.917 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.514 ' OD1' ' CG2' ' A' ' 136' ' ' VAL . 7.1 m-20 -94.68 142.45 27.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 73.2 mt -89.26 -37.15 9.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.324 -0.86 . . . . 0.0 109.22 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -39.09 24.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.514 -0.741 . . . . 0.0 109.439 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.36 29.94 13.3 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.14 -25.43 42.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -1.072 . . . . 0.0 109.09 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 117.48 5.77 14.01 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.629 ' NE2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -129.27 157.64 41.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.892 -1.357 . . . . 0.0 109.434 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.514 ' CG2' ' OD1' ' A' ' 129' ' ' ASP . 77.9 t -116.27 165.28 11.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.192 -0.943 . . . . 0.0 108.61 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 0.3 OUTLIER -141.39 -164.19 1.71 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.925 -1.109 . . . . 0.0 108.512 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 142' ' ' VAL . 65.1 t80 -81.45 -42.17 20.73 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.126 -0.984 . . . . 0.0 109.182 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -68.34 -29.43 68.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.392 -0.817 . . . . 0.0 109.199 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.27 -33.91 20.54 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.417 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 60.1 t80 -70.94 -24.43 62.44 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.561 -0.712 . . . . 0.0 109.293 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.487 HG12 ' OG1' ' A' ' 146' ' ' THR . 3.8 t -66.01 -51.64 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.498 -0.751 . . . . 0.0 109.991 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -59.79 -26.03 65.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.115 -0.991 . . . . 0.0 110.662 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -28.37 19.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.854 -1.154 . . . . 0.0 110.742 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.4 tpt -102.57 -61.86 1.34 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.012 -1.055 . . . . 0.0 109.801 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.487 ' OG1' HG12 ' A' ' 142' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.5 0 O-C-N 121.486 -0.759 . . . . 0.0 109.88 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -65.73 -35.8 81.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.416 -0.802 . . . . 0.0 109.531 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.455 HG23 ' HA ' ' A' ' 142' ' ' VAL . 2.8 mp -80.3 -37.65 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.271 -0.893 . . . . 0.0 110.026 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.473 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 5.7 ttp180 -48.53 -39.72 24.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.062 -1.024 . . . . 0.0 109.715 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 11.3 pt-20 -82.26 -50.74 8.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.111 -0.993 . . . . 0.0 109.875 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -45.59 -27.23 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.002 -1.061 . . . . 0.0 108.922 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.413 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 91.4 t80 -63.51 -56.99 11.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.419 -0.8 . . . . 0.0 109.753 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -62.03 -32.07 72.53 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.529 -0.732 . . . . 0.0 109.112 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 55.1 t -44.56 -30.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -99.44 -35.48 9.89 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.445 ' HB2' HG12 ' A' ' 100' ' ' ILE . 10.1 t0 -91.55 98.88 11.93 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.505 -0.747 . . . . 0.0 109.377 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 0.0 OUTLIER -90.32 -23.61 21.1 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.245 -0.909 . . . . 0.0 110.262 -179.487 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -79.01 3.68 16.54 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 109.337 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.61 31.76 0.09 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 95' ' ' ASP . 11.4 p-10 -80.47 -24.03 39.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.071 -1.252 . . . . 0.0 109.87 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.509 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 126.33 -44.64 1.23 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 52.3 m-85 -110.4 145.03 38.27 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.495 -1.003 . . . . 0.0 109.629 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 71.6 mt -90.43 94.31 4.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.453 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -66.58 158.61 29.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.106 -0.996 . . . . 0.0 109.208 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.49 -42.38 10.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.108 -0.995 . . . . 0.0 109.266 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.26 99.17 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.311 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.444 ' OE1' ' HB2' ' A' ' 95' ' ' ASP . 1.5 mm-40 -64.47 -24.15 67.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 0.0 109.199 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.422 HD21 HG11 ' A' ' 121' ' ' VAL . 34.7 tp -88.83 -16.83 31.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.49 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 5.6 ttt-85 -83.44 -35.23 25.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.505 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 106' ' ' ARG . 23.3 t60 -42.24 -49.9 4.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.667 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.7 t -95.59 -24.77 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.987 -1.071 . . . . 0.0 110.717 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.49 ' HB2' ' HA ' ' A' ' 106' ' ' ARG . 8.3 mmt -64.17 -23.49 67.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.05 -1.031 . . . . 0.0 109.758 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -82.1 -31.13 30.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 109.795 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.401 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 22.5 t-20 -56.88 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.456 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.401 ' HG ' ' C ' ' A' ' 111' ' ' ASN . 1.5 mt 56.92 24.11 8.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.478 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 109' ' ' MET . . . -117.67 51.94 0.71 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 57.4 178.87 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -1.165 . . . . 0.0 109.346 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -112.98 79.79 1.27 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.331 -0.856 . . . . 0.0 109.215 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.558 ' HB2' ' CB ' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -94.21 133.84 37.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.972 . . . . 0.0 109.378 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.558 ' CG2' ' N ' ' A' ' 118' ' ' ASP . 5.3 t -92.08 -146.14 0.21 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.363 -0.836 . . . . 0.0 109.237 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.558 ' N ' ' CG2' ' A' ' 117' ' ' THR . 3.9 m-20 -78.63 -48.85 14.28 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.552 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -54.48 -24.99 22.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 109.709 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.558 ' CB ' ' HB2' ' A' ' 116' ' ' LEU . 18.1 mm-40 -86.96 -47.98 8.52 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.457 HG21 ' HG ' ' A' ' 116' ' ' LEU . 92.5 t -54.81 -26.15 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.72 -0.613 . . . . 0.0 109.568 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -68.36 -34.89 76.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -79.95 -19.0 49.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.948 -1.095 . . . . 0.0 108.598 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 15.2 mmt -88.91 -20.78 24.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 7.6 mt -92.43 -45.6 14.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.73 0.776 . . . . 0.0 109.718 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.7 -26.35 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.682 -0.636 . . . . 0.0 110.723 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -90.35 -37.15 14.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.985 -1.072 . . . . 0.0 109.749 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.455 ' HB3' ' HE3' ' A' ' 144' ' ' MET . . . -80.09 -4.36 52.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.852 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -96.67 176.75 5.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 3.7 mt -69.92 -69.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.362 -0.836 . . . . 0.0 109.437 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 130' ' ' ILE . 3.0 p-10 -179.24 32.95 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.44 -0.788 . . . . 0.0 110.533 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 146.93 49.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.068 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 129' ' ' ASP . 2.2 p30 -112.55 -24.65 9.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -1.119 . . . . 0.0 109.035 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.29 -10.2 55.2 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.442 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 4.3 pt20 -144.91 -170.35 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -1.154 . . . . 0.0 109.133 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 137' ' ' ASN . 53.6 t -126.33 160.4 33.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.595 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 3.9 t-20 -141.53 -166.48 2.21 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.475 ' O ' HG21 ' A' ' 142' ' ' VAL . 88.4 t80 -78.19 -31.07 49.31 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.563 -1.336 . . . . 0.0 112.106 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -15.43 60.07 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.462 -1.399 . . . . 0.0 110.321 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.585 ' OE1' ' HB3' ' A' ' 137' ' ' ASN . 3.8 mp0 -100.57 -34.64 9.82 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.413 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 50.9 t80 -71.88 -25.28 61.87 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.475 HG21 ' O ' ' A' ' 138' ' ' TYR . 9.9 t -60.43 -55.27 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -65.44 -21.05 66.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.762 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.455 ' HE3' ' HB3' ' A' ' 128' ' ' ALA . 3.1 tpt -85.16 -20.55 30.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 0.0 109.726 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -39.64 20.58 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.141 -0.975 . . . . 0.0 109.482 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.929 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 86' ' ' ARG . 15.9 tt0 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.318 0.58 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.468 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 10.4 tt0 -46.38 -27.52 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 110.095 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mm -77.4 -47.45 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.17 -0.956 . . . . 0.0 110.446 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.444 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 5.3 mmm180 -47.73 -45.07 28.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.101 -0.999 . . . . 0.0 109.908 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 10.4 pt-20 -79.99 -39.79 29.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.059 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.519 ' N ' ' HG3' ' A' ' 87' ' ' GLU . . . -57.88 -19.54 30.23 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.912 -1.117 . . . . 0.0 108.48 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 82.4 t80 -71.53 -55.44 7.82 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.451 -0.78 . . . . 0.0 109.326 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -63.77 -27.45 69.2 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 108' ' ' VAL . 24.3 t -50.14 -30.72 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.588 ' CE2' ' HB ' ' A' ' 108' ' ' VAL . 65.1 m-85 -96.88 -33.91 11.45 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.467 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 23.3 t0 -97.83 91.94 5.6 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.773 -0.58 . . . . 0.0 109.649 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 94' ' ' LYS . 19.4 mmmt -90.19 -19.34 24.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.285 -0.884 . . . . 0.0 110.013 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -77.94 2.43 17.53 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.344 -0.848 . . . . 0.0 109.386 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 39.57 37.54 0.86 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -85.86 -25.65 26.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -1.194 . . . . 0.0 109.556 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.18 -48.1 0.98 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 136' ' ' VAL . 13.5 m-30 -112.85 178.4 4.3 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.564 -0.962 . . . . 0.0 108.786 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.467 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 54.2 mt -113.04 128.29 69.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.471 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -87.37 -178.96 6.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.838 . . . . 0.0 109.8 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.492 ' CB ' HG13 ' A' ' 121' ' ' VAL . . . -67.4 -47.28 70.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 0.0 109.181 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.81 -31.76 72.82 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.368 -0.832 . . . . 0.0 109.027 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 65.2 mm-40 -70.67 -23.1 62.44 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.541 ' CD2' ' HG3' ' A' ' 109' ' ' MET . 0.5 OUTLIER -82.64 -36.43 26.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.474 -0.766 . . . . 0.0 109.324 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -9.61 58.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.117 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -75.99 -34.65 59.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.83 . . . . 0.0 110.392 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.588 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 52.2 t -111.36 -42.79 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.919 -1.113 . . . . 0.0 110.582 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.541 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 4.4 mtm -55.03 -16.57 2.95 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.111 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.35 -34.84 23.56 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.851 -1.155 . . . . 0.0 108.938 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -55.86 28.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.829 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.47 7.74 3.33 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.968 . . . . 0.0 110.025 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.483 ' CA ' ' O ' ' A' ' 109' ' ' MET . . . -103.23 36.79 4.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 41.0 mt-10 64.85 114.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.439 -1.036 . . . . 0.0 108.789 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.63 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.447 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 109' ' ' MET . 0.9 OUTLIER -93.97 174.12 7.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 108.779 179.093 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.485 HG21 ' HG3' ' A' ' 120' ' ' GLU . 1.4 t -120.32 171.89 8.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 0.0 108.588 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 119' ' ' GLU . 1.1 m-20 -48.67 -48.35 40.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.073 -1.017 . . . . 0.0 110.615 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -41.81 -38.78 1.58 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.24 -0.912 . . . . 0.0 110.332 -179.152 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.485 ' HG3' HG21 ' A' ' 117' ' ' THR . 3.0 mt-10 -87.72 -46.6 9.34 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.391 -0.818 . . . . 0.0 110.086 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.492 HG13 ' CB ' ' A' ' 102' ' ' ALA . 71.1 t -32.83 -50.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.668 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -50.78 72.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.761 -1.212 . . . . 0.0 109.418 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.58 -13.4 61.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 108.794 179.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.448 ' HG3' HD11 ' A' ' 116' ' ' LEU . 5.8 mmt -89.35 -22.42 22.62 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.469 ' CG2' ' O ' ' A' ' 134' ' ' GLY . 4.0 mt -80.1 -42.99 22.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.19 -19.12 18.8 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.659 -0.651 . . . . 0.0 109.98 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 20.4 mm-40 -90.6 -24.56 20.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.133 -0.979 . . . . 0.0 110.018 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.41 -59.82 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.359 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 43.5 p30 -47.46 154.86 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.407 HD13 ' HG2' ' A' ' 140' ' ' GLU . 52.7 mt -102.05 -40.58 7.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.187 -0.946 . . . . 0.0 109.754 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.27 -40.77 36.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.52 -0.737 . . . . 0.0 109.641 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.53 33.37 5.11 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.07 -23.04 44.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -1.084 . . . . 0.0 109.099 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.469 ' O ' ' CG2' ' A' ' 125' ' ' ILE . . . 117.21 -30.06 6.45 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.75 167.51 10.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -1.199 . . . . 0.0 109.277 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.505 HG11 ' N ' ' A' ' 137' ' ' ASN . 68.6 t -119.98 160.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.2 -0.938 . . . . 0.0 108.666 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.505 ' N ' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -135.99 -164.41 1.55 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.63 -1.294 . . . . 0.0 108.648 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.444 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 64.9 t80 -75.66 -42.07 52.32 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.973 -1.079 . . . . 0.0 109.817 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -65.15 -47.8 75.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.117 -0.989 . . . . 0.0 109.432 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.503 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 55.8 mt-10 -69.84 -36.77 75.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.126 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 145' ' ' MET . 44.0 t80 -64.72 -27.62 69.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.844 . . . . 0.0 109.081 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.6 t -61.28 -47.83 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.837 . . . . 0.0 109.859 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -53.23 -37.75 62.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -0.978 . . . . 0.0 110.482 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.11 -23.31 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.055 -1.028 . . . . 0.0 110.022 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.52 ' CG ' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -86.08 -11.06 53.75 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.092 -1.005 . . . . 0.0 109.849 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.129 -0.982 . . . . 0.0 109.615 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 1.4 tt0 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 6.7 tt0 -79.17 7.96 6.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.536 -0.728 . . . . 0.0 109.612 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.405 HD13 ' HB ' ' A' ' 146' ' ' THR . 5.5 mm -117.89 -42.98 2.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.111 -0.993 . . . . 0.0 109.722 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.429 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 4.6 mtp180 -66.83 -33.32 75.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -0.981 . . . . 0.0 109.08 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 18.5 pt-20 -96.57 -26.77 15.12 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.24 -0.913 . . . . 0.0 109.106 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -67.64 -29.52 68.85 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 84.6 t80 -62.07 -56.05 22.84 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.568 -0.708 . . . . 0.0 109.196 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -33.35 74.98 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.253 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 23.7 t -47.91 -33.77 3.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.491 ' CD1' ' HB ' ' A' ' 108' ' ' VAL . 66.7 m-85 -92.33 -30.9 15.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.481 ' HB2' HG12 ' A' ' 100' ' ' ILE . 26.2 t0 -100.33 83.04 2.58 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -73.32 -21.12 60.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 110.248 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -77.87 0.52 23.68 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.251 -0.906 . . . . 0.0 109.012 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.42 50.68 1.78 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 7.8 p-10 -107.49 -14.26 14.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 109.802 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.39 -26.48 11.05 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.2 m-85 -121.12 146.66 46.51 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.377 -1.072 . . . . 0.0 109.262 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.481 HG12 ' HB2' ' A' ' 93' ' ' ASP . 76.6 mt -103.54 120.85 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.429 -0.794 . . . . 0.0 109.54 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.6 p -81.96 170.78 15.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.095 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.8 90.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.046 -1.034 . . . . 0.0 109.475 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.37 83.45 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.219 -0.926 . . . . 0.0 109.462 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -73.28 -20.9 60.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.18 -0.95 . . . . 0.0 108.586 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.502 HD13 ' CG ' ' A' ' 109' ' ' MET . 15.4 tp -87.21 -23.69 24.67 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.47 -0.769 . . . . 0.0 109.534 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.462 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 23.3 ttt180 -82.97 -39.5 21.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -50.1 -30.51 11.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 110.403 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.491 ' HB ' ' CD1' ' A' ' 92' ' ' PHE . 98.9 t -110.17 -26.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.001 -1.062 . . . . 0.0 110.173 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.502 ' CG ' HD13 ' A' ' 105' ' ' LEU . 2.3 mmt -61.95 -14.39 34.33 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.339 -0.851 . . . . 0.0 109.656 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -82.6 -35.26 27.22 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.283 -0.886 . . . . 0.0 109.655 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 110' ' ' THR . 10.7 m120 -43.43 -59.14 2.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.29 16.8 1.7 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.407 -0.808 . . . . 0.0 109.134 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 109' ' ' MET . . . -94.97 30.84 7.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 23.9 mm-40 71.1 167.28 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -1.179 . . . . 0.0 109.703 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -90.6 73.33 6.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -97.97 153.55 18.29 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.584 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.476 ' O ' HG21 ' A' ' 121' ' ' VAL . 1.7 p -101.05 -150.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.141 -0.974 . . . . 0.0 109.776 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.448 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 4.1 m-20 -77.86 -54.07 6.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.0 109.853 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HG3' ' OE1' ' A' ' 120' ' ' GLU . 10.9 pt-20 -48.98 -38.23 22.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 0.0 109.125 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 2.6 mm-40 -71.5 -46.64 59.2 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 117' ' ' THR . 21.3 t -37.64 -51.82 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.105 0.479 . . . . 0.0 110.109 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 122' ' ' ASP . 37.7 t0 -54.26 -46.9 72.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.109 -0.995 . . . . 0.0 109.844 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -63.37 -31.69 72.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.979 . . . . 0.0 109.75 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.432 ' HG3' HD12 ' A' ' 116' ' ' LEU . 18.2 mmt -73.06 -26.17 61.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.93 -1.106 . . . . 0.0 108.293 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.454 HG12 ' CD2' ' A' ' 105' ' ' LEU . 7.1 mt -76.28 -37.14 31.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -57.07 -14.28 3.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.845 -0.534 . . . . 0.0 110.206 -179.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -89.37 -30.14 18.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 0.0 109.277 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -102.96 -0.69 30.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.565 -0.71 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.414 ' CG ' HG23 ' A' ' 125' ' ' ILE . 7.5 m-20 -82.72 143.72 30.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.852 . . . . 0.0 110.01 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.503 HG12 ' CG ' ' A' ' 140' ' ' GLU . 33.0 mm -108.66 -32.9 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.323 -0.861 . . . . 0.0 109.139 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -97.6 -33.91 11.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.608 -0.683 . . . . 0.0 109.23 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.11 26.41 18.97 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.06 -28.25 39.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -1.142 . . . . 0.0 109.219 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.11 33.96 2.07 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -154.31 150.82 28.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.425 -1.044 . . . . 0.0 109.361 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 137' ' ' ASN . 89.6 t -112.86 167.1 6.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.186 -0.946 . . . . 0.0 109.318 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.635 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 7.5 p30 -150.6 -172.5 4.2 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.442 ' O ' HG21 ' A' ' 142' ' ' VAL . 51.7 t80 -68.53 -48.78 63.46 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.413 -1.429 . . . . 0.0 110.804 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 7.0 mp0 -54.86 -55.51 29.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.986 -1.071 . . . . 0.0 110.845 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.524 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 22.4 mt-10 -63.3 -41.91 99.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.863 -1.148 . . . . 0.0 109.904 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.437 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 51.8 t80 -64.68 -23.05 67.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 109.978 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 138' ' ' TYR . 43.2 t -76.37 -44.08 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.841 . . . . 0.0 110.47 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.47 -32.36 73.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.129 -0.982 . . . . 0.0 110.605 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -21.74 24.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.927 -1.108 . . . . 0.0 110.283 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.3 tpt -98.59 -6.63 29.61 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.897 -1.127 . . . . 0.0 110.649 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.405 ' HB ' HD13 ' A' ' 85' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 120.678 -1.264 . . . . 0.0 110.733 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 121.123 0.487 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.423 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -57.65 -30.14 65.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.973 . . . . 0.0 109.639 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mt -83.88 -40.72 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.916 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.8 mtt85 -58.64 -35.29 72.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.608 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -87.08 -31.68 20.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.577 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.5 -28.94 70.29 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.152 -0.967 . . . . 0.0 108.443 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.448 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 87.6 t80 -66.9 -53.0 36.42 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.408 -0.807 . . . . 0.0 109.507 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -66.2 -25.07 66.76 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 87' ' ' GLU . 2.7 t -52.7 -24.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.493 ' CE1' ' HB ' ' A' ' 108' ' ' VAL . 75.5 m-85 -108.34 -30.08 8.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -95.25 76.06 3.42 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.455 ' HB2' ' OE1' ' A' ' 104' ' ' GLU . 11.3 mmmt -79.86 -16.75 54.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 96' ' ' GLY . 18.8 m-20 -78.32 5.5 10.33 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.984 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.14 38.11 0.32 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -93.66 -69.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.401 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.9 -50.85 0.11 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.625 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 11.3 m-30 -109.66 155.37 21.57 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.413 -1.051 . . . . 0.0 108.784 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.407 HG23 ' HB2' ' A' ' 105' ' ' LEU . 94.1 mt -90.51 122.37 41.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 109.597 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.2 p -85.38 174.14 9.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.401 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.0 -33.04 74.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.132 -0.98 . . . . 0.0 109.447 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.4 68.44 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.228 -0.92 . . . . 0.0 109.565 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 60.3 mm-40 -78.71 -20.96 48.87 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.407 ' HB2' HG23 ' A' ' 100' ' ' ILE . 3.2 tp -93.25 -17.49 23.59 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.581 -0.699 . . . . 0.0 109.277 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.44 ' O ' ' OG1' ' A' ' 110' ' ' THR . 15.1 ttt-85 -80.58 -21.99 41.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.198 -0.939 . . . . 0.0 109.251 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -70.55 -27.79 64.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.307 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 79.4 t -111.07 -21.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.917 -1.114 . . . . 0.0 110.122 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.5 mmt -67.48 -41.04 85.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.016 -1.052 . . . . 0.0 109.18 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -73.69 -15.99 61.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.377 -0.827 . . . . 0.0 109.867 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER -59.09 87.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.899 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.481 ' CD2' ' C ' ' A' ' 111' ' ' ASN . 1.4 pt? 36.29 29.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.637 -0.664 . . . . 0.0 110.835 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -96.03 -12.57 52.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 0.4 OUTLIER 151.27 -167.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 65.2 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.007 . . . . 0.0 109.167 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 120' ' ' GLU . 1.7 pp -105.77 121.76 44.69 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.583 -0.698 . . . . 0.0 109.431 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' A' ' 118' ' ' ASP . 4.5 t -86.5 -146.89 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.623 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.549 ' N ' ' CG2' ' A' ' 117' ' ' THR . 1.2 m-20 -73.4 -57.58 3.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.853 . . . . 0.0 109.873 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -20.41 2.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.847 . . . . 0.0 110.014 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 27.4 mm-40 -89.77 -39.79 12.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 117' ' ' THR . 22.4 t -47.67 -61.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.185 0.517 . . . . 0.0 109.652 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 121' ' ' VAL . 49.4 t0 -41.75 -34.0 0.57 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.293 -0.879 . . . . 0.0 109.878 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -45.14 49.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 108.96 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.7 mmm -60.87 -20.67 62.27 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.18 -0.95 . . . . 0.0 108.723 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.495 ' CG2' ' OD1' ' A' ' 129' ' ' ASP . 3.0 mt -87.47 -38.81 12.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -19.22 4.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.816 -0.552 . . . . 0.0 109.657 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -89.29 -31.95 17.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 109.049 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.08 -5.0 57.03 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.409 -0.807 . . . . 0.0 109.255 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 125' ' ' ILE . 1.8 m-20 -95.18 133.72 38.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.313 -0.867 . . . . 0.0 109.382 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.474 ' CG1' ' CD ' ' A' ' 140' ' ' GLU . 41.3 mm -83.78 -49.74 16.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.142 -0.974 . . . . 0.0 109.383 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.45 -45.09 23.04 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.571 -0.706 . . . . 0.0 109.168 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.62 31.95 3.79 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.47 -27.36 41.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -1.038 . . . . 0.0 109.429 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 125' ' ' ILE . . . 121.72 -16.21 8.97 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.847 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.625 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -109.18 164.59 12.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.739 -1.448 . . . . 0.0 109.587 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 137' ' ' ASN . 53.8 t -121.87 163.65 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.257 -0.902 . . . . 0.0 108.707 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.542 ' ND2' ' HG2' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -135.1 -168.72 2.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.928 -1.108 . . . . 0.0 108.707 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.498 ' O ' ' CG2' ' A' ' 142' ' ' VAL . 73.0 t80 -80.47 -36.59 33.24 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.089 -1.007 . . . . 0.0 110.146 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -68.26 -34.26 75.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.542 ' HG2' ' ND2' ' A' ' 137' ' ' ASN . 4.1 mm-40 -83.52 -34.75 25.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 108.921 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.586 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 14.3 t80 -72.26 -23.17 61.16 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.45 -0.781 . . . . 0.0 109.158 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 48.4 t -74.99 -59.51 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 0.0 109.694 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 12.4 mt-30 -53.34 -24.11 11.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.825 . . . . 0.0 110.538 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.7 -37.08 13.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.036 -1.04 . . . . 0.0 110.96 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.586 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -84.8 -8.68 58.72 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.978 -1.077 . . . . 0.0 110.838 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 120.912 -1.118 . . . . 0.0 109.061 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -60.94 -19.51 60.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.716 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 mt -97.74 -38.13 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.185 -0.947 . . . . 0.0 110.047 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.526 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 2.9 ttt-85 -49.58 -32.13 12.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.041 -1.037 . . . . 0.0 109.49 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.1 mt-10 -91.01 -53.94 4.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 109.735 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.444 ' HA ' HG22 ' A' ' 91' ' ' VAL . . . -43.98 -27.03 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.0 108.79 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CD1' ' HA ' ' A' ' 138' ' ' TYR . 70.3 t80 -62.37 -58.08 8.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.411 -0.806 . . . . 0.0 109.141 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -60.04 -37.49 79.97 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.385 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 90' ' ' ARG . 59.5 t -42.9 -32.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.479 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 56.0 m-85 -95.93 -35.12 11.56 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.48 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 28.3 t0 -91.06 88.89 7.16 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -77.53 -21.16 53.08 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 110.229 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 96' ' ' GLY . 67.2 m-20 -78.21 0.4 25.24 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 109.133 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 35.47 49.25 0.94 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -106.79 -22.82 12.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.249 . . . . 0.0 109.666 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.36 -27.97 5.15 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.633 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.7 m-85 -121.61 145.46 47.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.412 -1.052 . . . . 0.0 108.985 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.48 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 56.8 mt -96.17 133.94 35.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.236 -0.915 . . . . 0.0 109.358 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.59 170.9 9.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.41 94.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 109.281 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.89 -35.83 77.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.391 -0.818 . . . . 0.0 109.703 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.57 ' O ' ' CE1' ' A' ' 107' ' ' HIS . 64.6 mm-40 -71.61 -21.86 61.79 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.174 -0.954 . . . . 0.0 108.495 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.495 ' HG ' ' CG ' ' A' ' 109' ' ' MET . 1.6 tp -99.73 4.49 45.49 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.585 -0.697 . . . . 0.0 109.212 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -96.92 -30.89 12.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.127 -0.983 . . . . 0.0 109.978 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.607 ' CD2' HG21 ' A' ' 108' ' ' VAL . 45.5 p-80 -88.07 -53.3 4.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 111.802 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.607 HG21 ' CD2' ' A' ' 107' ' ' HIS . 18.9 t -68.43 -54.14 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.168 -0.957 . . . . 0.0 110.968 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.495 ' CG ' ' HG ' ' A' ' 105' ' ' LEU . 1.5 mmt -35.98 -45.33 0.41 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.611 -0.681 . . . . 0.0 110.786 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -88.88 -33.31 17.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.992 -1.067 . . . . 0.0 109.994 -179.536 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.451 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER 41.19 51.49 3.46 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.275 -0.891 . . . . 0.0 109.864 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.451 ' HG ' ' C ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER 56.33 41.26 29.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.351 -0.843 . . . . 0.0 110.115 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -141.63 8.1 2.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 0.3 OUTLIER 155.1 57.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.752 -0.852 . . . . 0.0 108.999 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.516 ' N ' ' OG1' ' A' ' 110' ' ' THR . 3.1 ptpt -46.6 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.844 . . . . 0.0 110.318 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.401 ' HB2' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -70.59 156.81 38.96 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.146 -0.971 . . . . 0.0 108.794 179.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.454 HG21 ' CB ' ' A' ' 120' ' ' GLU . 2.0 t -82.0 -174.78 5.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 109.486 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.16 -57.65 3.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 109.281 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.56 -24.04 4.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 108.887 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.454 ' CB ' HG21 ' A' ' 117' ' ' THR . 16.0 tp10 -81.11 -40.88 23.36 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 117' ' ' THR . 58.0 t -54.73 -48.39 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -31.54 29.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.842 . . . . 0.0 109.249 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 26.1 mm-40 -73.92 -39.58 63.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 109.042 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.9 mtt -67.33 -23.91 65.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.041 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.08 -40.03 15.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.441 -0.787 . . . . 0.0 109.805 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -15.41 6.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.511 -0.743 . . . . 0.0 110.359 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 4.1 mt-10 -90.16 -27.41 19.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.009 -1.057 . . . . 0.0 109.582 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.09 -58.45 2.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.918 . . . . 0.0 109.6 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 129' ' ' ASP . 40.2 p-10 -45.25 123.94 4.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.645 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.2 mt -91.89 -38.32 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.27 -0.894 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -76.23 -37.3 57.86 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.454 -0.779 . . . . 0.0 109.722 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.88 32.32 4.46 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.448 ' OD1' ' HG2' ' A' ' 135' ' ' GLN . 2.3 p30 -79.54 -24.56 42.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -1.075 . . . . 0.0 109.638 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.2 28.87 5.94 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.448 ' HG2' ' OD1' ' A' ' 133' ' ' ASP . 3.1 pt20 -160.23 -169.28 2.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -1.181 . . . . 0.0 108.993 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 137' ' ' ASN . 57.5 t -136.47 169.07 20.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.989 -1.07 . . . . 0.0 110.129 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.633 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -143.63 -167.92 2.7 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.252 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.526 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 50.6 t80 -74.5 -38.36 62.87 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.805 -1.184 . . . . 0.0 109.497 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -49.68 68.02 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.308 -0.87 . . . . 0.0 109.701 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.507 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 50.2 mt-10 -68.23 -36.92 80.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.678 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.566 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 34.6 t80 -69.21 -26.91 65.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -0.921 . . . . 0.0 109.686 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.476 ' O ' HG21 ' A' ' 146' ' ' THR . 48.1 t -68.12 -43.3 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.619 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -72.44 -21.99 61.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 0.0 109.878 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.43 -22.32 22.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.566 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.6 tpt -92.34 -59.15 2.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.078 -1.014 . . . . 0.0 109.787 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.476 HG21 ' O ' ' A' ' 142' ' ' VAL . 4.8 t . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.367 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.49 -47.56 81.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 0.0 110.109 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.433 HG22 ' HA ' ' A' ' 142' ' ' VAL . 3.2 mt -65.07 -36.85 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.155 -0.965 . . . . 0.0 110.159 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.578 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.4 mtp85 -50.67 -34.29 25.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.112 -0.992 . . . . 0.0 109.372 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 88' ' ' ALA . 3.4 mt-10 -87.73 -52.73 5.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 109.742 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.64 -26.83 0.41 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 108.635 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.54 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 88.0 t80 -62.77 -57.64 10.22 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.43 -0.794 . . . . 0.0 109.572 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -61.06 -31.66 71.32 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 109.04 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 70.4 t -46.66 -35.48 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.591 ' CE2' ' CG1' ' A' ' 108' ' ' VAL . 28.0 m-85 -87.29 -47.71 8.6 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 90' ' ' ARG . 57.5 t0 -72.97 116.75 13.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.69 -25.29 21.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.142 -0.973 . . . . 0.0 110.125 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.9 OUTLIER -78.94 2.61 19.65 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 108.983 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.471 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.04 47.56 1.35 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -108.26 -38.63 5.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -1.202 . . . . 0.0 109.748 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.14 -10.44 2.27 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.578 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -130.26 151.06 51.18 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.165 -1.197 . . . . 0.0 109.946 -179.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.436 HG21 ' HB2' ' A' ' 104' ' ' GLU . 62.9 mt -114.0 141.18 31.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.24 -0.913 . . . . 0.0 109.339 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -100.44 -178.29 3.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.76 -46.17 72.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.338 -0.851 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.48 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . . . -56.47 -47.12 79.86 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.373 -0.829 . . . . 0.0 109.343 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.451 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 97.7 mt-10 -65.75 -22.88 66.63 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD2' ' CG ' ' A' ' 109' ' ' MET . 0.6 OUTLIER -77.86 -25.19 48.51 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.557 ' HG2' ' CG2' ' A' ' 121' ' ' VAL . 8.9 mtm-85 -77.74 -45.71 23.9 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.216 -0.928 . . . . 0.0 108.55 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -48.09 -27.22 2.19 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.454 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.591 ' CG1' ' CE2' ' A' ' 92' ' ' PHE . 98.8 t -112.82 -39.26 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.612 -1.305 . . . . 0.0 111.309 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.587 ' CG ' ' CD2' ' A' ' 105' ' ' LEU . 10.6 mmt -61.76 -15.89 44.9 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 109.727 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.504 HG21 ' N ' ' A' ' 111' ' ' ASN . 12.7 t -85.53 -25.12 26.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 109.34 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.504 ' N ' HG21 ' A' ' 110' ' ' THR . 11.5 t-20 -54.75 -34.77 62.99 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.282 -0.886 . . . . 0.0 109.38 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 1.95 3.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.795 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -110.74 30.52 8.05 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 2.2 mt-10 59.06 -95.53 0.06 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.329 -1.1 . . . . 0.0 109.304 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.94 136.21 33.59 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.07 -1.019 . . . . 0.0 109.601 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.512 ' HG ' ' HB3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -115.04 108.76 17.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.935 . . . . 0.0 109.544 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.53 -170.21 0.64 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.078 -1.014 . . . . 0.0 108.294 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -80.49 -54.96 5.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.915 -1.116 . . . . 0.0 108.882 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -22.62 65.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 108.838 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.61 -47.07 20.25 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.557 ' CG2' ' HG2' ' A' ' 106' ' ' ARG . 44.2 t -52.7 -46.5 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.488 -0.757 . . . . 0.0 110.087 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -48.64 -33.91 10.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 0.0 109.871 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -71.83 -37.96 70.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.404 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.6 mtt -68.54 -27.53 66.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.091 -1.006 . . . . 0.0 108.98 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.528 HG12 ' CD1' ' A' ' 105' ' ' LEU . 6.0 mt -78.19 -37.47 22.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.547 ' HG3' ' N ' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -57.82 -27.08 62.84 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.83 -0.544 . . . . 0.0 110.235 -179.417 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.547 ' N ' ' HG3' ' A' ' 126' ' ' ARG . 3.5 mt-10 -91.24 -16.95 26.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.021 -1.049 . . . . 0.0 109.859 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.465 ' HA ' ' HG2' ' A' ' 144' ' ' MET . . . -99.15 -66.36 0.91 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.114 -0.991 . . . . 0.0 109.794 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 128' ' ' ALA . 6.8 t70 -46.12 154.74 0.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.37 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.5 mm -88.89 -65.22 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.715 0.769 . . . . 0.0 109.268 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -176.91 57.09 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.564 -0.71 . . . . 0.0 109.342 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -104.32 -89.63 2.12 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -129.46 -19.54 3.41 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.73 -0.865 . . . . 0.0 110.128 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.459 ' O ' HG23 ' A' ' 125' ' ' ILE . . . 125.81 16.75 2.67 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.465 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 1.6 tt0 -112.56 163.38 14.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.23 -1.159 . . . . 0.0 108.674 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 137' ' ' ASN . 96.5 t -106.18 165.85 3.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 120.923 -1.11 . . . . 0.0 109.492 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.578 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -149.62 -171.31 3.86 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.578 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 62.9 t80 -69.0 -37.7 78.86 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.607 -1.308 . . . . 0.0 111.337 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.88 -40.38 79.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.053 . . . . 0.0 110.377 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.511 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 26.8 mt-10 -81.04 -23.04 38.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.933 -1.105 . . . . 0.0 109.192 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' A' ' 145' ' ' MET . 28.4 t80 -84.28 -23.62 30.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.38 -0.825 . . . . 0.0 109.607 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.498 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 52.2 t -73.97 -63.13 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.312 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -56.58 -24.54 48.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.465 ' HG2' ' HA ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -90.23 -31.8 16.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.906 -1.121 . . . . 0.0 110.029 -179.506 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 141' ' ' PHE . 2.1 ttp -77.04 -16.87 59.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.086 -1.009 . . . . 0.0 109.784 -179.879 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.355 0.597 . . . . 0.0 109.922 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -100.22 -18.65 16.77 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.468 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 2.7 mp -83.5 -35.11 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.595 -0.691 . . . . 0.0 109.665 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.37 -45.89 90.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.111 -0.993 . . . . 0.0 109.344 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.67 -31.66 24.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.14 -0.975 . . . . 0.0 109.069 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -61.57 -24.01 66.36 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 138' ' ' TYR . 73.6 t80 -66.31 -55.47 15.84 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.418 -0.801 . . . . 0.0 109.279 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -28.84 70.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.223 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 4.8 t -48.18 -29.04 2.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.582 ' CE2' ' HB ' ' A' ' 108' ' ' VAL . 78.6 m-85 -100.32 -35.94 9.43 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.424 ' HB2' HG12 ' A' ' 100' ' ' ILE . 41.5 t0 -90.36 87.16 6.69 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -77.25 -18.48 57.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.836 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ASN . 10.3 t70 -78.02 2.32 18.11 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.405 -0.81 . . . . 0.0 109.252 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.39 29.92 0.05 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' ASP . 4.0 t30 -88.93 -36.94 15.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.089 -1.242 . . . . 0.0 109.467 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.54 -14.17 4.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -128.37 146.55 50.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.25 -1.147 . . . . 0.0 109.746 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.438 HG21 ' HB2' ' A' ' 104' ' ' GLU . 87.0 mt -105.05 131.63 53.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.566 -0.709 . . . . 0.0 109.448 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.51 172.25 8.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.189 -0.944 . . . . 0.0 109.574 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.85 81.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 109.399 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.89 -35.89 75.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.362 -0.836 . . . . 0.0 109.332 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 66.1 mm-40 -70.64 -23.41 62.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.151 -0.968 . . . . 0.0 108.861 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 109' ' ' MET . 55.8 tp -83.9 -25.15 30.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.546 -0.722 . . . . 0.0 109.301 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.03 -24.95 43.28 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.246 -0.909 . . . . 0.0 108.967 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -59.91 -29.61 68.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 110.297 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.582 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 95.5 t -111.23 -46.62 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.887 -1.133 . . . . 0.0 110.203 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -52.69 -58.98 5.08 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.451 -0.78 . . . . 0.0 109.241 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -91.16 13.09 18.0 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.412 -0.805 . . . . 0.0 110.137 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.486 ' HB3' ' HA ' ' A' ' 108' ' ' VAL . 3.0 p-10 -43.41 -48.44 7.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 0.0 109.785 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 111' ' ' ASN . 20.1 mt -152.53 14.67 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.013 . . . . 0.0 109.94 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -106.3 -14.51 20.11 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 54.55 30.43 13.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.412 -1.052 . . . . 0.0 109.24 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -79.31 161.01 26.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 117' ' ' THR . 3.6 pp 31.95 -157.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.499 0.666 . . . . 0.0 111.391 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.559 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 4.0 t -152.19 -161.79 1.38 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.189 -0.945 . . . . 0.0 108.913 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.73 -50.15 11.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.065 -1.022 . . . . 0.0 110.14 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -67.56 -13.1 61.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 109.618 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.481 ' HB3' HG21 ' A' ' 117' ' ' THR . 5.5 tt0 -97.5 -34.77 10.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.27 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.503 HG21 ' CD1' ' A' ' 116' ' ' LEU . 11.6 t -49.5 -51.75 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -41.14 -37.65 0.93 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 109.805 -179.534 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.485 ' HG2' ' HD2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -68.25 -57.51 5.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.158 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.473 ' SD ' HD23 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -49.86 -22.73 1.58 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.158 179.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.447 HG21 HG21 ' A' ' 136' ' ' VAL . 3.4 mt -84.66 -38.65 13.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.63 0.729 . . . . 0.0 109.741 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.485 ' HD2' ' HG2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -62.02 -31.16 71.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.035 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.02 -9.51 53.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.106 -0.996 . . . . 0.0 109.113 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.57 -14.0 18.38 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.442 -0.786 . . . . 0.0 109.047 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.476 ' OD1' HG21 ' A' ' 136' ' ' VAL . 9.8 m-20 -92.63 164.27 13.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.433 -0.792 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.458 HD13 ' HG2' ' A' ' 140' ' ' GLU . 40.9 mt -86.16 -53.48 10.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.271 -0.893 . . . . 0.0 109.562 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.52 -46.58 46.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.495 -0.753 . . . . 0.0 109.673 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.79 30.71 4.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 135' ' ' GLN . 0.7 OUTLIER -79.85 -24.79 41.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -1.144 . . . . 0.0 109.596 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.39 16.91 9.77 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.548 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -128.65 147.53 50.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -1.088 . . . . 0.0 109.205 -179.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 137' ' ' ASN . 71.9 t -115.0 165.54 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.079 -1.013 . . . . 0.0 109.574 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.568 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -140.56 -168.05 2.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.5 ' HA ' ' CD1' ' A' ' 89' ' ' PHE . 38.2 t80 -65.67 -52.64 50.05 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.715 -1.24 . . . . 0.0 110.689 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.465 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 2.6 mt-10 -58.44 -60.56 3.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.051 -1.03 . . . . 0.0 110.155 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.459 ' OE1' ' HA ' ' A' ' 129' ' ' ASP . 13.5 mt-10 -52.14 -38.67 58.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 110.275 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.435 ' CE2' ' HA ' ' A' ' 89' ' ' PHE . 38.5 t80 -69.65 -29.22 66.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.981 -1.074 . . . . 0.0 109.81 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 59.7 t -67.34 -39.36 82.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.444 -0.785 . . . . 0.0 109.875 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -64.06 -32.09 73.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.6 tmm? -90.2 -21.47 22.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.019 . . . . 0.0 110.029 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -57.94 3.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.08 -1.012 . . . . 0.0 109.913 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.599 ' O ' ' CG2' ' A' ' 146' ' ' THR . 1.4 m . . . . . 0 C--N 1.305 -1.334 0 O-C-N 121.191 -0.943 . . . . 0.0 109.229 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.47 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.7 OUTLIER -61.31 -13.29 18.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 109.687 -179.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.4 mt -86.71 -49.54 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.128 -0.983 . . . . 0.0 109.207 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.604 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.2 ttp180 -47.97 -29.26 3.27 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.254 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 88' ' ' ALA . 46.5 mt-10 -93.46 -53.25 4.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.92 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.484 ' CB ' ' HE3' ' A' ' 145' ' ' MET . . . -45.82 -25.5 0.52 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.999 -1.063 . . . . 0.0 109.0 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 87.2 t80 -65.61 -56.25 13.24 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.441 -0.787 . . . . 0.0 109.604 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -62.08 -32.43 72.96 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.673 -0.642 . . . . 0.0 109.272 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.473 HG22 ' HA ' ' A' ' 88' ' ' ALA . 32.5 t -47.41 -31.08 2.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -96.9 -33.71 11.52 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.46 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 25.8 t0 -92.57 108.15 19.76 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.535 ' HD3' ' CE1' ' A' ' 107' ' ' HIS . 0.1 OUTLIER -80.1 -26.56 39.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.113 -0.992 . . . . 0.0 110.128 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 97' ' ' ASN . 47.3 m-20 -79.15 2.67 20.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.3 -0.875 . . . . 0.0 108.934 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 34.53 34.56 0.04 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' ASP . 3.5 t30 -87.32 -59.15 2.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -1.201 . . . . 0.0 109.836 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.39 -24.15 0.14 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.649 ' CE2' ' HB3' ' A' ' 137' ' ' ASN . 15.4 m-85 -122.42 139.88 53.34 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.257 -1.143 . . . . 0.0 109.791 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.487 HG21 ' N ' ' A' ' 101' ' ' SER . 63.1 mt -100.47 141.98 16.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.487 ' N ' HG21 ' A' ' 100' ' ' ILE . 88.9 p -109.91 -178.67 3.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.052 -1.03 . . . . 0.0 109.153 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 105' ' ' LEU . . . -62.38 -45.33 93.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 109.284 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.4 -46.43 88.71 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.37 -0.831 . . . . 0.0 109.539 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 107' ' ' HIS . 28.5 mt-10 -62.97 -24.26 67.82 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 121' ' ' VAL . 57.8 tp -71.28 -38.47 71.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.514 ' O ' ' CG ' ' A' ' 109' ' ' MET . 0.5 OUTLIER -70.92 -11.06 60.75 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.535 ' CE1' ' HD3' ' A' ' 94' ' ' LYS . 11.9 t-160 -57.82 -47.09 83.65 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.42 -0.8 . . . . 0.0 110.037 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.448 HG23 HG11 ' A' ' 91' ' ' VAL . 10.6 t -106.55 -5.66 10.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.243 -0.91 . . . . 0.0 110.103 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.514 ' CG ' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -39.12 -38.58 0.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 110.806 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.511 ' HA ' ' CA ' ' A' ' 114' ' ' GLU . 7.2 t -94.69 -34.65 12.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.869 -1.144 . . . . 0.0 110.226 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -58.14 -18.54 26.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.929 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 mt -145.39 -20.37 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.043 -1.036 . . . . 0.0 111.222 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' MET . . . -124.14 18.54 7.41 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.203 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.511 ' CA ' ' HA ' ' A' ' 110' ' ' THR . 22.5 mt-10 58.1 179.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -1.223 . . . . 0.0 109.601 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.461 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 0.3 OUTLIER -54.64 133.57 46.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.912 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 0.4 OUTLIER -108.89 -164.8 0.97 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.198 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.486 ' OG1' ' HG3' ' A' ' 120' ' ' GLU . 3.0 p -149.47 -150.09 0.33 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.398 -0.814 . . . . 0.0 108.85 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.51 -49.31 7.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.44 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -68.96 -15.72 63.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 0.0 109.889 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.486 ' HG3' ' OG1' ' A' ' 117' ' ' THR . 0.1 OUTLIER -94.52 -37.1 11.55 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.109 -0.994 . . . . 0.0 108.996 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.45 ' HA ' HD22 ' A' ' 105' ' ' LEU . 29.3 t -72.0 -70.38 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.819 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -50.76 -27.65 7.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 0.0 109.434 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 79.1 tt0 -75.2 -39.15 60.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 0.0 108.703 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . 0.439 ' SD ' HD23 ' A' ' 116' ' ' LEU . 23.1 mtp -61.83 -29.84 70.44 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.404 HG21 ' OD2' ' A' ' 129' ' ' ASP . 1.8 mt -77.08 -40.81 30.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.5 mtp85 -57.77 -33.15 68.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.624 -0.672 . . . . 0.0 109.931 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -81.38 -20.09 41.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 108.9 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.484 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -97.46 -6.54 33.61 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.514 -0.741 . . . . 0.0 109.469 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.404 ' OD2' HG21 ' A' ' 125' ' ' ILE . 4.3 m-20 -89.82 131.21 35.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.31 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.459 HD11 ' OE2' ' A' ' 140' ' ' GLU . 47.5 mt -104.9 -32.42 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.157 -0.965 . . . . 0.0 109.745 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.53 -41.86 6.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.767 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.23 36.21 2.0 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.3 p30 -79.16 -26.65 42.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.324 -1.104 . . . . 0.0 108.885 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 119.42 -40.75 2.15 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.44 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 15.3 pm0 -110.05 -177.39 3.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -1.164 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.509 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 99.5 t -122.64 171.83 10.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.343 -0.848 . . . . 0.0 108.852 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.649 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 1.4 p-10 -148.57 -175.04 4.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.795 -1.191 . . . . 0.0 108.828 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.604 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 52.5 t80 -71.75 -39.8 69.79 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.804 -1.185 . . . . 0.0 110.721 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.42 -48.5 75.13 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.992 -1.067 . . . . 0.0 109.985 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.474 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 1.3 mm-40 -71.83 -32.6 67.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.483 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 37.4 t80 -72.76 -25.78 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.868 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.502 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 39.6 t -74.01 -51.16 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -59.81 -30.67 69.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.185 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.428 ' HE3' ' CG1' ' A' ' 130' ' ' ILE . 8.1 tpp -84.46 -29.98 25.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.009 -1.057 . . . . 0.0 109.924 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.484 ' HE3' ' CB ' ' A' ' 88' ' ' ALA . 3.1 tmm? -91.41 -5.14 54.86 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.184 -0.947 . . . . 0.0 110.217 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.491 HG21 ' O ' ' A' ' 142' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.494 1.767 0 O-C-N 120.98 -1.075 . . . . 0.0 110.206 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.428 ' O ' ' CG ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER 173.01 132.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 77' ' ' LYS . 0.9 OUTLIER 40.66 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 0.0 109.881 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 t -169.73 163.82 9.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.57 6.25 11.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.45 104.22 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.286 -0.884 . . . . 0.0 109.43 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -64.31 -13.57 50.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.207 -0.933 . . . . 0.0 108.95 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 84' ' ' GLU . 1.3 mt-10 -75.8 -29.33 58.67 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.443 -0.786 . . . . 0.0 109.095 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -43.7 -33.85 1.34 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 109.65 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.459 ' HA ' ' HE1' ' A' ' 145' ' ' MET . 2.1 mp -93.17 -34.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.198 -0.939 . . . . 0.0 109.929 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.462 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 2.0 mmt85 -48.58 -37.91 19.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.641 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.7 mt-10 -87.01 -51.89 5.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.762 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.477 ' HA ' HG22 ' A' ' 91' ' ' VAL . . . -45.94 -25.06 0.48 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.994 -1.066 . . . . 0.0 109.11 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 77.6 t80 -66.5 -56.31 11.5 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.413 -0.804 . . . . 0.0 109.45 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -63.14 -27.51 69.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.295 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.477 HG22 ' HA ' ' A' ' 88' ' ' ALA . 41.2 t -50.34 -28.99 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.463 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 62.4 m-85 -100.96 -36.19 9.12 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.94 82.58 8.28 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.581 -0.7 . . . . 0.0 109.254 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.447 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 4.7 mmtt -80.61 -20.43 43.25 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.301 -0.875 . . . . 0.0 110.157 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' GLY . 2.6 m-20 -78.12 1.56 20.82 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.98 48.15 1.96 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -109.09 -18.28 13.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -1.196 . . . . 0.0 109.812 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.461 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 120.09 -36.65 3.35 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.577 ' CD1' ' OE1' ' A' ' 135' ' ' GLN . 54.7 m-85 -116.38 142.08 47.32 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.374 -1.074 . . . . 0.0 109.59 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 97.0 mt -90.25 123.78 42.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 108.962 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.4 p -82.05 173.5 12.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.14 -0.975 . . . . 0.0 109.427 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.486 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -63.4 -42.1 98.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.414 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.462 ' HA ' ' NH2' ' A' ' 106' ' ' ARG . . . -63.46 -30.23 71.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 56.1 mm-40 -72.15 -22.51 61.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.149 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 109' ' ' MET . 4.1 tp -88.71 -31.83 18.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.6 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.462 ' NH2' ' HA ' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -88.16 -9.59 52.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.164 -0.96 . . . . 0.0 109.175 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -88.31 -39.31 14.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.098 -1.001 . . . . 0.0 109.669 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 92' ' ' PHE . 57.3 t -88.62 -28.42 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 109.795 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 4.5 mtt -68.16 -20.98 64.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.238 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.518 ' CB ' ' O ' ' A' ' 114' ' ' GLU . 8.5 t -100.05 1.19 42.15 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.578 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 45.9 p-10 -57.51 -16.17 9.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 0.0 109.601 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.468 ' N ' ' OD1' ' A' ' 111' ' ' ASN . 1.2 mt -107.46 -20.93 13.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 109.641 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.6 -32.35 1.73 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 110' ' ' THR . 10.6 mt-10 -50.62 137.45 19.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.254 -1.145 . . . . 0.0 109.488 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 81.68 1.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.105 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.473 ' HB3' HG21 ' A' ' 121' ' ' VAL . 4.8 mp -63.91 136.29 57.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.0 t -90.81 -178.15 5.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 108.78 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -67.08 -54.98 16.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.892 -1.13 . . . . 0.0 110.178 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -60.73 -12.09 9.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.251 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.402 ' O ' ' CG ' ' A' ' 124' ' ' MET . 5.1 tp10 -97.46 -32.6 11.76 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.239 -0.913 . . . . 0.0 109.606 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 116' ' ' LEU . 25.3 t -72.64 -54.43 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 0.0 109.787 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.69 -34.83 62.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.119 -0.988 . . . . 0.0 109.689 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 1.0 OUTLIER -76.08 -35.71 59.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.095 -1.003 . . . . 0.0 109.243 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.402 ' CG ' ' O ' ' A' ' 120' ' ' GLU . 1.4 mmt -70.56 -21.05 62.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 108.716 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.486 HD13 ' HA ' ' A' ' 102' ' ' ALA . 2.0 mt -84.87 -42.77 16.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.451 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -48.79 -31.61 7.32 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 109.898 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.84 -24.62 20.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.022 -1.049 . . . . 0.0 110.394 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.81 -44.98 54.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 109.838 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.498 ' HB3' ' O ' ' A' ' 135' ' ' GLN . 12.9 p-10 -86.39 177.06 7.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.349 -0.845 . . . . 0.0 109.668 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.0 mt -85.9 -66.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.414 -0.804 . . . . 0.0 109.567 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -177.47 57.83 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.512 -0.742 . . . . 0.0 109.49 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.22 -87.15 1.78 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.4 p-10 -139.11 -24.51 0.88 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.999 -0.707 . . . . 0.0 110.249 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 125' ' ' ILE . . . 141.06 29.48 0.17 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.577 ' OE1' ' CD1' ' A' ' 99' ' ' TYR . 3.0 pt20 -119.63 166.85 12.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.263 . . . . 0.0 108.914 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.444 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 69.9 t -119.41 162.87 17.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.501 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 5.2 t-20 -141.29 -164.38 1.75 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.975 -1.078 . . . . 0.0 108.372 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.462 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 60.9 t80 -77.31 -49.5 14.85 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.686 -1.259 . . . . 0.0 110.15 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.29 -29.06 69.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.967 -1.083 . . . . 0.0 109.593 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.476 ' HB3' ' HA ' ' A' ' 129' ' ' ASP . 19.6 mt-10 -84.65 -32.87 23.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.107 -0.995 . . . . 0.0 108.856 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.42 ' CE2' ' HA ' ' A' ' 89' ' ' PHE . 42.8 t80 -71.66 -25.81 62.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.535 -0.728 . . . . 0.0 109.087 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 24.0 t -60.53 -47.07 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.444 -0.785 . . . . 0.0 109.511 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -64.42 -35.54 81.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 109.782 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.417 ' O ' ' HG2' ' A' ' 144' ' ' MET . 6.0 tmm? -83.34 -12.54 56.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.781 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.459 ' HE1' ' HA ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -81.88 -67.84 0.75 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.299 -0.876 . . . . 0.0 109.247 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.2 -85.78 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.412 -0.805 . . . . 0.0 109.285 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.31 167.21 2.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.355 -0.841 . . . . 0.0 109.586 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.587 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -66.33 176.75 1.69 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.84 . . . . 0.0 109.832 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.76 21.77 12.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.318 -0.864 . . . . 0.0 109.318 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.73 -173.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.979 . . . . 0.0 109.224 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.46 ' O ' ' OG ' ' A' ' 81' ' ' SER . 7.3 m-20 -144.18 -64.97 0.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 0.0 109.573 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 80' ' ' ASP . 5.8 p 47.59 22.99 0.35 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.339 -0.851 . . . . 0.0 110.193 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -73.55 -23.49 59.99 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.355 -0.841 . . . . 0.0 109.279 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -89.59 -27.36 20.27 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.457 -0.777 . . . . 0.0 109.112 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -47.83 84.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 142' ' ' VAL . 5.1 mt -75.3 -37.35 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.614 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.589 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -52.52 -30.71 31.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.193 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 23.1 mm-40 -90.93 -52.11 5.02 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.377 -0.827 . . . . 0.0 109.473 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -47.19 -24.86 0.78 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.989 . . . . 0.0 109.159 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 92.6 t80 -67.51 -56.46 9.43 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -63.76 -24.31 67.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 108' ' ' VAL . 24.4 t -52.73 -32.72 17.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.4 ' CE1' HG13 ' A' ' 108' ' ' VAL . 53.9 m-85 -95.32 -36.56 11.35 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.474 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 27.6 t0 -84.26 112.78 20.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.544 -0.722 . . . . 0.0 109.483 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.478 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -89.31 -24.42 22.03 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.095 -1.003 . . . . 0.0 109.825 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 97' ' ' ASN . 60.2 m-20 -78.6 1.41 22.77 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.571 -0.852 . . . . 0.0 108.748 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 36.32 31.41 0.04 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -88.16 -28.36 21.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.076 -1.249 . . . . 0.0 109.529 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.48 -19.76 5.03 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 2.0 m-30 -118.45 152.41 35.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -1.156 . . . . 0.0 109.562 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.474 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 52.3 mt -118.25 105.36 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.145 -0.972 . . . . 0.0 109.491 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 102' ' ' ALA . 2.3 p -74.17 151.79 39.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 0.0 109.258 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 101' ' ' SER . . . -43.79 -36.4 2.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.95 . . . . 0.0 109.771 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.34 -45.81 82.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.083 -1.011 . . . . 0.0 109.58 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.478 ' OE2' ' HB2' ' A' ' 94' ' ' LYS . 3.8 mm-40 -65.95 -21.44 66.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.118 -0.989 . . . . 0.0 108.785 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.536 ' O ' ' CG ' ' A' ' 109' ' ' MET . 10.6 tp -84.53 -25.14 28.99 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.459 -0.776 . . . . 0.0 109.581 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -77.79 -54.81 5.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.516 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.458 ' O ' HG23 ' A' ' 110' ' ' THR . 15.2 t60 -45.05 -45.4 10.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.954 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 91' ' ' VAL . 98.2 t -82.88 -24.4 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 110.107 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.536 ' CG ' ' O ' ' A' ' 105' ' ' LEU . 8.8 mmt -70.59 -14.06 62.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.071 -1.018 . . . . 0.0 109.256 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 107' ' ' HIS . 15.3 t -100.55 -6.32 25.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 109.686 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.442 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 1.2 t-20 -44.3 -51.97 7.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.228 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.442 ' HG ' ' C ' ' A' ' 111' ' ' ASN . 28.7 mt -145.83 13.46 1.32 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -129.11 22.6 5.06 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 2.8 mm-40 62.05 153.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.405 -1.056 . . . . 0.0 109.278 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 126.81 31.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 0.0 109.668 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' ' 109' ' ' MET . 10.2 mp -70.29 171.56 9.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.445 ' O ' HG22 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.83 -170.23 2.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.301 -0.874 . . . . 0.0 108.835 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.03 -49.83 8.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.182 -0.949 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.81 -12.04 57.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.816 . . . . 0.0 109.41 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -99.52 -41.64 7.28 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.362 -0.836 . . . . 0.0 109.75 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 117' ' ' THR . 29.4 t -56.51 -51.78 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.588 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.18 -27.42 54.41 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.183 -0.948 . . . . 0.0 109.733 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 85.4 mt-10 -79.12 -29.13 43.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.375 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.46 ' SD ' HD22 ' A' ' 116' ' ' LEU . 2.1 mtt -78.52 -24.85 45.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 108.542 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.531 HG22 ' CG2' ' A' ' 136' ' ' VAL . 5.7 mt -83.59 -39.27 14.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.563 0.697 . . . . 0.0 109.378 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.8 ptm180 -42.37 -21.87 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.735 -0.603 . . . . 0.0 111.494 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' ILE . 1.6 mt-10 -86.18 -42.51 13.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.579 -1.326 . . . . 0.0 108.918 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.442 ' HB2' HG23 ' A' ' 136' ' ' VAL . . . -92.36 7.56 42.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.444 ' CG ' HG21 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -69.0 132.71 47.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.548 0.69 . . . . 0.0 110.455 -179.008 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.526 ' HA ' ' HG3' ' A' ' 140' ' ' GLU . 12.3 mt -49.11 -43.6 15.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.565 -0.709 . . . . 0.0 109.645 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -156.67 -36.29 0.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.355 -0.841 . . . . 0.0 109.971 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 155.82 40.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -101.46 -23.35 14.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -1.153 . . . . 0.0 109.358 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.467 ' O ' HG23 ' A' ' 125' ' ' ILE . . . 109.76 -17.44 30.28 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.462 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -103.05 169.13 8.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.076 -1.249 . . . . 0.0 109.728 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.531 ' CG2' HG22 ' A' ' 125' ' ' ILE . 54.3 t -128.07 167.21 23.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.587 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 5.3 p-10 -138.4 -173.89 3.66 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.589 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 55.3 t80 -72.7 -43.02 63.59 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.682 -1.261 . . . . 0.0 111.657 -178.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -66.4 -32.42 73.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.785 -1.197 . . . . 0.0 110.743 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.564 ' CG ' ' OD1' ' A' ' 137' ' ' ASN . 41.5 mm-40 -86.4 -28.93 23.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.0 109.161 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.434 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 20.6 t80 -75.1 -24.09 58.05 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.453 ' HA ' HG22 ' A' ' 85' ' ' ILE . 42.3 t -69.33 -44.89 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.515 -0.741 . . . . 0.0 109.996 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -51.77 -38.29 54.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.082 -1.012 . . . . 0.0 109.946 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.42 -42.67 24.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.192 -0.943 . . . . 0.0 109.842 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.405 ' SD ' HG12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -68.36 -10.02 52.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.255 -0.903 . . . . 0.0 109.919 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.475 ' O ' HG21 ' A' ' 146' ' ' THR . 2.6 m -105.03 -5.94 20.46 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.164 -0.96 . . . . 0.0 109.299 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.3 126.64 17.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 109.689 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.32 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 77.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.948 . . . . 0.0 109.615 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -101.7 -175.53 2.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 109.591 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.51 97.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.376 -0.828 . . . . 0.0 109.667 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -105.23 114.57 28.83 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.336 -0.853 . . . . 0.0 109.137 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.9 m -83.87 11.6 7.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.392 -0.817 . . . . 0.0 109.66 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.49 -24.46 56.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 108.793 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -73.24 -13.58 61.17 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -59.96 -18.3 44.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.5 mm -71.94 -34.21 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.447 -0.783 . . . . 0.0 109.641 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.574 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -50.7 -39.34 51.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 109.304 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' PHE . 20.7 mt-10 -85.58 -50.68 7.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.181 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.86 -25.57 0.31 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.216 -0.927 . . . . 0.0 108.893 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 78.6 t80 -65.55 -56.65 11.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.283 -0.886 . . . . 0.0 109.2 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 5.3 mtp180 -61.23 -29.26 69.72 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 38.2 t -47.63 -35.02 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.571 ' CE2' HG13 ' A' ' 108' ' ' VAL . 61.3 m-85 -91.54 -37.84 12.88 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.474 ' OD1' ' OE2' ' A' ' 104' ' ' GLU . 44.1 t0 -89.78 90.12 8.06 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -78.58 -25.13 45.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 110.492 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.475 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 1.2 m-20 -79.84 7.07 9.45 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.165 -0.959 . . . . 0.0 109.33 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 40.21 38.9 1.43 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -87.92 -1.42 57.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.61 -21.94 23.43 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.656 ' CE1' ' CB ' ' A' ' 137' ' ' ASN . 1.5 m-85 -125.26 145.61 49.92 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.325 -1.103 . . . . 0.0 109.382 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.486 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 88.5 mt -103.04 101.16 11.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 109.592 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 p -73.29 -179.53 3.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -0.987 . . . . 0.0 109.223 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.16 90.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.59 -28.09 66.63 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.222 -0.924 . . . . 0.0 109.277 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.475 ' OE2' ' HB2' ' A' ' 95' ' ' ASP . 5.2 mm-40 -72.94 -31.6 64.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.112 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 109' ' ' MET . 16.2 tp -83.12 -27.57 30.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.313 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.421 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 2.2 ttt180 -65.26 -18.62 65.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.858 . . . . 0.0 108.82 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.505 ' CD2' HG21 ' A' ' 108' ' ' VAL . 33.9 t60 -82.76 -34.48 27.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.472 -0.767 . . . . 0.0 109.926 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.571 HG13 ' CE2' ' A' ' 92' ' ' PHE . 74.1 t -123.38 26.37 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.012 -1.055 . . . . 0.0 110.155 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.472 ' HB3' ' O ' ' A' ' 105' ' ' LEU . 9.2 ptt? -71.41 -21.58 61.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.067 -1.021 . . . . 0.0 108.815 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -88.84 -8.7 53.84 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.422 -0.799 . . . . 0.0 110.171 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.534 ' HB2' ' CG1' ' A' ' 108' ' ' VAL . 4.5 t-20 -36.44 -46.73 0.57 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.477 -0.764 . . . . 0.0 109.619 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.407 HD11 ' O ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER 174.92 35.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.49 -0.756 . . . . 0.0 109.071 179.134 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -116.12 36.1 3.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 22.8 mt-10 72.31 -160.72 0.11 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -1.019 . . . . 0.0 109.071 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.406 ' HB2' ' HE3' ' A' ' 115' ' ' LYS . 26.8 mtmt -120.93 89.81 3.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 109.691 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.478 ' HB2' ' HG2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -84.16 170.94 13.28 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.353 -0.842 . . . . 0.0 109.905 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.482 ' O ' HG21 ' A' ' 121' ' ' VAL . 5.4 t -112.1 -155.92 0.58 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.379 -0.826 . . . . 0.0 109.345 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.433 ' N ' HG22 ' A' ' 117' ' ' THR . 2.9 m-20 -84.44 -58.7 2.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.958 -1.089 . . . . 0.0 109.671 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -54.58 -18.86 4.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' A' ' 116' ' ' LEU . 3.2 tt0 -91.13 -37.0 13.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.357 -0.839 . . . . 0.0 109.764 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 117' ' ' THR . 2.9 t -41.85 -53.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.33 -0.856 . . . . 0.0 109.99 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -37.42 77.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.073 -1.017 . . . . 0.0 109.795 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -72.09 -19.06 61.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 0.0 109.377 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.5 mmm -85.73 -23.23 27.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.976 . . . . 0.0 108.424 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.462 HG23 ' O ' ' A' ' 134' ' ' GLY . 6.1 mt -84.32 -41.74 16.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.692 0.758 . . . . 0.0 109.164 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -61.44 -19.58 62.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 110.153 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -88.93 -31.77 18.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.01 . . . . 0.0 109.089 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.12 -5.83 51.96 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.608 -0.682 . . . . 0.0 109.394 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.465 ' OD2' ' OE1' ' A' ' 140' ' ' GLU . 1.2 t70 -100.23 166.59 10.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.451 ' N ' ' CG ' ' A' ' 129' ' ' ASP . 38.9 mm -86.78 -71.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.37 -0.831 . . . . 0.0 109.285 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 179.62 58.1 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.612 -0.68 . . . . 0.0 109.211 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.08 -89.5 1.92 Allowed Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -127.92 -25.84 3.0 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.69 0.757 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.462 ' O ' HG23 ' A' ' 125' ' ' ILE . . . 136.55 30.01 0.3 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 5.9 pt20 -128.74 -170.62 2.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.293 . . . . 0.0 108.938 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.486 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 92.8 t -127.33 169.82 18.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.994 -1.066 . . . . 0.0 109.604 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.656 ' CB ' ' CE1' ' A' ' 99' ' ' TYR . 7.7 p30 -149.37 -168.02 2.99 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.574 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 55.3 t80 -66.12 -55.24 17.43 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.44 -1.412 . . . . 0.0 110.461 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.507 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -53.66 -57.9 9.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.102 -0.999 . . . . 0.0 110.373 -179.322 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.527 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 19.6 mt-10 -57.68 -39.22 76.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.058 -1.026 . . . . 0.0 109.883 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.582 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 59.9 t80 -63.58 -28.05 69.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.538 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 139' ' ' GLU . 35.7 t -65.91 -53.12 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.421 -0.799 . . . . 0.0 109.722 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.471 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 3.0 mt-30 -58.43 -30.21 66.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 0.0 110.051 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.449 ' O ' ' HG2' ' A' ' 144' ' ' MET . 0.6 OUTLIER -86.92 -20.68 27.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.963 . . . . 0.0 109.958 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.582 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -96.31 -7.54 35.06 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.16 -0.963 . . . . 0.0 109.977 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p -115.37 -42.6 3.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.087 -1.008 . . . . 0.0 110.029 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 143' ' ' GLN . . . -59.29 97.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 0.0 109.75 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.678 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.466 ' O ' ' HB3' ' A' ' 77' ' ' LYS . 5.0 mtt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 76' ' ' MET . 22.8 ttpp 67.43 93.58 0.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.49 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.13 165.19 1.47 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 109.565 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.574 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.6 OUTLIER -69.63 162.8 26.93 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.284 -0.885 . . . . 0.0 109.207 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 79' ' ' THR . 0.2 OUTLIER 39.48 -88.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.615 -0.678 . . . . 0.0 110.575 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 79' ' ' THR . 0.1 OUTLIER 177.51 111.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.89 -1.131 . . . . 0.0 109.461 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 12.4 pt-20 -65.18 -14.94 61.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.163 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -84.72 -21.6 30.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.44 -0.787 . . . . 0.0 109.47 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.97 -19.59 61.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.895 . . . . 0.0 109.086 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 mt -116.71 -48.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.308 -0.87 . . . . 0.0 109.328 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.502 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.2 OUTLIER -56.33 -43.25 78.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.275 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -82.63 -31.99 28.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.341 -0.849 . . . . 0.0 109.491 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.467 ' HA ' HG22 ' A' ' 91' ' ' VAL . . . -61.5 -26.51 67.96 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.414 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 85.5 t80 -66.06 -56.89 9.27 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.507 -0.746 . . . . 0.0 109.417 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -64.03 -25.54 68.16 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 88' ' ' ALA . 17.6 t -53.13 -30.34 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.579 ' CE1' HG13 ' A' ' 108' ' ' VAL . 68.7 m-85 -97.22 -32.36 11.96 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.459 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 11.7 t70 -99.08 94.18 6.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -75.58 -23.4 56.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.056 -1.028 . . . . 0.0 109.671 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 97' ' ' ASN . 51.4 m-20 -78.5 0.92 24.12 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.339 -0.851 . . . . 0.0 108.943 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 31.26 37.46 0.03 OUTLIER Glycine 0 N--CA 1.498 2.826 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.6 OUTLIER -84.14 -32.93 24.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.26 . . . . 0.0 109.708 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.49 -34.08 2.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.7 m-85 -114.58 145.53 41.86 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.36 -1.082 . . . . 0.0 109.096 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.459 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 27.9 mt -100.07 122.6 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.171 -0.956 . . . . 0.0 109.469 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.59 -178.1 5.74 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.291 -0.881 . . . . 0.0 109.114 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.462 ' HB3' HG13 ' A' ' 121' ' ' VAL . . . -72.36 -36.19 68.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.131 -0.981 . . . . 0.0 109.303 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.45 -30.29 71.06 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.329 -0.857 . . . . 0.0 109.747 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 33.6 mm-40 -75.95 -22.7 55.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.168 -0.958 . . . . 0.0 109.189 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 63.5 tp -95.61 -11.02 27.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -0.764 . . . . 0.0 109.339 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -87.73 -43.26 12.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.314 -0.866 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.462 ' O ' HG21 ' A' ' 110' ' ' THR . 3.2 t60 -61.69 -41.84 98.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.952 . . . . 0.0 109.431 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.579 HG13 ' CE1' ' A' ' 92' ' ' PHE . 1.3 t -73.05 -40.0 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.156 -0.965 . . . . 0.0 109.161 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.463 ' HB3' HD11 ' A' ' 116' ' ' LEU . 2.4 mmt -68.1 -16.79 64.16 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 2.3 t -96.07 -20.95 18.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.845 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.478 ' OD1' ' O ' ' A' ' 108' ' ' VAL . 0.6 OUTLIER -52.18 -44.99 64.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 108.845 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 111' ' ' ASN . 33.1 mt -152.62 18.14 0.61 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.473 -0.767 . . . . 0.0 109.474 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -114.61 34.9 4.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 110' ' ' THR . 13.1 mm-40 62.09 -169.12 0.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.418 -1.048 . . . . 0.0 109.627 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.32 89.88 4.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.824 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.463 HD11 ' HB3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -57.39 131.31 49.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.497 HG21 ' HB3' ' A' ' 120' ' ' GLU . 1.1 t -79.47 177.75 8.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.09 -1.006 . . . . 0.0 108.839 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.85 -63.09 1.26 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.92 -1.113 . . . . 0.0 109.994 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 14.4 pt-20 -47.07 -44.39 20.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.948 . . . . 0.0 109.934 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.514 ' N ' ' CG ' ' A' ' 119' ' ' GLU . 39.8 tp10 -62.02 -41.15 97.78 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.757 -0.589 . . . . 0.0 110.454 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.462 HG13 ' HB3' ' A' ' 102' ' ' ALA . 46.9 t -65.89 -62.65 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.13 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -31.42 52.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.974 -1.079 . . . . 0.0 109.196 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 119' ' ' GLU . 30.3 mt-10 -71.06 -34.65 71.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.0 108.955 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.9 mmt -70.89 -28.15 64.33 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.342 -0.849 . . . . 0.0 108.842 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.447 HG22 HG22 ' A' ' 136' ' ' VAL . 2.7 mt -75.75 -42.08 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.424 -0.798 . . . . 0.0 109.15 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -14.63 3.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.673 -0.642 . . . . 0.0 110.165 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.2 -32.37 21.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 108.981 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.64 -7.25 50.54 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.467 -0.77 . . . . 0.0 109.348 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 0.3 OUTLIER -76.99 145.14 38.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.867 . . . . 0.0 109.808 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.502 ' CG1' ' OE1' ' A' ' 140' ' ' GLU . 32.0 mm -81.68 -39.38 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.155 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.18 -43.62 3.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.704 -0.622 . . . . 0.0 109.618 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.84 39.0 0.67 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.412 ' CG ' ' OE1' ' A' ' 135' ' ' GLN . 1.5 p30 -78.62 -25.03 45.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.294 -1.121 . . . . 0.0 108.771 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.21 26.95 4.12 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.65 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.587 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -156.86 170.36 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.935 -1.332 . . . . 0.0 109.369 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.482 HG13 ' N ' ' A' ' 137' ' ' ASN . 85.5 t -130.74 168.2 24.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.18 -0.95 . . . . 0.0 109.572 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.604 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -140.27 -165.57 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.502 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 57.9 t80 -80.96 -40.07 25.05 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.04 -1.037 . . . . 0.0 109.768 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -33.0 73.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.089 -1.007 . . . . 0.0 109.378 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.57 ' CG ' ' ND2' ' A' ' 137' ' ' ASN . 2.1 mm-40 -82.18 -38.92 23.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.045 -1.034 . . . . 0.0 108.98 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.578 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 31.3 t80 -67.41 -25.42 65.93 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 108.978 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 138' ' ' TYR . 40.0 t -70.71 -43.67 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.862 . . . . 0.0 109.713 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -61.58 -23.89 66.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 109.697 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -31.47 16.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.638 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.578 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -93.03 -2.67 55.43 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.261 -0.9 . . . . 0.0 109.917 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -130.87 -46.54 1.03 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.263 -0.898 . . . . 0.0 108.992 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.92 48.8 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.571 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.402 179.871 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.6 ptm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.558 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 2.1 ttpm? 56.22 62.62 2.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 109.373 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 77' ' ' LYS . 1.3 t0 82.74 -47.58 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.741 -0.599 . . . . 0.0 110.067 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.13 -166.95 0.18 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.04 . . . . 0.0 109.285 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 t70 56.85 14.25 1.77 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.293 -0.879 . . . . 0.0 110.47 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.6 m -79.54 -27.42 41.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.988 -1.07 . . . . 0.0 109.273 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -91.62 -27.82 17.9 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.568 0.699 . . . . 0.0 109.336 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -85.79 8.89 18.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.601 -0.687 . . . . 0.0 109.444 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.472 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 22.8 tt0 -47.25 -24.58 0.76 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.57 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 mp -80.39 -43.39 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.321 -0.862 . . . . 0.0 109.667 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -39.0 57.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 109.355 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 17.7 pt-20 -81.03 -47.8 13.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.516 ' N ' ' HG3' ' A' ' 87' ' ' GLU . . . -45.47 -32.06 2.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 108.805 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.4 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 90.4 t80 -58.96 -56.29 24.22 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.393 -0.817 . . . . 0.0 109.582 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -63.42 -30.0 71.2 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.693 -0.629 . . . . 0.0 109.453 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 74.5 t -49.23 -28.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -102.14 -32.18 10.23 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD1' ' OE1' ' A' ' 104' ' ' GLU . 30.6 t70 -91.05 80.14 5.73 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.64 -0.663 . . . . 0.0 109.624 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -21.0 59.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.845 . . . . 0.0 109.817 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -78.58 1.9 21.08 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.72 -0.792 . . . . 0.0 108.994 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 34.62 39.44 0.15 Allowed Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -94.42 -17.8 22.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.277 . . . . 0.0 109.686 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.98 -38.19 2.94 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.581 ' CE2' ' HB2' ' A' ' 137' ' ' ASN . 36.6 m-85 -115.36 140.47 49.1 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.291 -1.123 . . . . 0.0 109.32 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.501 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 72.1 mt -89.49 117.12 32.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.19 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.3 p -83.74 164.86 19.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.427 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -58.71 -35.3 72.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.522 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.44 -31.65 71.12 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.228 -0.92 . . . . 0.0 109.381 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' OE1' ' OD1' ' A' ' 93' ' ' ASP . 34.5 mt-10 -71.94 -24.22 61.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.202 -0.936 . . . . 0.0 108.948 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.5 tp -85.05 -33.96 22.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.259 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -61.25 -28.49 69.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 108.657 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -65.89 -49.25 68.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.544 -0.722 . . . . 0.0 109.451 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.468 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 23.8 t -103.16 41.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.497 ' HB2' ' CD1' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -92.39 -23.06 19.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.804 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.8 OUTLIER -100.55 -12.48 19.24 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.211 -0.931 . . . . 0.0 109.573 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.533 ' O ' ' CD2' ' A' ' 112' ' ' LEU . 19.7 p-10 -45.55 -44.87 13.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.044 -1.035 . . . . 0.0 108.915 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.533 ' CD2' ' O ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -159.5 22.69 0.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.306 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -123.72 45.02 1.22 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.5 mm-40 56.84 -141.18 0.81 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -1.234 . . . . 0.0 109.125 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -126.18 83.62 2.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.977 -1.077 . . . . 0.0 109.459 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.497 ' CD1' ' HB2' ' A' ' 109' ' ' MET . 35.2 mt -59.31 -160.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.138 -0.976 . . . . 0.0 109.587 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.524 ' O ' ' CG2' ' A' ' 121' ' ' VAL . 17.9 p -153.78 -161.58 1.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.39 -48.6 9.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.192 -0.943 . . . . 0.0 109.072 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.42 -16.18 60.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.285 -0.884 . . . . 0.0 108.796 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -88.81 -37.31 15.5 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 117' ' ' THR . 9.1 t -55.98 -52.54 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.418 -0.801 . . . . 0.0 109.014 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.406 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 3.5 m-20 -57.82 -23.35 52.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.173 -0.954 . . . . 0.0 109.327 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -81.37 -29.96 33.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.428 -0.795 . . . . 0.0 109.046 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.432 ' HE1' ' HA ' ' A' ' 124' ' ' MET . 0.0 OUTLIER -77.82 -25.85 49.14 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 134' ' ' GLY . 6.8 mt -84.65 -38.73 13.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.738 0.78 . . . . 0.0 109.031 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.2 ptm85 -54.33 -33.49 59.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.703 -0.623 . . . . 0.0 109.897 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 5.7 mt-10 -89.62 -18.09 27.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.064 -1.022 . . . . 0.0 109.336 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.35 -5.37 43.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.387 -0.821 . . . . 0.0 109.751 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.464 ' OD2' ' O ' ' A' ' 126' ' ' ARG . 3.0 p30 -81.99 177.78 8.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.88 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.503 ' CD1' ' OE2' ' A' ' 140' ' ' GLU . 36.0 mt -81.13 -50.31 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.497 -0.752 . . . . 0.0 109.78 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -133.09 -24.32 1.88 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.32 -0.862 . . . . 0.0 110.55 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 137.78 40.79 0.11 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -78.97 -24.15 44.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -1.11 . . . . 0.0 108.74 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.481 ' O ' HG22 ' A' ' 125' ' ' ILE . . . 102.06 -26.58 23.83 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -103.58 173.71 6.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -1.229 . . . . 0.0 109.451 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.505 HG13 ' N ' ' A' ' 137' ' ' ASN . 55.6 t -124.26 162.62 25.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.581 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 4.6 t-20 -141.54 -165.55 2.01 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.867 -1.146 . . . . 0.0 108.215 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.452 ' O ' ' CG2' ' A' ' 142' ' ' VAL . 72.1 t80 -75.99 -39.22 56.28 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.844 -1.16 . . . . 0.0 109.843 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -70.56 -34.12 71.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.235 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.503 ' OE2' ' CD1' ' A' ' 130' ' ' ILE . 7.8 mt-10 -80.2 -28.91 38.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 108.778 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.4 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 43.1 t80 -78.88 -25.12 43.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.433 -0.792 . . . . 0.0 109.3 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 48.1 t -58.86 -48.53 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 109.822 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -66.64 -26.37 67.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.001 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.2 ttp -81.93 -21.95 37.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.468 ' HG3' ' HB2' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -87.67 -65.51 1.01 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.245 -0.909 . . . . 0.0 109.756 -179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -45.38 45.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.333 -0.854 . . . . 0.0 109.657 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -93.62 174.95 6.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 0.0 109.607 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.311 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.28 0.562 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 65.88 156.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 109.569 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 54.7 68.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.8 m -90.91 91.08 8.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.262 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 81' ' ' SER . 0.4 OUTLIER -117.44 -75.89 0.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.753 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 80' ' ' ASP . 0.3 OUTLIER 165.67 117.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.337 -0.852 . . . . 0.0 109.075 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -67.02 -15.13 63.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -86.39 -15.47 40.29 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.413 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -55.73 24.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.943 . . . . 0.0 109.495 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.81 -41.64 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.536 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.577 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 4.2 ttp180 -49.86 -31.35 11.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.066 -1.021 . . . . 0.0 109.03 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 77.9 mt-10 -86.15 -57.54 2.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 110.105 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.514 ' CB ' ' SD ' ' A' ' 145' ' ' MET . . . -41.07 -32.98 0.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 109.031 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.456 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 89.9 t80 -59.76 -56.96 15.35 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.493 -0.754 . . . . 0.0 109.194 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.448 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -59.94 -35.85 75.82 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.759 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.474 HG22 ' HA ' ' A' ' 88' ' ' ALA . 66.1 t -42.93 -32.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -98.57 -31.7 11.82 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 13.2 t70 -95.6 81.68 3.55 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.607 -0.683 . . . . 0.0 109.316 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -22.35 55.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 110.296 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 97' ' ' ASN . 59.1 m-20 -78.51 2.15 20.02 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.281 -0.887 . . . . 0.0 109.21 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.09 29.83 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 95' ' ' ASP . 1.9 t30 -78.51 -36.44 44.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.101 -1.235 . . . . 0.0 109.551 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.71 -52.73 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 11.8 m-30 -106.42 156.52 18.44 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.352 -1.087 . . . . 0.0 109.003 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 74.2 mt -97.24 108.33 21.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.453 -0.779 . . . . 0.0 109.273 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -78.19 -177.56 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.759 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.65 -45.14 88.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -0.856 . . . . 0.0 109.17 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.97 -23.9 67.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.434 -0.791 . . . . 0.0 109.698 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -76.99 -31.89 56.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.023 -1.048 . . . . 0.0 108.892 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.53 ' CD2' ' HG3' ' A' ' 109' ' ' MET . 0.7 OUTLIER -89.27 -13.23 38.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -0.842 . . . . 0.0 108.899 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.498 ' O ' ' CG2' ' A' ' 110' ' ' THR . 10.1 ttt180 -90.15 -14.03 34.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.377 -0.827 . . . . 0.0 108.793 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -77.79 -26.47 49.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 110.172 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.8 t -106.67 -50.86 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 110.492 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.53 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 2.4 mmt -56.2 -19.55 14.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 109.858 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 106' ' ' ARG . 12.9 t -88.26 -28.94 20.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.119 -0.988 . . . . 0.0 109.645 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -52.93 -47.09 68.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.37 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pp -132.85 -3.72 3.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 110.131 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 109' ' ' MET . . . -103.79 20.05 42.52 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 16.3 mt-10 63.49 141.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -1.124 . . . . 0.0 109.186 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.469 ' HA ' ' OG1' ' A' ' 110' ' ' THR . 0.6 OUTLIER -50.39 100.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.752 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' A' ' 109' ' ' MET . 29.0 mt -59.57 133.18 55.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 109.264 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.519 HG21 ' CB ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -71.16 178.97 3.02 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.109 -0.994 . . . . 0.0 108.332 179.201 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.412 ' N ' ' OG1' ' A' ' 117' ' ' THR . 10.0 m-20 -60.52 -63.45 1.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.87 -1.144 . . . . 0.0 109.914 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -50.4 -42.19 53.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 109.947 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.519 ' CB ' HG21 ' A' ' 117' ' ' THR . 12.7 tp10 -63.04 -34.99 78.75 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.586 -0.696 . . . . 0.0 110.156 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.464 HG21 ' HB2' ' A' ' 116' ' ' LEU . 28.7 t -71.65 -65.37 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.276 -0.89 . . . . 0.0 109.638 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -48.82 -30.66 6.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.087 -1.008 . . . . 0.0 109.158 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.09 -38.94 61.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.166 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.534 ' O ' ' CG ' ' A' ' 127' ' ' GLU . 3.7 mmt -65.32 -23.89 67.13 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.524 HG21 ' CG2' ' A' ' 136' ' ' VAL . 3.2 mt -81.76 -38.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -47.97 -28.76 2.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.955 -0.466 . . . . 0.0 110.099 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 124' ' ' MET . 7.2 pt-20 -80.2 -37.39 33.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.887 -1.133 . . . . 0.0 108.589 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.405 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -78.47 -7.98 58.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.65 143.3 30.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.822 . . . . 0.0 109.255 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 130' ' ' ILE . 54.9 mt -94.8 -39.47 10.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 109.665 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.11 -44.81 7.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.455 -0.778 . . . . 0.0 109.956 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.19 39.94 1.09 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -79.08 -24.54 43.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -1.073 . . . . 0.0 108.776 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.492 ' O ' HG22 ' A' ' 125' ' ' ILE . . . 117.22 -36.77 3.58 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -98.75 170.07 9.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.061 -1.258 . . . . 0.0 109.118 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.524 ' CG2' HG21 ' A' ' 125' ' ' ILE . 52.0 t -127.9 162.79 33.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.176 -0.952 . . . . 0.0 108.556 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.507 ' N ' HG13 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -137.99 -169.76 2.63 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 109.094 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.577 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 78.7 t80 -77.62 -34.9 53.19 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.701 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -49.62 70.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.262 -0.899 . . . . 0.0 109.322 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -69.3 -39.79 78.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.331 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.456 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 47.7 t80 -66.38 -24.34 66.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.812 . . . . 0.0 109.793 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 40.8 t -70.29 -46.95 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.94 . . . . 0.0 109.963 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -70.28 -23.96 62.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 109.866 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -85.12 -23.77 28.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.514 ' SD ' ' CB ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -83.34 -51.63 7.25 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.91 -62.46 1.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.0 109.994 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.68 176.17 1.63 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.761 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 pttt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.546 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.332 0.587 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.93 125.3 10.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.732 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -104.78 -51.06 3.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.309 -0.87 . . . . 0.0 109.351 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.4 173.59 11.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.68 -59.88 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.735 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.7 t 60.91 16.79 7.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.481 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -79.98 -89.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 109.387 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -80.62 -1.2 41.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.499 -0.751 . . . . 0.0 109.584 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -58.42 -27.28 64.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.112 -0.993 . . . . 0.0 109.191 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.501 HG13 ' CG2' ' A' ' 146' ' ' THR . 4.5 mm -76.07 -39.86 36.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.371 -0.83 . . . . 0.0 109.262 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.56 -43.66 68.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 109.584 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 9.9 pt-20 -78.8 -41.59 29.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.991 . . . . 0.0 109.607 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.496 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -52.16 -30.37 26.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.104 -0.998 . . . . 0.0 108.648 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.446 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 90.4 t80 -64.39 -52.95 55.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.0 109.622 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -64.51 -24.21 67.53 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 52.7 t -56.35 -22.8 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -104.97 -36.27 7.38 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.41 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 39.4 t0 -83.99 108.29 16.86 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -84.28 -26.49 28.55 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.079 -1.013 . . . . 0.0 110.088 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.485 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -79.46 3.04 19.74 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 108.903 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 36.32 36.74 0.16 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 95' ' ' ASP . 14.5 p-10 -93.71 -42.87 8.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -1.187 . . . . 0.0 109.875 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.42 -20.71 1.52 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.641 ' CE1' ' CB ' ' A' ' 137' ' ' ASN . 1.7 m-85 -120.72 144.44 48.24 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.216 -1.167 . . . . 0.0 109.71 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.41 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 68.5 mt -108.54 110.21 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.547 -0.721 . . . . 0.0 109.537 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.75 162.92 28.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.245 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -55.06 -36.85 66.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.975 . . . . 0.0 109.38 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.44 78.59 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.375 -0.828 . . . . 0.0 109.343 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -72.24 -22.54 61.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.339 -0.851 . . . . 0.0 108.895 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 109' ' ' MET . 17.8 tp -90.03 -23.16 21.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.378 -0.826 . . . . 0.0 109.512 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.44 -34.33 23.49 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.16 -0.962 . . . . 0.0 109.882 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.423 ' O ' HG21 ' A' ' 110' ' ' THR . 35.0 t60 -61.12 -41.53 96.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.033 -1.042 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 91' ' ' VAL . 46.9 t -86.64 -23.86 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.816 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.492 ' CG ' ' O ' ' A' ' 105' ' ' LEU . 4.4 mmt -73.25 -21.33 60.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 9.3 t -89.55 -26.03 21.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.34 -0.85 . . . . 0.0 109.63 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.454 ' HB3' ' CD1' ' A' ' 112' ' ' LEU . 1.6 t30 -48.18 -57.49 5.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.445 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' A' ' 111' ' ' ASN . 1.8 mp -125.22 3.63 7.84 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.354 -0.841 . . . . 0.0 109.64 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . -108.86 56.4 0.47 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.9 mt-10 45.45 -134.53 0.78 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -1.15 . . . . 0.0 108.861 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -148.44 78.1 1.41 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.76 -1.212 . . . . 0.0 109.564 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.53 HD11 ' N ' ' A' ' 121' ' ' VAL . 1.4 pt? -67.85 144.81 55.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.095 -1.003 . . . . 0.0 109.0 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.468 ' OG1' ' HG2' ' A' ' 120' ' ' GLU . 21.9 p -77.55 -159.73 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.9 . . . . 0.0 109.956 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.21 -48.37 13.21 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.422 -0.799 . . . . 0.0 109.49 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.68 -21.96 20.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.137 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 23.6 mm-40 -87.5 -47.88 8.38 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.53 ' N ' HD11 ' A' ' 116' ' ' LEU . 49.0 t -46.96 -49.99 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.445 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.45 -38.16 68.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.832 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 15.6 mt-10 -67.45 -38.26 84.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.935 . . . . 0.0 109.629 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 21.9 mmm -68.51 -30.38 69.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.103 -0.998 . . . . 0.0 108.893 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.462 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 3.0 mt -71.96 -40.36 67.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.419 -0.801 . . . . 0.0 108.849 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -61.28 -18.93 60.89 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.558 -0.714 . . . . 0.0 109.189 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 7.1 mm-40 -90.4 -21.48 21.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.337 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 144' ' ' MET . . . -92.59 -65.18 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.493 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 30.4 p-10 -76.16 177.47 7.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.462 -0.774 . . . . 0.0 109.069 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.492 HG12 ' OE2' ' A' ' 140' ' ' GLU . 7.4 mm -85.89 -66.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -0.908 . . . . 0.0 109.721 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 130' ' ' ILE . 1.0 OUTLIER 173.46 65.01 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.802 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.92 -87.51 1.77 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.93 -17.61 7.26 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.765 -0.844 . . . . 0.0 109.327 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.436 ' O ' HD11 ' A' ' 125' ' ' ILE . . . 125.08 18.32 2.59 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.488 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 1.3 pt20 -118.68 171.37 8.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -1.184 . . . . 0.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 137' ' ' ASN . 84.1 t -125.43 169.41 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.141 -0.974 . . . . 0.0 109.862 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.641 ' CB ' ' CE1' ' A' ' 99' ' ' TYR . 1.8 p-10 -145.23 -173.21 4.04 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.498 ' CE1' ' CG2' ' A' ' 142' ' ' VAL . 49.9 t80 -69.81 -45.21 68.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.392 -1.443 . . . . 0.0 111.671 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.68 -47.82 83.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.902 -1.124 . . . . 0.0 110.651 -178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.493 ' CG ' ' OD1' ' A' ' 137' ' ' ASN . 0.8 OUTLIER -70.41 -36.52 74.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.892 -1.13 . . . . 0.0 109.78 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.595 ' CZ ' ' HG2' ' A' ' 145' ' ' MET . 6.2 t80 -67.66 -27.71 67.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.19 -0.943 . . . . 0.0 109.159 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.498 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 75.8 t -79.32 -62.62 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.369 -0.832 . . . . 0.0 109.662 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.44 ' C ' ' O ' ' A' ' 142' ' ' VAL . 7.8 mm100 -39.38 -34.65 0.22 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.473 -0.767 . . . . 0.0 110.73 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 128' ' ' ALA . 29.6 mmt -90.45 -45.75 8.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.871 -1.143 . . . . 0.0 110.624 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -71.61 -0.61 11.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 0.0 110.549 -178.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.501 ' CG2' HG13 ' A' ' 85' ' ' ILE . 7.8 p -125.24 -89.27 0.58 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.104 -0.997 . . . . 0.0 110.008 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' A' ' 148' ' ' LYS . . . -83.75 -175.38 5.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.079 -1.013 . . . . 0.0 110.202 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 147' ' ' ALA . 11.5 mptt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.159 -0.924 . . . . 0.0 109.67 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.8 tpt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.66 78.84 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.631 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -94.25 -168.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -0.956 . . . . 0.0 109.551 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -60.68 108.13 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.9 . . . . 0.0 109.757 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.523 ' CB ' ' OE2' ' A' ' 82' ' ' GLU . 73.7 m-20 -113.21 -29.95 7.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.125 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 80' ' ' ASP . 0.2 OUTLIER 66.32 13.7 9.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.348 -0.845 . . . . 0.0 109.743 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.523 ' OE2' ' CB ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -88.6 -16.77 31.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.098 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -89.95 -30.21 17.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -52.95 -23.15 6.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.474 -0.766 . . . . 0.0 109.401 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -81.81 -38.12 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.326 -0.859 . . . . 0.0 109.058 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.461 ' HG2' ' CZ ' ' A' ' 138' ' ' TYR . 9.9 mtt180 -61.19 -31.92 71.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.437 -0.79 . . . . 0.0 109.143 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.474 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -89.74 -34.99 16.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 109.136 179.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.481 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.56 -23.12 67.25 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.418 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 82.6 t80 -69.68 -54.31 14.46 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.4 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -63.54 -27.62 69.38 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 4.9 t -48.17 -31.11 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.489 ' CE1' ' HB ' ' A' ' 108' ' ' VAL . 83.3 m-85 -98.29 -37.59 9.59 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.457 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 43.2 t0 -87.39 92.32 9.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -84.0 -24.8 30.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.26 -0.9 . . . . 0.0 110.223 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -79.18 4.18 15.57 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.245 -0.91 . . . . 0.0 109.101 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 39.57 29.3 0.14 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 95' ' ' ASP . 15.4 p-10 -73.93 -39.0 64.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.116 . . . . 0.0 109.658 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.26 -48.34 0.68 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.484 ' CD2' ' HG3' ' A' ' 135' ' ' GLN . 8.7 m-30 -108.92 176.29 5.16 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.335 -1.097 . . . . 0.0 109.465 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.7 mt -119.31 115.3 47.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.643 -0.66 . . . . 0.0 109.424 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.5 p -80.29 159.11 25.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.651 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.484 ' HA ' HD13 ' A' ' 125' ' ' ILE . . . -51.93 -35.89 47.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 0.0 109.514 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.56 -41.21 88.99 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.152 -0.968 . . . . 0.0 109.117 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 13.6 mt-10 -65.84 -22.69 66.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.227 -0.921 . . . . 0.0 109.103 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 109' ' ' MET . 9.4 tp -85.54 -32.25 22.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.422 -0.799 . . . . 0.0 109.644 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -34.79 77.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.289 -0.882 . . . . 0.0 109.177 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -59.55 -27.15 65.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 109.985 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.489 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 17.5 t -102.33 -12.73 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.078 -1.014 . . . . 0.0 110.44 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.524 ' CG ' ' O ' ' A' ' 105' ' ' LEU . 0.5 OUTLIER -78.24 -11.18 59.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.909 -1.12 . . . . 0.0 109.618 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.444 HG21 ' N ' ' A' ' 111' ' ' ASN . 2.1 t -99.93 -30.72 11.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.07 -1.019 . . . . 0.0 110.123 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.444 ' N ' HG21 ' A' ' 110' ' ' THR . 0.8 OUTLIER -43.92 -45.49 7.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 109.221 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.8 23.48 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.648 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -115.04 19.76 15.0 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 2.2 mm-40 67.8 146.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -1.095 . . . . 0.0 109.223 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.42 81.5 1.42 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -0.963 . . . . 0.0 110.053 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.55 HD13 ' N ' ' A' ' 121' ' ' VAL . 2.7 pt? -63.33 151.75 39.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 109.008 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.482 ' OG1' ' HG2' ' A' ' 120' ' ' GLU . 44.4 p -84.45 -165.61 1.22 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.296 -0.877 . . . . 0.0 109.447 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -75.11 -46.57 33.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.712 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.439 ' O ' ' OE1' ' A' ' 123' ' ' GLU . 30.9 mt-10 -57.2 -16.42 8.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.763 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.482 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 5.2 mm-40 -95.17 -45.08 7.34 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.342 -0.849 . . . . 0.0 108.961 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.55 ' N ' HD13 ' A' ' 116' ' ' LEU . 41.8 t -49.42 -55.72 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.89 -0.507 . . . . 0.0 110.599 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.34 -36.54 84.05 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.852 -1.155 . . . . 0.0 109.042 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 119' ' ' GLU . 87.0 mt-10 -70.79 -15.56 62.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.179 -0.951 . . . . 0.0 108.56 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.434 ' SD ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -85.32 -30.94 23.31 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 102' ' ' ALA . 3.3 mt -74.42 -41.31 49.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.99 -15.23 3.23 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.706 -0.621 . . . . 0.0 110.007 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -87.33 -30.94 20.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.923 -1.111 . . . . 0.0 109.797 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.7 -58.48 2.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.337 -0.852 . . . . 0.0 109.506 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.435 ' OD2' HG21 ' A' ' 125' ' ' ILE . 8.6 p30 -53.05 155.49 2.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.713 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.8 mt -111.79 -44.39 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.295 -0.878 . . . . 0.0 109.703 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -72.51 -38.14 68.18 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.473 -0.767 . . . . 0.0 109.63 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.66 33.46 6.42 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -78.94 -26.28 43.6 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.318 -1.107 . . . . 0.0 108.681 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 124.22 -42.19 1.6 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.484 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -90.07 165.25 14.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.059 -1.26 . . . . 0.0 109.49 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 53.1 t -118.23 161.49 17.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.481 ' ND2' ' HG3' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -134.16 -164.62 1.53 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.714 -1.241 . . . . 0.0 108.659 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.5 ' O ' ' CG2' ' A' ' 142' ' ' VAL . 64.9 t80 -78.49 -38.48 40.8 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.205 -0.934 . . . . 0.0 110.206 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -70.45 -33.08 70.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.995 -1.066 . . . . 0.0 109.417 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.481 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 15.5 mt-10 -82.12 -34.07 29.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.159 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.417 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 38.5 t80 -75.47 -25.65 57.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.519 -0.738 . . . . 0.0 109.671 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.5 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 26.8 t -55.38 -48.98 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.786 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -65.9 -27.3 68.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.041 -1.037 . . . . 0.0 109.627 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -19.33 46.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.198 -0.939 . . . . 0.0 109.691 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.47 -39.13 47.62 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -56.7 -30.83 63.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.095 -1.003 . . . . 0.0 109.36 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.405 ' O ' ' OXT' ' A' ' 148' ' ' LYS . . . -73.62 168.08 20.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.338 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.405 ' OXT' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.385 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.23 0.538 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -78.7 113.03 16.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.166 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.33 176.63 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.681 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.6 t -139.08 154.0 48.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -151.39 -33.38 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 110.187 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.75 10.56 7.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.882 -1.136 . . . . 0.0 110.039 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -89.49 -37.99 14.36 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 108.856 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -90.6 -9.24 47.78 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.349 0.595 . . . . 0.0 109.469 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -47.09 -26.94 1.2 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.312 -0.868 . . . . 0.0 110.116 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 mt -72.45 -44.67 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.042 -1.036 . . . . 0.0 109.641 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.573 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -46.24 -33.4 3.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.059 -1.025 . . . . 0.0 109.441 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 88' ' ' ALA . 1.9 mt-10 -87.17 -55.44 3.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 109.977 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.449 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -42.69 -28.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 108.901 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 87' ' ' GLU . 79.6 t80 -62.61 -57.52 10.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.481 -0.762 . . . . 0.0 109.419 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.442 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 6.0 mtp180 -61.1 -32.99 72.65 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.67 -0.644 . . . . 0.0 109.302 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 39.1 t -45.31 -32.45 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.483 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 85.8 m-85 -94.47 -49.79 5.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.468 ' CA ' HG12 ' A' ' 100' ' ' ILE . 65.7 t0 -65.36 91.37 0.11 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -90.32 -21.01 22.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 111.238 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.46 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 10.5 p-10 -78.2 7.53 6.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.938 -1.101 . . . . 0.0 109.876 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.75 49.66 1.92 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.403 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 1.8 t30 -110.17 -64.58 1.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -1.114 . . . . 0.0 109.207 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.19 -47.27 0.11 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.593 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 7.6 m-30 -110.06 150.38 28.64 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.53 -0.982 . . . . 0.0 109.204 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.52 HG21 ' N ' ' A' ' 101' ' ' SER . 55.6 mt -85.43 152.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.419 -0.801 . . . . 0.0 109.511 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.52 ' N ' HG21 ' A' ' 100' ' ' ILE . 18.7 p -110.48 172.63 6.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.183 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.47 ' O ' HG12 ' A' ' 121' ' ' VAL . . . -62.96 -53.7 49.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.828 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.24 62.72 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 71.4 mt-10 -75.24 -30.0 60.39 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.123 -0.986 . . . . 0.0 108.561 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.442 ' HG ' ' HG3' ' A' ' 109' ' ' MET . 12.2 tp -81.18 -21.93 39.29 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.478 ' O ' ' HB ' ' A' ' 110' ' ' THR . 35.9 ttt-85 -78.86 -22.64 45.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.41 -0.806 . . . . 0.0 108.968 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -67.76 -38.49 83.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.468 -0.77 . . . . 0.0 110.427 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.439 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 92.4 t -99.17 -38.07 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.255 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.505 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . 16.3 mmt -61.14 -13.34 16.88 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.32 -0.862 . . . . 0.0 109.615 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -94.73 -29.41 14.8 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.22 -0.925 . . . . 0.0 108.849 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -68.12 0.39 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.905 . . . . 0.0 109.258 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.7 mt -114.33 15.19 18.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 109.328 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 109' ' ' MET . . . -111.04 51.35 0.7 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 48.29 -145.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -1.083 . . . . 0.0 109.545 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.56 101.01 9.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.02 . . . . 0.0 109.788 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.505 ' CD1' ' HB3' ' A' ' 109' ' ' MET . 0.1 OUTLIER -102.6 111.5 23.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.41 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.55 ' CG2' ' HG2' ' A' ' 120' ' ' GLU . 6.3 t -82.71 -146.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 108.735 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.487 ' N ' HG21 ' A' ' 117' ' ' THR . 2.9 m-20 -90.11 -48.45 7.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.023 -1.048 . . . . 0.0 109.884 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -60.23 -17.83 44.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.869 . . . . 0.0 109.586 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.55 ' HG2' ' CG2' ' A' ' 117' ' ' THR . 11.9 mm-40 -94.1 -47.76 6.53 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 117' ' ' THR . 47.7 t -47.49 -62.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.599 -0.688 . . . . 0.0 109.905 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -31.68 11.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.982 -1.074 . . . . 0.0 109.646 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -68.49 -40.18 81.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.224 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.464 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 36.2 mmm -63.39 -32.68 74.18 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mt -71.03 -39.25 74.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.567 -0.708 . . . . 0.0 109.463 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.509 ' HG3' ' N ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -55.06 -27.55 45.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 110.263 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.509 ' N ' ' HG3' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -89.33 -21.56 23.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.126 -0.984 . . . . 0.0 109.663 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.507 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -97.19 -5.82 36.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.824 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.417 ' OD2' ' O ' ' A' ' 135' ' ' GLN . 1.0 OUTLIER -97.45 133.32 42.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.7 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 57.0 mt -85.34 -50.23 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.358 -0.839 . . . . 0.0 109.426 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.1 -49.86 7.91 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.604 -0.685 . . . . 0.0 109.726 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.08 37.75 2.45 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -78.78 -25.19 44.33 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.317 -1.108 . . . . 0.0 108.821 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.19 28.96 1.88 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.485 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.593 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -159.18 165.85 32.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.068 -1.254 . . . . 0.0 109.256 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 55.8 t -122.6 162.86 21.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.12 -0.987 . . . . 0.0 108.654 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.516 ' ND2' ' HG3' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -132.44 -164.01 1.41 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.908 -1.12 . . . . 0.0 108.517 179.424 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 67.2 t80 -78.58 -49.59 13.01 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 110.323 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -59.84 -39.65 85.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.0 109.536 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.516 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 7.5 mt-10 -74.68 -38.96 62.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.049 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 39.0 t80 -65.64 -22.52 66.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.422 -0.798 . . . . 0.0 109.059 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.482 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 89.7 t -70.68 -40.66 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.552 -0.718 . . . . 0.0 110.079 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -65.98 -27.82 68.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.068 -1.02 . . . . 0.0 110.188 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.6 ttp -90.34 -26.54 19.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.094 -1.004 . . . . 0.0 110.058 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.577 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -97.68 -62.69 1.21 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.005 -1.06 . . . . 0.0 109.99 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.475 ' HB ' HG11 ' A' ' 142' ' ' VAL . 0.6 OUTLIER -52.53 -31.61 36.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.159 -0.963 . . . . 0.0 109.348 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.76 101.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.069 -1.02 . . . . 0.0 109.492 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.2 mttm . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.367 179.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.33 0.586 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.37 164.76 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.587 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.07 -38.28 2.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.84 . . . . 0.0 109.709 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.77 171.25 18.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.948 . . . . 0.0 109.778 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -114.04 -84.07 0.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.298 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 m -169.66 105.95 0.36 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.398 -0.814 . . . . 0.0 109.144 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.97 -13.05 21.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.264 -0.898 . . . . 0.0 109.443 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -71.2 -31.07 67.17 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.34 -0.85 . . . . 0.0 109.849 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.443 ' OE1' ' HE2' ' A' ' 145' ' ' MET . 0.0 OUTLIER -47.41 -39.42 15.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.961 -179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.502 HG21 ' CB ' ' A' ' 145' ' ' MET . 2.6 mt -91.72 -37.17 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.178 -0.952 . . . . 0.0 110.243 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.561 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 34.8 mtt180 -49.61 -28.91 6.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.005 . . . . 0.0 109.772 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -92.68 -54.02 3.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.078 -1.014 . . . . 0.0 109.478 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.453 ' HA ' HG22 ' A' ' 91' ' ' VAL . . . -44.51 -26.74 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.189 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 75.7 t80 -64.77 -55.9 16.94 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.111 -0.993 . . . . 0.0 109.403 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' CZ ' ' CB ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -62.88 -31.68 72.78 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.307 -179.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.453 HG22 ' HA ' ' A' ' 88' ' ' ALA . 41.0 t -47.41 -28.24 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.464 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 64.7 m-85 -102.74 -31.69 10.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.463 ' HB2' HG12 ' A' ' 100' ' ' ILE . 34.3 t0 -93.62 92.83 7.72 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.583 -0.698 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.553 ' NZ ' ' CD2' ' A' ' 107' ' ' HIS . 1.6 mmmm -90.28 -23.13 21.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.222 -0.924 . . . . 0.0 109.927 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.492 ' O ' ' C ' ' A' ' 96' ' ' GLY . 15.8 t0 -78.79 1.95 21.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 109.186 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 33.55 37.8 0.07 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 95' ' ' ASP . 12.9 p-10 -88.0 -28.53 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -1.178 . . . . 0.0 109.768 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 143.37 -54.27 0.59 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 14.6 m-30 -109.59 157.28 19.2 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.486 -1.008 . . . . 0.0 109.124 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.469 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 84.3 mt -90.28 117.4 33.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 109.026 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.0 p -74.48 159.86 31.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.168 -0.958 . . . . 0.0 109.265 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.79 -31.12 66.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.418 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.78 -35.34 62.54 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.168 -0.958 . . . . 0.0 109.042 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 50.7 mm-40 -73.3 -22.8 60.27 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.276 -0.89 . . . . 0.0 108.967 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.517 ' CD2' ' SD ' ' A' ' 109' ' ' MET . 5.3 tp -90.78 -25.16 20.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 0.0 109.032 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.496 ' O ' ' OG1' ' A' ' 110' ' ' THR . 2.0 ttt180 -77.4 -30.4 53.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.271 -0.893 . . . . 0.0 109.01 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.553 ' CD2' ' NZ ' ' A' ' 94' ' ' LYS . 71.3 t60 -58.03 -45.11 87.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.906 . . . . 0.0 110.057 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 25.9 t -91.65 -26.46 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.06 -1.025 . . . . 0.0 110.392 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.517 ' SD ' ' CD2' ' A' ' 105' ' ' LEU . 13.7 mtm -61.29 -42.63 98.98 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.102 -0.999 . . . . 0.0 109.038 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.541 ' O ' ' N ' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -59.31 -26.67 65.2 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.207 -0.933 . . . . 0.0 109.253 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 110' ' ' THR . 7.9 t-20 39.02 -93.03 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.662 -0.648 . . . . 0.0 110.088 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.541 ' N ' ' O ' ' A' ' 110' ' ' THR . 1.3 pp -148.71 68.34 1.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.143 -0.973 . . . . 0.0 109.226 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.56 -17.55 11.14 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -83.75 43.41 0.91 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.228 -1.16 . . . . 0.0 109.826 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.481 ' CA ' HG21 ' A' ' 110' ' ' THR . 13.7 ttpp -64.98 126.52 28.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 0.0 109.344 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.513 ' CD1' ' SD ' ' A' ' 109' ' ' MET . 45.5 mt -104.08 140.6 37.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.48 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.419 ' O ' HG21 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -66.98 -169.17 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.91 . . . . 0.0 108.71 179.33 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.47 -50.53 12.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.011 -1.055 . . . . 0.0 109.269 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -30.6 70.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.18 -0.95 . . . . 0.0 108.5 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 116' ' ' LEU . 9.8 tp10 -70.56 -41.88 71.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 117' ' ' THR . 34.6 t -61.5 -36.63 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.14 -25.53 67.02 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -75.01 -45.86 38.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.481 -0.762 . . . . 0.0 109.017 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 7.6 mmt -60.66 -28.28 68.47 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.21 -0.931 . . . . 0.0 108.76 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.471 HG12 HD21 ' A' ' 105' ' ' LEU . 2.4 mt -82.09 -35.24 13.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.519 -0.738 . . . . 0.0 109.475 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -59.69 -31.24 69.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 110.35 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.42 -5.24 56.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.029 -1.045 . . . . 0.0 110.509 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.06 -29.85 11.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.986 -1.071 . . . . 0.0 109.747 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.33 149.87 23.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.287 -0.883 . . . . 0.0 109.641 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 16.9 mt -113.38 -29.02 2.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.18 -0.95 . . . . 0.0 109.374 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.401 ' HB3' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -61.73 -33.6 74.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.88 21.39 55.83 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' A' ' 131' ' ' ASP . 0.7 OUTLIER -83.51 -27.56 29.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -1.169 . . . . 0.0 109.609 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.84 28.03 4.65 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.457 ' CD ' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -146.61 163.07 37.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -1.204 . . . . 0.0 109.391 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 94.2 t -117.78 168.2 9.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.327 -0.858 . . . . 0.0 109.188 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.538 ' C ' ' CE1' ' A' ' 89' ' ' PHE . 47.0 t30 -148.25 -166.29 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.561 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 60.2 t80 -80.62 -41.79 23.31 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.583 -1.323 . . . . 0.0 110.117 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.49 -29.99 66.67 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.104 -0.998 . . . . 0.0 109.303 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.427 ' HA ' ' OE1' ' A' ' 140' ' ' GLU . 6.1 mm-40 -85.26 -35.41 21.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.472 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 26.1 t80 -71.22 -26.87 63.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.536 -0.727 . . . . 0.0 109.16 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 138' ' ' TYR . 20.3 t -55.37 -44.31 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.189 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -57.94 -31.59 66.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.708 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.47 ' HE1' ' CE1' ' A' ' 141' ' ' PHE . 34.5 ttp -75.98 -39.57 55.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.454 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.502 ' CB ' HG21 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -69.77 -20.17 63.49 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.2 p -154.07 94.71 1.77 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -101.33 85.93 2.89 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.665 -0.647 . . . . 0.0 109.412 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.385 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.287 0.565 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.0 146.92 41.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.393 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -56.89 137.77 54.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.978 . . . . 0.0 109.2 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 9.5 t -144.99 139.9 27.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 79' ' ' THR . 3.0 t0 80.92 -55.67 0.31 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.902 -0.499 . . . . 0.0 110.251 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.41 20.43 1.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.92 -1.112 . . . . 0.0 109.527 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.44 -90.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.61 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -74.39 2.31 9.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.502 -0.749 . . . . 0.0 109.993 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.01 -19.46 4.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.064 -1.022 . . . . 0.0 109.338 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.412 HG23 ' HA ' ' A' ' 142' ' ' VAL . 5.8 mt -74.92 -39.72 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.282 -0.886 . . . . 0.0 109.548 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.576 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -46.52 -31.79 2.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.934 -1.103 . . . . 0.0 109.214 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 88' ' ' ALA . 15.5 mt-10 -91.88 -50.28 5.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.454 -0.779 . . . . 0.0 109.168 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.78 -25.87 0.34 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -0.906 . . . . 0.0 108.761 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' N ' ' C ' ' A' ' 87' ' ' GLU . 82.9 t80 -63.51 -55.61 22.59 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.284 -0.885 . . . . 0.0 109.004 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.427 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -60.86 -36.13 78.37 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 34.4 t -43.32 -28.35 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 90' ' ' ARG . 92.0 m-85 -106.36 -31.37 8.62 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.427 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 10.8 t0 -89.34 79.7 6.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.602 -0.686 . . . . 0.0 109.369 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -89.19 -16.97 30.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.386 -0.821 . . . . 0.0 109.745 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.459 ' O ' ' C ' ' A' ' 96' ' ' GLY . 12.6 t70 -77.19 0.39 21.98 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.397 -0.815 . . . . 0.0 108.988 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.96 50.3 2.07 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -108.12 -31.83 7.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -1.176 . . . . 0.0 109.587 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.39 -50.02 0.82 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.636 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 10.9 m-30 -114.03 146.04 40.73 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.339 -1.095 . . . . 0.0 109.217 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 81.9 mt -81.96 132.56 31.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.398 -0.814 . . . . 0.0 109.389 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.6 p -98.26 178.04 5.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 121' ' ' VAL . . . -65.7 -40.54 92.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 109.341 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.73 -31.1 70.8 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.267 -0.896 . . . . 0.0 109.407 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.53 -26.23 59.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.877 . . . . 0.0 108.667 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.549 ' CD2' ' CG ' ' A' ' 109' ' ' MET . 3.6 tt -82.11 -26.2 33.77 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.494 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 0.0 OUTLIER -73.03 -47.33 45.84 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 106' ' ' ARG . 28.0 t60 -40.93 -38.4 0.95 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.48 -0.762 . . . . 0.0 110.347 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.432 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 36.2 t -97.97 -28.11 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.972 -1.08 . . . . 0.0 110.297 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.549 ' CG ' ' CD2' ' A' ' 105' ' ' LEU . 3.9 mmt -64.33 -17.34 63.6 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.725 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.1 t -88.7 -18.55 27.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.455 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.432 ' OD1' ' HA ' ' A' ' 108' ' ' VAL . 7.3 m120 -58.48 97.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.875 . . . . 0.0 109.552 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt 61.32 13.45 4.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -117.96 41.91 1.95 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 52.89 -125.76 2.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.236 -1.155 . . . . 0.0 109.12 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 135.67 32.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.634 -1.292 . . . . 0.0 109.991 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.534 ' HG ' ' CG ' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -103.94 116.46 32.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.297 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.541 HG21 ' CB ' ' A' ' 120' ' ' GLU . 5.6 t -75.45 165.78 24.6 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.64 -52.67 63.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.845 -1.16 . . . . 0.0 110.237 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -59.41 -17.96 34.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.244 -0.91 . . . . 0.0 109.998 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.541 ' CB ' HG21 ' A' ' 117' ' ' THR . 7.7 tp10 -87.18 -40.16 14.83 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.434 HG21 ' CD2' ' A' ' 116' ' ' LEU . 21.9 t -61.41 -46.74 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.304 -0.872 . . . . 0.0 109.079 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -46.92 -28.82 1.74 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.383 -0.823 . . . . 0.0 109.751 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -75.54 -51.41 12.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.142 -0.974 . . . . 0.0 109.426 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.502 ' SD ' ' CD2' ' A' ' 116' ' ' LEU . 1.2 mpt? -59.91 -21.14 60.71 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.222 -0.924 . . . . 0.0 109.559 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.482 HG12 ' CD1' ' A' ' 105' ' ' LEU . 2.3 mt -84.85 -42.97 16.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.3 -0.875 . . . . 0.0 109.659 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -22.68 1.02 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.38 -0.825 . . . . 0.0 110.588 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -90.87 -30.37 16.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.919 -1.113 . . . . 0.0 110.379 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.464 ' HB2' HG23 ' A' ' 136' ' ' VAL . . . -76.19 -49.65 16.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.838 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.418 ' OD2' HG21 ' A' ' 125' ' ' ILE . 1.9 p30 -80.44 150.91 29.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.5 mt -117.69 -34.48 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.334 -0.854 . . . . 0.0 109.214 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -61.75 -39.88 93.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.536 -0.727 . . . . 0.0 109.286 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.56 29.44 29.8 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.18 -25.64 39.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.386 -1.067 . . . . 0.0 108.77 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 115.3 26.54 3.42 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.636 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -160.27 162.54 33.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.045 -1.268 . . . . 0.0 109.517 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.465 ' HB ' ' HB ' ' A' ' 100' ' ' ILE . 70.0 t -113.8 161.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.418 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 0.3 OUTLIER -135.79 -166.46 1.86 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.97 -1.081 . . . . 0.0 108.619 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.576 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 52.3 t80 -78.87 -37.44 40.27 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.415 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.423 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 5.2 tp10 -67.77 -38.99 84.15 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -77.09 -38.47 52.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.175 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 38.6 t80 -69.47 -23.49 63.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.394 -0.816 . . . . 0.0 109.456 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 138' ' ' TYR . 23.1 t -75.7 -54.01 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 109.84 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.423 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 2.8 mt-30 -63.34 -21.9 66.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.0 110.044 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -90.24 -32.82 16.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.076 -1.015 . . . . 0.0 109.941 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -93.25 -4.4 51.95 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.201 -0.937 . . . . 0.0 110.143 -179.326 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.473 ' CG2' ' N ' ' A' ' 147' ' ' ALA . 12.5 t -98.14 -45.47 6.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.044 -1.035 . . . . 0.0 109.587 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.473 ' N ' ' CG2' ' A' ' 146' ' ' THR . . . -43.36 159.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.608 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.649 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.269 0.557 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt 66.86 154.76 0.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -0.926 . . . . 0.0 109.461 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.23 1.56 12.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.506 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.4 p 45.91 -158.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.169 -0.957 . . . . 0.0 109.265 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.14 -1.44 10.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 109.903 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -72.56 -17.36 61.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 109.764 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.63 -22.74 20.12 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.675 -0.641 . . . . 0.0 109.544 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.92 11.45 20.38 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.603 -0.686 . . . . 0.0 109.617 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.406 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.0 OUTLIER -72.87 -23.74 60.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.206 -0.934 . . . . 0.0 109.709 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.416 HG23 HG21 ' A' ' 142' ' ' VAL . 3.5 mp -82.64 -37.85 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.142 -0.974 . . . . 0.0 109.929 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -42.05 95.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.56 -30.14 41.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.148 -0.97 . . . . 0.0 109.442 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 91' ' ' VAL . . . -67.38 -27.02 66.76 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 82.0 t80 -68.44 -54.61 15.93 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.652 0.739 . . . . 0.0 109.247 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -63.78 -27.91 69.51 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 88' ' ' ALA . 8.5 t -50.09 -30.1 6.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.469 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 87.1 m-85 -98.02 -35.42 10.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -90.13 95.71 10.33 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -89.98 -26.02 20.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.207 -0.933 . . . . 0.0 110.841 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -78.99 5.26 12.12 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.062 -1.024 . . . . 0.0 109.055 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 40.94 33.12 0.62 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -75.81 -70.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -1.117 . . . . 0.0 109.081 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.19 -53.98 0.09 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.629 ' CE2' ' NE2' ' A' ' 135' ' ' GLN . 9.7 m-30 -107.95 152.15 24.84 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.488 -1.007 . . . . 0.0 109.047 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.469 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 86.0 mt -88.63 128.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 109.911 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.9 p -90.36 -176.58 4.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.327 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.51 -50.71 57.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.74 -29.52 69.43 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.382 -0.824 . . . . 0.0 109.526 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 28.5 mt-10 -73.64 -30.79 63.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.16 -0.962 . . . . 0.0 108.953 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 2.2 tp -91.06 -9.21 46.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.46 -0.775 . . . . 0.0 109.211 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -91.53 -40.24 11.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.383 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.469 ' HA ' HG23 ' A' ' 110' ' ' THR . 24.4 t60 -54.83 -35.22 63.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.627 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 91' ' ' VAL . 71.1 t -88.85 -44.64 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.118 -0.989 . . . . 0.0 110.056 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.474 ' HE1' ' CE ' ' A' ' 124' ' ' MET . 97.1 mmm -68.13 -7.65 31.64 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 109.188 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.472 HG21 ' N ' ' A' ' 111' ' ' ASN . 6.6 t -98.86 -19.54 17.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.125 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.505 ' O ' ' CB ' ' A' ' 112' ' ' LEU . 3.3 m120 -89.23 31.3 0.9 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.129 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.505 ' CB ' ' O ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER 161.03 -19.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.585 -0.697 . . . . 0.0 109.725 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -85.83 20.86 17.38 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.506 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.529 ' O ' ' O ' ' A' ' 115' ' ' LYS . 13.3 mt-10 62.08 40.61 11.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.112 -1.228 . . . . 0.0 110.125 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 114' ' ' GLU . 3.1 ttpp 50.0 115.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.767 0.794 . . . . 0.0 111.45 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.435 ' HB3' HG21 ' A' ' 121' ' ' VAL . 0.7 OUTLIER -95.36 159.26 15.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 109.356 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 120' ' ' GLU . 21.7 p -92.41 -171.64 2.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 109.774 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.87 -47.82 8.3 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.465 -0.772 . . . . 0.0 109.025 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.42 -13.18 62.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 108.838 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.475 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 23.9 tp10 -93.46 -42.23 9.37 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.475 -0.766 . . . . 0.0 109.137 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 117' ' ' THR . 6.9 t -53.87 -61.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.422 -0.798 . . . . 0.0 109.775 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -48.1 -27.73 2.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.987 . . . . 0.0 109.952 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.497 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -77.33 -39.74 46.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.196 -0.94 . . . . 0.0 109.326 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.474 ' CE ' ' HE1' ' A' ' 109' ' ' MET . 25.1 mmm -66.38 -22.3 66.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.872 -1.142 . . . . 0.0 108.586 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.493 HG21 HG21 ' A' ' 136' ' ' VAL . 3.2 mt -86.91 -38.3 12.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -55.88 -22.82 27.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.636 -0.665 . . . . 0.0 110.062 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.458 ' N ' ' HG3' ' A' ' 126' ' ' ARG . 3.1 mt-10 -90.41 -34.57 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 0.0 109.75 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.24 -13.49 60.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.917 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.514 ' OD1' ' CG2' ' A' ' 136' ' ' VAL . 7.1 m-20 -94.68 142.45 27.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 73.2 mt -89.26 -37.15 9.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.324 -0.86 . . . . 0.0 109.22 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -39.09 24.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.514 -0.741 . . . . 0.0 109.439 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.36 29.94 13.3 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.14 -25.43 42.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -1.072 . . . . 0.0 109.09 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 117.48 5.77 14.01 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.629 ' NE2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -129.27 157.64 41.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.892 -1.357 . . . . 0.0 109.434 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.514 ' CG2' ' OD1' ' A' ' 129' ' ' ASP . 77.9 t -116.27 165.28 11.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.192 -0.943 . . . . 0.0 108.61 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 0.3 OUTLIER -141.39 -164.19 1.71 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.925 -1.109 . . . . 0.0 108.512 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 142' ' ' VAL . 65.1 t80 -81.45 -42.17 20.73 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.126 -0.984 . . . . 0.0 109.182 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -68.34 -29.43 68.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.392 -0.817 . . . . 0.0 109.199 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.27 -33.91 20.54 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.417 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 60.1 t80 -70.94 -24.43 62.44 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.561 -0.712 . . . . 0.0 109.293 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.487 HG12 ' OG1' ' A' ' 146' ' ' THR . 3.8 t -66.01 -51.64 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.498 -0.751 . . . . 0.0 109.991 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -59.79 -26.03 65.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.115 -0.991 . . . . 0.0 110.662 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -28.37 19.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.854 -1.154 . . . . 0.0 110.742 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.4 tpt -102.57 -61.86 1.34 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.012 -1.055 . . . . 0.0 109.801 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.487 ' OG1' HG12 ' A' ' 142' ' ' VAL . 0.3 OUTLIER -46.16 -38.68 8.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.486 -0.759 . . . . 0.0 109.88 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -97.73 154.69 17.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.455 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.466 ' CG ' ' O ' ' A' ' 76' ' ' MET . 2.2 ptt? . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 76' ' ' MET . 0.9 OUTLIER 71.42 176.98 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.945 . . . . 0.0 109.408 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -114.55 -11.0 12.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.765 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.4 m 52.33 91.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.125 -0.984 . . . . 0.0 109.34 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -65.55 110.07 2.58 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.345 -0.847 . . . . 0.0 109.766 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.11 18.39 21.78 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.313 -0.867 . . . . 0.0 109.105 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -82.16 -28.76 31.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.415 -0.803 . . . . 0.0 109.486 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.42 -20.94 62.05 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 109.202 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -65.73 -35.8 81.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.416 -0.802 . . . . 0.0 109.531 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.455 HG23 ' HA ' ' A' ' 142' ' ' VAL . 2.8 mp -80.3 -37.65 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.271 -0.893 . . . . 0.0 110.026 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.473 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 5.7 ttp180 -48.53 -39.72 24.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.062 -1.024 . . . . 0.0 109.715 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.444 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 11.3 pt-20 -82.26 -50.74 8.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.111 -0.993 . . . . 0.0 109.875 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -45.59 -27.23 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.002 -1.061 . . . . 0.0 108.922 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.413 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 91.4 t80 -63.51 -56.99 11.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.419 -0.8 . . . . 0.0 109.753 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -62.03 -32.07 72.53 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.529 -0.732 . . . . 0.0 109.112 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 55.1 t -44.56 -30.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -99.44 -35.48 9.89 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.445 ' HB2' HG12 ' A' ' 100' ' ' ILE . 10.1 t0 -91.55 98.88 11.93 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.505 -0.747 . . . . 0.0 109.377 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 0.0 OUTLIER -90.32 -23.61 21.1 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.245 -0.909 . . . . 0.0 110.262 -179.487 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -79.01 3.68 16.54 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 109.337 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.61 31.76 0.09 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 95' ' ' ASP . 11.4 p-10 -80.47 -24.03 39.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.071 -1.252 . . . . 0.0 109.87 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.509 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 126.33 -44.64 1.23 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.595 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 52.3 m-85 -110.4 145.03 38.27 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.495 -1.003 . . . . 0.0 109.629 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 71.6 mt -90.43 94.31 4.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.453 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -66.58 158.61 29.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.106 -0.996 . . . . 0.0 109.208 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -45.49 -42.38 10.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.108 -0.995 . . . . 0.0 109.266 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.26 99.17 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.311 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.444 ' OE1' ' HB2' ' A' ' 95' ' ' ASP . 1.5 mm-40 -64.47 -24.15 67.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 0.0 109.199 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.422 HD21 HG11 ' A' ' 121' ' ' VAL . 34.7 tp -88.83 -16.83 31.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.49 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 5.6 ttt-85 -83.44 -35.23 25.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.505 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.408 ' C ' ' O ' ' A' ' 106' ' ' ARG . 23.3 t60 -42.24 -49.9 4.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.667 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.7 t -95.59 -24.77 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.987 -1.071 . . . . 0.0 110.717 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.49 ' HB2' ' HA ' ' A' ' 106' ' ' ARG . 8.3 mmt -64.17 -23.49 67.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.05 -1.031 . . . . 0.0 109.758 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -82.1 -31.13 30.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 109.795 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.401 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 22.5 t-20 -56.88 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.456 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.401 ' HG ' ' C ' ' A' ' 111' ' ' ASN . 1.5 mt 56.92 24.11 8.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.478 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 109' ' ' MET . . . -117.67 51.94 0.71 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 57.4 178.87 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -1.165 . . . . 0.0 109.346 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -112.98 79.79 1.27 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.331 -0.856 . . . . 0.0 109.215 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.558 ' HB2' ' CB ' ' A' ' 120' ' ' GLU . 1.0 OUTLIER -94.21 133.84 37.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.972 . . . . 0.0 109.378 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.558 ' CG2' ' N ' ' A' ' 118' ' ' ASP . 5.3 t -92.08 -146.14 0.21 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.363 -0.836 . . . . 0.0 109.237 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.558 ' N ' ' CG2' ' A' ' 117' ' ' THR . 3.9 m-20 -78.63 -48.85 14.28 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.552 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -54.48 -24.99 22.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 109.709 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.558 ' CB ' ' HB2' ' A' ' 116' ' ' LEU . 18.1 mm-40 -86.96 -47.98 8.52 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.457 HG21 ' HG ' ' A' ' 116' ' ' LEU . 92.5 t -54.81 -26.15 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.72 -0.613 . . . . 0.0 109.568 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -68.36 -34.89 76.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -79.95 -19.0 49.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.948 -1.095 . . . . 0.0 108.598 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 15.2 mmt -88.91 -20.78 24.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 7.6 mt -92.43 -45.6 14.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.73 0.776 . . . . 0.0 109.718 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.7 -26.35 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.682 -0.636 . . . . 0.0 110.723 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -90.35 -37.15 14.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.985 -1.072 . . . . 0.0 109.749 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.455 ' HB3' ' HE3' ' A' ' 144' ' ' MET . . . -80.09 -4.36 52.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.852 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -96.67 176.75 5.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 3.7 mt -69.92 -69.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.362 -0.836 . . . . 0.0 109.437 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 130' ' ' ILE . 3.0 p-10 -179.24 32.95 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.44 -0.788 . . . . 0.0 110.533 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 146.93 49.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.068 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 129' ' ' ASP . 2.2 p30 -112.55 -24.65 9.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -1.119 . . . . 0.0 109.035 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.29 -10.2 55.2 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.442 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 4.3 pt20 -144.91 -170.35 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -1.154 . . . . 0.0 109.133 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 137' ' ' ASN . 53.6 t -126.33 160.4 33.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.595 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 3.9 t-20 -141.53 -166.48 2.21 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.475 ' O ' HG21 ' A' ' 142' ' ' VAL . 88.4 t80 -78.19 -31.07 49.31 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.563 -1.336 . . . . 0.0 112.106 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -15.43 60.07 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.462 -1.399 . . . . 0.0 110.321 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.585 ' OE1' ' HB3' ' A' ' 137' ' ' ASN . 3.8 mp0 -100.57 -34.64 9.82 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.413 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 50.9 t80 -71.88 -25.28 61.87 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.475 HG21 ' O ' ' A' ' 138' ' ' TYR . 9.9 t -60.43 -55.27 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -65.44 -21.05 66.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.762 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.455 ' HE3' ' HB3' ' A' ' 128' ' ' ALA . 3.1 tpt -85.16 -20.55 30.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 0.0 109.726 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -39.64 20.58 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.141 -0.975 . . . . 0.0 109.482 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 p -74.2 -57.85 3.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.81 -179.34 5.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 0.0 109.72 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.301 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 76' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -113.49 66.99 0.66 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 109.404 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.465 ' O ' HG22 ' A' ' 79' ' ' THR . 6.6 m-20 179.94 -88.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.839 . . . . 0.0 109.42 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.465 HG22 ' O ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 174.93 131.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.501 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -136.26 -92.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.183 -0.948 . . . . 0.0 109.527 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.98 7.14 3.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.11 -0.994 . . . . 0.0 109.763 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -90.05 -64.0 1.2 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.363 -0.836 . . . . 0.0 109.55 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 86' ' ' ARG . 15.9 tt0 -88.31 -9.17 53.69 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.646 -0.659 . . . . 0.0 109.807 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.468 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 10.4 tt0 -46.38 -27.52 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 110.095 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.1 mm -77.4 -47.45 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.17 -0.956 . . . . 0.0 110.446 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.444 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 5.3 mmm180 -47.73 -45.07 28.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.101 -0.999 . . . . 0.0 109.908 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 10.4 pt-20 -79.99 -39.79 29.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.059 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.519 ' N ' ' HG3' ' A' ' 87' ' ' GLU . . . -57.88 -19.54 30.23 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.912 -1.117 . . . . 0.0 108.48 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 82.4 t80 -71.53 -55.44 7.82 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.451 -0.78 . . . . 0.0 109.326 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -63.77 -27.45 69.2 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.44 ' O ' HG22 ' A' ' 108' ' ' VAL . 24.3 t -50.14 -30.72 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.588 ' CE2' ' HB ' ' A' ' 108' ' ' VAL . 65.1 m-85 -96.88 -33.91 11.45 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.467 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 23.3 t0 -97.83 91.94 5.6 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.773 -0.58 . . . . 0.0 109.649 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 94' ' ' LYS . 19.4 mmmt -90.19 -19.34 24.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.285 -0.884 . . . . 0.0 110.013 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -77.94 2.43 17.53 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.344 -0.848 . . . . 0.0 109.386 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 39.57 37.54 0.86 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -85.86 -25.65 26.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -1.194 . . . . 0.0 109.556 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.18 -48.1 0.98 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 136' ' ' VAL . 13.5 m-30 -112.85 178.4 4.3 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.564 -0.962 . . . . 0.0 108.786 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.467 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 54.2 mt -113.04 128.29 69.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.471 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -87.37 -178.96 6.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.838 . . . . 0.0 109.8 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.492 ' CB ' HG13 ' A' ' 121' ' ' VAL . . . -67.4 -47.28 70.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 0.0 109.181 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.81 -31.76 72.82 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.368 -0.832 . . . . 0.0 109.027 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 65.2 mm-40 -70.67 -23.1 62.44 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.541 ' CD2' ' HG3' ' A' ' 109' ' ' MET . 0.5 OUTLIER -82.64 -36.43 26.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.474 -0.766 . . . . 0.0 109.324 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -9.61 58.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.117 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -75.99 -34.65 59.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.83 . . . . 0.0 110.392 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.588 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 52.2 t -111.36 -42.79 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.919 -1.113 . . . . 0.0 110.582 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.541 ' HG3' ' CD2' ' A' ' 105' ' ' LEU . 4.4 mtm -55.03 -16.57 2.95 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.111 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.35 -34.84 23.56 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.851 -1.155 . . . . 0.0 108.938 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.26 -55.86 28.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.829 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.47 7.74 3.33 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.968 . . . . 0.0 110.025 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.483 ' CA ' ' O ' ' A' ' 109' ' ' MET . . . -103.23 36.79 4.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 41.0 mt-10 64.85 114.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.439 -1.036 . . . . 0.0 108.789 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.63 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.447 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.471 HD23 ' HB3' ' A' ' 109' ' ' MET . 0.9 OUTLIER -93.97 174.12 7.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 108.779 179.093 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.485 HG21 ' HG3' ' A' ' 120' ' ' GLU . 1.4 t -120.32 171.89 8.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 0.0 108.588 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 119' ' ' GLU . 1.1 m-20 -48.67 -48.35 40.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.073 -1.017 . . . . 0.0 110.615 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -41.81 -38.78 1.58 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.24 -0.912 . . . . 0.0 110.332 -179.152 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.485 ' HG3' HG21 ' A' ' 117' ' ' THR . 3.0 mt-10 -87.72 -46.6 9.34 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.391 -0.818 . . . . 0.0 110.086 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.492 HG13 ' CB ' ' A' ' 102' ' ' ALA . 71.1 t -32.83 -50.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.668 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -50.78 72.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.761 -1.212 . . . . 0.0 109.418 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.58 -13.4 61.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 108.794 179.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.448 ' HG3' HD11 ' A' ' 116' ' ' LEU . 5.8 mmt -89.35 -22.42 22.62 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.469 ' CG2' ' O ' ' A' ' 134' ' ' GLY . 4.0 mt -80.1 -42.99 22.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.19 -19.12 18.8 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.659 -0.651 . . . . 0.0 109.98 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 20.4 mm-40 -90.6 -24.56 20.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.133 -0.979 . . . . 0.0 110.018 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.41 -59.82 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.359 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.443 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 43.5 p30 -47.46 154.86 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.407 HD13 ' HG2' ' A' ' 140' ' ' GLU . 52.7 mt -102.05 -40.58 7.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.187 -0.946 . . . . 0.0 109.754 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.27 -40.77 36.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.52 -0.737 . . . . 0.0 109.641 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.53 33.37 5.11 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.07 -23.04 44.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -1.084 . . . . 0.0 109.099 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.469 ' O ' ' CG2' ' A' ' 125' ' ' ILE . . . 117.21 -30.06 6.45 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.75 167.51 10.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -1.199 . . . . 0.0 109.277 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.505 HG11 ' N ' ' A' ' 137' ' ' ASN . 68.6 t -119.98 160.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.2 -0.938 . . . . 0.0 108.666 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.505 ' N ' HG11 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -135.99 -164.41 1.55 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.63 -1.294 . . . . 0.0 108.648 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.444 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 64.9 t80 -75.66 -42.07 52.32 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.973 -1.079 . . . . 0.0 109.817 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -65.15 -47.8 75.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.117 -0.989 . . . . 0.0 109.432 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.503 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 55.8 mt-10 -69.84 -36.77 75.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.126 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 145' ' ' MET . 44.0 t80 -64.72 -27.62 69.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.844 . . . . 0.0 109.081 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.6 t -61.28 -47.83 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.837 . . . . 0.0 109.859 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -53.23 -37.75 62.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -0.978 . . . . 0.0 110.482 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.11 -23.31 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.055 -1.028 . . . . 0.0 110.022 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.52 ' CG ' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -86.08 -11.06 53.75 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.092 -1.005 . . . . 0.0 109.849 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 147' ' ' ALA . 1.1 p -81.99 -44.11 17.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -0.982 . . . . 0.0 109.615 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 146' ' ' THR . . . -44.8 130.73 7.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 76' ' ' MET . 0.0 OUTLIER 56.64 161.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 109.69 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.81 -92.29 0.21 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 0.0 109.379 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.99 125.17 6.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.641 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -115.93 -26.17 7.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 109.56 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 m -76.7 7.17 4.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.575 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 1.1 pt-20 -88.22 -31.45 19.06 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 108.88 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.575 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 1.4 tt0 -91.72 -12.77 33.06 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.53 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 6.7 tt0 -79.17 7.96 6.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.536 -0.728 . . . . 0.0 109.612 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.405 HD13 ' HB ' ' A' ' 146' ' ' THR . 5.5 mm -117.89 -42.98 2.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.111 -0.993 . . . . 0.0 109.722 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.429 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 4.6 mtp180 -66.83 -33.32 75.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -0.981 . . . . 0.0 109.08 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 18.5 pt-20 -96.57 -26.77 15.12 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.24 -0.913 . . . . 0.0 109.106 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -67.64 -29.52 68.85 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 84.6 t80 -62.07 -56.05 22.84 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.568 -0.708 . . . . 0.0 109.196 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -33.35 74.98 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.253 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 23.7 t -47.91 -33.77 3.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.491 ' CD1' ' HB ' ' A' ' 108' ' ' VAL . 66.7 m-85 -92.33 -30.9 15.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.481 ' HB2' HG12 ' A' ' 100' ' ' ILE . 26.2 t0 -100.33 83.04 2.58 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -73.32 -21.12 60.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 110.248 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -77.87 0.52 23.68 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.251 -0.906 . . . . 0.0 109.012 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.42 50.68 1.78 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 7.8 p-10 -107.49 -14.26 14.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 109.802 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.39 -26.48 11.05 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.635 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.2 m-85 -121.12 146.66 46.51 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.377 -1.072 . . . . 0.0 109.262 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.481 HG12 ' HB2' ' A' ' 93' ' ' ASP . 76.6 mt -103.54 120.85 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.429 -0.794 . . . . 0.0 109.54 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.6 p -81.96 170.78 15.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.095 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.8 90.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.046 -1.034 . . . . 0.0 109.475 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.37 83.45 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.219 -0.926 . . . . 0.0 109.462 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -73.28 -20.9 60.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.18 -0.95 . . . . 0.0 108.586 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.502 HD13 ' CG ' ' A' ' 109' ' ' MET . 15.4 tp -87.21 -23.69 24.67 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.47 -0.769 . . . . 0.0 109.534 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.462 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 23.3 ttt180 -82.97 -39.5 21.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -50.1 -30.51 11.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 110.403 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.491 ' HB ' ' CD1' ' A' ' 92' ' ' PHE . 98.9 t -110.17 -26.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.001 -1.062 . . . . 0.0 110.173 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.502 ' CG ' HD13 ' A' ' 105' ' ' LEU . 2.3 mmt -61.95 -14.39 34.33 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.339 -0.851 . . . . 0.0 109.656 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -82.6 -35.26 27.22 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.283 -0.886 . . . . 0.0 109.655 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 110' ' ' THR . 10.7 m120 -43.43 -59.14 2.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.29 16.8 1.7 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.407 -0.808 . . . . 0.0 109.134 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.461 ' CA ' ' O ' ' A' ' 109' ' ' MET . . . -94.97 30.84 7.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 23.9 mm-40 71.1 167.28 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -1.179 . . . . 0.0 109.703 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -90.6 73.33 6.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 120' ' ' GLU . 0.7 OUTLIER -97.97 153.55 18.29 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.584 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.476 ' O ' HG21 ' A' ' 121' ' ' VAL . 1.7 p -101.05 -150.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.141 -0.974 . . . . 0.0 109.776 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.448 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 4.1 m-20 -77.86 -54.07 6.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.0 109.853 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HG3' ' OE1' ' A' ' 120' ' ' GLU . 10.9 pt-20 -48.98 -38.23 22.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 0.0 109.125 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 2.6 mm-40 -71.5 -46.64 59.2 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 117' ' ' THR . 21.3 t -37.64 -51.82 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.105 0.479 . . . . 0.0 110.109 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 122' ' ' ASP . 37.7 t0 -54.26 -46.9 72.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.109 -0.995 . . . . 0.0 109.844 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -63.37 -31.69 72.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.979 . . . . 0.0 109.75 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.432 ' HG3' HD12 ' A' ' 116' ' ' LEU . 18.2 mmt -73.06 -26.17 61.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.93 -1.106 . . . . 0.0 108.293 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.454 HG12 ' CD2' ' A' ' 105' ' ' LEU . 7.1 mt -76.28 -37.14 31.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -57.07 -14.28 3.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.845 -0.534 . . . . 0.0 110.206 -179.636 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -89.37 -30.14 18.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 0.0 109.277 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -102.96 -0.69 30.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.565 -0.71 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.414 ' CG ' HG23 ' A' ' 125' ' ' ILE . 7.5 m-20 -82.72 143.72 30.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.852 . . . . 0.0 110.01 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.503 HG12 ' CG ' ' A' ' 140' ' ' GLU . 33.0 mm -108.66 -32.9 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.323 -0.861 . . . . 0.0 109.139 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -97.6 -33.91 11.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.608 -0.683 . . . . 0.0 109.23 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.11 26.41 18.97 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.06 -28.25 39.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -1.142 . . . . 0.0 109.219 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.11 33.96 2.07 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.437 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -154.31 150.82 28.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.425 -1.044 . . . . 0.0 109.361 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 137' ' ' ASN . 89.6 t -112.86 167.1 6.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.186 -0.946 . . . . 0.0 109.318 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.635 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 7.5 p30 -150.6 -172.5 4.2 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.442 ' O ' HG21 ' A' ' 142' ' ' VAL . 51.7 t80 -68.53 -48.78 63.46 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.413 -1.429 . . . . 0.0 110.804 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 7.0 mp0 -54.86 -55.51 29.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.986 -1.071 . . . . 0.0 110.845 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.524 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 22.4 mt-10 -63.3 -41.91 99.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.863 -1.148 . . . . 0.0 109.904 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.437 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 51.8 t80 -64.68 -23.05 67.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 109.978 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 138' ' ' TYR . 43.2 t -76.37 -44.08 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.841 . . . . 0.0 110.47 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 147' ' ' ALA . 1.6 mt-30 -64.47 -32.36 73.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.129 -0.982 . . . . 0.0 110.605 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -21.74 24.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.927 -1.108 . . . . 0.0 110.283 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.3 tpt -98.59 -6.63 29.61 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.897 -1.127 . . . . 0.0 110.649 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.575 ' CG2' ' N ' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -154.74 -52.25 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.678 -1.264 . . . . 0.0 110.733 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.575 ' N ' ' CG2' ' A' ' 146' ' ' THR . . . -86.72 80.61 8.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.042 . . . . 0.0 110.328 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.279 179.473 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.271 0.558 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt 68.7 86.86 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 109.771 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -77.21 141.43 40.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.285 -0.885 . . . . 0.0 109.079 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 m -122.83 110.56 15.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.952 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.485 ' O ' ' CB ' ' A' ' 81' ' ' SER . 4.8 t70 -93.29 -60.65 1.73 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 108.991 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER 166.67 115.11 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.469 -0.769 . . . . 0.0 109.308 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.41 -22.44 63.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.298 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -90.31 -1.23 57.9 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.55 -0.718 . . . . 0.0 109.738 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -57.65 -30.14 65.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.973 . . . . 0.0 109.639 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mt -83.88 -40.72 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.916 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.8 mtt85 -58.64 -35.29 72.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.608 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.8 OUTLIER -87.08 -31.68 20.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.577 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.5 -28.94 70.29 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.152 -0.967 . . . . 0.0 108.443 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.448 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 87.6 t80 -66.9 -53.0 36.42 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.408 -0.807 . . . . 0.0 109.507 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -66.2 -25.07 66.76 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 87' ' ' GLU . 2.7 t -52.7 -24.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.493 ' CE1' ' HB ' ' A' ' 108' ' ' VAL . 75.5 m-85 -108.34 -30.08 8.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -95.25 76.06 3.42 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.455 ' HB2' ' OE1' ' A' ' 104' ' ' GLU . 11.3 mmmt -79.86 -16.75 54.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 96' ' ' GLY . 18.8 m-20 -78.32 5.5 10.33 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.984 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.14 38.11 0.32 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -93.66 -69.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.401 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.9 -50.85 0.11 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.625 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 11.3 m-30 -109.66 155.37 21.57 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.413 -1.051 . . . . 0.0 108.784 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.407 HG23 ' HB2' ' A' ' 105' ' ' LEU . 94.1 mt -90.51 122.37 41.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 109.597 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.2 p -85.38 174.14 9.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.401 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.0 -33.04 74.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.132 -0.98 . . . . 0.0 109.447 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.4 68.44 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.228 -0.92 . . . . 0.0 109.565 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 60.3 mm-40 -78.71 -20.96 48.87 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.407 ' HB2' HG23 ' A' ' 100' ' ' ILE . 3.2 tp -93.25 -17.49 23.59 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.581 -0.699 . . . . 0.0 109.277 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.44 ' O ' ' OG1' ' A' ' 110' ' ' THR . 15.1 ttt-85 -80.58 -21.99 41.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.198 -0.939 . . . . 0.0 109.251 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -70.55 -27.79 64.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.307 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.493 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 79.4 t -111.07 -21.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.917 -1.114 . . . . 0.0 110.122 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 10.5 mmt -67.48 -41.04 85.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.016 -1.052 . . . . 0.0 109.18 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -73.69 -15.99 61.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.377 -0.827 . . . . 0.0 109.867 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 113' ' ' GLY . 0.1 OUTLIER -59.09 87.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.899 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.481 ' CD2' ' C ' ' A' ' 111' ' ' ASN . 1.4 pt? 36.29 29.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.637 -0.664 . . . . 0.0 110.835 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -96.03 -12.57 52.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.564 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 0.4 OUTLIER 151.27 -167.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 65.2 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.007 . . . . 0.0 109.167 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 120' ' ' GLU . 1.7 pp -105.77 121.76 44.69 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.583 -0.698 . . . . 0.0 109.431 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' A' ' 118' ' ' ASP . 4.5 t -86.5 -146.89 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.623 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.549 ' N ' ' CG2' ' A' ' 117' ' ' THR . 1.2 m-20 -73.4 -57.58 3.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.853 . . . . 0.0 109.873 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -20.41 2.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.847 . . . . 0.0 110.014 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 27.4 mm-40 -89.77 -39.79 12.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 117' ' ' THR . 22.4 t -47.67 -61.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.185 0.517 . . . . 0.0 109.652 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 121' ' ' VAL . 49.4 t0 -41.75 -34.0 0.57 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.293 -0.879 . . . . 0.0 109.878 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -45.14 49.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 108.96 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.7 mmm -60.87 -20.67 62.27 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.18 -0.95 . . . . 0.0 108.723 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.495 ' CG2' ' OD1' ' A' ' 129' ' ' ASP . 3.0 mt -87.47 -38.81 12.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -19.22 4.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.816 -0.552 . . . . 0.0 109.657 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -89.29 -31.95 17.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 109.049 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.08 -5.0 57.03 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.409 -0.807 . . . . 0.0 109.255 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 125' ' ' ILE . 1.8 m-20 -95.18 133.72 38.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.313 -0.867 . . . . 0.0 109.382 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.474 ' CG1' ' CD ' ' A' ' 140' ' ' GLU . 41.3 mm -83.78 -49.74 16.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.142 -0.974 . . . . 0.0 109.383 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.45 -45.09 23.04 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.571 -0.706 . . . . 0.0 109.168 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.62 31.95 3.79 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.47 -27.36 41.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -1.038 . . . . 0.0 109.429 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.464 ' O ' HG22 ' A' ' 125' ' ' ILE . . . 121.72 -16.21 8.97 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.847 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.625 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -109.18 164.59 12.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.739 -1.448 . . . . 0.0 109.587 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 137' ' ' ASN . 53.8 t -121.87 163.65 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.257 -0.902 . . . . 0.0 108.707 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.542 ' ND2' ' HG2' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -135.1 -168.72 2.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.928 -1.108 . . . . 0.0 108.707 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.498 ' O ' ' CG2' ' A' ' 142' ' ' VAL . 73.0 t80 -80.47 -36.59 33.24 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.089 -1.007 . . . . 0.0 110.146 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -68.26 -34.26 75.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.542 ' HG2' ' ND2' ' A' ' 137' ' ' ASN . 4.1 mm-40 -83.52 -34.75 25.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 108.921 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.586 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 14.3 t80 -72.26 -23.17 61.16 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.45 -0.781 . . . . 0.0 109.158 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 48.4 t -74.99 -59.51 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 0.0 109.694 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 12.4 mt-30 -53.34 -24.11 11.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.825 . . . . 0.0 110.538 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -90.7 -37.08 13.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.036 -1.04 . . . . 0.0 110.96 -178.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.586 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -84.8 -8.68 58.72 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.978 -1.077 . . . . 0.0 110.838 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -92.68 -35.01 13.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.912 -1.118 . . . . 0.0 109.061 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 148' ' ' LYS . . . -98.56 98.93 10.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.371 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 118.097 -0.954 . . . . 0.0 109.572 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 64.98 1.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 109.448 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -156.16 92.39 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -142.64 91.18 2.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.424 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.1 -77.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 109.644 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 t 62.08 26.63 16.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.387 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -84.74 -23.54 29.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.297 -0.877 . . . . 0.0 109.802 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -89.19 -17.85 28.29 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.432 -0.792 . . . . 0.0 109.485 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -60.94 -19.51 60.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.716 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.5 mt -97.74 -38.13 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.185 -0.947 . . . . 0.0 110.047 -179.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.526 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 2.9 ttt-85 -49.58 -32.13 12.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.041 -1.037 . . . . 0.0 109.49 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.1 mt-10 -91.01 -53.94 4.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 109.735 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.444 ' HA ' HG22 ' A' ' 91' ' ' VAL . . . -43.98 -27.03 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.0 108.79 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.504 ' CD1' ' HA ' ' A' ' 138' ' ' TYR . 70.3 t80 -62.37 -58.08 8.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.411 -0.806 . . . . 0.0 109.141 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -60.04 -37.49 79.97 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.385 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 90' ' ' ARG . 59.5 t -42.9 -32.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.479 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 56.0 m-85 -95.93 -35.12 11.56 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.48 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 28.3 t0 -91.06 88.89 7.16 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -77.53 -21.16 53.08 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 110.229 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 96' ' ' GLY . 67.2 m-20 -78.21 0.4 25.24 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 109.133 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 35.47 49.25 0.94 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -106.79 -22.82 12.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.249 . . . . 0.0 109.666 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.36 -27.97 5.15 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.633 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.7 m-85 -121.61 145.46 47.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.412 -1.052 . . . . 0.0 108.985 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.48 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 56.8 mt -96.17 133.94 35.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.236 -0.915 . . . . 0.0 109.358 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.59 170.9 9.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.41 94.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 109.281 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.89 -35.83 77.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.391 -0.818 . . . . 0.0 109.703 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.57 ' O ' ' CE1' ' A' ' 107' ' ' HIS . 64.6 mm-40 -71.61 -21.86 61.79 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.174 -0.954 . . . . 0.0 108.495 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.495 ' HG ' ' CG ' ' A' ' 109' ' ' MET . 1.6 tp -99.73 4.49 45.49 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.585 -0.697 . . . . 0.0 109.212 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -96.92 -30.89 12.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.127 -0.983 . . . . 0.0 109.978 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.607 ' CD2' HG21 ' A' ' 108' ' ' VAL . 45.5 p-80 -88.07 -53.3 4.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 111.802 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.607 HG21 ' CD2' ' A' ' 107' ' ' HIS . 18.9 t -68.43 -54.14 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.168 -0.957 . . . . 0.0 110.968 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.495 ' CG ' ' HG ' ' A' ' 105' ' ' LEU . 1.5 mmt -35.98 -45.33 0.41 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.611 -0.681 . . . . 0.0 110.786 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.516 ' OG1' ' N ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -88.88 -33.31 17.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.992 -1.067 . . . . 0.0 109.994 -179.536 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.451 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER 41.19 51.49 3.46 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.275 -0.891 . . . . 0.0 109.864 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.451 ' HG ' ' C ' ' A' ' 111' ' ' ASN . 0.8 OUTLIER 56.33 41.26 29.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.351 -0.843 . . . . 0.0 110.115 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -141.63 8.1 2.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 0.3 OUTLIER 155.1 57.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.752 -0.852 . . . . 0.0 108.999 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.516 ' N ' ' OG1' ' A' ' 110' ' ' THR . 3.1 ptpt -46.6 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.844 . . . . 0.0 110.318 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.401 ' HB2' ' CG ' ' A' ' 120' ' ' GLU . 0.2 OUTLIER -70.59 156.81 38.96 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.146 -0.971 . . . . 0.0 108.794 179.266 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.454 HG21 ' CB ' ' A' ' 120' ' ' GLU . 2.0 t -82.0 -174.78 5.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 109.486 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.16 -57.65 3.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 109.281 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.56 -24.04 4.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 108.887 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.454 ' CB ' HG21 ' A' ' 117' ' ' THR . 16.0 tp10 -81.11 -40.88 23.36 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 117' ' ' THR . 58.0 t -54.73 -48.39 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -31.54 29.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.842 . . . . 0.0 109.249 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 26.1 mm-40 -73.92 -39.58 63.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 109.042 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.9 mtt -67.33 -23.91 65.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.041 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.08 -40.03 15.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.441 -0.787 . . . . 0.0 109.805 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -15.41 6.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.511 -0.743 . . . . 0.0 110.359 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 4.1 mt-10 -90.16 -27.41 19.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.009 -1.057 . . . . 0.0 109.582 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.09 -58.45 2.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.918 . . . . 0.0 109.6 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 129' ' ' ASP . 40.2 p-10 -45.25 123.94 4.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.645 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.2 mt -91.89 -38.32 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.27 -0.894 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -76.23 -37.3 57.86 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.454 -0.779 . . . . 0.0 109.722 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.88 32.32 4.46 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.448 ' OD1' ' HG2' ' A' ' 135' ' ' GLN . 2.3 p30 -79.54 -24.56 42.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -1.075 . . . . 0.0 109.638 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.2 28.87 5.94 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.448 ' HG2' ' OD1' ' A' ' 133' ' ' ASP . 3.1 pt20 -160.23 -169.28 2.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -1.181 . . . . 0.0 108.993 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 137' ' ' ASN . 57.5 t -136.47 169.07 20.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.989 -1.07 . . . . 0.0 110.129 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.633 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -143.63 -167.92 2.7 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.252 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.526 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 50.6 t80 -74.5 -38.36 62.87 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.805 -1.184 . . . . 0.0 109.497 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -49.68 68.02 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.308 -0.87 . . . . 0.0 109.701 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.507 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 50.2 mt-10 -68.23 -36.92 80.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.678 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.566 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 34.6 t80 -69.21 -26.91 65.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -0.921 . . . . 0.0 109.686 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.476 ' O ' HG21 ' A' ' 146' ' ' THR . 48.1 t -68.12 -43.3 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.619 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -72.44 -21.99 61.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 0.0 109.878 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.43 -22.32 22.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.566 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.6 tpt -92.34 -59.15 2.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.078 -1.014 . . . . 0.0 109.787 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.514 ' CG2' ' N ' ' A' ' 147' ' ' ALA . 4.8 t -59.82 -44.78 93.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.367 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.514 ' N ' ' CG2' ' A' ' 146' ' ' THR . . . -99.81 157.84 16.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.383 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 78' ' ' ASP . 2.6 mtmt -146.1 160.02 42.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.704 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 77' ' ' LYS . 35.8 t70 44.9 87.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.32 -0.863 . . . . 0.0 109.646 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -52.19 141.74 18.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.377 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 79' ' ' THR . 0.8 OUTLIER -45.41 -96.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.326 -0.859 . . . . 0.0 109.848 -179.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 80' ' ' ASP . 48.9 m -167.05 21.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 83' ' ' GLU . 15.3 pt-20 -90.07 -41.66 11.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.022 -1.049 . . . . 0.0 109.477 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.42 ' N ' ' CG ' ' A' ' 82' ' ' GLU . 5.2 mt-10 -90.54 -14.67 32.13 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.49 -47.56 81.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 0.0 110.109 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.433 HG22 ' HA ' ' A' ' 142' ' ' VAL . 3.2 mt -65.07 -36.85 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.155 -0.965 . . . . 0.0 110.159 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.578 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.4 mtp85 -50.67 -34.29 25.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.112 -0.992 . . . . 0.0 109.372 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 88' ' ' ALA . 3.4 mt-10 -87.73 -52.73 5.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 109.742 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.64 -26.83 0.41 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 108.635 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.54 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 88.0 t80 -62.77 -57.64 10.22 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.43 -0.794 . . . . 0.0 109.572 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.45 ' O ' ' O ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -61.06 -31.66 71.32 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 109.04 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 70.4 t -46.66 -35.48 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.591 ' CE2' ' CG1' ' A' ' 108' ' ' VAL . 28.0 m-85 -87.29 -47.71 8.6 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 90' ' ' ARG . 57.5 t0 -72.97 116.75 13.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.69 -25.29 21.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.142 -0.973 . . . . 0.0 110.125 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.9 OUTLIER -78.94 2.61 19.65 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 108.983 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.471 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.04 47.56 1.35 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -108.26 -38.63 5.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -1.202 . . . . 0.0 109.748 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.14 -10.44 2.27 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.578 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -130.26 151.06 51.18 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.165 -1.197 . . . . 0.0 109.946 -179.661 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.436 HG21 ' HB2' ' A' ' 104' ' ' GLU . 62.9 mt -114.0 141.18 31.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.24 -0.913 . . . . 0.0 109.339 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -100.44 -178.29 3.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.76 -46.17 72.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.338 -0.851 . . . . 0.0 109.242 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.48 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . . . -56.47 -47.12 79.86 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.373 -0.829 . . . . 0.0 109.343 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.451 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 97.7 mt-10 -65.75 -22.88 66.63 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD2' ' CG ' ' A' ' 109' ' ' MET . 0.6 OUTLIER -77.86 -25.19 48.51 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.557 ' HG2' ' CG2' ' A' ' 121' ' ' VAL . 8.9 mtm-85 -77.74 -45.71 23.9 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.216 -0.928 . . . . 0.0 108.55 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -48.09 -27.22 2.19 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.454 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.591 ' CG1' ' CE2' ' A' ' 92' ' ' PHE . 98.8 t -112.82 -39.26 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.612 -1.305 . . . . 0.0 111.309 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.587 ' CG ' ' CD2' ' A' ' 105' ' ' LEU . 10.6 mmt -61.76 -15.89 44.9 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 109.727 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.504 HG21 ' N ' ' A' ' 111' ' ' ASN . 12.7 t -85.53 -25.12 26.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 109.34 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.504 ' N ' HG21 ' A' ' 110' ' ' THR . 11.5 t-20 -54.75 -34.77 62.99 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.282 -0.886 . . . . 0.0 109.38 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.15 1.95 3.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.795 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -110.74 30.52 8.05 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 2.2 mt-10 59.06 -95.53 0.06 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.329 -1.1 . . . . 0.0 109.304 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.94 136.21 33.59 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.07 -1.019 . . . . 0.0 109.601 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.512 ' HG ' ' HB3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -115.04 108.76 17.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.935 . . . . 0.0 109.544 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.53 -170.21 0.64 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.078 -1.014 . . . . 0.0 108.294 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -80.49 -54.96 5.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.915 -1.116 . . . . 0.0 108.882 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -22.62 65.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 108.838 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.61 -47.07 20.25 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.557 ' CG2' ' HG2' ' A' ' 106' ' ' ARG . 44.2 t -52.7 -46.5 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.488 -0.757 . . . . 0.0 110.087 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -48.64 -33.91 10.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 0.0 109.871 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -71.83 -37.96 70.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.404 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.6 mtt -68.54 -27.53 66.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.091 -1.006 . . . . 0.0 108.98 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.528 HG12 ' CD1' ' A' ' 105' ' ' LEU . 6.0 mt -78.19 -37.47 22.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.547 ' HG3' ' N ' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -57.82 -27.08 62.84 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.83 -0.544 . . . . 0.0 110.235 -179.417 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.547 ' N ' ' HG3' ' A' ' 126' ' ' ARG . 3.5 mt-10 -91.24 -16.95 26.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.021 -1.049 . . . . 0.0 109.859 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.465 ' HA ' ' HG2' ' A' ' 144' ' ' MET . . . -99.15 -66.36 0.91 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.114 -0.991 . . . . 0.0 109.794 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 128' ' ' ALA . 6.8 t70 -46.12 154.74 0.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.37 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.5 mm -88.89 -65.22 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.715 0.769 . . . . 0.0 109.268 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -176.91 57.09 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.564 -0.71 . . . . 0.0 109.342 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -104.32 -89.63 2.12 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -129.46 -19.54 3.41 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.73 -0.865 . . . . 0.0 110.128 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.459 ' O ' HG23 ' A' ' 125' ' ' ILE . . . 125.81 16.75 2.67 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.465 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 1.6 tt0 -112.56 163.38 14.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.23 -1.159 . . . . 0.0 108.674 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 137' ' ' ASN . 96.5 t -106.18 165.85 3.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 120.923 -1.11 . . . . 0.0 109.492 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.578 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -149.62 -171.31 3.86 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.578 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 62.9 t80 -69.0 -37.7 78.86 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.607 -1.308 . . . . 0.0 111.337 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.88 -40.38 79.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.053 . . . . 0.0 110.377 -179.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.511 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 26.8 mt-10 -81.04 -23.04 38.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.933 -1.105 . . . . 0.0 109.192 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' A' ' 145' ' ' MET . 28.4 t80 -84.28 -23.62 30.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.38 -0.825 . . . . 0.0 109.607 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.498 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 52.2 t -73.97 -63.13 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.312 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.449 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 2.4 mm100 -56.58 -24.54 48.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.465 ' HG2' ' HA ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -90.23 -31.8 16.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.906 -1.121 . . . . 0.0 110.029 -179.506 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 141' ' ' PHE . 2.1 ttp -77.04 -16.87 59.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.516 HG21 ' N ' ' A' ' 147' ' ' ALA . 5.8 t -127.64 -43.72 1.55 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.086 -1.009 . . . . 0.0 109.784 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.516 ' N ' HG21 ' A' ' 146' ' ' THR . . . -85.33 74.71 10.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.501 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.419 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.5 mmm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.04 179.76 0.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.73 16.88 6.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.852 . . . . 0.0 110.024 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.15 178.65 4.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.043 -1.036 . . . . 0.0 109.597 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.88 -69.28 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 109.853 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.458 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 0.4 OUTLIER 176.83 114.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.08 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -52.78 -22.24 5.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.366 -0.834 . . . . 0.0 110.298 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.71 27.76 1.46 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.922 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -100.22 -18.65 16.77 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.468 ' HA ' ' HB1' ' A' ' 88' ' ' ALA . 2.7 mp -83.5 -35.11 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.595 -0.691 . . . . 0.0 109.665 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.37 -45.89 90.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.111 -0.993 . . . . 0.0 109.344 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.67 -31.66 24.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.14 -0.975 . . . . 0.0 109.069 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 84' ' ' GLU . . . -61.57 -24.01 66.36 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 138' ' ' TYR . 73.6 t80 -66.31 -55.47 15.84 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.418 -0.801 . . . . 0.0 109.279 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -28.84 70.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.223 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 4.8 t -48.18 -29.04 2.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.582 ' CE2' ' HB ' ' A' ' 108' ' ' VAL . 78.6 m-85 -100.32 -35.94 9.43 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.424 ' HB2' HG12 ' A' ' 100' ' ' ILE . 41.5 t0 -90.36 87.16 6.69 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -77.25 -18.48 57.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.836 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ASN . 10.3 t70 -78.02 2.32 18.11 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.405 -0.81 . . . . 0.0 109.252 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.39 29.92 0.05 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' ASP . 4.0 t30 -88.93 -36.94 15.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.089 -1.242 . . . . 0.0 109.467 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.54 -14.17 4.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.568 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -128.37 146.55 50.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.25 -1.147 . . . . 0.0 109.746 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.438 HG21 ' HB2' ' A' ' 104' ' ' GLU . 87.0 mt -105.05 131.63 53.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.566 -0.709 . . . . 0.0 109.448 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.51 172.25 8.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.189 -0.944 . . . . 0.0 109.574 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.85 81.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 109.399 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.89 -35.89 75.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.362 -0.836 . . . . 0.0 109.332 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.47 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 66.1 mm-40 -70.64 -23.41 62.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.151 -0.968 . . . . 0.0 108.861 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.459 ' O ' ' HB2' ' A' ' 109' ' ' MET . 55.8 tp -83.9 -25.15 30.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.546 -0.722 . . . . 0.0 109.301 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.03 -24.95 43.28 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.246 -0.909 . . . . 0.0 108.967 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -59.91 -29.61 68.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 110.297 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.582 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 95.5 t -111.23 -46.62 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.887 -1.133 . . . . 0.0 110.203 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.459 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -52.69 -58.98 5.08 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.451 -0.78 . . . . 0.0 109.241 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.428 ' O ' ' C ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -91.16 13.09 18.0 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.412 -0.805 . . . . 0.0 110.137 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.486 ' HB3' ' HA ' ' A' ' 108' ' ' VAL . 3.0 p-10 -43.41 -48.44 7.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 0.0 109.785 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 111' ' ' ASN . 20.1 mt -152.53 14.67 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.013 . . . . 0.0 109.94 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -106.3 -14.51 20.11 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 54.55 30.43 13.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.412 -1.052 . . . . 0.0 109.24 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -79.31 161.01 26.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 117' ' ' THR . 3.6 pp 31.95 -157.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.499 0.666 . . . . 0.0 111.391 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.559 ' N ' ' CD1' ' A' ' 116' ' ' LEU . 4.0 t -152.19 -161.79 1.38 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.189 -0.945 . . . . 0.0 108.913 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.73 -50.15 11.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.065 -1.022 . . . . 0.0 110.14 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -67.56 -13.1 61.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 109.618 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.481 ' HB3' HG21 ' A' ' 117' ' ' THR . 5.5 tt0 -97.5 -34.77 10.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.27 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.503 HG21 ' CD1' ' A' ' 116' ' ' LEU . 11.6 t -49.5 -51.75 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -41.14 -37.65 0.93 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 109.805 -179.534 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.485 ' HG2' ' HD2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -68.25 -57.51 5.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.158 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.473 ' SD ' HD23 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -49.86 -22.73 1.58 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.158 179.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.447 HG21 HG21 ' A' ' 136' ' ' VAL . 3.4 mt -84.66 -38.65 13.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.63 0.729 . . . . 0.0 109.741 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.485 ' HD2' ' HG2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -62.02 -31.16 71.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.035 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.02 -9.51 53.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.106 -0.996 . . . . 0.0 109.113 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.57 -14.0 18.38 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.442 -0.786 . . . . 0.0 109.047 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.476 ' OD1' HG21 ' A' ' 136' ' ' VAL . 9.8 m-20 -92.63 164.27 13.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.433 -0.792 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.458 HD13 ' HG2' ' A' ' 140' ' ' GLU . 40.9 mt -86.16 -53.48 10.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.271 -0.893 . . . . 0.0 109.562 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.52 -46.58 46.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.495 -0.753 . . . . 0.0 109.673 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.79 30.71 4.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 135' ' ' GLN . 0.7 OUTLIER -79.85 -24.79 41.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -1.144 . . . . 0.0 109.596 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.39 16.91 9.77 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.548 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -128.65 147.53 50.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -1.088 . . . . 0.0 109.205 -179.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.478 ' CG1' ' N ' ' A' ' 137' ' ' ASN . 71.9 t -115.0 165.54 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.079 -1.013 . . . . 0.0 109.574 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.568 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 0.3 OUTLIER -140.56 -168.05 2.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.5 ' HA ' ' CD1' ' A' ' 89' ' ' PHE . 38.2 t80 -65.67 -52.64 50.05 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.715 -1.24 . . . . 0.0 110.689 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.465 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 2.6 mt-10 -58.44 -60.56 3.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.051 -1.03 . . . . 0.0 110.155 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.459 ' OE1' ' HA ' ' A' ' 129' ' ' ASP . 13.5 mt-10 -52.14 -38.67 58.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 110.275 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.435 ' CE2' ' HA ' ' A' ' 89' ' ' PHE . 38.5 t80 -69.65 -29.22 66.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.981 -1.074 . . . . 0.0 109.81 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' A' ' 138' ' ' TYR . 59.7 t -67.34 -39.36 82.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.444 -0.785 . . . . 0.0 109.875 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 147' ' ' ALA . 9.3 mm100 -64.06 -32.09 73.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.6 tmm? -90.2 -21.47 22.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.019 . . . . 0.0 110.029 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -57.94 3.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.08 -1.012 . . . . 0.0 109.913 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.599 ' O ' ' CG2' ' A' ' 146' ' ' THR . 1.4 m -105.98 12.99 29.89 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.191 -0.943 . . . . 0.0 109.229 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.565 ' C ' ' O ' ' A' ' 146' ' ' THR . . . -19.87 100.99 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.401 0.62 . . . . 0.0 111.36 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.587 -179.885 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -120.94 62.64 0.88 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.355 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -83.04 -12.86 56.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.435 ' O ' ' CG2' ' A' ' 79' ' ' THR . 14.5 t -168.24 49.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.146 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -41.99 108.13 0.09 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.451 -0.781 . . . . 0.0 109.664 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.464 ' O ' ' CD1' ' A' ' 85' ' ' ILE . 3.7 m -135.02 35.34 3.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.485 -0.759 . . . . 0.0 109.672 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -57.41 -88.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.918 . . . . 0.0 108.836 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -89.32 -5.24 57.69 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.687 -0.633 . . . . 0.0 109.296 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.47 ' O ' ' HB1' ' A' ' 88' ' ' ALA . 0.7 OUTLIER -61.31 -13.29 18.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 109.687 -179.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.464 ' CD1' ' O ' ' A' ' 81' ' ' SER . 8.4 mt -86.71 -49.54 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.128 -0.983 . . . . 0.0 109.207 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.604 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.2 ttp180 -47.97 -29.26 3.27 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.254 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 88' ' ' ALA . 46.5 mt-10 -93.46 -53.25 4.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.92 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.484 ' CB ' ' HE3' ' A' ' 145' ' ' MET . . . -45.82 -25.5 0.52 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.999 -1.063 . . . . 0.0 109.0 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 87.2 t80 -65.61 -56.25 13.24 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.441 -0.787 . . . . 0.0 109.604 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -62.08 -32.43 72.96 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.673 -0.642 . . . . 0.0 109.272 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.473 HG22 ' HA ' ' A' ' 88' ' ' ALA . 32.5 t -47.41 -31.08 2.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -96.9 -33.71 11.52 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.46 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 25.8 t0 -92.57 108.15 19.76 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.535 ' HD3' ' CE1' ' A' ' 107' ' ' HIS . 0.1 OUTLIER -80.1 -26.56 39.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.113 -0.992 . . . . 0.0 110.128 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 97' ' ' ASN . 47.3 m-20 -79.15 2.67 20.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.3 -0.875 . . . . 0.0 108.934 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 34.53 34.56 0.04 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' ASP . 3.5 t30 -87.32 -59.15 2.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -1.201 . . . . 0.0 109.836 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 166.39 -24.15 0.14 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.649 ' CE2' ' HB3' ' A' ' 137' ' ' ASN . 15.4 m-85 -122.42 139.88 53.34 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.257 -1.143 . . . . 0.0 109.791 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.487 HG21 ' N ' ' A' ' 101' ' ' SER . 63.1 mt -100.47 141.98 16.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.487 ' N ' HG21 ' A' ' 100' ' ' ILE . 88.9 p -109.91 -178.67 3.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.052 -1.03 . . . . 0.0 109.153 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 105' ' ' LEU . . . -62.38 -45.33 93.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 109.284 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.4 -46.43 88.71 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.37 -0.831 . . . . 0.0 109.539 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 107' ' ' HIS . 28.5 mt-10 -62.97 -24.26 67.82 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 121' ' ' VAL . 57.8 tp -71.28 -38.47 71.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.514 ' O ' ' CG ' ' A' ' 109' ' ' MET . 0.5 OUTLIER -70.92 -11.06 60.75 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.535 ' CE1' ' HD3' ' A' ' 94' ' ' LYS . 11.9 t-160 -57.82 -47.09 83.65 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.42 -0.8 . . . . 0.0 110.037 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.448 HG23 HG11 ' A' ' 91' ' ' VAL . 10.6 t -106.55 -5.66 10.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.243 -0.91 . . . . 0.0 110.103 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.514 ' CG ' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -39.12 -38.58 0.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 110.806 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.511 ' HA ' ' CA ' ' A' ' 114' ' ' GLU . 7.2 t -94.69 -34.65 12.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.869 -1.144 . . . . 0.0 110.226 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -58.14 -18.54 26.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.929 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 mt -145.39 -20.37 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.043 -1.036 . . . . 0.0 111.222 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' MET . . . -124.14 18.54 7.41 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.203 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.511 ' CA ' ' HA ' ' A' ' 110' ' ' THR . 22.5 mt-10 58.1 179.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -1.223 . . . . 0.0 109.601 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.461 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 0.3 OUTLIER -54.64 133.57 46.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.912 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 0.4 OUTLIER -108.89 -164.8 0.97 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.198 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.486 ' OG1' ' HG3' ' A' ' 120' ' ' GLU . 3.0 p -149.47 -150.09 0.33 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.398 -0.814 . . . . 0.0 108.85 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.51 -49.31 7.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.44 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -68.96 -15.72 63.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 0.0 109.889 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.486 ' HG3' ' OG1' ' A' ' 117' ' ' THR . 0.1 OUTLIER -94.52 -37.1 11.55 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.109 -0.994 . . . . 0.0 108.996 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.45 ' HA ' HD22 ' A' ' 105' ' ' LEU . 29.3 t -72.0 -70.38 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.819 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -50.76 -27.65 7.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 0.0 109.434 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 79.1 tt0 -75.2 -39.15 60.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 0.0 108.703 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . 0.439 ' SD ' HD23 ' A' ' 116' ' ' LEU . 23.1 mtp -61.83 -29.84 70.44 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.404 HG21 ' OD2' ' A' ' 129' ' ' ASP . 1.8 mt -77.08 -40.81 30.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.5 mtp85 -57.77 -33.15 68.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.624 -0.672 . . . . 0.0 109.931 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -81.38 -20.09 41.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 108.9 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.484 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -97.46 -6.54 33.61 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.514 -0.741 . . . . 0.0 109.469 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.404 ' OD2' HG21 ' A' ' 125' ' ' ILE . 4.3 m-20 -89.82 131.21 35.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.31 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.459 HD11 ' OE2' ' A' ' 140' ' ' GLU . 47.5 mt -104.9 -32.42 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.157 -0.965 . . . . 0.0 109.745 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.53 -41.86 6.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.767 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.23 36.21 2.0 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.3 p30 -79.16 -26.65 42.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.324 -1.104 . . . . 0.0 108.885 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 119.42 -40.75 2.15 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.44 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 15.3 pm0 -110.05 -177.39 3.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -1.164 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.509 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 99.5 t -122.64 171.83 10.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.343 -0.848 . . . . 0.0 108.852 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.649 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 1.4 p-10 -148.57 -175.04 4.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.795 -1.191 . . . . 0.0 108.828 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.604 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 52.5 t80 -71.75 -39.8 69.79 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.804 -1.185 . . . . 0.0 110.721 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.42 -48.5 75.13 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.992 -1.067 . . . . 0.0 109.985 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.474 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 1.3 mm-40 -71.83 -32.6 67.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.483 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 37.4 t80 -72.76 -25.78 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.868 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.502 ' CG2' ' CE1' ' A' ' 138' ' ' TYR . 39.6 t -74.01 -51.16 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.404 ' HA ' ' HB1' ' A' ' 147' ' ' ALA . 51.6 mt-30 -59.81 -30.67 69.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.185 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.428 ' HE3' ' CG1' ' A' ' 130' ' ' ILE . 8.1 tpp -84.46 -29.98 25.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.009 -1.057 . . . . 0.0 109.924 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.484 ' HE3' ' CB ' ' A' ' 88' ' ' ALA . 3.1 tmm? -91.41 -5.14 54.86 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.184 -0.947 . . . . 0.0 110.217 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.491 HG21 ' O ' ' A' ' 142' ' ' VAL . 1.2 t -140.43 -43.9 0.41 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.98 -1.075 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.478 ' N ' ' CG2' ' A' ' 146' ' ' THR . . . -84.62 163.37 19.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.987 . . . . 0.0 109.671 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.493 ' OXT' ' CG ' ' A' ' 148' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.318 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 86' ' ' ARG . 1.3 mt-10 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -43.7 -33.85 1.34 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 109.65 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.59 HG21 HG22 ' A' ' 142' ' ' VAL . 2.1 mp -93.17 -34.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.198 -0.939 . . . . 0.0 109.929 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.471 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 2.0 mmt85 -48.58 -37.91 19.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.641 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.7 mt-10 -87.01 -51.89 5.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.762 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.412 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -45.94 -25.06 0.48 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.994 -1.066 . . . . 0.0 109.11 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.442 ' HA ' ' CE2' ' A' ' 141' ' ' PHE . 77.6 t80 -66.5 -56.31 11.5 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.413 -0.804 . . . . 0.0 109.45 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.418 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 2.2 mtp180 -63.14 -27.51 69.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.295 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 108' ' ' VAL . 41.2 t -50.34 -28.99 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 62.4 m-85 -100.96 -36.19 9.12 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 27.1 t70 -83.94 82.58 8.28 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.581 -0.7 . . . . 0.0 109.254 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 4.7 mmtt -80.61 -20.43 43.25 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.301 -0.875 . . . . 0.0 110.157 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' GLY . 2.6 m-20 -78.12 1.56 20.82 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.98 48.15 1.96 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -109.09 -18.28 13.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -1.196 . . . . 0.0 109.812 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.09 -36.65 3.35 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.727 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 54.7 m-85 -116.38 142.08 47.32 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.374 -1.074 . . . . 0.0 109.59 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 97.0 mt -90.25 123.78 42.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 108.962 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.4 p -82.05 173.5 12.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.14 -0.975 . . . . 0.0 109.427 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -63.4 -42.1 98.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.414 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.468 ' HA ' ' NH2' ' A' ' 106' ' ' ARG . . . -63.46 -30.23 71.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 56.1 mm-40 -72.15 -22.51 61.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.149 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 109' ' ' MET . 4.1 tp -88.71 -31.83 18.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.6 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HE ' HG21 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.16 -9.59 52.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.164 -0.96 . . . . 0.0 109.175 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -88.31 -39.31 14.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.098 -1.001 . . . . 0.0 109.669 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 91' ' ' VAL . 57.3 t -88.62 -28.42 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 109.795 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 4.5 mtt -68.16 -20.98 64.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.238 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.518 ' CB ' ' O ' ' A' ' 114' ' ' GLU . 8.5 t -100.05 1.19 42.15 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.578 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 45.9 p-10 -57.51 -16.17 9.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 0.0 109.601 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.468 ' N ' ' OD1' ' A' ' 111' ' ' ASN . 1.2 mt -107.46 -20.93 13.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 109.641 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.6 -32.35 1.73 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 110' ' ' THR . 10.6 mt-10 -50.62 137.45 19.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.254 -1.145 . . . . 0.0 109.488 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 81.68 1.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.105 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.409 ' HB3' HG23 ' A' ' 121' ' ' VAL . 4.8 mp -63.91 136.29 57.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.0 t -90.81 -178.15 5.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 108.78 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -67.08 -54.98 16.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.892 -1.13 . . . . 0.0 110.178 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -60.73 -12.09 9.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.251 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 124' ' ' MET . 5.1 tp10 -97.46 -32.6 11.76 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.239 -0.913 . . . . 0.0 109.606 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.54 HG11 ' HB1' ' A' ' 102' ' ' ALA . 25.3 t -72.64 -54.43 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 0.0 109.787 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.69 -34.83 62.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.119 -0.988 . . . . 0.0 109.689 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 1.0 OUTLIER -76.08 -35.71 59.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.095 -1.003 . . . . 0.0 109.243 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 1.4 mmt -70.56 -21.05 62.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 108.716 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.499 HG21 ' O ' ' A' ' 134' ' ' GLY . 2.0 mt -84.87 -42.77 16.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -48.79 -31.61 7.32 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 109.898 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.84 -24.62 20.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.022 -1.049 . . . . 0.0 110.394 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.81 -44.98 54.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 109.838 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 135' ' ' GLN . 12.9 p-10 -86.39 177.06 7.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.349 -0.845 . . . . 0.0 109.668 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.0 mt -85.9 -66.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.414 -0.804 . . . . 0.0 109.567 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -177.47 57.83 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.512 -0.742 . . . . 0.0 109.49 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.22 -87.15 1.78 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.4 p-10 -139.11 -24.51 0.88 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.999 -0.707 . . . . 0.0 110.249 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.499 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 141.06 29.48 0.17 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.727 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 11.9 pt20 -119.63 166.85 12.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.263 . . . . 0.0 108.914 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 137' ' ' ASN . 69.9 t -119.41 162.87 17.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.517 ' N ' HG12 ' A' ' 136' ' ' VAL . 22.9 t30 -141.29 -164.38 1.75 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.975 -1.078 . . . . 0.0 108.372 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 142' ' ' VAL . 60.9 t80 -77.31 -49.5 14.85 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.686 -1.259 . . . . 0.0 110.15 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.29 -29.06 69.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.967 -1.083 . . . . 0.0 109.593 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.509 ' HB3' ' HA ' ' A' ' 129' ' ' ASP . 19.6 mt-10 -84.65 -32.87 23.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.107 -0.995 . . . . 0.0 108.856 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 89' ' ' PHE . 42.8 t80 -71.66 -25.81 62.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.535 -0.728 . . . . 0.0 109.087 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.59 HG22 HG21 ' A' ' 85' ' ' ILE . 24.0 t -60.53 -47.07 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.444 -0.785 . . . . 0.0 109.511 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -64.42 -35.54 81.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 109.782 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -83.34 -12.54 56.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.781 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.518 ' HE3' ' HA ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -81.88 -67.84 0.75 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.299 -0.876 . . . . 0.0 109.247 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.412 -0.805 . . . . 0.0 109.285 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -47.83 84.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.576 HG21 HG22 ' A' ' 142' ' ' VAL . 5.1 mt -75.3 -37.35 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.614 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.599 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -52.52 -30.71 31.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.193 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 23.1 mm-40 -90.93 -52.11 5.02 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.377 -0.827 . . . . 0.0 109.473 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -47.19 -24.86 0.78 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.989 . . . . 0.0 109.159 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 92.6 t80 -67.51 -56.46 9.43 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -63.76 -24.31 67.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 24.4 t -52.73 -32.72 17.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.543 ' HA ' HG21 ' A' ' 108' ' ' VAL . 53.9 m-85 -95.32 -36.56 11.35 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.468 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 27.6 t0 -84.26 112.78 20.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.544 -0.722 . . . . 0.0 109.483 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -89.31 -24.42 22.03 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.095 -1.003 . . . . 0.0 109.825 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 97' ' ' ASN . 60.2 m-20 -78.6 1.41 22.77 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.571 -0.852 . . . . 0.0 108.748 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 36.32 31.41 0.04 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -88.16 -28.36 21.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.076 -1.249 . . . . 0.0 109.529 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.48 -19.76 5.03 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.614 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 2.0 m-30 -118.45 152.41 35.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -1.156 . . . . 0.0 109.562 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.468 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 52.3 mt -118.25 105.36 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.145 -0.972 . . . . 0.0 109.491 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 102' ' ' ALA . 2.3 p -74.17 151.79 39.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 0.0 109.258 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.509 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -43.79 -36.4 2.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.95 . . . . 0.0 109.771 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.34 -45.81 82.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.083 -1.011 . . . . 0.0 109.58 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.487 ' OE2' ' HB2' ' A' ' 94' ' ' LYS . 3.8 mm-40 -65.95 -21.44 66.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.118 -0.989 . . . . 0.0 108.785 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.536 ' O ' ' CG ' ' A' ' 109' ' ' MET . 10.6 tp -84.53 -25.14 28.99 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.459 -0.776 . . . . 0.0 109.581 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.415 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 4.5 ttm180 -77.79 -54.81 5.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.516 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.628 ' O ' HG22 ' A' ' 110' ' ' THR . 15.2 t60 -45.05 -45.4 10.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.954 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.543 HG21 ' HA ' ' A' ' 92' ' ' PHE . 98.2 t -82.88 -24.4 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 110.107 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.612 ' HB3' HD13 ' A' ' 116' ' ' LEU . 8.8 mmt -70.59 -14.06 62.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.071 -1.018 . . . . 0.0 109.256 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 107' ' ' HIS . 15.3 t -100.55 -6.32 25.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 109.686 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.45 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 1.2 t-20 -44.3 -51.97 7.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.228 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.45 ' HG ' ' C ' ' A' ' 111' ' ' ASN . 28.7 mt -145.83 13.46 1.32 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -129.11 22.6 5.06 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 2.8 mm-40 62.05 153.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.405 -1.056 . . . . 0.0 109.278 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 126.81 31.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 0.0 109.668 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.64 HD21 ' SD ' ' A' ' 124' ' ' MET . 10.2 mp -70.29 171.56 9.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.83 -170.23 2.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.301 -0.874 . . . . 0.0 108.835 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.03 -49.83 8.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.182 -0.949 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.81 -12.04 57.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.816 . . . . 0.0 109.41 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.468 ' HG2' HD23 ' A' ' 116' ' ' LEU . 1.9 tt0 -99.52 -41.64 7.28 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.362 -0.836 . . . . 0.0 109.75 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 117' ' ' THR . 29.4 t -56.51 -51.78 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.588 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.18 -27.42 54.41 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.183 -0.948 . . . . 0.0 109.733 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 85.4 mt-10 -79.12 -29.13 43.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.375 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.64 ' SD ' HD21 ' A' ' 116' ' ' LEU . 2.1 mtt -78.52 -24.85 45.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 108.542 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.589 HG23 HG23 ' A' ' 136' ' ' VAL . 5.7 mt -83.59 -39.27 14.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.563 0.697 . . . . 0.0 109.378 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.8 ptm180 -42.37 -21.87 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.735 -0.603 . . . . 0.0 111.494 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' ILE . 1.6 mt-10 -86.18 -42.51 13.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.579 -1.326 . . . . 0.0 108.918 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.36 7.56 42.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.457 ' CG ' HG22 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -69.0 132.71 47.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.548 0.69 . . . . 0.0 110.455 -179.008 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.527 ' HA ' ' HG3' ' A' ' 140' ' ' GLU . 12.3 mt -49.11 -43.6 15.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.565 -0.709 . . . . 0.0 109.645 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -156.67 -36.29 0.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.355 -0.841 . . . . 0.0 109.971 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 155.82 40.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -101.46 -23.35 14.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -1.153 . . . . 0.0 109.358 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 109.76 -17.44 30.28 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.456 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -103.05 169.13 8.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.076 -1.249 . . . . 0.0 109.728 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.633 HG12 ' N ' ' A' ' 137' ' ' ASN . 54.3 t -128.07 167.21 23.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.633 ' N ' HG12 ' A' ' 136' ' ' VAL . 5.3 p-10 -138.4 -173.89 3.66 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.818 ' O ' HG23 ' A' ' 142' ' ' VAL . 55.3 t80 -72.7 -43.02 63.59 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.682 -1.261 . . . . 0.0 111.657 -178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.409 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 7.5 tt0 -66.4 -32.42 73.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.785 -1.197 . . . . 0.0 110.743 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.564 ' CG ' ' OD1' ' A' ' 137' ' ' ASN . 41.5 mm-40 -86.4 -28.93 23.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.0 109.161 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.436 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 20.6 t80 -75.1 -24.09 58.05 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 138' ' ' TYR . 42.3 t -69.33 -44.89 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.515 -0.741 . . . . 0.0 109.996 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -51.77 -38.29 54.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.082 -1.012 . . . . 0.0 109.946 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.42 -42.67 24.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.192 -0.943 . . . . 0.0 109.842 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.42 ' SD ' HG12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -68.36 -10.02 52.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.255 -0.903 . . . . 0.0 109.919 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.46 ' O ' HG22 ' A' ' 146' ' ' THR . 2.6 m . . . . . 0 C--N 1.303 -1.422 0 O-C-N 121.164 -0.96 . . . . 0.0 109.299 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -59.96 -18.3 44.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.524 HG21 HG22 ' A' ' 142' ' ' VAL . 22.5 mm -71.94 -34.21 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.447 -0.783 . . . . 0.0 109.641 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.583 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -50.7 -39.34 51.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 109.304 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' PHE . 20.7 mt-10 -85.58 -50.68 7.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.181 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.86 -25.57 0.31 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.216 -0.927 . . . . 0.0 108.893 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 78.6 t80 -65.55 -56.65 11.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.283 -0.886 . . . . 0.0 109.2 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.445 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 5.3 mtp180 -61.23 -29.26 69.72 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 38.2 t -47.63 -35.02 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.516 ' HD2' HD12 ' A' ' 105' ' ' LEU . 61.3 m-85 -91.54 -37.84 12.88 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.485 ' HB2' HG12 ' A' ' 100' ' ' ILE . 44.1 t0 -89.78 90.12 8.06 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -78.58 -25.13 45.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 110.492 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.477 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 1.2 m-20 -79.84 7.07 9.45 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.165 -0.959 . . . . 0.0 109.33 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 40.21 38.9 1.43 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -87.92 -1.42 57.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.61 -21.94 23.43 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.656 ' CE1' ' CB ' ' A' ' 137' ' ' ASN . 1.5 m-85 -125.26 145.61 49.92 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.325 -1.103 . . . . 0.0 109.382 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.503 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 88.5 mt -103.04 101.16 11.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 109.592 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 p -73.29 -179.53 3.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -0.987 . . . . 0.0 109.223 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.16 90.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.59 -28.09 66.63 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.222 -0.924 . . . . 0.0 109.277 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' A' ' 95' ' ' ASP . 5.2 mm-40 -72.94 -31.6 64.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.112 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.516 HD12 ' HD2' ' A' ' 92' ' ' PHE . 16.2 tp -83.12 -27.57 30.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.313 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.438 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 2.2 ttt180 -65.26 -18.62 65.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.858 . . . . 0.0 108.82 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.471 ' CD2' HG23 ' A' ' 108' ' ' VAL . 33.9 t60 -82.76 -34.48 27.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.472 -0.767 . . . . 0.0 109.926 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 108' ' ' VAL . 74.1 t -123.38 26.37 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.012 -1.055 . . . . 0.0 110.155 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.672 ' HB2' HD21 ' A' ' 116' ' ' LEU . 9.2 ptt? -71.41 -21.58 61.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.067 -1.021 . . . . 0.0 108.815 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -88.84 -8.7 53.84 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.422 -0.799 . . . . 0.0 110.171 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.723 ' HB2' HG12 ' A' ' 108' ' ' VAL . 4.5 t-20 -36.44 -46.73 0.57 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.477 -0.764 . . . . 0.0 109.619 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 174.92 35.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.49 -0.756 . . . . 0.0 109.071 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -116.12 36.1 3.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 22.8 mt-10 72.31 -160.72 0.11 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -1.019 . . . . 0.0 109.071 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' A' ' 115' ' ' LYS . 26.8 mtmt -120.93 89.81 3.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 109.691 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 109' ' ' MET . 0.3 OUTLIER -84.16 170.94 13.28 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.353 -0.842 . . . . 0.0 109.905 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 121' ' ' VAL . 5.4 t -112.1 -155.92 0.58 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.379 -0.826 . . . . 0.0 109.345 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.629 ' N ' HG23 ' A' ' 117' ' ' THR . 2.9 m-20 -84.44 -58.7 2.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.958 -1.089 . . . . 0.0 109.671 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -54.58 -18.86 4.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' HG2' ' HB2' ' A' ' 116' ' ' LEU . 3.2 tt0 -91.13 -37.0 13.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.357 -0.839 . . . . 0.0 109.764 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 117' ' ' THR . 2.9 t -41.85 -53.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.33 -0.856 . . . . 0.0 109.99 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -37.42 77.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.073 -1.017 . . . . 0.0 109.795 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -72.09 -19.06 61.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 0.0 109.377 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.5 mmm -85.73 -23.23 27.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.976 . . . . 0.0 108.424 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.667 HG23 HG23 ' A' ' 136' ' ' VAL . 6.1 mt -84.32 -41.74 16.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.692 0.758 . . . . 0.0 109.164 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -61.44 -19.58 62.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 110.153 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -88.93 -31.77 18.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.01 . . . . 0.0 109.089 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.12 -5.83 51.96 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.608 -0.682 . . . . 0.0 109.394 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.465 ' OD2' ' OE1' ' A' ' 140' ' ' GLU . 1.2 t70 -100.23 166.59 10.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.451 ' N ' ' CG ' ' A' ' 129' ' ' ASP . 38.9 mm -86.78 -71.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.37 -0.831 . . . . 0.0 109.285 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 179.62 58.1 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.612 -0.68 . . . . 0.0 109.211 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.08 -89.5 1.92 Allowed Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -127.92 -25.84 3.0 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.69 0.757 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.446 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 136.55 30.01 0.3 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 5.9 pt20 -128.74 -170.62 2.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.293 . . . . 0.0 108.938 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.667 HG23 HG23 ' A' ' 125' ' ' ILE . 92.8 t -127.33 169.82 18.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.994 -1.066 . . . . 0.0 109.604 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.656 ' CB ' ' CE1' ' A' ' 99' ' ' TYR . 7.7 p30 -149.37 -168.02 2.99 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.583 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 55.3 t80 -66.12 -55.24 17.43 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.44 -1.412 . . . . 0.0 110.461 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.507 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -53.66 -57.9 9.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.102 -0.999 . . . . 0.0 110.373 -179.322 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.538 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 19.6 mt-10 -57.68 -39.22 76.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.058 -1.026 . . . . 0.0 109.883 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.6 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 59.9 t80 -63.58 -28.05 69.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.538 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 85' ' ' ILE . 35.7 t -65.91 -53.12 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.421 -0.799 . . . . 0.0 109.722 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -58.43 -30.21 66.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 0.0 110.051 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 144' ' ' MET . 0.6 OUTLIER -86.92 -20.68 27.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.963 . . . . 0.0 109.958 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.6 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -96.31 -7.54 35.06 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.16 -0.963 . . . . 0.0 109.977 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.087 -1.008 . . . . 0.0 110.029 -179.619 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 1.3 tt0 -60.97 -19.59 61.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.895 . . . . 0.0 109.086 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 mt -116.71 -48.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.308 -0.87 . . . . 0.0 109.328 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.514 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.2 OUTLIER -56.33 -43.25 78.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.275 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.8 mm-40 -82.63 -31.99 28.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.341 -0.849 . . . . 0.0 109.491 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.439 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -61.5 -26.51 67.96 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.414 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 85.5 t80 -66.06 -56.89 9.27 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.507 -0.746 . . . . 0.0 109.417 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -64.03 -25.54 68.16 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 87' ' ' GLU . 17.6 t -53.13 -30.34 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.56 ' CE1' HG11 ' A' ' 108' ' ' VAL . 68.7 m-85 -97.22 -32.36 11.96 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.466 ' HB2' HG12 ' A' ' 100' ' ' ILE . 11.7 t70 -99.08 94.18 6.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -75.58 -23.4 56.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.056 -1.028 . . . . 0.0 109.671 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 97' ' ' ASN . 51.4 m-20 -78.5 0.92 24.12 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.339 -0.851 . . . . 0.0 108.943 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 31.26 37.46 0.03 OUTLIER Glycine 0 N--CA 1.498 2.826 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 95' ' ' ASP . 6.1 t-20 -84.14 -32.93 24.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.26 . . . . 0.0 109.708 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.49 -34.08 2.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.7 m-85 -114.58 145.53 41.86 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.36 -1.082 . . . . 0.0 109.096 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.466 HG12 ' HB2' ' A' ' 93' ' ' ASP . 27.9 mt -100.07 122.6 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.171 -0.956 . . . . 0.0 109.469 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.59 -178.1 5.74 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.291 -0.881 . . . . 0.0 109.114 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.36 -36.19 68.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.131 -0.981 . . . . 0.0 109.303 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.45 -30.29 71.06 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.329 -0.857 . . . . 0.0 109.747 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 33.6 mm-40 -75.95 -22.7 55.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.168 -0.958 . . . . 0.0 109.189 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.45 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 63.5 tp -95.61 -11.02 27.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -0.764 . . . . 0.0 109.339 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -87.73 -43.26 12.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.314 -0.866 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.711 ' O ' HG22 ' A' ' 110' ' ' THR . 3.2 t60 -61.69 -41.84 98.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.952 . . . . 0.0 109.431 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.565 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 1.3 t -73.05 -40.0 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.156 -0.965 . . . . 0.0 109.161 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.749 ' HB3' HD13 ' A' ' 116' ' ' LEU . 2.4 mmt -68.1 -16.79 64.16 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 107' ' ' HIS . 2.3 t -96.07 -20.95 18.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.845 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.565 ' ND2' ' O ' ' A' ' 108' ' ' VAL . 1.2 p30 -52.18 -44.99 64.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 108.845 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 112' ' ' LEU . 33.1 mt -152.62 18.14 0.61 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.473 -0.767 . . . . 0.0 109.474 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -114.61 34.9 4.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 110' ' ' THR . 13.1 mm-40 62.09 -169.12 0.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.418 -1.048 . . . . 0.0 109.627 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.32 89.88 4.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.824 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.749 HD13 ' HB3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -57.39 131.31 49.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.542 HG23 ' H ' ' A' ' 120' ' ' GLU . 1.1 t -79.47 177.75 8.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.09 -1.006 . . . . 0.0 108.839 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.85 -63.09 1.26 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.92 -1.113 . . . . 0.0 109.994 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 14.4 pt-20 -47.07 -44.39 20.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.948 . . . . 0.0 109.934 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.542 ' H ' HG23 ' A' ' 117' ' ' THR . 39.8 tp10 -62.02 -41.15 97.78 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.757 -0.589 . . . . 0.0 110.454 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 117' ' ' THR . 46.9 t -65.89 -62.65 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.13 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -31.42 52.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.974 -1.079 . . . . 0.0 109.196 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -71.06 -34.65 71.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.0 108.955 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 124' ' ' MET . 2.9 mmt -70.89 -28.15 64.33 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.342 -0.849 . . . . 0.0 108.842 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.465 HG23 HG23 ' A' ' 136' ' ' VAL . 2.7 mt -75.75 -42.08 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.424 -0.798 . . . . 0.0 109.15 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -14.63 3.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.673 -0.642 . . . . 0.0 110.165 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.2 -32.37 21.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 108.981 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.64 -7.25 50.54 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.467 -0.77 . . . . 0.0 109.348 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 0.3 OUTLIER -76.99 145.14 38.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.867 . . . . 0.0 109.808 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.502 ' CG1' ' OE1' ' A' ' 140' ' ' GLU . 32.0 mm -81.68 -39.38 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.155 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.18 -43.62 3.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.704 -0.622 . . . . 0.0 109.618 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.84 39.0 0.67 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.412 ' CG ' ' OE1' ' A' ' 135' ' ' GLN . 1.5 p30 -78.62 -25.03 45.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.294 -1.121 . . . . 0.0 108.771 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.21 26.95 4.12 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.65 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.586 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -156.86 170.36 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.935 -1.332 . . . . 0.0 109.369 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 137' ' ' ASN . 85.5 t -130.74 168.2 24.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.18 -0.95 . . . . 0.0 109.572 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.605 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -140.27 -165.57 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.77 ' O ' HG23 ' A' ' 142' ' ' VAL . 57.9 t80 -80.96 -40.07 25.05 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.04 -1.037 . . . . 0.0 109.768 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -33.0 73.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.089 -1.007 . . . . 0.0 109.378 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.572 ' HG2' ' ND2' ' A' ' 137' ' ' ASN . 2.1 mm-40 -82.18 -38.92 23.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.045 -1.034 . . . . 0.0 108.98 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.583 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 31.3 t80 -67.41 -25.42 65.93 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 108.978 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 138' ' ' TYR . 40.0 t -70.71 -43.67 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.862 . . . . 0.0 109.713 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -61.58 -23.89 66.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 109.697 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -31.47 16.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.638 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.583 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -93.03 -2.67 55.43 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.261 -0.9 . . . . 0.0 109.917 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.303 -1.446 0 O-C-N 121.263 -0.898 . . . . 0.0 108.992 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 22.8 tt0 -47.25 -24.58 0.76 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.57 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 mp -80.39 -43.39 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.321 -0.862 . . . . 0.0 109.667 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -39.0 57.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 109.355 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 17.7 pt-20 -81.03 -47.8 13.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 87' ' ' GLU . . . -45.47 -32.06 2.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 108.805 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.402 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 90.4 t80 -58.96 -56.29 24.22 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.393 -0.817 . . . . 0.0 109.582 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 3.2 mtp180 -63.42 -30.0 71.2 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.693 -0.629 . . . . 0.0 109.453 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 74.5 t -49.23 -28.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -102.14 -32.18 10.23 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD1' ' OE1' ' A' ' 104' ' ' GLU . 30.6 t70 -91.05 80.14 5.73 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.64 -0.663 . . . . 0.0 109.624 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -21.0 59.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.845 . . . . 0.0 109.817 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -78.58 1.9 21.08 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.72 -0.792 . . . . 0.0 108.994 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 34.62 39.44 0.15 Allowed Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 13.1 p-10 -94.42 -17.8 22.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.277 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.98 -38.19 2.94 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 137' ' ' ASN . 36.6 m-85 -115.36 140.47 49.1 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.291 -1.123 . . . . 0.0 109.32 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 72.1 mt -89.49 117.12 32.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.19 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.3 p -83.74 164.86 19.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.71 -35.3 72.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.522 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.44 -31.65 71.12 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.228 -0.92 . . . . 0.0 109.381 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' OE1' ' OD1' ' A' ' 93' ' ' ASP . 34.5 mt-10 -71.94 -24.22 61.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.202 -0.936 . . . . 0.0 108.948 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.5 tp -85.05 -33.96 22.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.259 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' A' ' 109' ' ' MET . 18.0 ttt180 -61.25 -28.49 69.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 108.657 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -65.89 -49.25 68.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.544 -0.722 . . . . 0.0 109.451 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 108' ' ' VAL . 23.8 t -103.16 41.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.892 ' HB2' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -92.39 -23.06 19.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.804 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.8 OUTLIER -100.55 -12.48 19.24 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.211 -0.931 . . . . 0.0 109.573 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.977 ' O ' HD23 ' A' ' 112' ' ' LEU . 19.7 p-10 -45.55 -44.87 13.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.044 -1.035 . . . . 0.0 108.915 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.977 HD23 ' O ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -159.5 22.69 0.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.306 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -123.72 45.02 1.22 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.5 mm-40 56.84 -141.18 0.81 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -1.234 . . . . 0.0 109.125 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -126.18 83.62 2.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.977 -1.077 . . . . 0.0 109.459 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.892 HD12 ' HB2' ' A' ' 109' ' ' MET . 35.2 mt -59.31 -160.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.138 -0.976 . . . . 0.0 109.587 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.831 ' O ' HG23 ' A' ' 121' ' ' VAL . 17.9 p -153.78 -161.58 1.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.39 -48.6 9.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.192 -0.943 . . . . 0.0 109.072 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.42 -16.18 60.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.285 -0.884 . . . . 0.0 108.796 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -88.81 -37.31 15.5 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 117' ' ' THR . 9.1 t -55.98 -52.54 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.418 -0.801 . . . . 0.0 109.014 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 3.5 m-20 -57.82 -23.35 52.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.173 -0.954 . . . . 0.0 109.327 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -81.37 -29.96 33.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.428 -0.795 . . . . 0.0 109.046 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.82 -25.85 49.14 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.627 HG21 ' O ' ' A' ' 134' ' ' GLY . 6.8 mt -84.65 -38.73 13.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.738 0.78 . . . . 0.0 109.031 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.2 ptm85 -54.33 -33.49 59.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.703 -0.623 . . . . 0.0 109.897 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 5.7 mt-10 -89.62 -18.09 27.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.064 -1.022 . . . . 0.0 109.336 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.35 -5.37 43.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.387 -0.821 . . . . 0.0 109.751 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.477 ' OD2' ' HA ' ' A' ' 126' ' ' ARG . 3.0 p30 -81.99 177.78 8.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.88 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.589 HD12 ' OE2' ' A' ' 140' ' ' GLU . 36.0 mt -81.13 -50.31 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.497 -0.752 . . . . 0.0 109.78 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -133.09 -24.32 1.88 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.32 -0.862 . . . . 0.0 110.55 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 137.78 40.79 0.11 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -78.97 -24.15 44.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -1.11 . . . . 0.0 108.74 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.627 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 102.06 -26.58 23.83 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -103.58 173.71 6.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -1.229 . . . . 0.0 109.451 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.603 HG23 HG23 ' A' ' 125' ' ' ILE . 55.6 t -124.26 162.62 25.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.576 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 31.4 t30 -141.54 -165.55 2.01 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.867 -1.146 . . . . 0.0 108.215 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.966 ' O ' HG23 ' A' ' 142' ' ' VAL . 72.1 t80 -75.99 -39.22 56.28 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.844 -1.16 . . . . 0.0 109.843 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -70.56 -34.12 71.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.235 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.589 ' OE2' HD12 ' A' ' 130' ' ' ILE . 7.8 mt-10 -80.2 -28.91 38.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 108.778 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.402 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 43.1 t80 -78.88 -25.12 43.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.433 -0.792 . . . . 0.0 109.3 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 138' ' ' TYR . 48.1 t -58.86 -48.53 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 109.822 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -66.64 -26.37 67.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.001 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.2 ttp -81.93 -21.95 37.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.67 -65.51 1.01 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.245 -0.909 . . . . 0.0 109.756 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.333 -0.854 . . . . 0.0 109.657 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.376 0.608 . . . . 0.0 109.413 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -55.73 24.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.943 . . . . 0.0 109.495 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.81 -41.64 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.536 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.584 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 4.2 ttp180 -49.86 -31.35 11.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.066 -1.021 . . . . 0.0 109.03 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 77.9 mt-10 -86.15 -57.54 2.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 110.105 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.514 ' CB ' ' SD ' ' A' ' 145' ' ' MET . . . -41.07 -32.98 0.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 109.031 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.46 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 89.9 t80 -59.76 -56.96 15.35 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.493 -0.754 . . . . 0.0 109.194 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.474 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -59.94 -35.85 75.82 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.759 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 66.1 t -42.93 -32.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -98.57 -31.7 11.82 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.474 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 13.2 t70 -95.6 81.68 3.55 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.607 -0.683 . . . . 0.0 109.316 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -22.35 55.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 110.296 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 97' ' ' ASN . 59.1 m-20 -78.51 2.15 20.02 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.281 -0.887 . . . . 0.0 109.21 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.09 29.83 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 95' ' ' ASP . 1.9 t30 -78.51 -36.44 44.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.101 -1.235 . . . . 0.0 109.551 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.71 -52.73 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 11.8 m-30 -106.42 156.52 18.44 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.352 -1.087 . . . . 0.0 109.003 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.411 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 74.2 mt -97.24 108.33 21.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.453 -0.779 . . . . 0.0 109.273 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -78.19 -177.56 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.759 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.695 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -64.65 -45.14 88.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -0.856 . . . . 0.0 109.17 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.97 -23.9 67.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.434 -0.791 . . . . 0.0 109.698 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -76.99 -31.89 56.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.023 -1.048 . . . . 0.0 108.892 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.633 HD12 HG12 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -89.27 -13.23 38.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -0.842 . . . . 0.0 108.899 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.498 ' O ' ' CG2' ' A' ' 110' ' ' THR . 10.1 ttt180 -90.15 -14.03 34.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.377 -0.827 . . . . 0.0 108.793 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -77.79 -26.47 49.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 110.172 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.8 t -106.67 -50.86 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 110.492 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.664 ' HB3' HD11 ' A' ' 116' ' ' LEU . 2.4 mmt -56.2 -19.55 14.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 109.858 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 106' ' ' ARG . 12.9 t -88.26 -28.94 20.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.119 -0.988 . . . . 0.0 109.645 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -52.93 -47.09 68.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.37 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pp -132.85 -3.72 3.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 110.131 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 109' ' ' MET . . . -103.79 20.05 42.52 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 16.3 mt-10 63.49 141.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -1.124 . . . . 0.0 109.186 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HA ' ' OG1' ' A' ' 110' ' ' THR . 0.6 OUTLIER -50.39 100.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.752 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 109' ' ' MET . 29.0 mt -59.57 133.18 55.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 109.264 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -71.16 178.97 3.02 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.109 -0.994 . . . . 0.0 108.332 179.201 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.412 ' N ' ' OG1' ' A' ' 117' ' ' THR . 10.0 m-20 -60.52 -63.45 1.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.87 -1.144 . . . . 0.0 109.914 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 1.4 pt-20 -50.4 -42.19 53.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 109.947 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.48 ' H ' HG23 ' A' ' 117' ' ' THR . 12.7 tp10 -63.04 -34.99 78.75 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.586 -0.696 . . . . 0.0 110.156 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.695 HG11 ' HB1' ' A' ' 102' ' ' ALA . 28.7 t -71.65 -65.37 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.276 -0.89 . . . . 0.0 109.638 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -48.82 -30.66 6.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.087 -1.008 . . . . 0.0 109.158 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 0.5 OUTLIER -75.09 -38.94 61.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.166 179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.566 ' HG3' HD13 ' A' ' 116' ' ' LEU . 3.7 mmt -65.32 -23.89 67.13 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.689 HG23 HG23 ' A' ' 136' ' ' VAL . 3.2 mt -81.76 -38.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -47.97 -28.76 2.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.955 -0.466 . . . . 0.0 110.099 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 124' ' ' MET . 7.2 pt-20 -80.2 -37.39 33.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.887 -1.133 . . . . 0.0 108.589 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -78.47 -7.98 58.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.65 143.3 30.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.822 . . . . 0.0 109.255 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.8 -39.47 10.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 109.665 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.11 -44.81 7.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.455 -0.778 . . . . 0.0 109.956 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.19 39.94 1.09 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -79.08 -24.54 43.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -1.073 . . . . 0.0 108.776 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.522 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 117.22 -36.77 3.58 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -98.75 170.07 9.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.061 -1.258 . . . . 0.0 109.118 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.689 HG23 HG23 ' A' ' 125' ' ' ILE . 52.0 t -127.9 162.79 33.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.176 -0.952 . . . . 0.0 108.556 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -137.99 -169.76 2.63 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 109.094 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.97 ' O ' HG23 ' A' ' 142' ' ' VAL . 78.7 t80 -77.62 -34.9 53.19 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.701 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -49.62 70.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.262 -0.899 . . . . 0.0 109.322 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -69.3 -39.79 78.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.331 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.46 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 47.7 t80 -66.38 -24.34 66.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.812 . . . . 0.0 109.793 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.97 HG23 ' O ' ' A' ' 138' ' ' TYR . 40.8 t -70.29 -46.95 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.94 . . . . 0.0 109.963 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -70.28 -23.96 62.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 109.866 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -85.12 -23.77 28.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.514 ' SD ' ' CB ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -83.34 -51.63 7.25 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.0 109.994 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -58.42 -27.28 64.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.112 -0.993 . . . . 0.0 109.191 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.596 HG21 HG13 ' A' ' 142' ' ' VAL . 4.5 mm -76.07 -39.86 36.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.371 -0.83 . . . . 0.0 109.262 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.406 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -53.56 -43.66 68.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 109.584 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 9.9 pt-20 -78.8 -41.59 29.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.991 . . . . 0.0 109.607 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.505 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -52.16 -30.37 26.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.104 -0.998 . . . . 0.0 108.648 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.446 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 90.4 t80 -64.39 -52.95 55.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.0 109.622 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -64.51 -24.21 67.53 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 52.7 t -56.35 -22.8 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -104.97 -36.27 7.38 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.411 ' HB2' HG12 ' A' ' 100' ' ' ILE . 39.4 t0 -83.99 108.29 16.86 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -84.28 -26.49 28.55 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.079 -1.013 . . . . 0.0 110.088 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.485 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -79.46 3.04 19.74 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 108.903 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 36.32 36.74 0.16 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 95' ' ' ASP . 14.5 p-10 -93.71 -42.87 8.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -1.187 . . . . 0.0 109.875 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.42 -20.71 1.52 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.641 ' CE1' ' CB ' ' A' ' 137' ' ' ASN . 1.7 m-85 -120.72 144.44 48.24 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.216 -1.167 . . . . 0.0 109.71 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.411 HG12 ' HB2' ' A' ' 93' ' ' ASP . 68.5 mt -108.54 110.21 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.547 -0.721 . . . . 0.0 109.537 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.75 162.92 28.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.245 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.526 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -55.06 -36.85 66.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.975 . . . . 0.0 109.38 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.44 78.59 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.375 -0.828 . . . . 0.0 109.343 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -72.24 -22.54 61.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.339 -0.851 . . . . 0.0 108.895 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 109' ' ' MET . 17.8 tp -90.03 -23.16 21.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.378 -0.826 . . . . 0.0 109.512 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.433 ' HB2' HG21 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -84.44 -34.33 23.49 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.16 -0.962 . . . . 0.0 109.882 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.535 ' O ' HG22 ' A' ' 110' ' ' THR . 35.0 t60 -61.12 -41.53 96.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.033 -1.042 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 91' ' ' VAL . 46.9 t -86.64 -23.86 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.816 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.492 ' CG ' ' O ' ' A' ' 105' ' ' LEU . 4.4 mmt -73.25 -21.33 60.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 107' ' ' HIS . 9.3 t -89.55 -26.03 21.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.34 -0.85 . . . . 0.0 109.63 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.693 ' HB3' HD12 ' A' ' 112' ' ' LEU . 1.6 t30 -48.18 -57.49 5.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.445 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 111' ' ' ASN . 1.8 mp -125.22 3.63 7.84 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.354 -0.841 . . . . 0.0 109.64 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . -108.86 56.4 0.47 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.9 mt-10 45.45 -134.53 0.78 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -1.15 . . . . 0.0 108.861 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -148.44 78.1 1.41 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.76 -1.212 . . . . 0.0 109.564 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.751 ' H ' HD23 ' A' ' 116' ' ' LEU . 1.4 pt? -67.85 144.81 55.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.095 -1.003 . . . . 0.0 109.0 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.719 ' O ' HG23 ' A' ' 121' ' ' VAL . 21.9 p -77.55 -159.73 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.9 . . . . 0.0 109.956 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.21 -48.37 13.21 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.422 -0.799 . . . . 0.0 109.49 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.68 -21.96 20.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.137 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 23.6 mm-40 -87.5 -47.88 8.38 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 117' ' ' THR . 49.0 t -46.96 -49.99 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.445 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.45 -38.16 68.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.832 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 15.6 mt-10 -67.45 -38.26 84.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.935 . . . . 0.0 109.629 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 21.9 mmm -68.51 -30.38 69.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.103 -0.998 . . . . 0.0 108.893 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.462 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 3.0 mt -71.96 -40.36 67.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.419 -0.801 . . . . 0.0 108.849 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -61.28 -18.93 60.89 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.558 -0.714 . . . . 0.0 109.189 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 7.1 mm-40 -90.4 -21.48 21.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.337 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 144' ' ' MET . . . -92.59 -65.18 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 30.4 p-10 -76.16 177.47 7.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.462 -0.774 . . . . 0.0 109.069 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.499 HG12 ' OE2' ' A' ' 140' ' ' GLU . 7.4 mm -85.89 -66.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -0.908 . . . . 0.0 109.721 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 173.46 65.01 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.92 -87.51 1.77 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.93 -17.61 7.26 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.765 -0.844 . . . . 0.0 109.327 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 125.08 18.32 2.59 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.48 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 1.3 pt20 -118.68 171.37 8.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -1.184 . . . . 0.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 137' ' ' ASN . 84.1 t -125.43 169.41 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.141 -0.974 . . . . 0.0 109.862 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.641 ' CB ' ' CE1' ' A' ' 99' ' ' TYR . 1.8 p-10 -145.23 -173.21 4.04 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.693 ' O ' HG23 ' A' ' 142' ' ' VAL . 49.9 t80 -69.81 -45.21 68.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.392 -1.443 . . . . 0.0 111.671 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.454 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 0.3 OUTLIER -61.68 -47.82 83.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.902 -1.124 . . . . 0.0 110.651 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.527 ' HB3' ' HA ' ' A' ' 129' ' ' ASP . 0.8 OUTLIER -70.41 -36.52 74.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.892 -1.13 . . . . 0.0 109.78 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.597 ' CZ ' ' HG2' ' A' ' 145' ' ' MET . 6.2 t80 -67.66 -27.71 67.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.19 -0.943 . . . . 0.0 109.159 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 138' ' ' TYR . 75.8 t -79.32 -62.62 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.369 -0.832 . . . . 0.0 109.662 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.44 ' C ' ' O ' ' A' ' 142' ' ' VAL . 7.8 mm100 -39.38 -34.65 0.22 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.473 -0.767 . . . . 0.0 110.73 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 128' ' ' ALA . 29.6 mmt -90.45 -45.75 8.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.871 -1.143 . . . . 0.0 110.624 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.597 ' HG2' ' CZ ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -71.61 -0.61 11.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 0.0 110.549 -178.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.494 ' CG2' HG13 ' A' ' 85' ' ' ILE . 7.8 p . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.104 -0.997 . . . . 0.0 110.008 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -52.95 -23.15 6.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.474 -0.766 . . . . 0.0 109.401 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -81.81 -38.12 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.326 -0.859 . . . . 0.0 109.058 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.474 ' HG2' ' CZ ' ' A' ' 138' ' ' TYR . 9.9 mtt180 -61.19 -31.92 71.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.437 -0.79 . . . . 0.0 109.143 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -89.74 -34.99 16.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 109.136 179.686 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.494 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.56 -23.12 67.25 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.42 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 82.6 t80 -69.68 -54.31 14.46 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -63.54 -27.62 69.38 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 4.9 t -48.17 -31.11 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.498 ' CE1' ' HB ' ' A' ' 108' ' ' VAL . 83.3 m-85 -98.29 -37.59 9.59 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.468 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 43.2 t0 -87.39 92.32 9.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -84.0 -24.8 30.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.26 -0.9 . . . . 0.0 110.223 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -79.18 4.18 15.57 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.245 -0.91 . . . . 0.0 109.101 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 39.57 29.3 0.14 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 95' ' ' ASP . 15.4 p-10 -73.93 -39.0 64.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.116 . . . . 0.0 109.658 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.26 -48.34 0.68 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.488 ' CD2' ' HG3' ' A' ' 135' ' ' GLN . 8.7 m-30 -108.92 176.29 5.16 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.335 -1.097 . . . . 0.0 109.465 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.7 mt -119.31 115.3 47.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.643 -0.66 . . . . 0.0 109.424 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.5 p -80.29 159.11 25.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.651 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.465 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -51.93 -35.89 47.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 0.0 109.514 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.56 -41.21 88.99 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.152 -0.968 . . . . 0.0 109.117 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 13.6 mt-10 -65.84 -22.69 66.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.227 -0.921 . . . . 0.0 109.103 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 109' ' ' MET . 9.4 tp -85.54 -32.25 22.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.422 -0.799 . . . . 0.0 109.644 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -34.79 77.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.289 -0.882 . . . . 0.0 109.177 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -59.55 -27.15 65.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 109.985 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.498 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 17.5 t -102.33 -12.73 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.078 -1.014 . . . . 0.0 110.44 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.815 ' HB3' HD22 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -78.24 -11.18 59.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.909 -1.12 . . . . 0.0 109.618 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 111' ' ' ASN . 2.1 t -99.93 -30.72 11.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.07 -1.019 . . . . 0.0 110.123 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -43.92 -45.49 7.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 109.221 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.8 23.48 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.648 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -115.04 19.76 15.0 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 67.8 146.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -1.095 . . . . 0.0 109.223 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.42 81.5 1.42 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -0.963 . . . . 0.0 110.053 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' A' ' 109' ' ' MET . 2.7 pt? -63.33 151.75 39.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 109.008 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.509 ' OG1' ' HG2' ' A' ' 120' ' ' GLU . 44.4 p -84.45 -165.61 1.22 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.296 -0.877 . . . . 0.0 109.447 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -75.11 -46.57 33.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.712 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.439 ' O ' ' OE1' ' A' ' 123' ' ' GLU . 30.9 mt-10 -57.2 -16.42 8.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.763 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.509 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 5.2 mm-40 -95.17 -45.08 7.34 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.342 -0.849 . . . . 0.0 108.961 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.603 HG22 HD11 ' A' ' 116' ' ' LEU . 41.8 t -49.42 -55.72 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.89 -0.507 . . . . 0.0 110.599 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.34 -36.54 84.05 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.852 -1.155 . . . . 0.0 109.042 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 119' ' ' GLU . 87.0 mt-10 -70.79 -15.56 62.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.179 -0.951 . . . . 0.0 108.56 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.434 ' SD ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -85.32 -30.94 23.31 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.698 HG22 ' OD2' ' A' ' 129' ' ' ASP . 3.3 mt -74.42 -41.31 49.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.99 -15.23 3.23 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.706 -0.621 . . . . 0.0 110.007 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -87.33 -30.94 20.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.923 -1.111 . . . . 0.0 109.797 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.402 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -88.7 -58.48 2.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.337 -0.852 . . . . 0.0 109.506 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.698 ' OD2' HG22 ' A' ' 125' ' ' ILE . 8.6 p30 -53.05 155.49 2.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.713 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.8 mt -111.79 -44.39 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.295 -0.878 . . . . 0.0 109.703 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -72.51 -38.14 68.18 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.473 -0.767 . . . . 0.0 109.63 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.66 33.46 6.42 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -78.94 -26.28 43.6 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.318 -1.107 . . . . 0.0 108.681 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.587 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 124.22 -42.19 1.6 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.488 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -90.07 165.25 14.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.059 -1.26 . . . . 0.0 109.49 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 137' ' ' ASN . 53.1 t -118.23 161.49 17.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.521 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -134.16 -164.62 1.53 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.714 -1.241 . . . . 0.0 108.659 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.991 ' O ' HG23 ' A' ' 142' ' ' VAL . 64.9 t80 -78.49 -38.48 40.8 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.205 -0.934 . . . . 0.0 110.206 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -70.45 -33.08 70.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.995 -1.066 . . . . 0.0 109.417 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.48 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 15.5 mt-10 -82.12 -34.07 29.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.159 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.42 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 38.5 t80 -75.47 -25.65 57.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.519 -0.738 . . . . 0.0 109.671 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.991 HG23 ' O ' ' A' ' 138' ' ' TYR . 26.8 t -55.38 -48.98 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.786 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -65.9 -27.3 68.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.041 -1.037 . . . . 0.0 109.627 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -80.39 -19.33 46.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.198 -0.939 . . . . 0.0 109.691 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.442 ' HG3' ' HB3' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -77.47 -39.13 47.62 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.095 -1.003 . . . . 0.0 109.36 179.826 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 86' ' ' ARG . 4.9 tt0 . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 121.349 0.595 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -47.09 -26.94 1.2 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.312 -0.868 . . . . 0.0 110.116 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 mt -72.45 -44.67 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.042 -1.036 . . . . 0.0 109.641 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.584 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -46.24 -33.4 3.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.059 -1.025 . . . . 0.0 109.441 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 88' ' ' ALA . 1.9 mt-10 -87.17 -55.44 3.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 109.977 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -42.69 -28.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 108.901 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 87' ' ' GLU . 79.6 t80 -62.61 -57.52 10.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.481 -0.762 . . . . 0.0 109.419 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.461 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 6.0 mtp180 -61.1 -32.99 72.65 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.67 -0.644 . . . . 0.0 109.302 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.488 HG12 HG21 ' A' ' 108' ' ' VAL . 39.1 t -45.31 -32.45 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.706 ' CD1' HD12 ' A' ' 105' ' ' LEU . 85.8 m-85 -94.47 -49.79 5.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.487 ' CA ' HG12 ' A' ' 100' ' ' ILE . 65.7 t0 -65.36 91.37 0.11 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -90.32 -21.01 22.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 111.238 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.46 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 10.5 p-10 -78.2 7.53 6.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.938 -1.101 . . . . 0.0 109.876 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.75 49.66 1.92 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.425 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 1.8 t30 -110.17 -64.58 1.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -1.114 . . . . 0.0 109.207 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.19 -47.27 0.11 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.593 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 7.6 m-30 -110.06 150.38 28.64 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.53 -0.982 . . . . 0.0 109.204 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.487 HG12 ' CA ' ' A' ' 93' ' ' ASP . 55.6 mt -85.43 152.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.419 -0.801 . . . . 0.0 109.511 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.7 p -110.48 172.63 6.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.183 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.96 -53.7 49.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.828 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.24 62.72 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 71.4 mt-10 -75.24 -30.0 60.39 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.123 -0.986 . . . . 0.0 108.561 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.706 HD12 ' CD1' ' A' ' 92' ' ' PHE . 12.2 tp -81.18 -21.93 39.29 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.776 ' HB2' HG21 ' A' ' 121' ' ' VAL . 35.9 ttt-85 -78.86 -22.64 45.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.41 -0.806 . . . . 0.0 108.968 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -67.76 -38.49 83.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.468 -0.77 . . . . 0.0 110.427 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.488 HG21 HG12 ' A' ' 91' ' ' VAL . 92.4 t -99.17 -38.07 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.255 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.979 ' HB3' HD13 ' A' ' 116' ' ' LEU . 16.3 mmt -61.14 -13.34 16.88 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.32 -0.862 . . . . 0.0 109.615 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -94.73 -29.41 14.8 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.22 -0.925 . . . . 0.0 108.849 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -68.12 0.39 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.905 . . . . 0.0 109.258 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.7 mt -114.33 15.19 18.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 109.328 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 109' ' ' MET . . . -111.04 51.35 0.7 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 48.29 -145.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -1.083 . . . . 0.0 109.545 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.56 101.01 9.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.02 . . . . 0.0 109.788 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.979 HD13 ' HB3' ' A' ' 109' ' ' MET . 0.1 OUTLIER -102.6 111.5 23.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.41 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.905 HG22 ' HG2' ' A' ' 120' ' ' GLU . 6.3 t -82.71 -146.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 108.735 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.7 ' N ' HG23 ' A' ' 117' ' ' THR . 2.9 m-20 -90.11 -48.45 7.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.023 -1.048 . . . . 0.0 109.884 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -60.23 -17.83 44.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.869 . . . . 0.0 109.586 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.905 ' HG2' HG22 ' A' ' 117' ' ' THR . 11.9 mm-40 -94.1 -47.76 6.53 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 117' ' ' THR . 47.7 t -47.49 -62.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.599 -0.688 . . . . 0.0 109.905 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -31.68 11.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.982 -1.074 . . . . 0.0 109.646 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -68.49 -40.18 81.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.224 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.492 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 36.2 mmm -63.39 -32.68 74.18 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mt -71.03 -39.25 74.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.567 -0.708 . . . . 0.0 109.463 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -55.06 -27.55 45.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 110.263 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -89.33 -21.56 23.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.126 -0.984 . . . . 0.0 109.663 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -97.19 -5.82 36.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.824 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' HG22 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -97.45 133.32 42.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.7 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 57.0 mt -85.34 -50.23 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.358 -0.839 . . . . 0.0 109.426 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.1 -49.86 7.91 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.604 -0.685 . . . . 0.0 109.726 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.08 37.75 2.45 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -78.78 -25.19 44.33 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.317 -1.108 . . . . 0.0 108.821 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.19 28.96 1.88 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.485 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.593 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -159.18 165.85 32.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.068 -1.254 . . . . 0.0 109.256 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 137' ' ' ASN . 55.8 t -122.6 162.86 21.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.12 -0.987 . . . . 0.0 108.654 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.534 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -132.44 -164.01 1.41 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.908 -1.12 . . . . 0.0 108.517 179.424 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 1.013 ' O ' HG23 ' A' ' 142' ' ' VAL . 67.2 t80 -78.58 -49.59 13.01 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 110.323 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -59.84 -39.65 85.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.0 109.536 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.517 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 7.5 mt-10 -74.68 -38.96 62.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.049 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 39.0 t80 -65.64 -22.52 66.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.422 -0.798 . . . . 0.0 109.059 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 1.013 HG23 ' O ' ' A' ' 138' ' ' TYR . 89.7 t -70.68 -40.66 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.552 -0.718 . . . . 0.0 110.079 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -65.98 -27.82 68.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.068 -1.02 . . . . 0.0 110.188 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.6 ttp -90.34 -26.54 19.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.094 -1.004 . . . . 0.0 110.058 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -97.68 -62.69 1.21 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.005 -1.06 . . . . 0.0 109.99 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.159 -0.963 . . . . 0.0 109.348 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 121.033 0.444 . . . . 0.0 109.849 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.41 -39.42 15.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.961 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.66 HG23 ' CB ' ' A' ' 145' ' ' MET . 2.6 mt -91.72 -37.17 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.178 -0.952 . . . . 0.0 110.243 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.57 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 34.8 mtt180 -49.61 -28.91 6.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.005 . . . . 0.0 109.772 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -92.68 -54.02 3.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.078 -1.014 . . . . 0.0 109.478 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -44.51 -26.74 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.189 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 75.7 t80 -64.77 -55.9 16.94 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.111 -0.993 . . . . 0.0 109.403 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.411 ' CZ ' ' CB ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -62.88 -31.68 72.78 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.307 -179.743 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 108' ' ' VAL . 41.0 t -47.41 -28.24 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 64.7 m-85 -102.74 -31.69 10.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.472 ' HB2' HG12 ' A' ' 100' ' ' ILE . 34.3 t0 -93.62 92.83 7.72 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.583 -0.698 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.447 ' NZ ' ' CE1' ' A' ' 107' ' ' HIS . 1.6 mmmm -90.28 -23.13 21.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.222 -0.924 . . . . 0.0 109.927 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.492 ' O ' ' C ' ' A' ' 96' ' ' GLY . 15.8 t0 -78.79 1.95 21.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 109.186 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 33.55 37.8 0.07 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 95' ' ' ASP . 12.9 p-10 -88.0 -28.53 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -1.178 . . . . 0.0 109.768 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 143.37 -54.27 0.59 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 14.6 m-30 -109.59 157.28 19.2 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.486 -1.008 . . . . 0.0 109.124 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 84.3 mt -90.28 117.4 33.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 109.026 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.0 p -74.48 159.86 31.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.168 -0.958 . . . . 0.0 109.265 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.79 -31.12 66.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.418 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.78 -35.34 62.54 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.168 -0.958 . . . . 0.0 109.042 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 50.7 mm-40 -73.3 -22.8 60.27 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.276 -0.89 . . . . 0.0 108.967 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 125' ' ' ILE . 5.3 tp -90.78 -25.16 20.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 0.0 109.032 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.496 ' O ' ' OG1' ' A' ' 110' ' ' THR . 2.0 ttt180 -77.4 -30.4 53.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.271 -0.893 . . . . 0.0 109.01 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.447 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 26.6 t-80 -58.03 -45.11 87.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.906 . . . . 0.0 110.057 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 91' ' ' VAL . 25.9 t -91.65 -26.46 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.06 -1.025 . . . . 0.0 110.392 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.576 ' CE ' HD12 ' A' ' 116' ' ' LEU . 13.7 mtm -61.29 -42.63 98.98 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.102 -0.999 . . . . 0.0 109.038 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.937 HG23 ' HA ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -59.31 -26.67 65.2 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.207 -0.933 . . . . 0.0 109.253 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 110' ' ' THR . 7.9 t-20 39.02 -93.03 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.662 -0.648 . . . . 0.0 110.088 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.839 ' O ' HD12 ' A' ' 112' ' ' LEU . 1.3 pp -148.71 68.34 1.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.143 -0.973 . . . . 0.0 109.226 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.56 -17.55 11.14 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -83.75 43.41 0.91 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.228 -1.16 . . . . 0.0 109.826 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.937 ' HA ' HG23 ' A' ' 110' ' ' THR . 13.7 ttpp -64.98 126.52 28.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 0.0 109.344 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.576 HD12 ' CE ' ' A' ' 109' ' ' MET . 45.5 mt -104.08 140.6 37.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.48 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -66.98 -169.17 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.91 . . . . 0.0 108.71 179.33 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.47 -50.53 12.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.011 -1.055 . . . . 0.0 109.269 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -30.6 70.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.18 -0.95 . . . . 0.0 108.5 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.49 ' CG ' HD22 ' A' ' 116' ' ' LEU . 9.8 tp10 -70.56 -41.88 71.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 117' ' ' THR . 34.6 t -61.5 -36.63 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.14 -25.53 67.02 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -75.01 -45.86 38.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.481 -0.762 . . . . 0.0 109.017 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 7.6 mmt -60.66 -28.28 68.47 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.21 -0.931 . . . . 0.0 108.76 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.563 HG12 HD22 ' A' ' 105' ' ' LEU . 2.4 mt -82.09 -35.24 13.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.519 -0.738 . . . . 0.0 109.475 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -59.69 -31.24 69.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 110.35 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.42 -5.24 56.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.029 -1.045 . . . . 0.0 110.509 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.06 -29.85 11.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.986 -1.071 . . . . 0.0 109.747 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.33 149.87 23.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.287 -0.883 . . . . 0.0 109.641 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.818 HD12 ' OE1' ' A' ' 140' ' ' GLU . 16.9 mt -113.38 -29.02 2.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.18 -0.95 . . . . 0.0 109.374 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' HB3' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -61.73 -33.6 74.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.88 21.39 55.83 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' OD2' ' HB3' ' A' ' 131' ' ' ASP . 0.7 OUTLIER -83.51 -27.56 29.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -1.169 . . . . 0.0 109.609 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.84 28.03 4.65 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.457 ' CD ' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -146.61 163.07 37.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -1.204 . . . . 0.0 109.391 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 137' ' ' ASN . 94.2 t -117.78 168.2 9.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.327 -0.858 . . . . 0.0 109.188 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.599 ' N ' HG12 ' A' ' 136' ' ' VAL . 47.0 t30 -148.25 -166.29 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.888 ' O ' HG23 ' A' ' 142' ' ' VAL . 60.2 t80 -80.62 -41.79 23.31 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.583 -1.323 . . . . 0.0 110.117 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.49 -29.99 66.67 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.104 -0.998 . . . . 0.0 109.303 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.818 ' OE1' HD12 ' A' ' 130' ' ' ILE . 6.1 mm-40 -85.26 -35.41 21.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 26.1 t80 -71.22 -26.87 63.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.536 -0.727 . . . . 0.0 109.16 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 138' ' ' TYR . 20.3 t -55.37 -44.31 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.189 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -57.94 -31.59 66.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.708 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.493 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 34.5 ttp -75.98 -39.57 55.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.454 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.66 ' CB ' HG23 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -69.77 -20.17 63.49 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.2 p . . . . . 0 N--CA 1.488 1.44 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.053 0.454 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.01 -19.46 4.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.064 -1.022 . . . . 0.0 109.338 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' A' ' 142' ' ' VAL . 5.8 mt -74.92 -39.72 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.282 -0.886 . . . . 0.0 109.548 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.586 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -46.52 -31.79 2.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.934 -1.103 . . . . 0.0 109.214 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 88' ' ' ALA . 15.5 mt-10 -91.88 -50.28 5.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.454 -0.779 . . . . 0.0 109.168 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.488 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.78 -25.87 0.34 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -0.906 . . . . 0.0 108.761 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' N ' ' C ' ' A' ' 87' ' ' GLU . 82.9 t80 -63.51 -55.61 22.59 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.284 -0.885 . . . . 0.0 109.004 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.45 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -60.86 -36.13 78.37 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 34.4 t -43.32 -28.35 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 90' ' ' ARG . 92.0 m-85 -106.36 -31.37 8.62 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.45 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 10.8 t0 -89.34 79.7 6.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.602 -0.686 . . . . 0.0 109.369 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -89.19 -16.97 30.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.386 -0.821 . . . . 0.0 109.745 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.459 ' O ' ' C ' ' A' ' 96' ' ' GLY . 12.6 t70 -77.19 0.39 21.98 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.397 -0.815 . . . . 0.0 108.988 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.96 50.3 2.07 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.12 -31.83 7.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -1.176 . . . . 0.0 109.587 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.39 -50.02 0.82 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.636 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 10.9 m-30 -114.03 146.04 40.73 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.339 -1.095 . . . . 0.0 109.217 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 81.9 mt -81.96 132.56 31.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.398 -0.814 . . . . 0.0 109.389 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.6 p -98.26 178.04 5.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.547 ' CA ' HG11 ' A' ' 121' ' ' VAL . . . -65.7 -40.54 92.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 109.341 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.73 -31.1 70.8 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.267 -0.896 . . . . 0.0 109.407 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.53 -26.23 59.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.877 . . . . 0.0 108.667 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.904 ' O ' HD23 ' A' ' 105' ' ' LEU . 3.6 tt -82.11 -26.2 33.77 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.787 HH12 HG21 ' A' ' 110' ' ' THR . 0.0 OUTLIER -73.03 -47.33 45.84 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 106' ' ' ARG . 28.0 t60 -40.93 -38.4 0.95 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.48 -0.762 . . . . 0.0 110.347 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.449 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 36.2 t -97.97 -28.11 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.972 -1.08 . . . . 0.0 110.297 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.701 ' CG ' HD22 ' A' ' 116' ' ' LEU . 3.9 mmt -64.33 -17.34 63.6 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.725 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.787 HG21 HH12 ' A' ' 106' ' ' ARG . 1.1 t -88.7 -18.55 27.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.455 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.449 ' OD1' ' HA ' ' A' ' 108' ' ' VAL . 7.3 m120 -58.48 97.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.875 . . . . 0.0 109.552 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt 61.32 13.45 4.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -117.96 41.91 1.95 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 52.89 -125.76 2.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.236 -1.155 . . . . 0.0 109.12 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 135.67 32.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.634 -1.292 . . . . 0.0 109.991 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.859 HD21 ' SD ' ' A' ' 124' ' ' MET . 0.7 OUTLIER -103.94 116.46 32.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.297 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.467 HG23 ' H ' ' A' ' 120' ' ' GLU . 5.6 t -75.45 165.78 24.6 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.64 -52.67 63.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.845 -1.16 . . . . 0.0 110.237 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -59.41 -17.96 34.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.244 -0.91 . . . . 0.0 109.998 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.546 ' CG ' ' HG ' ' A' ' 116' ' ' LEU . 7.7 tp10 -87.18 -40.16 14.83 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.547 HG11 ' CA ' ' A' ' 102' ' ' ALA . 21.9 t -61.41 -46.74 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.304 -0.872 . . . . 0.0 109.079 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -46.92 -28.82 1.74 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.383 -0.823 . . . . 0.0 109.751 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -75.54 -51.41 12.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.142 -0.974 . . . . 0.0 109.426 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.859 ' SD ' HD21 ' A' ' 116' ' ' LEU . 1.2 mpt? -59.91 -21.14 60.71 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.222 -0.924 . . . . 0.0 109.559 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.547 HG12 HD12 ' A' ' 105' ' ' LEU . 2.3 mt -84.85 -42.97 16.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.3 -0.875 . . . . 0.0 109.659 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -22.68 1.02 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.38 -0.825 . . . . 0.0 110.588 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -90.87 -30.37 16.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.919 -1.113 . . . . 0.0 110.379 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.19 -49.65 16.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.838 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.407 ' OD2' HG22 ' A' ' 125' ' ' ILE . 1.9 p30 -80.44 150.91 29.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.5 mt -117.69 -34.48 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.334 -0.854 . . . . 0.0 109.214 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -61.75 -39.88 93.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.536 -0.727 . . . . 0.0 109.286 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.56 29.44 29.8 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.18 -25.64 39.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.386 -1.067 . . . . 0.0 108.77 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 115.3 26.54 3.42 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.636 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -160.27 162.54 33.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.045 -1.268 . . . . 0.0 109.517 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 137' ' ' ASN . 70.0 t -113.8 161.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.52 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -135.79 -166.46 1.86 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.97 -1.081 . . . . 0.0 108.619 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 142' ' ' VAL . 52.3 t80 -78.87 -37.44 40.27 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.415 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.423 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 5.2 tp10 -67.77 -38.99 84.15 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -77.09 -38.47 52.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.175 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 38.6 t80 -69.47 -23.49 63.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.394 -0.816 . . . . 0.0 109.456 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 138' ' ' TYR . 23.1 t -75.7 -54.01 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 109.84 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.423 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 2.8 mt-30 -63.34 -21.9 66.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.0 110.044 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -90.24 -32.82 16.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.076 -1.015 . . . . 0.0 109.941 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -93.25 -4.4 51.95 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.201 -0.937 . . . . 0.0 110.143 -179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 142' ' ' VAL . 12.5 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.044 -1.035 . . . . 0.0 109.587 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.351 0.596 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -23.74 60.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.206 -0.934 . . . . 0.0 109.709 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.9 HG12 HG23 ' A' ' 146' ' ' THR . 3.5 mp -82.64 -37.85 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.142 -0.974 . . . . 0.0 109.929 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -42.05 95.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.722 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -79.56 -30.14 41.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.148 -0.97 . . . . 0.0 109.442 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -67.38 -27.02 66.76 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 82.0 t80 -68.44 -54.61 15.93 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.652 0.739 . . . . 0.0 109.247 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -63.78 -27.91 69.51 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 87' ' ' GLU . 8.5 t -50.09 -30.1 6.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.48 ' HB2' HD13 ' A' ' 100' ' ' ILE . 87.1 m-85 -98.02 -35.42 10.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -90.13 95.71 10.33 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -89.98 -26.02 20.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.207 -0.933 . . . . 0.0 110.841 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -78.99 5.26 12.12 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.062 -1.024 . . . . 0.0 109.055 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 40.94 33.12 0.62 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -75.81 -70.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -1.117 . . . . 0.0 109.081 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.19 -53.98 0.09 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.629 ' CE2' ' NE2' ' A' ' 135' ' ' GLN . 9.7 m-30 -107.95 152.15 24.84 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.488 -1.007 . . . . 0.0 109.047 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.488 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 86.0 mt -88.63 128.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 109.911 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.9 p -90.36 -176.58 4.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.327 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.664 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -67.51 -50.71 57.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.74 -29.52 69.43 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.382 -0.824 . . . . 0.0 109.526 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 28.5 mt-10 -73.64 -30.79 63.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.16 -0.962 . . . . 0.0 108.953 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 109' ' ' MET . 2.2 tp -91.06 -9.21 46.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.46 -0.775 . . . . 0.0 109.211 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -91.53 -40.24 11.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.383 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.579 ' O ' HG22 ' A' ' 110' ' ' THR . 24.4 t60 -54.83 -35.22 63.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.627 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 91' ' ' VAL . 71.1 t -88.85 -44.64 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.118 -0.989 . . . . 0.0 110.056 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.551 ' HB3' HD13 ' A' ' 116' ' ' LEU . 97.1 mmm -68.13 -7.65 31.64 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 109.188 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 107' ' ' HIS . 6.6 t -98.86 -19.54 17.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.125 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.636 ' O ' HD23 ' A' ' 112' ' ' LEU . 3.3 m120 -89.23 31.3 0.9 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.129 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER 161.03 -19.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.585 -0.697 . . . . 0.0 109.725 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -85.83 20.86 17.38 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.506 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.529 ' O ' ' O ' ' A' ' 115' ' ' LYS . 13.3 mt-10 62.08 40.61 11.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.112 -1.228 . . . . 0.0 110.125 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 114' ' ' GLU . 3.1 ttpp 50.0 115.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.767 0.794 . . . . 0.0 111.45 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' A' ' 124' ' ' MET . 0.7 OUTLIER -95.36 159.26 15.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 109.356 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 121' ' ' VAL . 21.7 p -92.41 -171.64 2.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 109.774 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.87 -47.82 8.3 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.465 -0.772 . . . . 0.0 109.025 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.42 -13.18 62.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 108.838 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 23.9 tp10 -93.46 -42.23 9.37 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.475 -0.766 . . . . 0.0 109.137 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.664 HG11 ' HB1' ' A' ' 102' ' ' ALA . 6.9 t -53.87 -61.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.422 -0.798 . . . . 0.0 109.775 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -48.1 -27.73 2.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.987 . . . . 0.0 109.952 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -77.33 -39.74 46.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.196 -0.94 . . . . 0.0 109.326 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.553 ' HG3' HD21 ' A' ' 116' ' ' LEU . 25.1 mmm -66.38 -22.3 66.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.872 -1.142 . . . . 0.0 108.586 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.636 HG23 HG23 ' A' ' 136' ' ' VAL . 3.2 mt -86.91 -38.3 12.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -55.88 -22.82 27.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.636 -0.665 . . . . 0.0 110.062 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.488 ' HG2' ' HG3' ' A' ' 126' ' ' ARG . 3.1 mt-10 -90.41 -34.57 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 0.0 109.75 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.24 -13.49 60.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.917 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.844 ' OD1' HG22 ' A' ' 136' ' ' VAL . 7.1 m-20 -94.68 142.45 27.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.615 HD12 ' OE2' ' A' ' 140' ' ' GLU . 73.2 mt -89.26 -37.15 9.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.324 -0.86 . . . . 0.0 109.22 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -39.09 24.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.514 -0.741 . . . . 0.0 109.439 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.36 29.94 13.3 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.14 -25.43 42.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -1.072 . . . . 0.0 109.09 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 117.48 5.77 14.01 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.629 ' NE2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -129.27 157.64 41.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.892 -1.357 . . . . 0.0 109.434 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.844 HG22 ' OD1' ' A' ' 129' ' ' ASP . 77.9 t -116.27 165.28 11.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.192 -0.943 . . . . 0.0 108.61 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -141.39 -164.19 1.71 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.925 -1.109 . . . . 0.0 108.512 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.501 ' O ' HG23 ' A' ' 142' ' ' VAL . 65.1 t80 -81.45 -42.17 20.73 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.126 -0.984 . . . . 0.0 109.182 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -68.34 -29.43 68.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.392 -0.817 . . . . 0.0 109.199 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.615 ' OE2' HD12 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -86.27 -33.91 20.54 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.418 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 60.1 t80 -70.94 -24.43 62.44 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.561 -0.712 . . . . 0.0 109.293 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.683 HG13 ' OG1' ' A' ' 146' ' ' THR . 3.8 t -66.01 -51.64 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.498 -0.751 . . . . 0.0 109.991 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -59.79 -26.03 65.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.115 -0.991 . . . . 0.0 110.662 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -28.37 19.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.854 -1.154 . . . . 0.0 110.742 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.4 tpt -102.57 -61.86 1.34 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.012 -1.055 . . . . 0.0 109.801 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.9 HG23 HG12 ' A' ' 85' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.5 0 O-C-N 121.486 -0.759 . . . . 0.0 109.88 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 2.2 tm-20 -65.73 -35.8 81.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.416 -0.802 . . . . 0.0 109.531 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.603 HG21 ' HA ' ' A' ' 142' ' ' VAL . 2.8 mp -80.3 -37.65 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.271 -0.893 . . . . 0.0 110.026 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.483 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 5.7 ttp180 -48.53 -39.72 24.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.062 -1.024 . . . . 0.0 109.715 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 11.3 pt-20 -82.26 -50.74 8.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.111 -0.993 . . . . 0.0 109.875 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -45.59 -27.23 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.002 -1.061 . . . . 0.0 108.922 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.416 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 91.4 t80 -63.51 -56.99 11.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.419 -0.8 . . . . 0.0 109.753 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -62.03 -32.07 72.53 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.529 -0.732 . . . . 0.0 109.112 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 55.1 t -44.56 -30.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -99.44 -35.48 9.89 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.457 ' HB2' HG12 ' A' ' 100' ' ' ILE . 10.1 t0 -91.55 98.88 11.93 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.505 -0.747 . . . . 0.0 109.377 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.418 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 0.0 OUTLIER -90.32 -23.61 21.1 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.245 -0.909 . . . . 0.0 110.262 -179.487 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -79.01 3.68 16.54 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 109.337 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.61 31.76 0.09 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 95' ' ' ASP . 11.4 p-10 -80.47 -24.03 39.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.071 -1.252 . . . . 0.0 109.87 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 126.33 -44.64 1.23 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 52.3 m-85 -110.4 145.03 38.27 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.495 -1.003 . . . . 0.0 109.629 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 71.6 mt -90.43 94.31 4.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.453 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -66.58 158.61 29.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.106 -0.996 . . . . 0.0 109.208 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.552 ' HA ' HG11 ' A' ' 121' ' ' VAL . . . -45.49 -42.38 10.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.108 -0.995 . . . . 0.0 109.266 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.26 99.17 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.311 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.455 ' OE1' ' HB2' ' A' ' 95' ' ' ASP . 1.5 mm-40 -64.47 -24.15 67.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 0.0 109.199 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.481 HD23 HG13 ' A' ' 121' ' ' VAL . 34.7 tp -88.83 -16.83 31.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.747 ' O ' HG22 ' A' ' 110' ' ' THR . 5.6 ttt-85 -83.44 -35.23 25.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.505 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.418 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 23.3 t60 -42.24 -49.9 4.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.667 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.7 t -95.59 -24.77 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.987 -1.071 . . . . 0.0 110.717 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.521 ' HB2' ' HA ' ' A' ' 106' ' ' ARG . 8.3 mmt -64.17 -23.49 67.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.05 -1.031 . . . . 0.0 109.758 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -82.1 -31.13 30.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 109.795 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.405 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 22.5 t-20 -56.88 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.456 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 112' ' ' LEU . 1.5 mt 56.92 24.11 8.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.478 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -117.67 51.94 0.71 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 57.4 178.87 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -1.165 . . . . 0.0 109.346 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -112.98 79.79 1.27 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.331 -0.856 . . . . 0.0 109.215 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.584 HD11 HG22 ' A' ' 121' ' ' VAL . 1.0 OUTLIER -94.21 133.84 37.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.972 . . . . 0.0 109.378 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.901 ' O ' HG23 ' A' ' 121' ' ' VAL . 5.3 t -92.08 -146.14 0.21 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.363 -0.836 . . . . 0.0 109.237 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.778 ' N ' HG23 ' A' ' 117' ' ' THR . 3.9 m-20 -78.63 -48.85 14.28 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.552 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 117' ' ' THR . 20.8 mt-10 -54.48 -24.99 22.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 109.709 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.597 ' HG2' HG22 ' A' ' 117' ' ' THR . 18.1 mm-40 -86.96 -47.98 8.52 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 117' ' ' THR . 92.5 t -54.81 -26.15 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.72 -0.613 . . . . 0.0 109.568 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -68.36 -34.89 76.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -79.95 -19.0 49.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.948 -1.095 . . . . 0.0 108.598 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 15.2 mmt -88.91 -20.78 24.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.681 HG23 HG23 ' A' ' 136' ' ' VAL . 7.6 mt -92.43 -45.6 14.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.73 0.776 . . . . 0.0 109.718 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.7 -26.35 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.682 -0.636 . . . . 0.0 110.723 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -90.35 -37.15 14.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.985 -1.072 . . . . 0.0 109.749 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.43 ' HB2' ' CE ' ' A' ' 144' ' ' MET . . . -80.09 -4.36 52.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.852 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -96.67 176.75 5.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 3.7 mt -69.92 -69.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.362 -0.836 . . . . 0.0 109.437 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 130' ' ' ILE . 3.0 p-10 -179.24 32.95 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.44 -0.788 . . . . 0.0 110.533 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 146.93 49.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.068 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 129' ' ' ASP . 2.2 p30 -112.55 -24.65 9.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -1.119 . . . . 0.0 109.035 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.29 -10.2 55.2 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.448 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 4.3 pt20 -144.91 -170.35 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -1.154 . . . . 0.0 109.133 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.681 HG23 HG23 ' A' ' 125' ' ' ILE . 53.6 t -126.33 160.4 33.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.607 ' HB3' ' OE1' ' A' ' 140' ' ' GLU . 19.5 t30 -141.53 -166.48 2.21 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.755 ' O ' HG23 ' A' ' 142' ' ' VAL . 88.4 t80 -78.19 -31.07 49.31 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.563 -1.336 . . . . 0.0 112.106 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -15.43 60.07 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.462 -1.399 . . . . 0.0 110.321 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.607 ' OE1' ' HB3' ' A' ' 137' ' ' ASN . 3.8 mp0 -100.57 -34.64 9.82 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.416 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 50.9 t80 -71.88 -25.28 61.87 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 138' ' ' TYR . 9.9 t -60.43 -55.27 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -65.44 -21.05 66.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.762 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.43 ' CE ' ' HB2' ' A' ' 128' ' ' ALA . 3.1 tpt -85.16 -20.55 30.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 0.0 109.726 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -39.64 20.58 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.141 -0.975 . . . . 0.0 109.482 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.929 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 86' ' ' ARG . 15.9 tt0 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.318 0.58 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -46.38 -27.52 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 110.095 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.826 HG21 HG22 ' A' ' 142' ' ' VAL . 5.1 mm -77.4 -47.45 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.17 -0.956 . . . . 0.0 110.446 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.476 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 5.3 mmm180 -47.73 -45.07 28.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.101 -0.999 . . . . 0.0 109.908 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 10.4 pt-20 -79.99 -39.79 29.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.059 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.539 ' N ' ' HG3' ' A' ' 87' ' ' GLU . . . -57.88 -19.54 30.23 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.912 -1.117 . . . . 0.0 108.48 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 82.4 t80 -71.53 -55.44 7.82 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.451 -0.78 . . . . 0.0 109.326 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -63.77 -27.45 69.2 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.513 HG12 HG21 ' A' ' 108' ' ' VAL . 24.3 t -50.14 -30.72 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.6 ' CE2' ' HB ' ' A' ' 108' ' ' VAL . 65.1 m-85 -96.88 -33.91 11.45 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.467 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 23.3 t0 -97.83 91.94 5.6 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.773 -0.58 . . . . 0.0 109.649 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 94' ' ' LYS . 19.4 mmmt -90.19 -19.34 24.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.285 -0.884 . . . . 0.0 110.013 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -77.94 2.43 17.53 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.344 -0.848 . . . . 0.0 109.386 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 39.57 37.54 0.86 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -85.86 -25.65 26.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -1.194 . . . . 0.0 109.556 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.18 -48.1 0.98 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.487 ' HB3' ' O ' ' A' ' 136' ' ' VAL . 13.5 m-30 -112.85 178.4 4.3 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.564 -0.962 . . . . 0.0 108.786 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.467 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 54.2 mt -113.04 128.29 69.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.471 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -87.37 -178.96 6.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.838 . . . . 0.0 109.8 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.596 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -67.4 -47.28 70.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 0.0 109.181 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.81 -31.76 72.82 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.368 -0.832 . . . . 0.0 109.027 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 65.2 mm-40 -70.67 -23.1 62.44 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 1.05 HD22 ' CE ' ' A' ' 109' ' ' MET . 0.5 OUTLIER -82.64 -36.43 26.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.474 -0.766 . . . . 0.0 109.324 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -9.61 58.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.117 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -75.99 -34.65 59.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.83 . . . . 0.0 110.392 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.6 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 52.2 t -111.36 -42.79 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.919 -1.113 . . . . 0.0 110.582 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . 1.05 ' CE ' HD22 ' A' ' 105' ' ' LEU . 4.4 mtm -55.03 -16.57 2.95 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.111 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.35 -34.84 23.56 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.851 -1.155 . . . . 0.0 108.938 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.782 ' HB3' HD23 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -56.26 -55.86 28.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.829 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.782 HD23 ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -135.47 7.74 3.33 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.968 . . . . 0.0 110.025 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.483 ' CA ' ' O ' ' A' ' 109' ' ' MET . . . -103.23 36.79 4.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.56 ' O ' HD23 ' A' ' 116' ' ' LEU . 41.0 mt-10 64.85 114.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.439 -1.036 . . . . 0.0 108.789 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.63 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.447 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.701 ' H ' HD23 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -93.97 174.12 7.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 108.779 179.093 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 121' ' ' VAL . 1.4 t -120.32 171.89 8.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 0.0 108.588 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 119' ' ' GLU . 1.1 m-20 -48.67 -48.35 40.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.073 -1.017 . . . . 0.0 110.615 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -41.81 -38.78 1.58 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.24 -0.912 . . . . 0.0 110.332 -179.152 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 121' ' ' VAL . 3.0 mt-10 -87.72 -46.6 9.34 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.391 -0.818 . . . . 0.0 110.086 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.596 HG11 ' HB1' ' A' ' 102' ' ' ALA . 71.1 t -32.83 -50.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.668 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -50.78 72.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.761 -1.212 . . . . 0.0 109.418 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.58 -13.4 61.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 108.794 179.349 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.432 ' HG3' HD13 ' A' ' 116' ' ' LEU . 5.8 mmt -89.35 -22.42 22.62 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.932 HG21 ' O ' ' A' ' 134' ' ' GLY . 4.0 mt -80.1 -42.99 22.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.19 -19.12 18.8 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.659 -0.651 . . . . 0.0 109.98 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 20.4 mm-40 -90.6 -24.56 20.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.133 -0.979 . . . . 0.0 110.018 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.41 -59.82 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.359 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 43.5 p30 -47.46 154.86 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.7 mt -102.05 -40.58 7.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.187 -0.946 . . . . 0.0 109.754 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.27 -40.77 36.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.52 -0.737 . . . . 0.0 109.641 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.53 33.37 5.11 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.07 -23.04 44.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -1.084 . . . . 0.0 109.099 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.932 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 117.21 -30.06 6.45 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.75 167.51 10.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -1.199 . . . . 0.0 109.277 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 68.6 t -119.98 160.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.2 -0.938 . . . . 0.0 108.666 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.5 ' ND2' ' HG3' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -135.99 -164.41 1.55 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.63 -1.294 . . . . 0.0 108.648 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.547 ' O ' HG23 ' A' ' 142' ' ' VAL . 64.9 t80 -75.66 -42.07 52.32 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.973 -1.079 . . . . 0.0 109.817 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -65.15 -47.8 75.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.117 -0.989 . . . . 0.0 109.432 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.5 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 55.8 mt-10 -69.84 -36.77 75.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.126 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 145' ' ' MET . 44.0 t80 -64.72 -27.62 69.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.844 . . . . 0.0 109.081 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.826 HG22 HG21 ' A' ' 85' ' ' ILE . 4.6 t -61.28 -47.83 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.837 . . . . 0.0 109.859 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -53.23 -37.75 62.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -0.978 . . . . 0.0 110.482 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.11 -23.31 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.055 -1.028 . . . . 0.0 110.022 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.52 ' CG ' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -86.08 -11.06 53.75 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.092 -1.005 . . . . 0.0 109.849 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.129 -0.982 . . . . 0.0 109.615 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 1.4 tt0 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.59 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 6.7 tt0 -79.17 7.96 6.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.536 -0.728 . . . . 0.0 109.612 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.5 mm -117.89 -42.98 2.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.111 -0.993 . . . . 0.0 109.722 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.451 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 4.6 mtp180 -66.83 -33.32 75.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -0.981 . . . . 0.0 109.08 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.689 ' O ' HG23 ' A' ' 91' ' ' VAL . 18.5 pt-20 -96.57 -26.77 15.12 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.24 -0.913 . . . . 0.0 109.106 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -67.64 -29.52 68.85 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 84.6 t80 -62.07 -56.05 22.84 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.568 -0.708 . . . . 0.0 109.196 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -33.35 74.98 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.253 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.751 ' O ' HG21 ' A' ' 108' ' ' VAL . 23.7 t -47.91 -33.77 3.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.499 ' CD1' ' HB ' ' A' ' 108' ' ' VAL . 66.7 m-85 -92.33 -30.9 15.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.496 ' HB2' HG12 ' A' ' 100' ' ' ILE . 26.2 t0 -100.33 83.04 2.58 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -73.32 -21.12 60.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 110.248 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -77.87 0.52 23.68 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.251 -0.906 . . . . 0.0 109.012 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.42 50.68 1.78 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.45 HD21 ' H ' ' A' ' 97' ' ' ASN . 0.8 OUTLIER -107.49 -14.26 14.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 109.802 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.39 -26.48 11.05 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.671 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.2 m-85 -121.12 146.66 46.51 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.377 -1.072 . . . . 0.0 109.262 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.496 HG12 ' HB2' ' A' ' 93' ' ' ASP . 76.6 mt -103.54 120.85 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.429 -0.794 . . . . 0.0 109.54 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.6 p -81.96 170.78 15.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.095 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.829 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -59.55 -45.8 90.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.046 -1.034 . . . . 0.0 109.475 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.37 83.45 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.219 -0.926 . . . . 0.0 109.462 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -73.28 -20.9 60.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.18 -0.95 . . . . 0.0 108.586 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 105' ' ' LEU . 15.4 tp -87.21 -23.69 24.67 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.47 -0.769 . . . . 0.0 109.534 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.488 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 23.3 ttt180 -82.97 -39.5 21.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -50.1 -30.51 11.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 110.403 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.751 HG21 ' O ' ' A' ' 91' ' ' VAL . 98.9 t -110.17 -26.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.001 -1.062 . . . . 0.0 110.173 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.659 ' HB3' HD21 ' A' ' 116' ' ' LEU . 2.3 mmt -61.95 -14.39 34.33 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.339 -0.851 . . . . 0.0 109.656 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -82.6 -35.26 27.22 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.283 -0.886 . . . . 0.0 109.655 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 110' ' ' THR . 10.7 m120 -43.43 -59.14 2.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.461 ' C ' HD12 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -144.29 16.8 1.7 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.407 -0.808 . . . . 0.0 109.134 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.487 ' O ' HD23 ' A' ' 116' ' ' LEU . . . -94.97 30.84 7.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.431 ' HG2' ' C ' ' A' ' 113' ' ' GLY . 23.9 mm-40 71.1 167.28 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -1.179 . . . . 0.0 109.703 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -90.6 73.33 6.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.659 HD21 ' HB3' ' A' ' 109' ' ' MET . 0.7 OUTLIER -97.97 153.55 18.29 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.584 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.896 ' O ' HG23 ' A' ' 121' ' ' VAL . 1.7 p -101.05 -150.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.141 -0.974 . . . . 0.0 109.776 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 4.1 m-20 -77.86 -54.07 6.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.0 109.853 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.432 ' HG3' ' OE1' ' A' ' 120' ' ' GLU . 10.9 pt-20 -48.98 -38.23 22.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 0.0 109.125 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 2.6 mm-40 -71.5 -46.64 59.2 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 117' ' ' THR . 21.3 t -37.64 -51.82 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.105 0.479 . . . . 0.0 110.109 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 122' ' ' ASP . 37.7 t0 -54.26 -46.9 72.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.109 -0.995 . . . . 0.0 109.844 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -63.37 -31.69 72.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.979 . . . . 0.0 109.75 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 18.2 mmt -73.06 -26.17 61.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.93 -1.106 . . . . 0.0 108.293 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 105' ' ' LEU . 7.1 mt -76.28 -37.14 31.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -57.07 -14.28 3.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.845 -0.534 . . . . 0.0 110.206 -179.636 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -89.37 -30.14 18.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 0.0 109.277 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -102.96 -0.69 30.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.565 -0.71 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.446 ' CG ' HG22 ' A' ' 125' ' ' ILE . 7.5 m-20 -82.72 143.72 30.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.852 . . . . 0.0 110.01 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.529 HG12 ' CG ' ' A' ' 140' ' ' GLU . 33.0 mm -108.66 -32.9 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.323 -0.861 . . . . 0.0 109.139 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -97.6 -33.91 11.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.608 -0.683 . . . . 0.0 109.23 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.11 26.41 18.97 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.06 -28.25 39.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -1.142 . . . . 0.0 109.219 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.11 33.96 2.07 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.438 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 1.8 tt0 -154.31 150.82 28.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.425 -1.044 . . . . 0.0 109.361 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.621 HG12 ' N ' ' A' ' 137' ' ' ASN . 89.6 t -112.86 167.1 6.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.186 -0.946 . . . . 0.0 109.318 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.671 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 7.5 p30 -150.6 -172.5 4.2 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.762 ' O ' HG23 ' A' ' 142' ' ' VAL . 51.7 t80 -68.53 -48.78 63.46 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.413 -1.429 . . . . 0.0 110.804 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 7.0 mp0 -54.86 -55.51 29.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.986 -1.071 . . . . 0.0 110.845 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.536 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 22.4 mt-10 -63.3 -41.91 99.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.863 -1.148 . . . . 0.0 109.904 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.441 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 51.8 t80 -64.68 -23.05 67.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 109.978 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 138' ' ' TYR . 43.2 t -76.37 -44.08 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.841 . . . . 0.0 110.47 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.47 -32.36 73.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.129 -0.982 . . . . 0.0 110.605 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -21.74 24.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.927 -1.108 . . . . 0.0 110.283 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.3 tpt -98.59 -6.63 29.61 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.897 -1.127 . . . . 0.0 110.649 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 120.678 -1.264 . . . . 0.0 110.733 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 121.123 0.487 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -30.14 65.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.973 . . . . 0.0 109.639 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mt -83.88 -40.72 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.916 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.8 mtt85 -58.64 -35.29 72.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.608 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.46 ' OE2' ' N ' ' A' ' 88' ' ' ALA . 0.8 OUTLIER -87.08 -31.68 20.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.577 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.5 -28.94 70.29 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.152 -0.967 . . . . 0.0 108.443 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.451 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 87.6 t80 -66.9 -53.0 36.42 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.408 -0.807 . . . . 0.0 109.507 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 1.8 mtp180 -66.2 -25.07 66.76 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 2.7 t -52.7 -24.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.501 ' CE1' ' HB ' ' A' ' 108' ' ' VAL . 75.5 m-85 -108.34 -30.08 8.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 39.0 t0 -95.25 76.06 3.42 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.447 ' HB2' ' OE1' ' A' ' 104' ' ' GLU . 11.3 mmmt -79.86 -16.75 54.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 96' ' ' GLY . 18.8 m-20 -78.32 5.5 10.33 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.984 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.14 38.11 0.32 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -93.66 -69.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.401 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.9 -50.85 0.11 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.625 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 11.3 m-30 -109.66 155.37 21.57 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.413 -1.051 . . . . 0.0 108.784 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.497 HD13 ' CB ' ' A' ' 92' ' ' PHE . 94.1 mt -90.51 122.37 41.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 109.597 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.2 p -85.38 174.14 9.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.401 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.548 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -66.0 -33.04 74.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.132 -0.98 . . . . 0.0 109.447 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.4 68.44 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.228 -0.92 . . . . 0.0 109.565 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 60.3 mm-40 -78.71 -20.96 48.87 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.578 HD22 HG12 ' A' ' 125' ' ' ILE . 3.2 tp -93.25 -17.49 23.59 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.581 -0.699 . . . . 0.0 109.277 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.429 ' O ' ' OG1' ' A' ' 110' ' ' THR . 15.1 ttt-85 -80.58 -21.99 41.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.198 -0.939 . . . . 0.0 109.251 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -70.55 -27.79 64.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.307 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.501 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 79.4 t -111.07 -21.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.917 -1.114 . . . . 0.0 110.122 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.502 ' HB3' HD21 ' A' ' 116' ' ' LEU . 10.5 mmt -67.48 -41.04 85.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.016 -1.052 . . . . 0.0 109.18 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -73.69 -15.99 61.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.377 -0.827 . . . . 0.0 109.867 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.838 ' C ' HD23 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -59.09 87.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.899 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.838 HD23 ' C ' ' A' ' 111' ' ' ASN . 1.4 pt? 36.29 29.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.637 -0.664 . . . . 0.0 110.835 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -96.03 -12.57 52.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 1.025 ' HG3' HD23 ' A' ' 116' ' ' LEU . 0.4 OUTLIER 151.27 -167.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 65.2 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.007 . . . . 0.0 109.167 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.025 HD23 ' HG3' ' A' ' 114' ' ' GLU . 1.7 pp -105.77 121.76 44.69 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.583 -0.698 . . . . 0.0 109.431 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.81 HG23 ' N ' ' A' ' 118' ' ' ASP . 4.5 t -86.5 -146.89 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.623 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.81 ' N ' HG23 ' A' ' 117' ' ' THR . 1.2 m-20 -73.4 -57.58 3.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.853 . . . . 0.0 109.873 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -20.41 2.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.847 . . . . 0.0 110.014 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.675 ' HG2' HG22 ' A' ' 117' ' ' THR . 27.4 mm-40 -89.77 -39.79 12.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 117' ' ' THR . 22.4 t -47.67 -61.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.185 0.517 . . . . 0.0 109.652 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 121' ' ' VAL . 49.4 t0 -41.75 -34.0 0.57 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.293 -0.879 . . . . 0.0 109.878 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -45.14 49.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 108.96 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.549 ' HE2' HD22 ' A' ' 116' ' ' LEU . 65.7 mmm -60.87 -20.67 62.27 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.18 -0.95 . . . . 0.0 108.723 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.578 HG12 HD22 ' A' ' 105' ' ' LEU . 3.0 mt -87.47 -38.81 12.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -19.22 4.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.816 -0.552 . . . . 0.0 109.657 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -89.29 -31.95 17.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 109.049 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 144' ' ' MET . . . -90.08 -5.0 57.03 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.409 -0.807 . . . . 0.0 109.255 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 125' ' ' ILE . 1.8 m-20 -95.18 133.72 38.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.313 -0.867 . . . . 0.0 109.382 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.493 HG13 ' OE1' ' A' ' 140' ' ' GLU . 41.3 mm -83.78 -49.74 16.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.142 -0.974 . . . . 0.0 109.383 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.45 -45.09 23.04 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.571 -0.706 . . . . 0.0 109.168 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.62 31.95 3.79 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.47 -27.36 41.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -1.038 . . . . 0.0 109.429 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.501 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 121.72 -16.21 8.97 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.847 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.625 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -109.18 164.59 12.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.739 -1.448 . . . . 0.0 109.587 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.559 HG23 HG23 ' A' ' 125' ' ' ILE . 53.8 t -121.87 163.65 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.257 -0.902 . . . . 0.0 108.707 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.567 ' ND2' ' HG2' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -135.1 -168.72 2.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.928 -1.108 . . . . 0.0 108.707 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.895 ' O ' HG23 ' A' ' 142' ' ' VAL . 73.0 t80 -80.47 -36.59 33.24 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.089 -1.007 . . . . 0.0 110.146 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -68.26 -34.26 75.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.567 ' HG2' ' ND2' ' A' ' 137' ' ' ASN . 4.1 mm-40 -83.52 -34.75 25.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 108.921 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.576 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 14.3 t80 -72.26 -23.17 61.16 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.45 -0.781 . . . . 0.0 109.158 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 138' ' ' TYR . 48.4 t -74.99 -59.51 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 0.0 109.694 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 12.4 mt-30 -53.34 -24.11 11.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.825 . . . . 0.0 110.538 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -90.7 -37.08 13.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.036 -1.04 . . . . 0.0 110.96 -178.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -84.8 -8.68 58.72 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.978 -1.077 . . . . 0.0 110.838 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 120.912 -1.118 . . . . 0.0 109.061 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -60.94 -19.51 60.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.716 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.47 HG21 ' HA ' ' A' ' 142' ' ' VAL . 3.5 mt -97.74 -38.13 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.185 -0.947 . . . . 0.0 110.047 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.535 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 2.9 ttt-85 -49.58 -32.13 12.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.041 -1.037 . . . . 0.0 109.49 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.1 mt-10 -91.01 -53.94 4.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 109.735 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -43.98 -27.03 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.0 108.79 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 138' ' ' TYR . 70.3 t80 -62.37 -58.08 8.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.411 -0.806 . . . . 0.0 109.141 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -60.04 -37.49 79.97 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.385 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.629 ' O ' HG21 ' A' ' 108' ' ' VAL . 59.5 t -42.9 -32.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.495 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 56.0 m-85 -95.93 -35.12 11.56 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.477 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 28.3 t0 -91.06 88.89 7.16 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -77.53 -21.16 53.08 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 110.229 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 96' ' ' GLY . 67.2 m-20 -78.21 0.4 25.24 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 109.133 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 35.47 49.25 0.94 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -106.79 -22.82 12.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.249 . . . . 0.0 109.666 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.36 -27.97 5.15 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.638 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.7 m-85 -121.61 145.46 47.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.412 -1.052 . . . . 0.0 108.985 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.477 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 56.8 mt -96.17 133.94 35.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.236 -0.915 . . . . 0.0 109.358 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.59 170.9 9.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.41 94.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 109.281 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.89 -35.83 77.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.391 -0.818 . . . . 0.0 109.703 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.57 ' O ' ' CE1' ' A' ' 107' ' ' HIS . 64.6 mm-40 -71.61 -21.86 61.79 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.174 -0.954 . . . . 0.0 108.495 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.505 ' HG ' ' CG ' ' A' ' 109' ' ' MET . 1.6 tp -99.73 4.49 45.49 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.585 -0.697 . . . . 0.0 109.212 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -96.92 -30.89 12.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.127 -0.983 . . . . 0.0 109.978 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.95 ' CD2' HG23 ' A' ' 108' ' ' VAL . 45.5 p-80 -88.07 -53.3 4.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 111.802 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.95 HG23 ' CD2' ' A' ' 107' ' ' HIS . 18.9 t -68.43 -54.14 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.168 -0.957 . . . . 0.0 110.968 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.505 ' CG ' ' HG ' ' A' ' 105' ' ' LEU . 1.5 mmt -35.98 -45.33 0.41 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.611 -0.681 . . . . 0.0 110.786 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.658 HG21 ' HA ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -88.88 -33.31 17.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.992 -1.067 . . . . 0.0 109.994 -179.536 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.459 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER 41.19 51.49 3.46 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.275 -0.891 . . . . 0.0 109.864 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER 56.33 41.26 29.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.351 -0.843 . . . . 0.0 110.115 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -141.63 8.1 2.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 0.3 OUTLIER 155.1 57.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.752 -0.852 . . . . 0.0 108.999 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.658 ' HA ' HG21 ' A' ' 110' ' ' THR . 3.1 ptpt -46.6 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.844 . . . . 0.0 110.318 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -70.59 156.81 38.96 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.146 -0.971 . . . . 0.0 108.794 179.266 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.978 ' O ' HG23 ' A' ' 121' ' ' VAL . 2.0 t -82.0 -174.78 5.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 109.486 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.16 -57.65 3.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 109.281 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.56 -24.04 4.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 108.887 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.429 ' CB ' HG22 ' A' ' 117' ' ' THR . 16.0 tp10 -81.11 -40.88 23.36 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 117' ' ' THR . 58.0 t -54.73 -48.39 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -31.54 29.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.842 . . . . 0.0 109.249 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 26.1 mm-40 -73.92 -39.58 63.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 109.042 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.9 mtt -67.33 -23.91 65.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.041 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.08 -40.03 15.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.441 -0.787 . . . . 0.0 109.805 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -15.41 6.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.511 -0.743 . . . . 0.0 110.359 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 4.1 mt-10 -90.16 -27.41 19.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.009 -1.057 . . . . 0.0 109.582 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.09 -58.45 2.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.918 . . . . 0.0 109.6 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 129' ' ' ASP . 40.2 p-10 -45.25 123.94 4.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.645 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.2 mt -91.89 -38.32 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.27 -0.894 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -76.23 -37.3 57.86 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.454 -0.779 . . . . 0.0 109.722 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.88 32.32 4.46 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.46 ' OD1' ' HG2' ' A' ' 135' ' ' GLN . 2.3 p30 -79.54 -24.56 42.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -1.075 . . . . 0.0 109.638 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.2 28.87 5.94 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.46 ' HG2' ' OD1' ' A' ' 133' ' ' ASP . 3.1 pt20 -160.23 -169.28 2.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -1.181 . . . . 0.0 108.993 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.619 HG12 ' N ' ' A' ' 137' ' ' ASN . 57.5 t -136.47 169.07 20.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.989 -1.07 . . . . 0.0 110.129 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.638 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -143.63 -167.92 2.7 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.252 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.888 ' O ' HG23 ' A' ' 142' ' ' VAL . 50.6 t80 -74.5 -38.36 62.87 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.805 -1.184 . . . . 0.0 109.497 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -49.68 68.02 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.308 -0.87 . . . . 0.0 109.701 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.508 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 50.2 mt-10 -68.23 -36.92 80.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.678 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.566 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 34.6 t80 -69.21 -26.91 65.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -0.921 . . . . 0.0 109.686 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 138' ' ' TYR . 48.1 t -68.12 -43.3 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.619 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -72.44 -21.99 61.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 0.0 109.878 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.43 -22.32 22.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.566 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.6 tpt -92.34 -59.15 2.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.078 -1.014 . . . . 0.0 109.787 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 142' ' ' VAL . 4.8 t . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.367 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.49 -47.56 81.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 0.0 110.109 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.679 ' CG2' HG22 ' A' ' 142' ' ' VAL . 3.2 mt -65.07 -36.85 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.155 -0.965 . . . . 0.0 110.159 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.587 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.4 mtp85 -50.67 -34.29 25.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.112 -0.992 . . . . 0.0 109.372 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 88' ' ' ALA . 3.4 mt-10 -87.73 -52.73 5.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 109.742 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.64 -26.83 0.41 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 108.635 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.54 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 88.0 t80 -62.77 -57.64 10.22 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.43 -0.794 . . . . 0.0 109.572 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.467 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -61.06 -31.66 71.32 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 109.04 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 70.4 t -46.66 -35.48 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.933 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 28.0 m-85 -87.29 -47.71 8.6 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 57.5 t0 -72.97 116.75 13.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.69 -25.29 21.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.142 -0.973 . . . . 0.0 110.125 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.9 OUTLIER -78.94 2.61 19.65 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 108.983 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.471 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.04 47.56 1.35 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -108.26 -38.63 5.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -1.202 . . . . 0.0 109.748 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.14 -10.44 2.27 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -130.26 151.06 51.18 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.165 -1.197 . . . . 0.0 109.946 -179.661 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.417 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 62.9 mt -114.0 141.18 31.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.24 -0.913 . . . . 0.0 109.339 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -100.44 -178.29 3.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.456 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -67.76 -46.17 72.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.338 -0.851 . . . . 0.0 109.242 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.49 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . . . -56.47 -47.12 79.86 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.373 -0.829 . . . . 0.0 109.343 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.451 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 97.7 mt-10 -65.75 -22.88 66.63 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD2' ' CG ' ' A' ' 109' ' ' MET . 0.6 OUTLIER -77.86 -25.19 48.51 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.521 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.835 ' HG2' HG21 ' A' ' 121' ' ' VAL . 8.9 mtm-85 -77.74 -45.71 23.9 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.216 -0.928 . . . . 0.0 108.55 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -48.09 -27.22 2.19 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.454 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.933 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 98.8 t -112.82 -39.26 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.612 -1.305 . . . . 0.0 111.309 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.587 ' CG ' ' CD2' ' A' ' 105' ' ' LEU . 10.6 mmt -61.76 -15.89 44.9 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 109.727 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.7 t -85.53 -25.12 26.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 109.34 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -54.75 -34.77 62.99 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.282 -0.886 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.47 ' H ' HD12 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -135.15 1.95 3.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.795 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -110.74 30.52 8.05 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 2.2 mt-10 59.06 -95.53 0.06 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.329 -1.1 . . . . 0.0 109.304 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -139.94 136.21 33.59 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.07 -1.019 . . . . 0.0 109.601 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.72 HD13 ' HG2' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -115.04 108.76 17.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.935 . . . . 0.0 109.544 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -72.53 -170.21 0.64 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.078 -1.014 . . . . 0.0 108.294 179.0 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -80.49 -54.96 5.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.915 -1.116 . . . . 0.0 108.882 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -22.62 65.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 108.838 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.72 ' HG2' HD13 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -77.61 -47.07 20.25 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.835 HG21 ' HG2' ' A' ' 106' ' ' ARG . 44.2 t -52.7 -46.5 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.488 -0.757 . . . . 0.0 110.087 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -48.64 -33.91 10.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 0.0 109.871 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -71.83 -37.96 70.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.404 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.428 ' SD ' HD11 ' A' ' 116' ' ' LEU . 2.6 mtt -68.54 -27.53 66.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.091 -1.006 . . . . 0.0 108.98 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 134' ' ' GLY . 6.0 mt -78.19 -37.47 22.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -57.82 -27.08 62.84 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.83 -0.544 . . . . 0.0 110.235 -179.417 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 126' ' ' ARG . 3.5 mt-10 -91.24 -16.95 26.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.021 -1.049 . . . . 0.0 109.859 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.534 ' O ' ' HE2' ' A' ' 144' ' ' MET . . . -99.15 -66.36 0.91 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.114 -0.991 . . . . 0.0 109.794 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 128' ' ' ALA . 6.8 t70 -46.12 154.74 0.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.37 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.5 mm -88.89 -65.22 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.715 0.769 . . . . 0.0 109.268 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -176.91 57.09 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.564 -0.71 . . . . 0.0 109.342 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -104.32 -89.63 2.12 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -129.46 -19.54 3.41 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.73 -0.865 . . . . 0.0 110.128 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.558 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 125.81 16.75 2.67 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 4.1 tt0 -112.56 163.38 14.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.23 -1.159 . . . . 0.0 108.674 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.576 HG12 ' N ' ' A' ' 137' ' ' ASN . 96.5 t -106.18 165.85 3.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 120.923 -1.11 . . . . 0.0 109.492 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.606 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -149.62 -171.31 3.86 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.893 ' O ' HG23 ' A' ' 142' ' ' VAL . 62.9 t80 -69.0 -37.7 78.86 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.607 -1.308 . . . . 0.0 111.337 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.41 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -68.88 -40.38 79.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.053 . . . . 0.0 110.377 -179.153 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.517 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 26.8 mt-10 -81.04 -23.04 38.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.933 -1.105 . . . . 0.0 109.192 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 145' ' ' MET . 28.4 t80 -84.28 -23.62 30.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.38 -0.825 . . . . 0.0 109.607 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 138' ' ' TYR . 52.2 t -73.97 -63.13 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.312 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -56.58 -24.54 48.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.534 ' HE2' ' O ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -90.23 -31.8 16.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.906 -1.121 . . . . 0.0 110.029 -179.506 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 141' ' ' PHE . 2.1 ttp -77.04 -16.87 59.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.086 -1.009 . . . . 0.0 109.784 -179.879 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.355 0.597 . . . . 0.0 109.922 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.611 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -100.22 -18.65 16.77 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.063 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.748 HG21 HG13 ' A' ' 142' ' ' VAL . 2.7 mp -83.5 -35.11 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.595 -0.691 . . . . 0.0 109.665 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.37 -45.89 90.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.111 -0.993 . . . . 0.0 109.344 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.67 -31.66 24.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.14 -0.975 . . . . 0.0 109.069 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -61.57 -24.01 66.36 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 138' ' ' TYR . 73.6 t80 -66.31 -55.47 15.84 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.418 -0.801 . . . . 0.0 109.279 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -28.84 70.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.223 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 4.8 t -48.18 -29.04 2.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.586 ' CE2' ' HB ' ' A' ' 108' ' ' VAL . 78.6 m-85 -100.32 -35.94 9.43 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.437 ' HB2' HG12 ' A' ' 100' ' ' ILE . 41.5 t0 -90.36 87.16 6.69 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -77.25 -18.48 57.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.836 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ASN . 10.3 t70 -78.02 2.32 18.11 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.405 -0.81 . . . . 0.0 109.252 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.39 29.92 0.05 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' ASP . 4.0 t30 -88.93 -36.94 15.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.089 -1.242 . . . . 0.0 109.467 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.54 -14.17 4.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -128.37 146.55 50.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.25 -1.147 . . . . 0.0 109.746 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 93' ' ' ASP . 87.0 mt -105.05 131.63 53.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.566 -0.709 . . . . 0.0 109.448 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.51 172.25 8.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.189 -0.944 . . . . 0.0 109.574 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.85 81.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 109.399 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.89 -35.89 75.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.362 -0.836 . . . . 0.0 109.332 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 66.1 mm-40 -70.64 -23.41 62.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.151 -0.968 . . . . 0.0 108.861 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.947 HD23 HG13 ' A' ' 121' ' ' VAL . 55.8 tp -83.9 -25.15 30.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.546 -0.722 . . . . 0.0 109.301 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.03 -24.95 43.28 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.246 -0.909 . . . . 0.0 108.967 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -59.91 -29.61 68.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 110.297 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.586 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 95.5 t -111.23 -46.62 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.887 -1.133 . . . . 0.0 110.203 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -52.69 -58.98 5.08 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.451 -0.78 . . . . 0.0 109.241 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -91.16 13.09 18.0 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.412 -0.805 . . . . 0.0 110.137 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.517 ' HB3' ' HA ' ' A' ' 108' ' ' VAL . 5.6 p30 -43.41 -48.44 7.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 0.0 109.785 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 111' ' ' ASN . 20.1 mt -152.53 14.67 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.013 . . . . 0.0 109.94 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -106.3 -14.51 20.11 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.743 ' HA ' HG22 ' A' ' 110' ' ' THR . 37.1 mt-10 54.55 30.43 13.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.412 -1.052 . . . . 0.0 109.24 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -79.31 161.01 26.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.763 HD13 HG23 ' A' ' 121' ' ' VAL . 3.6 pp 31.95 -157.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.499 0.666 . . . . 0.0 111.391 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.881 ' O ' HG23 ' A' ' 121' ' ' VAL . 4.0 t -152.19 -161.79 1.38 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.189 -0.945 . . . . 0.0 108.913 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.57 ' N ' HG23 ' A' ' 117' ' ' THR . 1.0 OUTLIER -79.73 -50.15 11.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.065 -1.022 . . . . 0.0 110.14 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -67.56 -13.1 61.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 109.618 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 116' ' ' LEU . 5.5 tt0 -97.5 -34.77 10.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.27 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.947 HG13 HD23 ' A' ' 105' ' ' LEU . 11.6 t -49.5 -51.75 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -41.14 -37.65 0.93 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 109.805 -179.534 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.522 ' HG2' ' HD2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -68.25 -57.51 5.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.158 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.533 ' SD ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -49.86 -22.73 1.58 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.158 179.557 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.682 HG23 HG23 ' A' ' 136' ' ' VAL . 3.4 mt -84.66 -38.65 13.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.63 0.729 . . . . 0.0 109.741 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.522 ' HD2' ' HG2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -62.02 -31.16 71.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.035 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.02 -9.51 53.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.106 -0.996 . . . . 0.0 109.113 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.57 -14.0 18.38 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.442 -0.786 . . . . 0.0 109.047 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.592 ' OD1' HG22 ' A' ' 136' ' ' VAL . 9.8 m-20 -92.63 164.27 13.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.433 -0.792 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.9 mt -86.16 -53.48 10.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.271 -0.893 . . . . 0.0 109.562 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.52 -46.58 46.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.495 -0.753 . . . . 0.0 109.673 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.79 30.71 4.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 135' ' ' GLN . 0.7 OUTLIER -79.85 -24.79 41.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -1.144 . . . . 0.0 109.596 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.39 16.91 9.77 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.561 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 1.5 mt-30 -128.65 147.53 50.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -1.088 . . . . 0.0 109.205 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.682 HG23 HG23 ' A' ' 125' ' ' ILE . 71.9 t -115.0 165.54 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.079 -1.013 . . . . 0.0 109.574 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.606 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -140.56 -168.05 2.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.582 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.975 ' O ' HG23 ' A' ' 142' ' ' VAL . 38.2 t80 -65.67 -52.64 50.05 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.715 -1.24 . . . . 0.0 110.689 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.465 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 2.6 mt-10 -58.44 -60.56 3.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.051 -1.03 . . . . 0.0 110.155 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 129' ' ' ASP . 13.5 mt-10 -52.14 -38.67 58.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 110.275 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.463 ' CE2' ' HA ' ' A' ' 89' ' ' PHE . 38.5 t80 -69.65 -29.22 66.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.981 -1.074 . . . . 0.0 109.81 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.975 HG23 ' O ' ' A' ' 138' ' ' TYR . 59.7 t -67.34 -39.36 82.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.444 -0.785 . . . . 0.0 109.875 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -64.06 -32.09 73.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.6 tmm? -90.2 -21.47 22.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.019 . . . . 0.0 110.029 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -57.94 3.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.08 -1.012 . . . . 0.0 109.913 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.653 ' O ' HG22 ' A' ' 146' ' ' THR . 1.4 m . . . . . 0 C--N 1.305 -1.334 0 O-C-N 121.191 -0.943 . . . . 0.0 109.229 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.31 -13.29 18.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 109.687 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.533 ' CG2' HG22 ' A' ' 142' ' ' VAL . 8.4 mt -86.71 -49.54 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.128 -0.983 . . . . 0.0 109.207 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.614 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.2 ttp180 -47.97 -29.26 3.27 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.254 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 88' ' ' ALA . 46.5 mt-10 -93.46 -53.25 4.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.92 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -45.82 -25.5 0.52 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.999 -1.063 . . . . 0.0 109.0 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 87.2 t80 -65.61 -56.25 13.24 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.441 -0.787 . . . . 0.0 109.604 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -62.08 -32.43 72.96 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.673 -0.642 . . . . 0.0 109.272 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 32.5 t -47.41 -31.08 2.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 64.4 m-85 -96.9 -33.71 11.52 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.453 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 25.8 t0 -92.57 108.15 19.76 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.539 ' HD3' ' CE1' ' A' ' 107' ' ' HIS . 0.1 OUTLIER -80.1 -26.56 39.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.113 -0.992 . . . . 0.0 110.128 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 97' ' ' ASN . 47.3 m-20 -79.15 2.67 20.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.3 -0.875 . . . . 0.0 108.934 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 34.53 34.56 0.04 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' ASP . 11.6 t-20 -87.32 -59.15 2.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -1.201 . . . . 0.0 109.836 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 137' ' ' ASN . . . 166.39 -24.15 0.14 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.647 ' CE2' ' HB3' ' A' ' 137' ' ' ASN . 15.4 m-85 -122.42 139.88 53.34 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.257 -1.143 . . . . 0.0 109.791 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.528 HG23 ' HB2' ' A' ' 104' ' ' GLU . 63.1 mt -100.47 141.98 16.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.447 ' OG ' ' HG3' ' A' ' 104' ' ' GLU . 88.9 p -109.91 -178.67 3.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.052 -1.03 . . . . 0.0 109.153 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 105' ' ' LEU . . . -62.38 -45.33 93.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 109.284 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.4 -46.43 88.71 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.37 -0.831 . . . . 0.0 109.539 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.528 ' HB2' HG23 ' A' ' 100' ' ' ILE . 28.5 mt-10 -62.97 -24.26 67.82 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.839 HD23 HG13 ' A' ' 121' ' ' VAL . 57.8 tp -71.28 -38.47 71.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.514 ' O ' ' CG ' ' A' ' 109' ' ' MET . 0.5 OUTLIER -70.92 -11.06 60.75 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.687 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.539 ' CE1' ' HD3' ' A' ' 94' ' ' LYS . 11.9 t-160 -57.82 -47.09 83.65 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.42 -0.8 . . . . 0.0 110.037 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' ' C ' ' A' ' 109' ' ' MET . 10.6 t -106.55 -5.66 10.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.243 -0.91 . . . . 0.0 110.103 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.525 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -39.12 -38.58 0.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 110.806 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.527 ' HA ' ' CA ' ' A' ' 114' ' ' GLU . 7.2 t -94.69 -34.65 12.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.869 -1.144 . . . . 0.0 110.226 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.433 ' HB2' HG13 ' A' ' 108' ' ' VAL . 15.6 m-80 -58.14 -18.54 26.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.929 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 mt -145.39 -20.37 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.043 -1.036 . . . . 0.0 111.222 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' MET . . . -124.14 18.54 7.41 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.203 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.527 ' CA ' ' HA ' ' A' ' 110' ' ' THR . 22.5 mt-10 58.1 179.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -1.223 . . . . 0.0 109.601 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 0.3 OUTLIER -54.64 133.57 46.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.912 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 0.4 OUTLIER -108.89 -164.8 0.97 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.198 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.516 ' OG1' ' HG3' ' A' ' 120' ' ' GLU . 3.0 p -149.47 -150.09 0.33 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.398 -0.814 . . . . 0.0 108.85 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.51 -49.31 7.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.44 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -68.96 -15.72 63.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 0.0 109.889 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.516 ' HG3' ' OG1' ' A' ' 117' ' ' THR . 0.1 OUTLIER -94.52 -37.1 11.55 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.109 -0.994 . . . . 0.0 108.996 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.839 HG13 HD23 ' A' ' 105' ' ' LEU . 29.3 t -72.0 -70.38 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.819 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -50.76 -27.65 7.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 0.0 109.434 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 79.1 tt0 -75.2 -39.15 60.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 0.0 108.703 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . 0.641 ' HB2' HD21 ' A' ' 105' ' ' LEU . 23.1 mtp -61.83 -29.84 70.44 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.8 mt -77.08 -40.81 30.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.5 mtp85 -57.77 -33.15 68.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.624 -0.672 . . . . 0.0 109.931 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -81.38 -20.09 41.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 108.9 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.478 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -97.46 -6.54 33.61 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.514 -0.741 . . . . 0.0 109.469 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.82 131.21 35.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.31 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.463 HD12 ' CD ' ' A' ' 140' ' ' GLU . 47.5 mt -104.9 -32.42 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.157 -0.965 . . . . 0.0 109.745 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.53 -41.86 6.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.767 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.23 36.21 2.0 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.3 p30 -79.16 -26.65 42.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.324 -1.104 . . . . 0.0 108.885 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 119.42 -40.75 2.15 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.47 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 15.3 pm0 -110.05 -177.39 3.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -1.164 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 137' ' ' ASN . 99.5 t -122.64 171.83 10.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.343 -0.848 . . . . 0.0 108.852 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.647 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 1.4 p-10 -148.57 -175.04 4.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.795 -1.191 . . . . 0.0 108.828 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.662 ' O ' HG23 ' A' ' 142' ' ' VAL . 52.5 t80 -71.75 -39.8 69.79 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.804 -1.185 . . . . 0.0 110.721 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.42 -48.5 75.13 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.992 -1.067 . . . . 0.0 109.985 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.482 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 1.3 mm-40 -71.83 -32.6 67.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.495 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 37.4 t80 -72.76 -25.78 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.868 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 138' ' ' TYR . 39.6 t -74.01 -51.16 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -59.81 -30.67 69.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.185 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 8.1 tpp -84.46 -29.98 25.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.009 -1.057 . . . . 0.0 109.924 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.495 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 3.1 tmm? -91.41 -5.14 54.86 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.184 -0.947 . . . . 0.0 110.217 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 142' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.494 1.767 0 O-C-N 120.98 -1.075 . . . . 0.0 110.206 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.428 ' O ' ' CG ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER 173.01 132.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 77' ' ' LYS . 0.9 OUTLIER 40.66 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 0.0 109.881 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 t -169.73 163.82 9.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.57 6.25 11.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.45 104.22 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.286 -0.884 . . . . 0.0 109.43 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -64.31 -13.57 50.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.207 -0.933 . . . . 0.0 108.95 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 86' ' ' ARG . 1.3 mt-10 -75.8 -29.33 58.67 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.443 -0.786 . . . . 0.0 109.095 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -43.7 -33.85 1.34 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 109.65 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.59 HG21 HG22 ' A' ' 142' ' ' VAL . 2.1 mp -93.17 -34.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.198 -0.939 . . . . 0.0 109.929 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.471 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 2.0 mmt85 -48.58 -37.91 19.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.641 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.7 mt-10 -87.01 -51.89 5.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.762 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.412 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -45.94 -25.06 0.48 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.994 -1.066 . . . . 0.0 109.11 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.442 ' HA ' ' CE2' ' A' ' 141' ' ' PHE . 77.6 t80 -66.5 -56.31 11.5 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.413 -0.804 . . . . 0.0 109.45 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.418 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 2.2 mtp180 -63.14 -27.51 69.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.295 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 108' ' ' VAL . 41.2 t -50.34 -28.99 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 62.4 m-85 -100.96 -36.19 9.12 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 27.1 t70 -83.94 82.58 8.28 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.581 -0.7 . . . . 0.0 109.254 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 4.7 mmtt -80.61 -20.43 43.25 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.301 -0.875 . . . . 0.0 110.157 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' GLY . 2.6 m-20 -78.12 1.56 20.82 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.98 48.15 1.96 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -109.09 -18.28 13.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -1.196 . . . . 0.0 109.812 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 120.09 -36.65 3.35 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.727 ' CD1' ' NE2' ' A' ' 135' ' ' GLN . 54.7 m-85 -116.38 142.08 47.32 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.374 -1.074 . . . . 0.0 109.59 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 97.0 mt -90.25 123.78 42.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 108.962 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.4 p -82.05 173.5 12.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.14 -0.975 . . . . 0.0 109.427 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -63.4 -42.1 98.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.414 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.468 ' HA ' ' NH2' ' A' ' 106' ' ' ARG . . . -63.46 -30.23 71.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 56.1 mm-40 -72.15 -22.51 61.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.149 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 109' ' ' MET . 4.1 tp -88.71 -31.83 18.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.6 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HE ' HG21 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.16 -9.59 52.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.164 -0.96 . . . . 0.0 109.175 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -88.31 -39.31 14.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.098 -1.001 . . . . 0.0 109.669 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 91' ' ' VAL . 57.3 t -88.62 -28.42 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 109.795 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 4.5 mtt -68.16 -20.98 64.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.238 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.518 ' CB ' ' O ' ' A' ' 114' ' ' GLU . 8.5 t -100.05 1.19 42.15 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.578 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 45.9 p-10 -57.51 -16.17 9.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 0.0 109.601 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.468 ' N ' ' OD1' ' A' ' 111' ' ' ASN . 1.2 mt -107.46 -20.93 13.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 109.641 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.6 -32.35 1.73 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 110' ' ' THR . 10.6 mt-10 -50.62 137.45 19.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.254 -1.145 . . . . 0.0 109.488 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 81.68 1.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.105 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.409 ' HB3' HG23 ' A' ' 121' ' ' VAL . 4.8 mp -63.91 136.29 57.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.0 t -90.81 -178.15 5.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 108.78 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -67.08 -54.98 16.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.892 -1.13 . . . . 0.0 110.178 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -60.73 -12.09 9.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.251 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 124' ' ' MET . 5.1 tp10 -97.46 -32.6 11.76 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.239 -0.913 . . . . 0.0 109.606 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.54 HG11 ' HB1' ' A' ' 102' ' ' ALA . 25.3 t -72.64 -54.43 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 0.0 109.787 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.69 -34.83 62.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.119 -0.988 . . . . 0.0 109.689 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 1.0 OUTLIER -76.08 -35.71 59.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.095 -1.003 . . . . 0.0 109.243 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 1.4 mmt -70.56 -21.05 62.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 108.716 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.499 HG21 ' O ' ' A' ' 134' ' ' GLY . 2.0 mt -84.87 -42.77 16.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -48.79 -31.61 7.32 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 109.898 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.84 -24.62 20.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.022 -1.049 . . . . 0.0 110.394 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.81 -44.98 54.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 109.838 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 135' ' ' GLN . 12.9 p-10 -86.39 177.06 7.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.349 -0.845 . . . . 0.0 109.668 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.0 mt -85.9 -66.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.414 -0.804 . . . . 0.0 109.567 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -177.47 57.83 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.512 -0.742 . . . . 0.0 109.49 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.22 -87.15 1.78 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.4 p-10 -139.11 -24.51 0.88 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.999 -0.707 . . . . 0.0 110.249 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.499 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 141.06 29.48 0.17 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.727 ' NE2' ' CD1' ' A' ' 99' ' ' TYR . 11.9 pt20 -119.63 166.85 12.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.263 . . . . 0.0 108.914 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 137' ' ' ASN . 69.9 t -119.41 162.87 17.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.517 ' N ' HG12 ' A' ' 136' ' ' VAL . 22.9 t30 -141.29 -164.38 1.75 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.975 -1.078 . . . . 0.0 108.372 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 142' ' ' VAL . 60.9 t80 -77.31 -49.5 14.85 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.686 -1.259 . . . . 0.0 110.15 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.29 -29.06 69.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.967 -1.083 . . . . 0.0 109.593 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.509 ' HB3' ' HA ' ' A' ' 129' ' ' ASP . 19.6 mt-10 -84.65 -32.87 23.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.107 -0.995 . . . . 0.0 108.856 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 89' ' ' PHE . 42.8 t80 -71.66 -25.81 62.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.535 -0.728 . . . . 0.0 109.087 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.59 HG22 HG21 ' A' ' 85' ' ' ILE . 24.0 t -60.53 -47.07 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.444 -0.785 . . . . 0.0 109.511 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -64.42 -35.54 81.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 109.782 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -83.34 -12.54 56.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.781 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.518 ' HE3' ' HA ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -81.88 -67.84 0.75 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.299 -0.876 . . . . 0.0 109.247 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.2 -85.78 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.412 -0.805 . . . . 0.0 109.285 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.31 167.21 2.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.355 -0.841 . . . . 0.0 109.586 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.587 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -66.33 176.75 1.69 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.84 . . . . 0.0 109.832 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.76 21.77 12.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.318 -0.864 . . . . 0.0 109.318 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.73 -173.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.979 . . . . 0.0 109.224 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.454 ' O ' ' OG ' ' A' ' 81' ' ' SER . 7.3 m-20 -144.18 -64.97 0.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 0.0 109.573 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 80' ' ' ASP . 5.8 p 47.59 22.99 0.35 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.339 -0.851 . . . . 0.0 110.193 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -73.55 -23.49 59.99 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.355 -0.841 . . . . 0.0 109.279 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -89.59 -27.36 20.27 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.457 -0.777 . . . . 0.0 109.112 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -47.83 84.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.576 HG21 HG22 ' A' ' 142' ' ' VAL . 5.1 mt -75.3 -37.35 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.614 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.599 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -52.52 -30.71 31.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.193 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 23.1 mm-40 -90.93 -52.11 5.02 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.377 -0.827 . . . . 0.0 109.473 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -47.19 -24.86 0.78 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.989 . . . . 0.0 109.159 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 92.6 t80 -67.51 -56.46 9.43 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -63.76 -24.31 67.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 24.4 t -52.73 -32.72 17.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.543 ' HA ' HG21 ' A' ' 108' ' ' VAL . 53.9 m-85 -95.32 -36.56 11.35 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.468 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 27.6 t0 -84.26 112.78 20.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.544 -0.722 . . . . 0.0 109.483 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -89.31 -24.42 22.03 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.095 -1.003 . . . . 0.0 109.825 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 97' ' ' ASN . 60.2 m-20 -78.6 1.41 22.77 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.571 -0.852 . . . . 0.0 108.748 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 36.32 31.41 0.04 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -88.16 -28.36 21.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.076 -1.249 . . . . 0.0 109.529 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.48 -19.76 5.03 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.614 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 2.0 m-30 -118.45 152.41 35.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -1.156 . . . . 0.0 109.562 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.468 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 52.3 mt -118.25 105.36 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.145 -0.972 . . . . 0.0 109.491 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 102' ' ' ALA . 2.3 p -74.17 151.79 39.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 0.0 109.258 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.509 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -43.79 -36.4 2.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.95 . . . . 0.0 109.771 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.34 -45.81 82.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.083 -1.011 . . . . 0.0 109.58 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.487 ' OE2' ' HB2' ' A' ' 94' ' ' LYS . 3.8 mm-40 -65.95 -21.44 66.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.118 -0.989 . . . . 0.0 108.785 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.536 ' O ' ' CG ' ' A' ' 109' ' ' MET . 10.6 tp -84.53 -25.14 28.99 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.459 -0.776 . . . . 0.0 109.581 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.415 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 4.5 ttm180 -77.79 -54.81 5.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.516 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.628 ' O ' HG22 ' A' ' 110' ' ' THR . 15.2 t60 -45.05 -45.4 10.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.954 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.543 HG21 ' HA ' ' A' ' 92' ' ' PHE . 98.2 t -82.88 -24.4 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 110.107 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.612 ' HB3' HD13 ' A' ' 116' ' ' LEU . 8.8 mmt -70.59 -14.06 62.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.071 -1.018 . . . . 0.0 109.256 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 107' ' ' HIS . 15.3 t -100.55 -6.32 25.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 109.686 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.45 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 1.2 t-20 -44.3 -51.97 7.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.228 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.45 ' HG ' ' C ' ' A' ' 111' ' ' ASN . 28.7 mt -145.83 13.46 1.32 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -129.11 22.6 5.06 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 2.8 mm-40 62.05 153.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.405 -1.056 . . . . 0.0 109.278 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 126.81 31.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 0.0 109.668 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.64 HD21 ' SD ' ' A' ' 124' ' ' MET . 10.2 mp -70.29 171.56 9.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.83 -170.23 2.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.301 -0.874 . . . . 0.0 108.835 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.03 -49.83 8.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.182 -0.949 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.81 -12.04 57.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.816 . . . . 0.0 109.41 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.468 ' HG2' HD23 ' A' ' 116' ' ' LEU . 1.9 tt0 -99.52 -41.64 7.28 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.362 -0.836 . . . . 0.0 109.75 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 117' ' ' THR . 29.4 t -56.51 -51.78 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.588 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.18 -27.42 54.41 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.183 -0.948 . . . . 0.0 109.733 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 85.4 mt-10 -79.12 -29.13 43.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.375 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.64 ' SD ' HD21 ' A' ' 116' ' ' LEU . 2.1 mtt -78.52 -24.85 45.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 108.542 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.589 HG23 HG23 ' A' ' 136' ' ' VAL . 5.7 mt -83.59 -39.27 14.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.563 0.697 . . . . 0.0 109.378 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.8 ptm180 -42.37 -21.87 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.735 -0.603 . . . . 0.0 111.494 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' ILE . 1.6 mt-10 -86.18 -42.51 13.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.579 -1.326 . . . . 0.0 108.918 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.36 7.56 42.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.457 ' CG ' HG22 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -69.0 132.71 47.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.548 0.69 . . . . 0.0 110.455 -179.008 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.527 ' HA ' ' HG3' ' A' ' 140' ' ' GLU . 12.3 mt -49.11 -43.6 15.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.565 -0.709 . . . . 0.0 109.645 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -156.67 -36.29 0.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.355 -0.841 . . . . 0.0 109.971 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 155.82 40.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -101.46 -23.35 14.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -1.153 . . . . 0.0 109.358 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 109.76 -17.44 30.28 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.456 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -103.05 169.13 8.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.076 -1.249 . . . . 0.0 109.728 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.633 HG12 ' N ' ' A' ' 137' ' ' ASN . 54.3 t -128.07 167.21 23.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.633 ' N ' HG12 ' A' ' 136' ' ' VAL . 5.3 p-10 -138.4 -173.89 3.66 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.818 ' O ' HG23 ' A' ' 142' ' ' VAL . 55.3 t80 -72.7 -43.02 63.59 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.682 -1.261 . . . . 0.0 111.657 -178.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.409 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 7.5 tt0 -66.4 -32.42 73.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.785 -1.197 . . . . 0.0 110.743 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.564 ' CG ' ' OD1' ' A' ' 137' ' ' ASN . 41.5 mm-40 -86.4 -28.93 23.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.0 109.161 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.436 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 20.6 t80 -75.1 -24.09 58.05 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 138' ' ' TYR . 42.3 t -69.33 -44.89 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.515 -0.741 . . . . 0.0 109.996 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -51.77 -38.29 54.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.082 -1.012 . . . . 0.0 109.946 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.42 -42.67 24.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.192 -0.943 . . . . 0.0 109.842 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.42 ' SD ' HG12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -68.36 -10.02 52.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.255 -0.903 . . . . 0.0 109.919 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.46 ' O ' HG22 ' A' ' 146' ' ' THR . 2.6 m -105.03 -5.94 20.46 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.164 -0.96 . . . . 0.0 109.299 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.3 126.64 17.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 109.689 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.32 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 77.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.948 . . . . 0.0 109.615 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -101.7 -175.53 2.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 109.591 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.51 97.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.376 -0.828 . . . . 0.0 109.667 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -105.23 114.57 28.83 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.336 -0.853 . . . . 0.0 109.137 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.9 m -83.87 11.6 7.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.392 -0.817 . . . . 0.0 109.66 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.49 -24.46 56.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 108.793 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -73.24 -13.58 61.17 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -59.96 -18.3 44.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.524 HG21 HG22 ' A' ' 142' ' ' VAL . 22.5 mm -71.94 -34.21 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.447 -0.783 . . . . 0.0 109.641 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.583 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -50.7 -39.34 51.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 109.304 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' PHE . 20.7 mt-10 -85.58 -50.68 7.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.181 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.86 -25.57 0.31 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.216 -0.927 . . . . 0.0 108.893 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 78.6 t80 -65.55 -56.65 11.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.283 -0.886 . . . . 0.0 109.2 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.445 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 5.3 mtp180 -61.23 -29.26 69.72 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 38.2 t -47.63 -35.02 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.516 ' HD2' HD12 ' A' ' 105' ' ' LEU . 61.3 m-85 -91.54 -37.84 12.88 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.485 ' HB2' HG12 ' A' ' 100' ' ' ILE . 44.1 t0 -89.78 90.12 8.06 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -78.58 -25.13 45.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 110.492 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.477 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 1.2 m-20 -79.84 7.07 9.45 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.165 -0.959 . . . . 0.0 109.33 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 40.21 38.9 1.43 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -87.92 -1.42 57.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.61 -21.94 23.43 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.656 ' CE1' ' CB ' ' A' ' 137' ' ' ASN . 1.5 m-85 -125.26 145.61 49.92 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.325 -1.103 . . . . 0.0 109.382 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.503 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 88.5 mt -103.04 101.16 11.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 109.592 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 p -73.29 -179.53 3.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -0.987 . . . . 0.0 109.223 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.16 90.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.59 -28.09 66.63 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.222 -0.924 . . . . 0.0 109.277 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' A' ' 95' ' ' ASP . 5.2 mm-40 -72.94 -31.6 64.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.112 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.516 HD12 ' HD2' ' A' ' 92' ' ' PHE . 16.2 tp -83.12 -27.57 30.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.313 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.438 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 2.2 ttt180 -65.26 -18.62 65.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.858 . . . . 0.0 108.82 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.471 ' CD2' HG23 ' A' ' 108' ' ' VAL . 33.9 t60 -82.76 -34.48 27.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.472 -0.767 . . . . 0.0 109.926 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 108' ' ' VAL . 74.1 t -123.38 26.37 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.012 -1.055 . . . . 0.0 110.155 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.672 ' HB2' HD21 ' A' ' 116' ' ' LEU . 9.2 ptt? -71.41 -21.58 61.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.067 -1.021 . . . . 0.0 108.815 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -88.84 -8.7 53.84 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.422 -0.799 . . . . 0.0 110.171 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.723 ' HB2' HG12 ' A' ' 108' ' ' VAL . 4.5 t-20 -36.44 -46.73 0.57 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.477 -0.764 . . . . 0.0 109.619 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 174.92 35.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.49 -0.756 . . . . 0.0 109.071 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -116.12 36.1 3.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 22.8 mt-10 72.31 -160.72 0.11 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -1.019 . . . . 0.0 109.071 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' A' ' 115' ' ' LYS . 26.8 mtmt -120.93 89.81 3.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 109.691 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 109' ' ' MET . 0.3 OUTLIER -84.16 170.94 13.28 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.353 -0.842 . . . . 0.0 109.905 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 121' ' ' VAL . 5.4 t -112.1 -155.92 0.58 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.379 -0.826 . . . . 0.0 109.345 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.629 ' N ' HG23 ' A' ' 117' ' ' THR . 2.9 m-20 -84.44 -58.7 2.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.958 -1.089 . . . . 0.0 109.671 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -54.58 -18.86 4.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' HG2' ' HB2' ' A' ' 116' ' ' LEU . 3.2 tt0 -91.13 -37.0 13.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.357 -0.839 . . . . 0.0 109.764 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 117' ' ' THR . 2.9 t -41.85 -53.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.33 -0.856 . . . . 0.0 109.99 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -37.42 77.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.073 -1.017 . . . . 0.0 109.795 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -72.09 -19.06 61.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 0.0 109.377 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.5 mmm -85.73 -23.23 27.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.976 . . . . 0.0 108.424 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.667 HG23 HG23 ' A' ' 136' ' ' VAL . 6.1 mt -84.32 -41.74 16.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.692 0.758 . . . . 0.0 109.164 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -61.44 -19.58 62.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 110.153 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -88.93 -31.77 18.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.01 . . . . 0.0 109.089 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.12 -5.83 51.96 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.608 -0.682 . . . . 0.0 109.394 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.465 ' OD2' ' OE1' ' A' ' 140' ' ' GLU . 1.2 t70 -100.23 166.59 10.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.451 ' N ' ' CG ' ' A' ' 129' ' ' ASP . 38.9 mm -86.78 -71.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.37 -0.831 . . . . 0.0 109.285 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 179.62 58.1 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.612 -0.68 . . . . 0.0 109.211 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.08 -89.5 1.92 Allowed Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -127.92 -25.84 3.0 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.69 0.757 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.446 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 136.55 30.01 0.3 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 5.9 pt20 -128.74 -170.62 2.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.293 . . . . 0.0 108.938 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.667 HG23 HG23 ' A' ' 125' ' ' ILE . 92.8 t -127.33 169.82 18.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.994 -1.066 . . . . 0.0 109.604 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.656 ' CB ' ' CE1' ' A' ' 99' ' ' TYR . 7.7 p30 -149.37 -168.02 2.99 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.583 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 55.3 t80 -66.12 -55.24 17.43 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.44 -1.412 . . . . 0.0 110.461 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.507 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -53.66 -57.9 9.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.102 -0.999 . . . . 0.0 110.373 -179.322 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.538 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 19.6 mt-10 -57.68 -39.22 76.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.058 -1.026 . . . . 0.0 109.883 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.6 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 59.9 t80 -63.58 -28.05 69.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.538 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 85' ' ' ILE . 35.7 t -65.91 -53.12 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.421 -0.799 . . . . 0.0 109.722 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -58.43 -30.21 66.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 0.0 110.051 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 144' ' ' MET . 0.6 OUTLIER -86.92 -20.68 27.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.963 . . . . 0.0 109.958 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.6 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -96.31 -7.54 35.06 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.16 -0.963 . . . . 0.0 109.977 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p -115.37 -42.6 3.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.087 -1.008 . . . . 0.0 110.029 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.29 97.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 0.0 109.75 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.678 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.474 ' O ' ' HB3' ' A' ' 77' ' ' LYS . 5.0 mtt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 76' ' ' MET . 22.8 ttpp 67.43 93.58 0.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.49 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.13 165.19 1.47 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 109.565 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.574 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.6 OUTLIER -69.63 162.8 26.93 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.284 -0.885 . . . . 0.0 109.207 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 79' ' ' THR . 0.2 OUTLIER 39.48 -88.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.615 -0.678 . . . . 0.0 110.575 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 79' ' ' THR . 0.1 OUTLIER 177.51 111.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.89 -1.131 . . . . 0.0 109.461 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 12.4 pt-20 -65.18 -14.94 61.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.163 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -84.72 -21.6 30.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.44 -0.787 . . . . 0.0 109.47 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 1.3 tt0 -60.97 -19.59 61.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.895 . . . . 0.0 109.086 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 mt -116.71 -48.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.308 -0.87 . . . . 0.0 109.328 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.514 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.2 OUTLIER -56.33 -43.25 78.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.275 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.8 mm-40 -82.63 -31.99 28.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.341 -0.849 . . . . 0.0 109.491 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.439 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -61.5 -26.51 67.96 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.414 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 85.5 t80 -66.06 -56.89 9.27 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.507 -0.746 . . . . 0.0 109.417 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -64.03 -25.54 68.16 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 87' ' ' GLU . 17.6 t -53.13 -30.34 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.56 ' CE1' HG11 ' A' ' 108' ' ' VAL . 68.7 m-85 -97.22 -32.36 11.96 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.466 ' HB2' HG12 ' A' ' 100' ' ' ILE . 11.7 t70 -99.08 94.18 6.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -75.58 -23.4 56.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.056 -1.028 . . . . 0.0 109.671 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 97' ' ' ASN . 51.4 m-20 -78.5 0.92 24.12 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.339 -0.851 . . . . 0.0 108.943 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 31.26 37.46 0.03 OUTLIER Glycine 0 N--CA 1.498 2.826 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 95' ' ' ASP . 6.1 t-20 -84.14 -32.93 24.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.26 . . . . 0.0 109.708 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.49 -34.08 2.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.7 m-85 -114.58 145.53 41.86 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.36 -1.082 . . . . 0.0 109.096 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.466 HG12 ' HB2' ' A' ' 93' ' ' ASP . 27.9 mt -100.07 122.6 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.171 -0.956 . . . . 0.0 109.469 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.59 -178.1 5.74 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.291 -0.881 . . . . 0.0 109.114 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.36 -36.19 68.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.131 -0.981 . . . . 0.0 109.303 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.45 -30.29 71.06 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.329 -0.857 . . . . 0.0 109.747 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 33.6 mm-40 -75.95 -22.7 55.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.168 -0.958 . . . . 0.0 109.189 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.45 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 63.5 tp -95.61 -11.02 27.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -0.764 . . . . 0.0 109.339 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -87.73 -43.26 12.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.314 -0.866 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.711 ' O ' HG22 ' A' ' 110' ' ' THR . 3.2 t60 -61.69 -41.84 98.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.952 . . . . 0.0 109.431 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.565 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 1.3 t -73.05 -40.0 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.156 -0.965 . . . . 0.0 109.161 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.749 ' HB3' HD13 ' A' ' 116' ' ' LEU . 2.4 mmt -68.1 -16.79 64.16 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 107' ' ' HIS . 2.3 t -96.07 -20.95 18.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.845 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.565 ' ND2' ' O ' ' A' ' 108' ' ' VAL . 1.2 p30 -52.18 -44.99 64.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 108.845 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 112' ' ' LEU . 33.1 mt -152.62 18.14 0.61 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.473 -0.767 . . . . 0.0 109.474 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -114.61 34.9 4.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 110' ' ' THR . 13.1 mm-40 62.09 -169.12 0.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.418 -1.048 . . . . 0.0 109.627 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.32 89.88 4.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.824 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.749 HD13 ' HB3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -57.39 131.31 49.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.542 HG23 ' H ' ' A' ' 120' ' ' GLU . 1.1 t -79.47 177.75 8.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.09 -1.006 . . . . 0.0 108.839 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.85 -63.09 1.26 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.92 -1.113 . . . . 0.0 109.994 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 14.4 pt-20 -47.07 -44.39 20.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.948 . . . . 0.0 109.934 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.542 ' H ' HG23 ' A' ' 117' ' ' THR . 39.8 tp10 -62.02 -41.15 97.78 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.757 -0.589 . . . . 0.0 110.454 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 117' ' ' THR . 46.9 t -65.89 -62.65 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.13 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -31.42 52.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.974 -1.079 . . . . 0.0 109.196 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -71.06 -34.65 71.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.0 108.955 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 124' ' ' MET . 2.9 mmt -70.89 -28.15 64.33 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.342 -0.849 . . . . 0.0 108.842 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.465 HG23 HG23 ' A' ' 136' ' ' VAL . 2.7 mt -75.75 -42.08 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.424 -0.798 . . . . 0.0 109.15 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -14.63 3.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.673 -0.642 . . . . 0.0 110.165 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.2 -32.37 21.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 108.981 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.64 -7.25 50.54 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.467 -0.77 . . . . 0.0 109.348 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 0.3 OUTLIER -76.99 145.14 38.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.867 . . . . 0.0 109.808 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.502 ' CG1' ' OE1' ' A' ' 140' ' ' GLU . 32.0 mm -81.68 -39.38 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.155 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.18 -43.62 3.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.704 -0.622 . . . . 0.0 109.618 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.84 39.0 0.67 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.412 ' CG ' ' OE1' ' A' ' 135' ' ' GLN . 1.5 p30 -78.62 -25.03 45.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.294 -1.121 . . . . 0.0 108.771 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.21 26.95 4.12 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.65 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.586 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -156.86 170.36 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.935 -1.332 . . . . 0.0 109.369 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 137' ' ' ASN . 85.5 t -130.74 168.2 24.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.18 -0.95 . . . . 0.0 109.572 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.605 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -140.27 -165.57 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.77 ' O ' HG23 ' A' ' 142' ' ' VAL . 57.9 t80 -80.96 -40.07 25.05 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.04 -1.037 . . . . 0.0 109.768 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -33.0 73.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.089 -1.007 . . . . 0.0 109.378 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.572 ' HG2' ' ND2' ' A' ' 137' ' ' ASN . 2.1 mm-40 -82.18 -38.92 23.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.045 -1.034 . . . . 0.0 108.98 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.583 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 31.3 t80 -67.41 -25.42 65.93 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 108.978 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 138' ' ' TYR . 40.0 t -70.71 -43.67 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.862 . . . . 0.0 109.713 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.511 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 69.7 mt-30 -61.58 -23.89 66.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 109.697 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.403 ' HA ' ' OXT' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -90.28 -31.47 16.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.638 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.583 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -93.03 -2.67 55.43 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.261 -0.9 . . . . 0.0 109.917 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -130.87 -46.54 1.03 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.263 -0.898 . . . . 0.0 108.992 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -93.92 48.8 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.571 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.403 ' OXT' ' HA ' ' A' ' 144' ' ' MET . 17.3 mmtp . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.402 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.74 ' N ' ' HG1' ' A' ' 79' ' ' THR . 4.6 ptm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.558 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 2.1 ttpm? 56.22 62.62 2.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 109.373 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 77' ' ' LYS . 1.3 t0 82.74 -47.58 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.741 -0.599 . . . . 0.0 110.067 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.74 ' HG1' ' N ' ' A' ' 76' ' ' MET . 0.2 OUTLIER 60.13 -166.95 0.18 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.04 . . . . 0.0 109.285 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 t70 56.85 14.25 1.77 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.293 -0.879 . . . . 0.0 110.47 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.6 m -79.54 -27.42 41.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.988 -1.07 . . . . 0.0 109.273 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -91.62 -27.82 17.9 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.568 0.699 . . . . 0.0 109.336 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -85.79 8.89 18.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.601 -0.687 . . . . 0.0 109.444 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 22.8 tt0 -47.25 -24.58 0.76 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.57 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 mp -80.39 -43.39 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.321 -0.862 . . . . 0.0 109.667 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -39.0 57.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 109.355 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 17.7 pt-20 -81.03 -47.8 13.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 87' ' ' GLU . . . -45.47 -32.06 2.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 108.805 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.402 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 90.4 t80 -58.96 -56.29 24.22 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.393 -0.817 . . . . 0.0 109.582 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 3.2 mtp180 -63.42 -30.0 71.2 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.693 -0.629 . . . . 0.0 109.453 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 74.5 t -49.23 -28.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -102.14 -32.18 10.23 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD1' ' OE1' ' A' ' 104' ' ' GLU . 30.6 t70 -91.05 80.14 5.73 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.64 -0.663 . . . . 0.0 109.624 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -21.0 59.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.845 . . . . 0.0 109.817 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -78.58 1.9 21.08 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.72 -0.792 . . . . 0.0 108.994 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 34.62 39.44 0.15 Allowed Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 13.1 p-10 -94.42 -17.8 22.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.277 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.98 -38.19 2.94 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 137' ' ' ASN . 36.6 m-85 -115.36 140.47 49.1 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.291 -1.123 . . . . 0.0 109.32 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 72.1 mt -89.49 117.12 32.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.19 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.3 p -83.74 164.86 19.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.71 -35.3 72.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.522 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.44 -31.65 71.12 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.228 -0.92 . . . . 0.0 109.381 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' OE1' ' OD1' ' A' ' 93' ' ' ASP . 34.5 mt-10 -71.94 -24.22 61.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.202 -0.936 . . . . 0.0 108.948 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.5 tp -85.05 -33.96 22.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.259 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' A' ' 109' ' ' MET . 18.0 ttt180 -61.25 -28.49 69.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 108.657 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -65.89 -49.25 68.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.544 -0.722 . . . . 0.0 109.451 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 108' ' ' VAL . 23.8 t -103.16 41.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.892 ' HB2' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -92.39 -23.06 19.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.804 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.8 OUTLIER -100.55 -12.48 19.24 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.211 -0.931 . . . . 0.0 109.573 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.977 ' O ' HD23 ' A' ' 112' ' ' LEU . 19.7 p-10 -45.55 -44.87 13.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.044 -1.035 . . . . 0.0 108.915 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.977 HD23 ' O ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -159.5 22.69 0.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.306 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -123.72 45.02 1.22 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.5 mm-40 56.84 -141.18 0.81 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -1.234 . . . . 0.0 109.125 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -126.18 83.62 2.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.977 -1.077 . . . . 0.0 109.459 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.892 HD12 ' HB2' ' A' ' 109' ' ' MET . 35.2 mt -59.31 -160.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.138 -0.976 . . . . 0.0 109.587 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.831 ' O ' HG23 ' A' ' 121' ' ' VAL . 17.9 p -153.78 -161.58 1.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.39 -48.6 9.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.192 -0.943 . . . . 0.0 109.072 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.42 -16.18 60.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.285 -0.884 . . . . 0.0 108.796 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -88.81 -37.31 15.5 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 117' ' ' THR . 9.1 t -55.98 -52.54 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.418 -0.801 . . . . 0.0 109.014 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 3.5 m-20 -57.82 -23.35 52.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.173 -0.954 . . . . 0.0 109.327 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -81.37 -29.96 33.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.428 -0.795 . . . . 0.0 109.046 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.82 -25.85 49.14 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.627 HG21 ' O ' ' A' ' 134' ' ' GLY . 6.8 mt -84.65 -38.73 13.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.738 0.78 . . . . 0.0 109.031 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.2 ptm85 -54.33 -33.49 59.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.703 -0.623 . . . . 0.0 109.897 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 5.7 mt-10 -89.62 -18.09 27.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.064 -1.022 . . . . 0.0 109.336 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.35 -5.37 43.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.387 -0.821 . . . . 0.0 109.751 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.477 ' OD2' ' HA ' ' A' ' 126' ' ' ARG . 3.0 p30 -81.99 177.78 8.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.88 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.589 HD12 ' OE2' ' A' ' 140' ' ' GLU . 36.0 mt -81.13 -50.31 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.497 -0.752 . . . . 0.0 109.78 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -133.09 -24.32 1.88 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.32 -0.862 . . . . 0.0 110.55 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 137.78 40.79 0.11 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -78.97 -24.15 44.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -1.11 . . . . 0.0 108.74 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.627 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 102.06 -26.58 23.83 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -103.58 173.71 6.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -1.229 . . . . 0.0 109.451 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.603 HG23 HG23 ' A' ' 125' ' ' ILE . 55.6 t -124.26 162.62 25.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.576 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 31.4 t30 -141.54 -165.55 2.01 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.867 -1.146 . . . . 0.0 108.215 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.966 ' O ' HG23 ' A' ' 142' ' ' VAL . 72.1 t80 -75.99 -39.22 56.28 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.844 -1.16 . . . . 0.0 109.843 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -70.56 -34.12 71.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.235 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.589 ' OE2' HD12 ' A' ' 130' ' ' ILE . 7.8 mt-10 -80.2 -28.91 38.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 108.778 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.402 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 43.1 t80 -78.88 -25.12 43.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.433 -0.792 . . . . 0.0 109.3 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 138' ' ' TYR . 48.1 t -58.86 -48.53 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 109.822 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.555 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 4.6 mt-30 -66.64 -26.37 67.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.001 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.2 ttp -81.93 -21.95 37.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.67 -65.51 1.01 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.245 -0.909 . . . . 0.0 109.756 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -45.38 45.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.333 -0.854 . . . . 0.0 109.657 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -93.62 174.95 6.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 0.0 109.607 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.311 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.28 0.562 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 65.88 156.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 109.569 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 54.7 68.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.8 m -90.91 91.08 8.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.262 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 81' ' ' SER . 0.4 OUTLIER -117.44 -75.89 0.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.753 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 80' ' ' ASP . 0.3 OUTLIER 165.67 117.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.337 -0.852 . . . . 0.0 109.075 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -67.02 -15.13 63.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -86.39 -15.47 40.29 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.413 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -55.73 24.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.943 . . . . 0.0 109.495 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.81 -41.64 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.536 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.584 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 4.2 ttp180 -49.86 -31.35 11.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.066 -1.021 . . . . 0.0 109.03 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 77.9 mt-10 -86.15 -57.54 2.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 110.105 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.514 ' CB ' ' SD ' ' A' ' 145' ' ' MET . . . -41.07 -32.98 0.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 109.031 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.46 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 89.9 t80 -59.76 -56.96 15.35 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.493 -0.754 . . . . 0.0 109.194 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.474 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -59.94 -35.85 75.82 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.759 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 66.1 t -42.93 -32.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -98.57 -31.7 11.82 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.474 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 13.2 t70 -95.6 81.68 3.55 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.607 -0.683 . . . . 0.0 109.316 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -22.35 55.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 110.296 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 97' ' ' ASN . 59.1 m-20 -78.51 2.15 20.02 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.281 -0.887 . . . . 0.0 109.21 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.09 29.83 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 95' ' ' ASP . 1.9 t30 -78.51 -36.44 44.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.101 -1.235 . . . . 0.0 109.551 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.71 -52.73 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 11.8 m-30 -106.42 156.52 18.44 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.352 -1.087 . . . . 0.0 109.003 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.411 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 74.2 mt -97.24 108.33 21.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.453 -0.779 . . . . 0.0 109.273 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -78.19 -177.56 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.759 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.695 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -64.65 -45.14 88.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -0.856 . . . . 0.0 109.17 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.97 -23.9 67.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.434 -0.791 . . . . 0.0 109.698 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -76.99 -31.89 56.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.023 -1.048 . . . . 0.0 108.892 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.633 HD12 HG12 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -89.27 -13.23 38.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -0.842 . . . . 0.0 108.899 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.498 ' O ' ' CG2' ' A' ' 110' ' ' THR . 10.1 ttt180 -90.15 -14.03 34.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.377 -0.827 . . . . 0.0 108.793 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -77.79 -26.47 49.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 110.172 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.8 t -106.67 -50.86 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 110.492 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.664 ' HB3' HD11 ' A' ' 116' ' ' LEU . 2.4 mmt -56.2 -19.55 14.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 109.858 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 106' ' ' ARG . 12.9 t -88.26 -28.94 20.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.119 -0.988 . . . . 0.0 109.645 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -52.93 -47.09 68.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.37 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pp -132.85 -3.72 3.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 110.131 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 109' ' ' MET . . . -103.79 20.05 42.52 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 16.3 mt-10 63.49 141.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -1.124 . . . . 0.0 109.186 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HA ' ' OG1' ' A' ' 110' ' ' THR . 0.6 OUTLIER -50.39 100.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.752 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 109' ' ' MET . 29.0 mt -59.57 133.18 55.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 109.264 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -71.16 178.97 3.02 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.109 -0.994 . . . . 0.0 108.332 179.201 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.412 ' N ' ' OG1' ' A' ' 117' ' ' THR . 10.0 m-20 -60.52 -63.45 1.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.87 -1.144 . . . . 0.0 109.914 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 1.4 pt-20 -50.4 -42.19 53.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 109.947 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.48 ' H ' HG23 ' A' ' 117' ' ' THR . 12.7 tp10 -63.04 -34.99 78.75 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.586 -0.696 . . . . 0.0 110.156 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.695 HG11 ' HB1' ' A' ' 102' ' ' ALA . 28.7 t -71.65 -65.37 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.276 -0.89 . . . . 0.0 109.638 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -48.82 -30.66 6.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.087 -1.008 . . . . 0.0 109.158 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 0.5 OUTLIER -75.09 -38.94 61.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.166 179.636 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.566 ' HG3' HD13 ' A' ' 116' ' ' LEU . 3.7 mmt -65.32 -23.89 67.13 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.689 HG23 HG23 ' A' ' 136' ' ' VAL . 3.2 mt -81.76 -38.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -47.97 -28.76 2.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.955 -0.466 . . . . 0.0 110.099 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 124' ' ' MET . 7.2 pt-20 -80.2 -37.39 33.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.887 -1.133 . . . . 0.0 108.589 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -78.47 -7.98 58.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.65 143.3 30.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.822 . . . . 0.0 109.255 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.8 -39.47 10.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 109.665 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.11 -44.81 7.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.455 -0.778 . . . . 0.0 109.956 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.19 39.94 1.09 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -79.08 -24.54 43.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -1.073 . . . . 0.0 108.776 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.522 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 117.22 -36.77 3.58 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -98.75 170.07 9.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.061 -1.258 . . . . 0.0 109.118 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.689 HG23 HG23 ' A' ' 125' ' ' ILE . 52.0 t -127.9 162.79 33.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.176 -0.952 . . . . 0.0 108.556 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -137.99 -169.76 2.63 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 109.094 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.97 ' O ' HG23 ' A' ' 142' ' ' VAL . 78.7 t80 -77.62 -34.9 53.19 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.701 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -49.62 70.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.262 -0.899 . . . . 0.0 109.322 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -69.3 -39.79 78.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.331 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.46 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 47.7 t80 -66.38 -24.34 66.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.812 . . . . 0.0 109.793 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.97 HG23 ' O ' ' A' ' 138' ' ' TYR . 40.8 t -70.29 -46.95 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.94 . . . . 0.0 109.963 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 22.5 mm100 -70.28 -23.96 62.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 109.866 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -85.12 -23.77 28.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.514 ' SD ' ' CB ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -83.34 -51.63 7.25 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.91 -62.46 1.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.0 109.994 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -65.68 176.17 1.63 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.761 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 pttt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.546 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.332 0.587 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.93 125.3 10.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.732 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -104.78 -51.06 3.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.309 -0.87 . . . . 0.0 109.351 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.4 173.59 11.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.68 -59.88 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.735 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.7 t 60.91 16.79 7.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.481 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -79.98 -89.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 109.387 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -80.62 -1.2 41.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.499 -0.751 . . . . 0.0 109.584 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -58.42 -27.28 64.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.112 -0.993 . . . . 0.0 109.191 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.596 HG21 HG13 ' A' ' 142' ' ' VAL . 4.5 mm -76.07 -39.86 36.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.371 -0.83 . . . . 0.0 109.262 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.406 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -53.56 -43.66 68.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 109.584 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 9.9 pt-20 -78.8 -41.59 29.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.991 . . . . 0.0 109.607 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.505 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -52.16 -30.37 26.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.104 -0.998 . . . . 0.0 108.648 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.446 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 90.4 t80 -64.39 -52.95 55.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.0 109.622 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -64.51 -24.21 67.53 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 52.7 t -56.35 -22.8 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -104.97 -36.27 7.38 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.411 ' HB2' HG12 ' A' ' 100' ' ' ILE . 39.4 t0 -83.99 108.29 16.86 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -84.28 -26.49 28.55 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.079 -1.013 . . . . 0.0 110.088 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.485 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -79.46 3.04 19.74 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 108.903 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 36.32 36.74 0.16 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 95' ' ' ASP . 14.5 p-10 -93.71 -42.87 8.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -1.187 . . . . 0.0 109.875 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.42 -20.71 1.52 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.641 ' CE1' ' CB ' ' A' ' 137' ' ' ASN . 1.7 m-85 -120.72 144.44 48.24 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.216 -1.167 . . . . 0.0 109.71 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.411 HG12 ' HB2' ' A' ' 93' ' ' ASP . 68.5 mt -108.54 110.21 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.547 -0.721 . . . . 0.0 109.537 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.75 162.92 28.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.245 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.526 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -55.06 -36.85 66.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.975 . . . . 0.0 109.38 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.44 78.59 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.375 -0.828 . . . . 0.0 109.343 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -72.24 -22.54 61.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.339 -0.851 . . . . 0.0 108.895 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 109' ' ' MET . 17.8 tp -90.03 -23.16 21.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.378 -0.826 . . . . 0.0 109.512 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.433 ' HB2' HG21 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -84.44 -34.33 23.49 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.16 -0.962 . . . . 0.0 109.882 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.535 ' O ' HG22 ' A' ' 110' ' ' THR . 35.0 t60 -61.12 -41.53 96.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.033 -1.042 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 91' ' ' VAL . 46.9 t -86.64 -23.86 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.816 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.492 ' CG ' ' O ' ' A' ' 105' ' ' LEU . 4.4 mmt -73.25 -21.33 60.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 107' ' ' HIS . 9.3 t -89.55 -26.03 21.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.34 -0.85 . . . . 0.0 109.63 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.693 ' HB3' HD12 ' A' ' 112' ' ' LEU . 1.6 t30 -48.18 -57.49 5.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.445 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 111' ' ' ASN . 1.8 mp -125.22 3.63 7.84 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.354 -0.841 . . . . 0.0 109.64 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . -108.86 56.4 0.47 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.9 mt-10 45.45 -134.53 0.78 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -1.15 . . . . 0.0 108.861 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -148.44 78.1 1.41 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.76 -1.212 . . . . 0.0 109.564 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.751 ' H ' HD23 ' A' ' 116' ' ' LEU . 1.4 pt? -67.85 144.81 55.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.095 -1.003 . . . . 0.0 109.0 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.719 ' O ' HG23 ' A' ' 121' ' ' VAL . 21.9 p -77.55 -159.73 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.9 . . . . 0.0 109.956 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.21 -48.37 13.21 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.422 -0.799 . . . . 0.0 109.49 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.68 -21.96 20.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.137 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 23.6 mm-40 -87.5 -47.88 8.38 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 117' ' ' THR . 49.0 t -46.96 -49.99 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.445 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.45 -38.16 68.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.832 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 15.6 mt-10 -67.45 -38.26 84.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.935 . . . . 0.0 109.629 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 21.9 mmm -68.51 -30.38 69.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.103 -0.998 . . . . 0.0 108.893 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.462 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 3.0 mt -71.96 -40.36 67.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.419 -0.801 . . . . 0.0 108.849 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -61.28 -18.93 60.89 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.558 -0.714 . . . . 0.0 109.189 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 7.1 mm-40 -90.4 -21.48 21.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.337 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 144' ' ' MET . . . -92.59 -65.18 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 30.4 p-10 -76.16 177.47 7.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.462 -0.774 . . . . 0.0 109.069 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.499 HG12 ' OE2' ' A' ' 140' ' ' GLU . 7.4 mm -85.89 -66.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -0.908 . . . . 0.0 109.721 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 173.46 65.01 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.92 -87.51 1.77 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.93 -17.61 7.26 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.765 -0.844 . . . . 0.0 109.327 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 125.08 18.32 2.59 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.48 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 1.3 pt20 -118.68 171.37 8.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -1.184 . . . . 0.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 137' ' ' ASN . 84.1 t -125.43 169.41 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.141 -0.974 . . . . 0.0 109.862 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.641 ' CB ' ' CE1' ' A' ' 99' ' ' TYR . 1.8 p-10 -145.23 -173.21 4.04 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.693 ' O ' HG23 ' A' ' 142' ' ' VAL . 49.9 t80 -69.81 -45.21 68.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.392 -1.443 . . . . 0.0 111.671 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.454 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 0.3 OUTLIER -61.68 -47.82 83.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.902 -1.124 . . . . 0.0 110.651 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.527 ' HB3' ' HA ' ' A' ' 129' ' ' ASP . 0.8 OUTLIER -70.41 -36.52 74.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.892 -1.13 . . . . 0.0 109.78 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.597 ' CZ ' ' HG2' ' A' ' 145' ' ' MET . 6.2 t80 -67.66 -27.71 67.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.19 -0.943 . . . . 0.0 109.159 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 138' ' ' TYR . 75.8 t -79.32 -62.62 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.369 -0.832 . . . . 0.0 109.662 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.44 ' C ' ' O ' ' A' ' 142' ' ' VAL . 7.8 mm100 -39.38 -34.65 0.22 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.473 -0.767 . . . . 0.0 110.73 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 128' ' ' ALA . 29.6 mmt -90.45 -45.75 8.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.871 -1.143 . . . . 0.0 110.624 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.597 ' HG2' ' CZ ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -71.61 -0.61 11.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 0.0 110.549 -178.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.494 ' CG2' HG13 ' A' ' 85' ' ' ILE . 7.8 p -125.24 -89.27 0.58 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.104 -0.997 . . . . 0.0 110.008 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' A' ' 148' ' ' LYS . . . -83.75 -175.38 5.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.079 -1.013 . . . . 0.0 110.202 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 147' ' ' ALA . 11.5 mptt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.159 -0.924 . . . . 0.0 109.67 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.8 tpt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.66 78.84 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.631 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -94.25 -168.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -0.956 . . . . 0.0 109.551 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -60.68 108.13 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.9 . . . . 0.0 109.757 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.523 ' CB ' ' OE2' ' A' ' 82' ' ' GLU . 73.7 m-20 -113.21 -29.95 7.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.125 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.453 ' O ' ' OG ' ' A' ' 81' ' ' SER . 0.2 OUTLIER 66.32 13.7 9.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.348 -0.845 . . . . 0.0 109.743 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.523 ' OE2' ' CB ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -88.6 -16.77 31.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.098 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -89.95 -30.21 17.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -52.95 -23.15 6.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.474 -0.766 . . . . 0.0 109.401 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -81.81 -38.12 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.326 -0.859 . . . . 0.0 109.058 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.474 ' HG2' ' CZ ' ' A' ' 138' ' ' TYR . 9.9 mtt180 -61.19 -31.92 71.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.437 -0.79 . . . . 0.0 109.143 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -89.74 -34.99 16.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 109.136 179.686 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.494 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.56 -23.12 67.25 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.42 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 82.6 t80 -69.68 -54.31 14.46 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -63.54 -27.62 69.38 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 4.9 t -48.17 -31.11 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.498 ' CE1' ' HB ' ' A' ' 108' ' ' VAL . 83.3 m-85 -98.29 -37.59 9.59 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.468 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 43.2 t0 -87.39 92.32 9.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -84.0 -24.8 30.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.26 -0.9 . . . . 0.0 110.223 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -79.18 4.18 15.57 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.245 -0.91 . . . . 0.0 109.101 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 39.57 29.3 0.14 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 95' ' ' ASP . 15.4 p-10 -73.93 -39.0 64.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.116 . . . . 0.0 109.658 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.26 -48.34 0.68 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.488 ' CD2' ' HG3' ' A' ' 135' ' ' GLN . 8.7 m-30 -108.92 176.29 5.16 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.335 -1.097 . . . . 0.0 109.465 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.7 mt -119.31 115.3 47.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.643 -0.66 . . . . 0.0 109.424 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.5 p -80.29 159.11 25.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.651 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.465 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -51.93 -35.89 47.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 0.0 109.514 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.56 -41.21 88.99 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.152 -0.968 . . . . 0.0 109.117 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 13.6 mt-10 -65.84 -22.69 66.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.227 -0.921 . . . . 0.0 109.103 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 109' ' ' MET . 9.4 tp -85.54 -32.25 22.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.422 -0.799 . . . . 0.0 109.644 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -34.79 77.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.289 -0.882 . . . . 0.0 109.177 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -59.55 -27.15 65.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 109.985 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.498 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 17.5 t -102.33 -12.73 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.078 -1.014 . . . . 0.0 110.44 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.815 ' HB3' HD22 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -78.24 -11.18 59.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.909 -1.12 . . . . 0.0 109.618 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 111' ' ' ASN . 2.1 t -99.93 -30.72 11.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.07 -1.019 . . . . 0.0 110.123 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -43.92 -45.49 7.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 109.221 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.8 23.48 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.648 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -115.04 19.76 15.0 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 67.8 146.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -1.095 . . . . 0.0 109.223 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.42 81.5 1.42 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -0.963 . . . . 0.0 110.053 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' A' ' 109' ' ' MET . 2.7 pt? -63.33 151.75 39.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 109.008 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.509 ' OG1' ' HG2' ' A' ' 120' ' ' GLU . 44.4 p -84.45 -165.61 1.22 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.296 -0.877 . . . . 0.0 109.447 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -75.11 -46.57 33.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.712 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.439 ' O ' ' OE1' ' A' ' 123' ' ' GLU . 30.9 mt-10 -57.2 -16.42 8.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.763 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.509 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 5.2 mm-40 -95.17 -45.08 7.34 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.342 -0.849 . . . . 0.0 108.961 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.603 HG22 HD11 ' A' ' 116' ' ' LEU . 41.8 t -49.42 -55.72 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.89 -0.507 . . . . 0.0 110.599 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.34 -36.54 84.05 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.852 -1.155 . . . . 0.0 109.042 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 119' ' ' GLU . 87.0 mt-10 -70.79 -15.56 62.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.179 -0.951 . . . . 0.0 108.56 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.434 ' SD ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -85.32 -30.94 23.31 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.698 HG22 ' OD2' ' A' ' 129' ' ' ASP . 3.3 mt -74.42 -41.31 49.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.99 -15.23 3.23 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.706 -0.621 . . . . 0.0 110.007 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -87.33 -30.94 20.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.923 -1.111 . . . . 0.0 109.797 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.402 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -88.7 -58.48 2.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.337 -0.852 . . . . 0.0 109.506 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.698 ' OD2' HG22 ' A' ' 125' ' ' ILE . 8.6 p30 -53.05 155.49 2.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.713 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.8 mt -111.79 -44.39 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.295 -0.878 . . . . 0.0 109.703 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -72.51 -38.14 68.18 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.473 -0.767 . . . . 0.0 109.63 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.66 33.46 6.42 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -78.94 -26.28 43.6 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.318 -1.107 . . . . 0.0 108.681 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.587 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 124.22 -42.19 1.6 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.488 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -90.07 165.25 14.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.059 -1.26 . . . . 0.0 109.49 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 137' ' ' ASN . 53.1 t -118.23 161.49 17.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.521 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -134.16 -164.62 1.53 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.714 -1.241 . . . . 0.0 108.659 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.991 ' O ' HG23 ' A' ' 142' ' ' VAL . 64.9 t80 -78.49 -38.48 40.8 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.205 -0.934 . . . . 0.0 110.206 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -70.45 -33.08 70.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.995 -1.066 . . . . 0.0 109.417 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.48 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 15.5 mt-10 -82.12 -34.07 29.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.159 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.42 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 38.5 t80 -75.47 -25.65 57.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.519 -0.738 . . . . 0.0 109.671 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.991 HG23 ' O ' ' A' ' 138' ' ' TYR . 26.8 t -55.38 -48.98 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.786 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -65.9 -27.3 68.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.041 -1.037 . . . . 0.0 109.627 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -80.39 -19.33 46.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.198 -0.939 . . . . 0.0 109.691 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.442 ' HG3' ' HB3' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -77.47 -39.13 47.62 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -56.7 -30.83 63.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.095 -1.003 . . . . 0.0 109.36 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.405 ' O ' ' OXT' ' A' ' 148' ' ' LYS . . . -73.62 168.08 20.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.338 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.405 ' OXT' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.385 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.23 0.538 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -78.7 113.03 16.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.166 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.33 176.63 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.681 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.6 t -139.08 154.0 48.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -151.39 -33.38 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 110.187 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.75 10.56 7.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.882 -1.136 . . . . 0.0 110.039 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.401 ' O ' HD12 ' A' ' 85' ' ' ILE . 4.5 mm-40 -89.49 -37.99 14.36 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 108.856 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 86' ' ' ARG . 4.9 tt0 -90.6 -9.24 47.78 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.349 0.595 . . . . 0.0 109.469 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -47.09 -26.94 1.2 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.312 -0.868 . . . . 0.0 110.116 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 82' ' ' GLU . 2.6 mt -72.45 -44.67 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.042 -1.036 . . . . 0.0 109.641 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.584 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -46.24 -33.4 3.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.059 -1.025 . . . . 0.0 109.441 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 88' ' ' ALA . 1.9 mt-10 -87.17 -55.44 3.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 109.977 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -42.69 -28.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 108.901 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 87' ' ' GLU . 79.6 t80 -62.61 -57.52 10.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.481 -0.762 . . . . 0.0 109.419 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.461 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 6.0 mtp180 -61.1 -32.99 72.65 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.67 -0.644 . . . . 0.0 109.302 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.488 HG12 HG21 ' A' ' 108' ' ' VAL . 39.1 t -45.31 -32.45 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.706 ' CD1' HD12 ' A' ' 105' ' ' LEU . 85.8 m-85 -94.47 -49.79 5.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.487 ' CA ' HG12 ' A' ' 100' ' ' ILE . 65.7 t0 -65.36 91.37 0.11 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -90.32 -21.01 22.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 111.238 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.46 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 10.5 p-10 -78.2 7.53 6.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.938 -1.101 . . . . 0.0 109.876 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.75 49.66 1.92 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.425 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 1.8 t30 -110.17 -64.58 1.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -1.114 . . . . 0.0 109.207 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.19 -47.27 0.11 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.593 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 7.6 m-30 -110.06 150.38 28.64 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.53 -0.982 . . . . 0.0 109.204 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.487 HG12 ' CA ' ' A' ' 93' ' ' ASP . 55.6 mt -85.43 152.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.419 -0.801 . . . . 0.0 109.511 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.7 p -110.48 172.63 6.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.183 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.96 -53.7 49.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.828 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.24 62.72 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 71.4 mt-10 -75.24 -30.0 60.39 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.123 -0.986 . . . . 0.0 108.561 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.706 HD12 ' CD1' ' A' ' 92' ' ' PHE . 12.2 tp -81.18 -21.93 39.29 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.776 ' HB2' HG21 ' A' ' 121' ' ' VAL . 35.9 ttt-85 -78.86 -22.64 45.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.41 -0.806 . . . . 0.0 108.968 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -67.76 -38.49 83.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.468 -0.77 . . . . 0.0 110.427 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.488 HG21 HG12 ' A' ' 91' ' ' VAL . 92.4 t -99.17 -38.07 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.255 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.979 ' HB3' HD13 ' A' ' 116' ' ' LEU . 16.3 mmt -61.14 -13.34 16.88 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.32 -0.862 . . . . 0.0 109.615 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -94.73 -29.41 14.8 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.22 -0.925 . . . . 0.0 108.849 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -68.12 0.39 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.905 . . . . 0.0 109.258 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.7 mt -114.33 15.19 18.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 109.328 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 109' ' ' MET . . . -111.04 51.35 0.7 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 48.29 -145.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -1.083 . . . . 0.0 109.545 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.56 101.01 9.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.02 . . . . 0.0 109.788 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.979 HD13 ' HB3' ' A' ' 109' ' ' MET . 0.1 OUTLIER -102.6 111.5 23.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.41 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.905 HG22 ' HG2' ' A' ' 120' ' ' GLU . 6.3 t -82.71 -146.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 108.735 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.7 ' N ' HG23 ' A' ' 117' ' ' THR . 2.9 m-20 -90.11 -48.45 7.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.023 -1.048 . . . . 0.0 109.884 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -60.23 -17.83 44.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.869 . . . . 0.0 109.586 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.905 ' HG2' HG22 ' A' ' 117' ' ' THR . 11.9 mm-40 -94.1 -47.76 6.53 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 117' ' ' THR . 47.7 t -47.49 -62.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.599 -0.688 . . . . 0.0 109.905 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -31.68 11.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.982 -1.074 . . . . 0.0 109.646 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -68.49 -40.18 81.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.224 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.492 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 36.2 mmm -63.39 -32.68 74.18 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mt -71.03 -39.25 74.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.567 -0.708 . . . . 0.0 109.463 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -55.06 -27.55 45.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 110.263 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -89.33 -21.56 23.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.126 -0.984 . . . . 0.0 109.663 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -97.19 -5.82 36.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.824 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' HG22 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -97.45 133.32 42.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.7 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 57.0 mt -85.34 -50.23 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.358 -0.839 . . . . 0.0 109.426 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.1 -49.86 7.91 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.604 -0.685 . . . . 0.0 109.726 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.08 37.75 2.45 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -78.78 -25.19 44.33 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.317 -1.108 . . . . 0.0 108.821 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.19 28.96 1.88 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.485 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.593 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -159.18 165.85 32.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.068 -1.254 . . . . 0.0 109.256 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 137' ' ' ASN . 55.8 t -122.6 162.86 21.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.12 -0.987 . . . . 0.0 108.654 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.534 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -132.44 -164.01 1.41 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.908 -1.12 . . . . 0.0 108.517 179.424 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 1.013 ' O ' HG23 ' A' ' 142' ' ' VAL . 67.2 t80 -78.58 -49.59 13.01 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 110.323 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -59.84 -39.65 85.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.0 109.536 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.517 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 7.5 mt-10 -74.68 -38.96 62.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.049 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 39.0 t80 -65.64 -22.52 66.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.422 -0.798 . . . . 0.0 109.059 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 1.013 HG23 ' O ' ' A' ' 138' ' ' TYR . 89.7 t -70.68 -40.66 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.552 -0.718 . . . . 0.0 110.079 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 7.6 mt-30 -65.98 -27.82 68.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.068 -1.02 . . . . 0.0 110.188 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.6 ttp -90.34 -26.54 19.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.094 -1.004 . . . . 0.0 110.058 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -97.68 -62.69 1.21 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.005 -1.06 . . . . 0.0 109.99 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -52.53 -31.61 36.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.159 -0.963 . . . . 0.0 109.348 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -50.76 101.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.069 -1.02 . . . . 0.0 109.492 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.2 mttm . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.367 179.887 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.33 0.586 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.37 164.76 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.587 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.07 -38.28 2.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.84 . . . . 0.0 109.709 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.77 171.25 18.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.948 . . . . 0.0 109.778 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -114.04 -84.07 0.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.298 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 m -169.66 105.95 0.36 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.398 -0.814 . . . . 0.0 109.144 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.97 -13.05 21.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.264 -0.898 . . . . 0.0 109.443 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -71.2 -31.07 67.17 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.34 -0.85 . . . . 0.0 109.849 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.41 -39.42 15.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.961 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.66 HG23 ' CB ' ' A' ' 145' ' ' MET . 2.6 mt -91.72 -37.17 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.178 -0.952 . . . . 0.0 110.243 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.57 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 34.8 mtt180 -49.61 -28.91 6.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.005 . . . . 0.0 109.772 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -92.68 -54.02 3.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.078 -1.014 . . . . 0.0 109.478 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -44.51 -26.74 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.189 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 75.7 t80 -64.77 -55.9 16.94 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.111 -0.993 . . . . 0.0 109.403 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' CZ ' ' CB ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -62.88 -31.68 72.78 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.307 -179.743 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 108' ' ' VAL . 41.0 t -47.41 -28.24 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 64.7 m-85 -102.74 -31.69 10.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.472 ' HB2' HG12 ' A' ' 100' ' ' ILE . 34.3 t0 -93.62 92.83 7.72 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.583 -0.698 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.447 ' NZ ' ' CE1' ' A' ' 107' ' ' HIS . 1.6 mmmm -90.28 -23.13 21.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.222 -0.924 . . . . 0.0 109.927 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.492 ' O ' ' C ' ' A' ' 96' ' ' GLY . 15.8 t0 -78.79 1.95 21.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 109.186 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 33.55 37.8 0.07 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 95' ' ' ASP . 12.9 p-10 -88.0 -28.53 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -1.178 . . . . 0.0 109.768 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 143.37 -54.27 0.59 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 14.6 m-30 -109.59 157.28 19.2 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.486 -1.008 . . . . 0.0 109.124 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 84.3 mt -90.28 117.4 33.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 109.026 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.0 p -74.48 159.86 31.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.168 -0.958 . . . . 0.0 109.265 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.79 -31.12 66.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.418 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.78 -35.34 62.54 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.168 -0.958 . . . . 0.0 109.042 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 50.7 mm-40 -73.3 -22.8 60.27 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.276 -0.89 . . . . 0.0 108.967 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 125' ' ' ILE . 5.3 tp -90.78 -25.16 20.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 0.0 109.032 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.496 ' O ' ' OG1' ' A' ' 110' ' ' THR . 2.0 ttt180 -77.4 -30.4 53.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.271 -0.893 . . . . 0.0 109.01 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.447 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 26.6 t-80 -58.03 -45.11 87.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.906 . . . . 0.0 110.057 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 91' ' ' VAL . 25.9 t -91.65 -26.46 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.06 -1.025 . . . . 0.0 110.392 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.576 ' CE ' HD12 ' A' ' 116' ' ' LEU . 13.7 mtm -61.29 -42.63 98.98 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.102 -0.999 . . . . 0.0 109.038 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.937 HG23 ' HA ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -59.31 -26.67 65.2 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.207 -0.933 . . . . 0.0 109.253 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 110' ' ' THR . 7.9 t-20 39.02 -93.03 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.662 -0.648 . . . . 0.0 110.088 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.839 ' O ' HD12 ' A' ' 112' ' ' LEU . 1.3 pp -148.71 68.34 1.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.143 -0.973 . . . . 0.0 109.226 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.56 -17.55 11.14 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -83.75 43.41 0.91 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.228 -1.16 . . . . 0.0 109.826 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.937 ' HA ' HG23 ' A' ' 110' ' ' THR . 13.7 ttpp -64.98 126.52 28.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 0.0 109.344 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.576 HD12 ' CE ' ' A' ' 109' ' ' MET . 45.5 mt -104.08 140.6 37.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.48 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -66.98 -169.17 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.91 . . . . 0.0 108.71 179.33 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.47 -50.53 12.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.011 -1.055 . . . . 0.0 109.269 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -30.6 70.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.18 -0.95 . . . . 0.0 108.5 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.49 ' CG ' HD22 ' A' ' 116' ' ' LEU . 9.8 tp10 -70.56 -41.88 71.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 117' ' ' THR . 34.6 t -61.5 -36.63 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.14 -25.53 67.02 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -75.01 -45.86 38.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.481 -0.762 . . . . 0.0 109.017 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 7.6 mmt -60.66 -28.28 68.47 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.21 -0.931 . . . . 0.0 108.76 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.563 HG12 HD22 ' A' ' 105' ' ' LEU . 2.4 mt -82.09 -35.24 13.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.519 -0.738 . . . . 0.0 109.475 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -59.69 -31.24 69.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 110.35 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.42 -5.24 56.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.029 -1.045 . . . . 0.0 110.509 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.06 -29.85 11.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.986 -1.071 . . . . 0.0 109.747 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.33 149.87 23.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.287 -0.883 . . . . 0.0 109.641 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.818 HD12 ' OE1' ' A' ' 140' ' ' GLU . 16.9 mt -113.38 -29.02 2.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.18 -0.95 . . . . 0.0 109.374 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' HB3' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -61.73 -33.6 74.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.88 21.39 55.83 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' OD2' ' HB3' ' A' ' 131' ' ' ASP . 0.7 OUTLIER -83.51 -27.56 29.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -1.169 . . . . 0.0 109.609 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.84 28.03 4.65 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.457 ' CD ' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -146.61 163.07 37.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -1.204 . . . . 0.0 109.391 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 137' ' ' ASN . 94.2 t -117.78 168.2 9.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.327 -0.858 . . . . 0.0 109.188 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.599 ' N ' HG12 ' A' ' 136' ' ' VAL . 47.0 t30 -148.25 -166.29 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.888 ' O ' HG23 ' A' ' 142' ' ' VAL . 60.2 t80 -80.62 -41.79 23.31 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.583 -1.323 . . . . 0.0 110.117 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.49 -29.99 66.67 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.104 -0.998 . . . . 0.0 109.303 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.818 ' OE1' HD12 ' A' ' 130' ' ' ILE . 6.1 mm-40 -85.26 -35.41 21.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 26.1 t80 -71.22 -26.87 63.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.536 -0.727 . . . . 0.0 109.16 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 138' ' ' TYR . 20.3 t -55.37 -44.31 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.189 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -57.94 -31.59 66.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.708 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.493 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 34.5 ttp -75.98 -39.57 55.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.454 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.66 ' CB ' HG23 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -69.77 -20.17 63.49 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.2 p -154.07 94.71 1.77 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -101.33 85.93 2.89 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.665 -0.647 . . . . 0.0 109.412 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.385 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.287 0.565 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.0 146.92 41.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.393 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -56.89 137.77 54.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.978 . . . . 0.0 109.2 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 9.5 t -144.99 139.9 27.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 79' ' ' THR . 3.0 t0 80.92 -55.67 0.31 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.902 -0.499 . . . . 0.0 110.251 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.41 20.43 1.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.92 -1.112 . . . . 0.0 109.527 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.44 -90.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.61 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -74.39 2.31 9.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.502 -0.749 . . . . 0.0 109.993 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.01 -19.46 4.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.064 -1.022 . . . . 0.0 109.338 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' A' ' 142' ' ' VAL . 5.8 mt -74.92 -39.72 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.282 -0.886 . . . . 0.0 109.548 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.586 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -46.52 -31.79 2.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.934 -1.103 . . . . 0.0 109.214 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 88' ' ' ALA . 15.5 mt-10 -91.88 -50.28 5.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.454 -0.779 . . . . 0.0 109.168 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.488 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.78 -25.87 0.34 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -0.906 . . . . 0.0 108.761 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' N ' ' C ' ' A' ' 87' ' ' GLU . 82.9 t80 -63.51 -55.61 22.59 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.284 -0.885 . . . . 0.0 109.004 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.45 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -60.86 -36.13 78.37 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 34.4 t -43.32 -28.35 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 90' ' ' ARG . 92.0 m-85 -106.36 -31.37 8.62 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.45 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 10.8 t0 -89.34 79.7 6.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.602 -0.686 . . . . 0.0 109.369 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -89.19 -16.97 30.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.386 -0.821 . . . . 0.0 109.745 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.459 ' O ' ' C ' ' A' ' 96' ' ' GLY . 12.6 t70 -77.19 0.39 21.98 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.397 -0.815 . . . . 0.0 108.988 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.96 50.3 2.07 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.12 -31.83 7.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -1.176 . . . . 0.0 109.587 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.39 -50.02 0.82 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.636 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 10.9 m-30 -114.03 146.04 40.73 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.339 -1.095 . . . . 0.0 109.217 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 81.9 mt -81.96 132.56 31.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.398 -0.814 . . . . 0.0 109.389 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.6 p -98.26 178.04 5.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.547 ' CA ' HG11 ' A' ' 121' ' ' VAL . . . -65.7 -40.54 92.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 109.341 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.73 -31.1 70.8 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.267 -0.896 . . . . 0.0 109.407 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.53 -26.23 59.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.877 . . . . 0.0 108.667 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.904 ' O ' HD23 ' A' ' 105' ' ' LEU . 3.6 tt -82.11 -26.2 33.77 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.787 HH12 HG21 ' A' ' 110' ' ' THR . 0.0 OUTLIER -73.03 -47.33 45.84 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 106' ' ' ARG . 28.0 t60 -40.93 -38.4 0.95 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.48 -0.762 . . . . 0.0 110.347 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.449 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 36.2 t -97.97 -28.11 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.972 -1.08 . . . . 0.0 110.297 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.701 ' CG ' HD22 ' A' ' 116' ' ' LEU . 3.9 mmt -64.33 -17.34 63.6 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.725 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.787 HG21 HH12 ' A' ' 106' ' ' ARG . 1.1 t -88.7 -18.55 27.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.455 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.449 ' OD1' ' HA ' ' A' ' 108' ' ' VAL . 7.3 m120 -58.48 97.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.875 . . . . 0.0 109.552 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt 61.32 13.45 4.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -117.96 41.91 1.95 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 52.89 -125.76 2.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.236 -1.155 . . . . 0.0 109.12 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 135.67 32.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.634 -1.292 . . . . 0.0 109.991 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.859 HD21 ' SD ' ' A' ' 124' ' ' MET . 0.7 OUTLIER -103.94 116.46 32.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.297 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.467 HG23 ' H ' ' A' ' 120' ' ' GLU . 5.6 t -75.45 165.78 24.6 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.64 -52.67 63.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.845 -1.16 . . . . 0.0 110.237 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -59.41 -17.96 34.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.244 -0.91 . . . . 0.0 109.998 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.546 ' CG ' ' HG ' ' A' ' 116' ' ' LEU . 7.7 tp10 -87.18 -40.16 14.83 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.547 HG11 ' CA ' ' A' ' 102' ' ' ALA . 21.9 t -61.41 -46.74 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.304 -0.872 . . . . 0.0 109.079 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -46.92 -28.82 1.74 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.383 -0.823 . . . . 0.0 109.751 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -75.54 -51.41 12.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.142 -0.974 . . . . 0.0 109.426 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.859 ' SD ' HD21 ' A' ' 116' ' ' LEU . 1.2 mpt? -59.91 -21.14 60.71 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.222 -0.924 . . . . 0.0 109.559 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.547 HG12 HD12 ' A' ' 105' ' ' LEU . 2.3 mt -84.85 -42.97 16.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.3 -0.875 . . . . 0.0 109.659 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -22.68 1.02 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.38 -0.825 . . . . 0.0 110.588 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -90.87 -30.37 16.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.919 -1.113 . . . . 0.0 110.379 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.19 -49.65 16.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.838 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.407 ' OD2' HG22 ' A' ' 125' ' ' ILE . 1.9 p30 -80.44 150.91 29.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.5 mt -117.69 -34.48 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.334 -0.854 . . . . 0.0 109.214 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -61.75 -39.88 93.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.536 -0.727 . . . . 0.0 109.286 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.56 29.44 29.8 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.18 -25.64 39.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.386 -1.067 . . . . 0.0 108.77 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 115.3 26.54 3.42 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.636 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -160.27 162.54 33.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.045 -1.268 . . . . 0.0 109.517 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 137' ' ' ASN . 70.0 t -113.8 161.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.52 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -135.79 -166.46 1.86 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.97 -1.081 . . . . 0.0 108.619 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 142' ' ' VAL . 52.3 t80 -78.87 -37.44 40.27 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.415 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.423 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 5.2 tp10 -67.77 -38.99 84.15 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -77.09 -38.47 52.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.175 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 38.6 t80 -69.47 -23.49 63.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.394 -0.816 . . . . 0.0 109.456 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 138' ' ' TYR . 23.1 t -75.7 -54.01 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 109.84 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.423 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 2.8 mt-30 -63.34 -21.9 66.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.0 110.044 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -90.24 -32.82 16.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.076 -1.015 . . . . 0.0 109.941 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -93.25 -4.4 51.95 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.201 -0.937 . . . . 0.0 110.143 -179.326 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.595 HG23 ' N ' ' A' ' 147' ' ' ALA . 12.5 t -98.14 -45.47 6.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.044 -1.035 . . . . 0.0 109.587 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.595 ' N ' HG23 ' A' ' 146' ' ' THR . . . -43.36 159.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.608 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.649 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.269 0.557 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt 66.86 154.76 0.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -0.926 . . . . 0.0 109.461 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.23 1.56 12.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.506 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.4 p 45.91 -158.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.169 -0.957 . . . . 0.0 109.265 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.14 -1.44 10.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 109.903 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -72.56 -17.36 61.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 109.764 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.63 -22.74 20.12 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.675 -0.641 . . . . 0.0 109.544 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.92 11.45 20.38 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.603 -0.686 . . . . 0.0 109.617 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -23.74 60.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.206 -0.934 . . . . 0.0 109.709 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.9 HG12 HG23 ' A' ' 146' ' ' THR . 3.5 mp -82.64 -37.85 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.142 -0.974 . . . . 0.0 109.929 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -42.05 95.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.722 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -79.56 -30.14 41.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.148 -0.97 . . . . 0.0 109.442 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -67.38 -27.02 66.76 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 82.0 t80 -68.44 -54.61 15.93 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.652 0.739 . . . . 0.0 109.247 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -63.78 -27.91 69.51 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 87' ' ' GLU . 8.5 t -50.09 -30.1 6.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.48 ' HB2' HD13 ' A' ' 100' ' ' ILE . 87.1 m-85 -98.02 -35.42 10.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -90.13 95.71 10.33 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -89.98 -26.02 20.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.207 -0.933 . . . . 0.0 110.841 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -78.99 5.26 12.12 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.062 -1.024 . . . . 0.0 109.055 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 40.94 33.12 0.62 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -75.81 -70.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -1.117 . . . . 0.0 109.081 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.19 -53.98 0.09 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.629 ' CE2' ' NE2' ' A' ' 135' ' ' GLN . 9.7 m-30 -107.95 152.15 24.84 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.488 -1.007 . . . . 0.0 109.047 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 86.0 mt -88.63 128.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 109.911 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.9 p -90.36 -176.58 4.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.327 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.664 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -67.51 -50.71 57.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.74 -29.52 69.43 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.382 -0.824 . . . . 0.0 109.526 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 28.5 mt-10 -73.64 -30.79 63.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.16 -0.962 . . . . 0.0 108.953 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 109' ' ' MET . 2.2 tp -91.06 -9.21 46.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.46 -0.775 . . . . 0.0 109.211 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -91.53 -40.24 11.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.383 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.579 ' O ' HG22 ' A' ' 110' ' ' THR . 24.4 t60 -54.83 -35.22 63.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.627 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 91' ' ' VAL . 71.1 t -88.85 -44.64 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.118 -0.989 . . . . 0.0 110.056 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.551 ' HB3' HD13 ' A' ' 116' ' ' LEU . 97.1 mmm -68.13 -7.65 31.64 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 109.188 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 107' ' ' HIS . 6.6 t -98.86 -19.54 17.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.125 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.636 ' O ' HD23 ' A' ' 112' ' ' LEU . 3.3 m120 -89.23 31.3 0.9 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.129 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER 161.03 -19.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.585 -0.697 . . . . 0.0 109.725 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -85.83 20.86 17.38 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.506 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.529 ' O ' ' O ' ' A' ' 115' ' ' LYS . 13.3 mt-10 62.08 40.61 11.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.112 -1.228 . . . . 0.0 110.125 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 114' ' ' GLU . 3.1 ttpp 50.0 115.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.767 0.794 . . . . 0.0 111.45 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' A' ' 124' ' ' MET . 0.7 OUTLIER -95.36 159.26 15.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 109.356 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 121' ' ' VAL . 21.7 p -92.41 -171.64 2.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 109.774 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.87 -47.82 8.3 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.465 -0.772 . . . . 0.0 109.025 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.42 -13.18 62.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 108.838 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 23.9 tp10 -93.46 -42.23 9.37 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.475 -0.766 . . . . 0.0 109.137 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.664 HG11 ' HB1' ' A' ' 102' ' ' ALA . 6.9 t -53.87 -61.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.422 -0.798 . . . . 0.0 109.775 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -48.1 -27.73 2.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.987 . . . . 0.0 109.952 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -77.33 -39.74 46.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.196 -0.94 . . . . 0.0 109.326 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.553 ' HG3' HD21 ' A' ' 116' ' ' LEU . 25.1 mmm -66.38 -22.3 66.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.872 -1.142 . . . . 0.0 108.586 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.636 HG23 HG23 ' A' ' 136' ' ' VAL . 3.2 mt -86.91 -38.3 12.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -55.88 -22.82 27.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.636 -0.665 . . . . 0.0 110.062 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.488 ' HG2' ' HG3' ' A' ' 126' ' ' ARG . 3.1 mt-10 -90.41 -34.57 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 0.0 109.75 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.24 -13.49 60.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.917 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.844 ' OD1' HG22 ' A' ' 136' ' ' VAL . 7.1 m-20 -94.68 142.45 27.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.615 HD12 ' OE2' ' A' ' 140' ' ' GLU . 73.2 mt -89.26 -37.15 9.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.324 -0.86 . . . . 0.0 109.22 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -39.09 24.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.514 -0.741 . . . . 0.0 109.439 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.36 29.94 13.3 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.14 -25.43 42.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -1.072 . . . . 0.0 109.09 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 117.48 5.77 14.01 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.629 ' NE2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -129.27 157.64 41.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.892 -1.357 . . . . 0.0 109.434 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.844 HG22 ' OD1' ' A' ' 129' ' ' ASP . 77.9 t -116.27 165.28 11.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.192 -0.943 . . . . 0.0 108.61 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -141.39 -164.19 1.71 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.925 -1.109 . . . . 0.0 108.512 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.501 ' O ' HG23 ' A' ' 142' ' ' VAL . 65.1 t80 -81.45 -42.17 20.73 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.126 -0.984 . . . . 0.0 109.182 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -68.34 -29.43 68.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.392 -0.817 . . . . 0.0 109.199 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.615 ' OE2' HD12 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -86.27 -33.91 20.54 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.418 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 60.1 t80 -70.94 -24.43 62.44 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.561 -0.712 . . . . 0.0 109.293 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.683 HG13 ' OG1' ' A' ' 146' ' ' THR . 3.8 t -66.01 -51.64 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.498 -0.751 . . . . 0.0 109.991 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -59.79 -26.03 65.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.115 -0.991 . . . . 0.0 110.662 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -28.37 19.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.854 -1.154 . . . . 0.0 110.742 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.4 tpt -102.57 -61.86 1.34 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.012 -1.055 . . . . 0.0 109.801 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.9 HG23 HG12 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -46.16 -38.68 8.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.486 -0.759 . . . . 0.0 109.88 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -97.73 154.69 17.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.455 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.466 ' CG ' ' O ' ' A' ' 76' ' ' MET . 2.2 ptt? . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 76' ' ' MET . 0.9 OUTLIER 71.42 176.98 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.945 . . . . 0.0 109.408 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -114.55 -11.0 12.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.765 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.4 m 52.33 91.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.125 -0.984 . . . . 0.0 109.34 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -65.55 110.07 2.58 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.345 -0.847 . . . . 0.0 109.766 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.11 18.39 21.78 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.313 -0.867 . . . . 0.0 109.105 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -82.16 -28.76 31.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.415 -0.803 . . . . 0.0 109.486 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.42 -20.94 62.05 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 109.202 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 2.2 tm-20 -65.73 -35.8 81.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.416 -0.802 . . . . 0.0 109.531 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.603 HG21 ' HA ' ' A' ' 142' ' ' VAL . 2.8 mp -80.3 -37.65 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.271 -0.893 . . . . 0.0 110.026 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.483 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 5.7 ttp180 -48.53 -39.72 24.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.062 -1.024 . . . . 0.0 109.715 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 11.3 pt-20 -82.26 -50.74 8.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.111 -0.993 . . . . 0.0 109.875 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -45.59 -27.23 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.002 -1.061 . . . . 0.0 108.922 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.416 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 91.4 t80 -63.51 -56.99 11.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.419 -0.8 . . . . 0.0 109.753 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -62.03 -32.07 72.53 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.529 -0.732 . . . . 0.0 109.112 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 55.1 t -44.56 -30.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -99.44 -35.48 9.89 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.457 ' HB2' HG12 ' A' ' 100' ' ' ILE . 10.1 t0 -91.55 98.88 11.93 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.505 -0.747 . . . . 0.0 109.377 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.418 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 0.0 OUTLIER -90.32 -23.61 21.1 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.245 -0.909 . . . . 0.0 110.262 -179.487 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -79.01 3.68 16.54 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 109.337 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.61 31.76 0.09 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 95' ' ' ASP . 11.4 p-10 -80.47 -24.03 39.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.071 -1.252 . . . . 0.0 109.87 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 126.33 -44.64 1.23 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 52.3 m-85 -110.4 145.03 38.27 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.495 -1.003 . . . . 0.0 109.629 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 71.6 mt -90.43 94.31 4.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.453 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -66.58 158.61 29.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.106 -0.996 . . . . 0.0 109.208 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.552 ' HA ' HG11 ' A' ' 121' ' ' VAL . . . -45.49 -42.38 10.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.108 -0.995 . . . . 0.0 109.266 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.26 99.17 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.311 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.455 ' OE1' ' HB2' ' A' ' 95' ' ' ASP . 1.5 mm-40 -64.47 -24.15 67.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 0.0 109.199 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.481 HD23 HG13 ' A' ' 121' ' ' VAL . 34.7 tp -88.83 -16.83 31.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.747 ' O ' HG22 ' A' ' 110' ' ' THR . 5.6 ttt-85 -83.44 -35.23 25.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.505 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.418 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 23.3 t60 -42.24 -49.9 4.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.667 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.7 t -95.59 -24.77 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.987 -1.071 . . . . 0.0 110.717 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.521 ' HB2' ' HA ' ' A' ' 106' ' ' ARG . 8.3 mmt -64.17 -23.49 67.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.05 -1.031 . . . . 0.0 109.758 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -82.1 -31.13 30.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 109.795 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.405 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 22.5 t-20 -56.88 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.456 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 112' ' ' LEU . 1.5 mt 56.92 24.11 8.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.478 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -117.67 51.94 0.71 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 57.4 178.87 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -1.165 . . . . 0.0 109.346 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -112.98 79.79 1.27 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.331 -0.856 . . . . 0.0 109.215 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.584 HD11 HG22 ' A' ' 121' ' ' VAL . 1.0 OUTLIER -94.21 133.84 37.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.972 . . . . 0.0 109.378 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.901 ' O ' HG23 ' A' ' 121' ' ' VAL . 5.3 t -92.08 -146.14 0.21 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.363 -0.836 . . . . 0.0 109.237 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.778 ' N ' HG23 ' A' ' 117' ' ' THR . 3.9 m-20 -78.63 -48.85 14.28 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.552 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 117' ' ' THR . 20.8 mt-10 -54.48 -24.99 22.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 109.709 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.597 ' HG2' HG22 ' A' ' 117' ' ' THR . 18.1 mm-40 -86.96 -47.98 8.52 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 117' ' ' THR . 92.5 t -54.81 -26.15 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.72 -0.613 . . . . 0.0 109.568 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -68.36 -34.89 76.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -79.95 -19.0 49.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.948 -1.095 . . . . 0.0 108.598 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 15.2 mmt -88.91 -20.78 24.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.681 HG23 HG23 ' A' ' 136' ' ' VAL . 7.6 mt -92.43 -45.6 14.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.73 0.776 . . . . 0.0 109.718 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.7 -26.35 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.682 -0.636 . . . . 0.0 110.723 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -90.35 -37.15 14.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.985 -1.072 . . . . 0.0 109.749 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.43 ' HB2' ' CE ' ' A' ' 144' ' ' MET . . . -80.09 -4.36 52.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.852 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -96.67 176.75 5.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 3.7 mt -69.92 -69.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.362 -0.836 . . . . 0.0 109.437 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 130' ' ' ILE . 3.0 p-10 -179.24 32.95 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.44 -0.788 . . . . 0.0 110.533 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 146.93 49.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.068 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 129' ' ' ASP . 2.2 p30 -112.55 -24.65 9.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -1.119 . . . . 0.0 109.035 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.29 -10.2 55.2 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.448 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 4.3 pt20 -144.91 -170.35 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -1.154 . . . . 0.0 109.133 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.681 HG23 HG23 ' A' ' 125' ' ' ILE . 53.6 t -126.33 160.4 33.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.607 ' HB3' ' OE1' ' A' ' 140' ' ' GLU . 19.5 t30 -141.53 -166.48 2.21 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.755 ' O ' HG23 ' A' ' 142' ' ' VAL . 88.4 t80 -78.19 -31.07 49.31 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.563 -1.336 . . . . 0.0 112.106 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -15.43 60.07 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.462 -1.399 . . . . 0.0 110.321 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.607 ' OE1' ' HB3' ' A' ' 137' ' ' ASN . 3.8 mp0 -100.57 -34.64 9.82 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.416 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 50.9 t80 -71.88 -25.28 61.87 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 138' ' ' TYR . 9.9 t -60.43 -55.27 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -65.44 -21.05 66.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.762 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.43 ' CE ' ' HB2' ' A' ' 128' ' ' ALA . 3.1 tpt -85.16 -20.55 30.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 0.0 109.726 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -39.64 20.58 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.141 -0.975 . . . . 0.0 109.482 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 p -74.2 -57.85 3.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.81 -179.34 5.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 0.0 109.72 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.301 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 76' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -113.49 66.99 0.66 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 109.404 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 79' ' ' THR . 6.6 m-20 179.94 -88.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.839 . . . . 0.0 109.42 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 174.93 131.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.501 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -136.26 -92.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.183 -0.948 . . . . 0.0 109.527 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.98 7.14 3.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.11 -0.994 . . . . 0.0 109.763 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -90.05 -64.0 1.2 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.363 -0.836 . . . . 0.0 109.55 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 86' ' ' ARG . 15.9 tt0 -88.31 -9.17 53.69 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.646 -0.659 . . . . 0.0 109.807 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -46.38 -27.52 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 110.095 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.826 HG21 HG22 ' A' ' 142' ' ' VAL . 5.1 mm -77.4 -47.45 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.17 -0.956 . . . . 0.0 110.446 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.476 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 5.3 mmm180 -47.73 -45.07 28.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.101 -0.999 . . . . 0.0 109.908 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 10.4 pt-20 -79.99 -39.79 29.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.059 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.539 ' N ' ' HG3' ' A' ' 87' ' ' GLU . . . -57.88 -19.54 30.23 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.912 -1.117 . . . . 0.0 108.48 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 82.4 t80 -71.53 -55.44 7.82 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.451 -0.78 . . . . 0.0 109.326 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -63.77 -27.45 69.2 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.513 HG12 HG21 ' A' ' 108' ' ' VAL . 24.3 t -50.14 -30.72 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.6 ' CE2' ' HB ' ' A' ' 108' ' ' VAL . 65.1 m-85 -96.88 -33.91 11.45 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.467 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 23.3 t0 -97.83 91.94 5.6 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.773 -0.58 . . . . 0.0 109.649 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 94' ' ' LYS . 19.4 mmmt -90.19 -19.34 24.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.285 -0.884 . . . . 0.0 110.013 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -77.94 2.43 17.53 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.344 -0.848 . . . . 0.0 109.386 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 39.57 37.54 0.86 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -85.86 -25.65 26.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -1.194 . . . . 0.0 109.556 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.18 -48.1 0.98 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.487 ' HB3' ' O ' ' A' ' 136' ' ' VAL . 13.5 m-30 -112.85 178.4 4.3 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.564 -0.962 . . . . 0.0 108.786 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.467 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 54.2 mt -113.04 128.29 69.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.471 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -87.37 -178.96 6.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.838 . . . . 0.0 109.8 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.596 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -67.4 -47.28 70.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 0.0 109.181 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.81 -31.76 72.82 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.368 -0.832 . . . . 0.0 109.027 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 65.2 mm-40 -70.67 -23.1 62.44 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 1.05 HD22 ' CE ' ' A' ' 109' ' ' MET . 0.5 OUTLIER -82.64 -36.43 26.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.474 -0.766 . . . . 0.0 109.324 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -9.61 58.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.117 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -75.99 -34.65 59.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.83 . . . . 0.0 110.392 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.6 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 52.2 t -111.36 -42.79 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.919 -1.113 . . . . 0.0 110.582 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . 1.05 ' CE ' HD22 ' A' ' 105' ' ' LEU . 4.4 mtm -55.03 -16.57 2.95 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.111 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.35 -34.84 23.56 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.851 -1.155 . . . . 0.0 108.938 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.782 ' HB3' HD23 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -56.26 -55.86 28.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.829 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.782 HD23 ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -135.47 7.74 3.33 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.968 . . . . 0.0 110.025 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.483 ' CA ' ' O ' ' A' ' 109' ' ' MET . . . -103.23 36.79 4.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.56 ' O ' HD23 ' A' ' 116' ' ' LEU . 41.0 mt-10 64.85 114.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.439 -1.036 . . . . 0.0 108.789 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.63 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.447 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.701 ' H ' HD23 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -93.97 174.12 7.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 108.779 179.093 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 121' ' ' VAL . 1.4 t -120.32 171.89 8.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 0.0 108.588 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 119' ' ' GLU . 1.1 m-20 -48.67 -48.35 40.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.073 -1.017 . . . . 0.0 110.615 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -41.81 -38.78 1.58 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.24 -0.912 . . . . 0.0 110.332 -179.152 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 121' ' ' VAL . 3.0 mt-10 -87.72 -46.6 9.34 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.391 -0.818 . . . . 0.0 110.086 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.596 HG11 ' HB1' ' A' ' 102' ' ' ALA . 71.1 t -32.83 -50.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.668 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -50.78 72.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.761 -1.212 . . . . 0.0 109.418 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.58 -13.4 61.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 108.794 179.349 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.432 ' HG3' HD13 ' A' ' 116' ' ' LEU . 5.8 mmt -89.35 -22.42 22.62 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.932 HG21 ' O ' ' A' ' 134' ' ' GLY . 4.0 mt -80.1 -42.99 22.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.19 -19.12 18.8 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.659 -0.651 . . . . 0.0 109.98 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 20.4 mm-40 -90.6 -24.56 20.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.133 -0.979 . . . . 0.0 110.018 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.41 -59.82 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.359 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 43.5 p30 -47.46 154.86 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.7 mt -102.05 -40.58 7.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.187 -0.946 . . . . 0.0 109.754 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.27 -40.77 36.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.52 -0.737 . . . . 0.0 109.641 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.53 33.37 5.11 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.07 -23.04 44.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -1.084 . . . . 0.0 109.099 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.932 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 117.21 -30.06 6.45 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.75 167.51 10.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -1.199 . . . . 0.0 109.277 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 68.6 t -119.98 160.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.2 -0.938 . . . . 0.0 108.666 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.5 ' ND2' ' HG3' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -135.99 -164.41 1.55 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.63 -1.294 . . . . 0.0 108.648 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.547 ' O ' HG23 ' A' ' 142' ' ' VAL . 64.9 t80 -75.66 -42.07 52.32 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.973 -1.079 . . . . 0.0 109.817 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -65.15 -47.8 75.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.117 -0.989 . . . . 0.0 109.432 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.5 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 55.8 mt-10 -69.84 -36.77 75.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.126 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 145' ' ' MET . 44.0 t80 -64.72 -27.62 69.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.844 . . . . 0.0 109.081 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.826 HG22 HG21 ' A' ' 85' ' ' ILE . 4.6 t -61.28 -47.83 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.837 . . . . 0.0 109.859 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -53.23 -37.75 62.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -0.978 . . . . 0.0 110.482 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.11 -23.31 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.055 -1.028 . . . . 0.0 110.022 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.52 ' CG ' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -86.08 -11.06 53.75 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.092 -1.005 . . . . 0.0 109.849 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 147' ' ' ALA . 1.1 p -81.99 -44.11 17.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -0.982 . . . . 0.0 109.615 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 146' ' ' THR . . . -44.8 130.73 7.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 76' ' ' MET . 0.0 OUTLIER 56.64 161.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 109.69 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.81 -92.29 0.21 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 0.0 109.379 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.99 125.17 6.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.641 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -115.93 -26.17 7.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 109.56 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 m -76.7 7.17 4.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.581 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 1.1 pt-20 -88.22 -31.45 19.06 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 108.88 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.581 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 1.4 tt0 -91.72 -12.77 33.06 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.59 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 6.7 tt0 -79.17 7.96 6.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.536 -0.728 . . . . 0.0 109.612 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.5 mm -117.89 -42.98 2.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.111 -0.993 . . . . 0.0 109.722 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.451 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 4.6 mtp180 -66.83 -33.32 75.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -0.981 . . . . 0.0 109.08 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.689 ' O ' HG23 ' A' ' 91' ' ' VAL . 18.5 pt-20 -96.57 -26.77 15.12 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.24 -0.913 . . . . 0.0 109.106 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -67.64 -29.52 68.85 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 84.6 t80 -62.07 -56.05 22.84 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.568 -0.708 . . . . 0.0 109.196 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -33.35 74.98 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.253 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.751 ' O ' HG21 ' A' ' 108' ' ' VAL . 23.7 t -47.91 -33.77 3.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.499 ' CD1' ' HB ' ' A' ' 108' ' ' VAL . 66.7 m-85 -92.33 -30.9 15.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.496 ' HB2' HG12 ' A' ' 100' ' ' ILE . 26.2 t0 -100.33 83.04 2.58 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -73.32 -21.12 60.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 110.248 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -77.87 0.52 23.68 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.251 -0.906 . . . . 0.0 109.012 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.42 50.68 1.78 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.45 HD21 ' H ' ' A' ' 97' ' ' ASN . 0.8 OUTLIER -107.49 -14.26 14.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 109.802 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.39 -26.48 11.05 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.671 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.2 m-85 -121.12 146.66 46.51 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.377 -1.072 . . . . 0.0 109.262 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.496 HG12 ' HB2' ' A' ' 93' ' ' ASP . 76.6 mt -103.54 120.85 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.429 -0.794 . . . . 0.0 109.54 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.6 p -81.96 170.78 15.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.095 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.829 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -59.55 -45.8 90.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.046 -1.034 . . . . 0.0 109.475 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.37 83.45 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.219 -0.926 . . . . 0.0 109.462 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -73.28 -20.9 60.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.18 -0.95 . . . . 0.0 108.586 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 105' ' ' LEU . 15.4 tp -87.21 -23.69 24.67 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.47 -0.769 . . . . 0.0 109.534 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.488 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 23.3 ttt180 -82.97 -39.5 21.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -50.1 -30.51 11.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 110.403 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.751 HG21 ' O ' ' A' ' 91' ' ' VAL . 98.9 t -110.17 -26.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.001 -1.062 . . . . 0.0 110.173 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.659 ' HB3' HD21 ' A' ' 116' ' ' LEU . 2.3 mmt -61.95 -14.39 34.33 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.339 -0.851 . . . . 0.0 109.656 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -82.6 -35.26 27.22 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.283 -0.886 . . . . 0.0 109.655 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 110' ' ' THR . 10.7 m120 -43.43 -59.14 2.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.461 ' C ' HD12 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -144.29 16.8 1.7 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.407 -0.808 . . . . 0.0 109.134 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.487 ' O ' HD23 ' A' ' 116' ' ' LEU . . . -94.97 30.84 7.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.431 ' HG2' ' C ' ' A' ' 113' ' ' GLY . 23.9 mm-40 71.1 167.28 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -1.179 . . . . 0.0 109.703 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -90.6 73.33 6.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.659 HD21 ' HB3' ' A' ' 109' ' ' MET . 0.7 OUTLIER -97.97 153.55 18.29 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.584 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.896 ' O ' HG23 ' A' ' 121' ' ' VAL . 1.7 p -101.05 -150.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.141 -0.974 . . . . 0.0 109.776 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 4.1 m-20 -77.86 -54.07 6.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.0 109.853 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.432 ' HG3' ' OE1' ' A' ' 120' ' ' GLU . 10.9 pt-20 -48.98 -38.23 22.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 0.0 109.125 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 2.6 mm-40 -71.5 -46.64 59.2 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 117' ' ' THR . 21.3 t -37.64 -51.82 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.105 0.479 . . . . 0.0 110.109 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 122' ' ' ASP . 37.7 t0 -54.26 -46.9 72.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.109 -0.995 . . . . 0.0 109.844 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -63.37 -31.69 72.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.979 . . . . 0.0 109.75 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 18.2 mmt -73.06 -26.17 61.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.93 -1.106 . . . . 0.0 108.293 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 105' ' ' LEU . 7.1 mt -76.28 -37.14 31.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -57.07 -14.28 3.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.845 -0.534 . . . . 0.0 110.206 -179.636 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -89.37 -30.14 18.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 0.0 109.277 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -102.96 -0.69 30.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.565 -0.71 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.446 ' CG ' HG22 ' A' ' 125' ' ' ILE . 7.5 m-20 -82.72 143.72 30.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.852 . . . . 0.0 110.01 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.529 HG12 ' CG ' ' A' ' 140' ' ' GLU . 33.0 mm -108.66 -32.9 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.323 -0.861 . . . . 0.0 109.139 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -97.6 -33.91 11.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.608 -0.683 . . . . 0.0 109.23 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.11 26.41 18.97 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.06 -28.25 39.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -1.142 . . . . 0.0 109.219 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.11 33.96 2.07 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.438 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 1.8 tt0 -154.31 150.82 28.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.425 -1.044 . . . . 0.0 109.361 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.621 HG12 ' N ' ' A' ' 137' ' ' ASN . 89.6 t -112.86 167.1 6.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.186 -0.946 . . . . 0.0 109.318 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.671 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 7.5 p30 -150.6 -172.5 4.2 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.762 ' O ' HG23 ' A' ' 142' ' ' VAL . 51.7 t80 -68.53 -48.78 63.46 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.413 -1.429 . . . . 0.0 110.804 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 7.0 mp0 -54.86 -55.51 29.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.986 -1.071 . . . . 0.0 110.845 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.536 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 22.4 mt-10 -63.3 -41.91 99.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.863 -1.148 . . . . 0.0 109.904 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.441 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 51.8 t80 -64.68 -23.05 67.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 109.978 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 138' ' ' TYR . 43.2 t -76.37 -44.08 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.841 . . . . 0.0 110.47 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.846 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 1.6 mt-30 -64.47 -32.36 73.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.129 -0.982 . . . . 0.0 110.605 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -21.74 24.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.927 -1.108 . . . . 0.0 110.283 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.3 tpt -98.59 -6.63 29.61 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.897 -1.127 . . . . 0.0 110.649 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.575 ' CG2' ' N ' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -154.74 -52.25 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.678 -1.264 . . . . 0.0 110.733 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.846 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -86.72 80.61 8.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.042 . . . . 0.0 110.328 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.279 179.473 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.271 0.558 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt 68.7 86.86 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 109.771 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -77.21 141.43 40.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.285 -0.885 . . . . 0.0 109.079 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 m -122.83 110.56 15.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.952 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.485 ' O ' ' CB ' ' A' ' 81' ' ' SER . 4.8 t70 -93.29 -60.65 1.73 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 108.991 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER 166.67 115.11 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.469 -0.769 . . . . 0.0 109.308 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.41 -22.44 63.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.298 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -90.31 -1.23 57.9 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.55 -0.718 . . . . 0.0 109.738 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -57.65 -30.14 65.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.973 . . . . 0.0 109.639 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mt -83.88 -40.72 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.916 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.8 mtt85 -58.64 -35.29 72.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.608 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' OE2' ' N ' ' A' ' 88' ' ' ALA . 0.8 OUTLIER -87.08 -31.68 20.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.577 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.5 -28.94 70.29 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.152 -0.967 . . . . 0.0 108.443 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.451 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 87.6 t80 -66.9 -53.0 36.42 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.408 -0.807 . . . . 0.0 109.507 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 1.8 mtp180 -66.2 -25.07 66.76 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 2.7 t -52.7 -24.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.501 ' CE1' ' HB ' ' A' ' 108' ' ' VAL . 75.5 m-85 -108.34 -30.08 8.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 39.0 t0 -95.25 76.06 3.42 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.447 ' HB2' ' OE1' ' A' ' 104' ' ' GLU . 11.3 mmmt -79.86 -16.75 54.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 96' ' ' GLY . 18.8 m-20 -78.32 5.5 10.33 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.984 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.14 38.11 0.32 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -93.66 -69.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.401 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.9 -50.85 0.11 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.625 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 11.3 m-30 -109.66 155.37 21.57 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.413 -1.051 . . . . 0.0 108.784 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.497 HD13 ' CB ' ' A' ' 92' ' ' PHE . 94.1 mt -90.51 122.37 41.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 109.597 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.2 p -85.38 174.14 9.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.401 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.548 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -66.0 -33.04 74.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.132 -0.98 . . . . 0.0 109.447 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.4 68.44 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.228 -0.92 . . . . 0.0 109.565 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 60.3 mm-40 -78.71 -20.96 48.87 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.578 HD22 HG12 ' A' ' 125' ' ' ILE . 3.2 tp -93.25 -17.49 23.59 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.581 -0.699 . . . . 0.0 109.277 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.429 ' O ' ' OG1' ' A' ' 110' ' ' THR . 15.1 ttt-85 -80.58 -21.99 41.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.198 -0.939 . . . . 0.0 109.251 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -70.55 -27.79 64.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.307 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.501 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 79.4 t -111.07 -21.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.917 -1.114 . . . . 0.0 110.122 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.502 ' HB3' HD21 ' A' ' 116' ' ' LEU . 10.5 mmt -67.48 -41.04 85.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.016 -1.052 . . . . 0.0 109.18 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -73.69 -15.99 61.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.377 -0.827 . . . . 0.0 109.867 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.838 ' C ' HD23 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -59.09 87.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.899 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.838 HD23 ' C ' ' A' ' 111' ' ' ASN . 1.4 pt? 36.29 29.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.637 -0.664 . . . . 0.0 110.835 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -96.03 -12.57 52.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 1.025 ' HG3' HD23 ' A' ' 116' ' ' LEU . 0.4 OUTLIER 151.27 -167.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 65.2 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.007 . . . . 0.0 109.167 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.025 HD23 ' HG3' ' A' ' 114' ' ' GLU . 1.7 pp -105.77 121.76 44.69 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.583 -0.698 . . . . 0.0 109.431 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.81 HG23 ' N ' ' A' ' 118' ' ' ASP . 4.5 t -86.5 -146.89 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.623 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.81 ' N ' HG23 ' A' ' 117' ' ' THR . 1.2 m-20 -73.4 -57.58 3.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.853 . . . . 0.0 109.873 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -20.41 2.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.847 . . . . 0.0 110.014 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.675 ' HG2' HG22 ' A' ' 117' ' ' THR . 27.4 mm-40 -89.77 -39.79 12.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 117' ' ' THR . 22.4 t -47.67 -61.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.185 0.517 . . . . 0.0 109.652 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 121' ' ' VAL . 49.4 t0 -41.75 -34.0 0.57 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.293 -0.879 . . . . 0.0 109.878 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -45.14 49.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 108.96 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.549 ' HE2' HD22 ' A' ' 116' ' ' LEU . 65.7 mmm -60.87 -20.67 62.27 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.18 -0.95 . . . . 0.0 108.723 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.578 HG12 HD22 ' A' ' 105' ' ' LEU . 3.0 mt -87.47 -38.81 12.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -19.22 4.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.816 -0.552 . . . . 0.0 109.657 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -89.29 -31.95 17.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 109.049 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 144' ' ' MET . . . -90.08 -5.0 57.03 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.409 -0.807 . . . . 0.0 109.255 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 125' ' ' ILE . 1.8 m-20 -95.18 133.72 38.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.313 -0.867 . . . . 0.0 109.382 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.493 HG13 ' OE1' ' A' ' 140' ' ' GLU . 41.3 mm -83.78 -49.74 16.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.142 -0.974 . . . . 0.0 109.383 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.45 -45.09 23.04 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.571 -0.706 . . . . 0.0 109.168 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.62 31.95 3.79 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.47 -27.36 41.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -1.038 . . . . 0.0 109.429 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.501 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 121.72 -16.21 8.97 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.847 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.625 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -109.18 164.59 12.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.739 -1.448 . . . . 0.0 109.587 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.559 HG23 HG23 ' A' ' 125' ' ' ILE . 53.8 t -121.87 163.65 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.257 -0.902 . . . . 0.0 108.707 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.567 ' ND2' ' HG2' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -135.1 -168.72 2.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.928 -1.108 . . . . 0.0 108.707 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.895 ' O ' HG23 ' A' ' 142' ' ' VAL . 73.0 t80 -80.47 -36.59 33.24 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.089 -1.007 . . . . 0.0 110.146 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -68.26 -34.26 75.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.567 ' HG2' ' ND2' ' A' ' 137' ' ' ASN . 4.1 mm-40 -83.52 -34.75 25.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 108.921 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.576 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 14.3 t80 -72.26 -23.17 61.16 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.45 -0.781 . . . . 0.0 109.158 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 138' ' ' TYR . 48.4 t -74.99 -59.51 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 0.0 109.694 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 12.4 mt-30 -53.34 -24.11 11.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.825 . . . . 0.0 110.538 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -90.7 -37.08 13.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.036 -1.04 . . . . 0.0 110.96 -178.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -84.8 -8.68 58.72 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.978 -1.077 . . . . 0.0 110.838 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -92.68 -35.01 13.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.912 -1.118 . . . . 0.0 109.061 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 148' ' ' LYS . . . -98.56 98.93 10.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.371 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 118.097 -0.954 . . . . 0.0 109.572 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 64.98 1.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 109.448 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -156.16 92.39 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -142.64 91.18 2.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.424 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.1 -77.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 109.644 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 t 62.08 26.63 16.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.387 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -84.74 -23.54 29.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.297 -0.877 . . . . 0.0 109.802 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -89.19 -17.85 28.29 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.432 -0.792 . . . . 0.0 109.485 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -60.94 -19.51 60.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.716 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.47 HG21 ' HA ' ' A' ' 142' ' ' VAL . 3.5 mt -97.74 -38.13 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.185 -0.947 . . . . 0.0 110.047 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.535 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 2.9 ttt-85 -49.58 -32.13 12.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.041 -1.037 . . . . 0.0 109.49 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.1 mt-10 -91.01 -53.94 4.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 109.735 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -43.98 -27.03 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.0 108.79 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 138' ' ' TYR . 70.3 t80 -62.37 -58.08 8.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.411 -0.806 . . . . 0.0 109.141 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -60.04 -37.49 79.97 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.385 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.629 ' O ' HG21 ' A' ' 108' ' ' VAL . 59.5 t -42.9 -32.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.495 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 56.0 m-85 -95.93 -35.12 11.56 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.477 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 28.3 t0 -91.06 88.89 7.16 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -77.53 -21.16 53.08 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 110.229 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 96' ' ' GLY . 67.2 m-20 -78.21 0.4 25.24 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 109.133 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 35.47 49.25 0.94 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -106.79 -22.82 12.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.249 . . . . 0.0 109.666 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.36 -27.97 5.15 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.638 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.7 m-85 -121.61 145.46 47.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.412 -1.052 . . . . 0.0 108.985 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.477 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 56.8 mt -96.17 133.94 35.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.236 -0.915 . . . . 0.0 109.358 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.59 170.9 9.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.41 94.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 109.281 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.89 -35.83 77.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.391 -0.818 . . . . 0.0 109.703 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.57 ' O ' ' CE1' ' A' ' 107' ' ' HIS . 64.6 mm-40 -71.61 -21.86 61.79 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.174 -0.954 . . . . 0.0 108.495 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.505 ' HG ' ' CG ' ' A' ' 109' ' ' MET . 1.6 tp -99.73 4.49 45.49 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.585 -0.697 . . . . 0.0 109.212 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -96.92 -30.89 12.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.127 -0.983 . . . . 0.0 109.978 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.95 ' CD2' HG23 ' A' ' 108' ' ' VAL . 45.5 p-80 -88.07 -53.3 4.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 111.802 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.95 HG23 ' CD2' ' A' ' 107' ' ' HIS . 18.9 t -68.43 -54.14 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.168 -0.957 . . . . 0.0 110.968 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.505 ' CG ' ' HG ' ' A' ' 105' ' ' LEU . 1.5 mmt -35.98 -45.33 0.41 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.611 -0.681 . . . . 0.0 110.786 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.658 HG21 ' HA ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -88.88 -33.31 17.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.992 -1.067 . . . . 0.0 109.994 -179.536 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.459 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER 41.19 51.49 3.46 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.275 -0.891 . . . . 0.0 109.864 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER 56.33 41.26 29.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.351 -0.843 . . . . 0.0 110.115 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -141.63 8.1 2.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 0.3 OUTLIER 155.1 57.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.752 -0.852 . . . . 0.0 108.999 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.658 ' HA ' HG21 ' A' ' 110' ' ' THR . 3.1 ptpt -46.6 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.844 . . . . 0.0 110.318 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -70.59 156.81 38.96 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.146 -0.971 . . . . 0.0 108.794 179.266 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.978 ' O ' HG23 ' A' ' 121' ' ' VAL . 2.0 t -82.0 -174.78 5.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 109.486 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.16 -57.65 3.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 109.281 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.56 -24.04 4.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 108.887 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.429 ' CB ' HG22 ' A' ' 117' ' ' THR . 16.0 tp10 -81.11 -40.88 23.36 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 117' ' ' THR . 58.0 t -54.73 -48.39 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -31.54 29.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.842 . . . . 0.0 109.249 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 26.1 mm-40 -73.92 -39.58 63.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 109.042 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.9 mtt -67.33 -23.91 65.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.041 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.08 -40.03 15.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.441 -0.787 . . . . 0.0 109.805 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -15.41 6.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.511 -0.743 . . . . 0.0 110.359 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 4.1 mt-10 -90.16 -27.41 19.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.009 -1.057 . . . . 0.0 109.582 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.09 -58.45 2.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.918 . . . . 0.0 109.6 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 129' ' ' ASP . 40.2 p-10 -45.25 123.94 4.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.645 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.2 mt -91.89 -38.32 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.27 -0.894 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -76.23 -37.3 57.86 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.454 -0.779 . . . . 0.0 109.722 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.88 32.32 4.46 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.46 ' OD1' ' HG2' ' A' ' 135' ' ' GLN . 2.3 p30 -79.54 -24.56 42.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -1.075 . . . . 0.0 109.638 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.2 28.87 5.94 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.46 ' HG2' ' OD1' ' A' ' 133' ' ' ASP . 3.1 pt20 -160.23 -169.28 2.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -1.181 . . . . 0.0 108.993 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.619 HG12 ' N ' ' A' ' 137' ' ' ASN . 57.5 t -136.47 169.07 20.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.989 -1.07 . . . . 0.0 110.129 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.638 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -143.63 -167.92 2.7 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.252 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.888 ' O ' HG23 ' A' ' 142' ' ' VAL . 50.6 t80 -74.5 -38.36 62.87 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.805 -1.184 . . . . 0.0 109.497 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -49.68 68.02 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.308 -0.87 . . . . 0.0 109.701 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.508 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 50.2 mt-10 -68.23 -36.92 80.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.678 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.566 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 34.6 t80 -69.21 -26.91 65.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -0.921 . . . . 0.0 109.686 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 138' ' ' TYR . 48.1 t -68.12 -43.3 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.619 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 14.8 mt-30 -72.44 -21.99 61.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 0.0 109.878 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.43 -22.32 22.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.566 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.6 tpt -92.34 -59.15 2.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.078 -1.014 . . . . 0.0 109.787 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.514 ' CG2' ' N ' ' A' ' 147' ' ' ALA . 4.8 t -59.82 -44.78 93.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.367 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.514 ' N ' ' CG2' ' A' ' 146' ' ' THR . . . -99.81 157.84 16.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.383 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 78' ' ' ASP . 2.6 mtmt -146.1 160.02 42.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.704 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 77' ' ' LYS . 35.8 t70 44.9 87.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.32 -0.863 . . . . 0.0 109.646 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -52.19 141.74 18.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.377 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 79' ' ' THR . 0.8 OUTLIER -45.41 -96.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.326 -0.859 . . . . 0.0 109.848 -179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -167.05 21.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 83' ' ' GLU . 15.3 pt-20 -90.07 -41.66 11.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.022 -1.049 . . . . 0.0 109.477 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.42 ' N ' ' CG ' ' A' ' 82' ' ' GLU . 5.2 mt-10 -90.54 -14.67 32.13 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.49 -47.56 81.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 0.0 110.109 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.679 ' CG2' HG22 ' A' ' 142' ' ' VAL . 3.2 mt -65.07 -36.85 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.155 -0.965 . . . . 0.0 110.159 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.587 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.4 mtp85 -50.67 -34.29 25.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.112 -0.992 . . . . 0.0 109.372 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 88' ' ' ALA . 3.4 mt-10 -87.73 -52.73 5.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 109.742 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.64 -26.83 0.41 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 108.635 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.54 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 88.0 t80 -62.77 -57.64 10.22 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.43 -0.794 . . . . 0.0 109.572 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.467 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -61.06 -31.66 71.32 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 109.04 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 70.4 t -46.66 -35.48 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.933 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 28.0 m-85 -87.29 -47.71 8.6 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 57.5 t0 -72.97 116.75 13.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.69 -25.29 21.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.142 -0.973 . . . . 0.0 110.125 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.9 OUTLIER -78.94 2.61 19.65 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 108.983 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.471 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.04 47.56 1.35 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -108.26 -38.63 5.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -1.202 . . . . 0.0 109.748 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.14 -10.44 2.27 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -130.26 151.06 51.18 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.165 -1.197 . . . . 0.0 109.946 -179.661 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.417 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 62.9 mt -114.0 141.18 31.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.24 -0.913 . . . . 0.0 109.339 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -100.44 -178.29 3.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.456 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -67.76 -46.17 72.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.338 -0.851 . . . . 0.0 109.242 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.49 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . . . -56.47 -47.12 79.86 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.373 -0.829 . . . . 0.0 109.343 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.451 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 97.7 mt-10 -65.75 -22.88 66.63 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD2' ' CG ' ' A' ' 109' ' ' MET . 0.6 OUTLIER -77.86 -25.19 48.51 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.521 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.835 ' HG2' HG21 ' A' ' 121' ' ' VAL . 8.9 mtm-85 -77.74 -45.71 23.9 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.216 -0.928 . . . . 0.0 108.55 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -48.09 -27.22 2.19 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.454 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.933 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 98.8 t -112.82 -39.26 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.612 -1.305 . . . . 0.0 111.309 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.587 ' CG ' ' CD2' ' A' ' 105' ' ' LEU . 10.6 mmt -61.76 -15.89 44.9 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 109.727 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.7 t -85.53 -25.12 26.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 109.34 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -54.75 -34.77 62.99 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.282 -0.886 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.47 ' H ' HD12 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -135.15 1.95 3.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.795 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -110.74 30.52 8.05 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 2.2 mt-10 59.06 -95.53 0.06 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.329 -1.1 . . . . 0.0 109.304 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -139.94 136.21 33.59 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.07 -1.019 . . . . 0.0 109.601 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.72 HD13 ' HG2' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -115.04 108.76 17.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.935 . . . . 0.0 109.544 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -72.53 -170.21 0.64 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.078 -1.014 . . . . 0.0 108.294 179.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -80.49 -54.96 5.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.915 -1.116 . . . . 0.0 108.882 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -22.62 65.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 108.838 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.72 ' HG2' HD13 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -77.61 -47.07 20.25 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.835 HG21 ' HG2' ' A' ' 106' ' ' ARG . 44.2 t -52.7 -46.5 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.488 -0.757 . . . . 0.0 110.087 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -48.64 -33.91 10.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 0.0 109.871 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -71.83 -37.96 70.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.404 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.428 ' SD ' HD11 ' A' ' 116' ' ' LEU . 2.6 mtt -68.54 -27.53 66.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.091 -1.006 . . . . 0.0 108.98 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 134' ' ' GLY . 6.0 mt -78.19 -37.47 22.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -57.82 -27.08 62.84 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.83 -0.544 . . . . 0.0 110.235 -179.417 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 126' ' ' ARG . 3.5 mt-10 -91.24 -16.95 26.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.021 -1.049 . . . . 0.0 109.859 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.534 ' O ' ' HE2' ' A' ' 144' ' ' MET . . . -99.15 -66.36 0.91 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.114 -0.991 . . . . 0.0 109.794 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 128' ' ' ALA . 6.8 t70 -46.12 154.74 0.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.37 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.5 mm -88.89 -65.22 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.715 0.769 . . . . 0.0 109.268 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -176.91 57.09 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.564 -0.71 . . . . 0.0 109.342 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -104.32 -89.63 2.12 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -129.46 -19.54 3.41 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.73 -0.865 . . . . 0.0 110.128 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.558 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 125.81 16.75 2.67 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 4.1 tt0 -112.56 163.38 14.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.23 -1.159 . . . . 0.0 108.674 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.576 HG12 ' N ' ' A' ' 137' ' ' ASN . 96.5 t -106.18 165.85 3.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 120.923 -1.11 . . . . 0.0 109.492 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.606 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -149.62 -171.31 3.86 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.893 ' O ' HG23 ' A' ' 142' ' ' VAL . 62.9 t80 -69.0 -37.7 78.86 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.607 -1.308 . . . . 0.0 111.337 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.41 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -68.88 -40.38 79.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.053 . . . . 0.0 110.377 -179.153 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.517 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 26.8 mt-10 -81.04 -23.04 38.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.933 -1.105 . . . . 0.0 109.192 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 145' ' ' MET . 28.4 t80 -84.28 -23.62 30.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.38 -0.825 . . . . 0.0 109.607 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 138' ' ' TYR . 52.2 t -73.97 -63.13 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.312 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.832 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 2.4 mm100 -56.58 -24.54 48.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.534 ' HE2' ' O ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -90.23 -31.8 16.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.906 -1.121 . . . . 0.0 110.029 -179.506 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 141' ' ' PHE . 2.1 ttp -77.04 -16.87 59.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.517 HG23 ' N ' ' A' ' 147' ' ' ALA . 5.8 t -127.64 -43.72 1.55 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.086 -1.009 . . . . 0.0 109.784 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -85.33 74.71 10.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.501 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.419 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.5 mmm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.04 179.76 0.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.73 16.88 6.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.852 . . . . 0.0 110.024 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.15 178.65 4.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.043 -1.036 . . . . 0.0 109.597 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.88 -69.28 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 109.853 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.481 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 0.4 OUTLIER 176.83 114.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.08 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -52.78 -22.24 5.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.366 -0.834 . . . . 0.0 110.298 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.71 27.76 1.46 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.922 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.611 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -100.22 -18.65 16.77 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.063 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.748 HG21 HG13 ' A' ' 142' ' ' VAL . 2.7 mp -83.5 -35.11 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.595 -0.691 . . . . 0.0 109.665 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.37 -45.89 90.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.111 -0.993 . . . . 0.0 109.344 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.67 -31.66 24.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.14 -0.975 . . . . 0.0 109.069 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -61.57 -24.01 66.36 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 138' ' ' TYR . 73.6 t80 -66.31 -55.47 15.84 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.418 -0.801 . . . . 0.0 109.279 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -28.84 70.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.223 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 4.8 t -48.18 -29.04 2.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.586 ' CE2' ' HB ' ' A' ' 108' ' ' VAL . 78.6 m-85 -100.32 -35.94 9.43 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.437 ' HB2' HG12 ' A' ' 100' ' ' ILE . 41.5 t0 -90.36 87.16 6.69 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -77.25 -18.48 57.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.836 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ASN . 10.3 t70 -78.02 2.32 18.11 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.405 -0.81 . . . . 0.0 109.252 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.39 29.92 0.05 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' ASP . 4.0 t30 -88.93 -36.94 15.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.089 -1.242 . . . . 0.0 109.467 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.54 -14.17 4.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -128.37 146.55 50.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.25 -1.147 . . . . 0.0 109.746 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 93' ' ' ASP . 87.0 mt -105.05 131.63 53.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.566 -0.709 . . . . 0.0 109.448 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.51 172.25 8.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.189 -0.944 . . . . 0.0 109.574 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.85 81.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 109.399 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.89 -35.89 75.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.362 -0.836 . . . . 0.0 109.332 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 66.1 mm-40 -70.64 -23.41 62.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.151 -0.968 . . . . 0.0 108.861 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.947 HD23 HG13 ' A' ' 121' ' ' VAL . 55.8 tp -83.9 -25.15 30.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.546 -0.722 . . . . 0.0 109.301 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.03 -24.95 43.28 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.246 -0.909 . . . . 0.0 108.967 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -59.91 -29.61 68.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 110.297 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.586 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 95.5 t -111.23 -46.62 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.887 -1.133 . . . . 0.0 110.203 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -52.69 -58.98 5.08 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.451 -0.78 . . . . 0.0 109.241 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -91.16 13.09 18.0 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.412 -0.805 . . . . 0.0 110.137 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.517 ' HB3' ' HA ' ' A' ' 108' ' ' VAL . 5.6 p30 -43.41 -48.44 7.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 0.0 109.785 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 111' ' ' ASN . 20.1 mt -152.53 14.67 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.013 . . . . 0.0 109.94 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -106.3 -14.51 20.11 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.743 ' HA ' HG22 ' A' ' 110' ' ' THR . 37.1 mt-10 54.55 30.43 13.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.412 -1.052 . . . . 0.0 109.24 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -79.31 161.01 26.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.763 HD13 HG23 ' A' ' 121' ' ' VAL . 3.6 pp 31.95 -157.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.499 0.666 . . . . 0.0 111.391 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.881 ' O ' HG23 ' A' ' 121' ' ' VAL . 4.0 t -152.19 -161.79 1.38 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.189 -0.945 . . . . 0.0 108.913 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.57 ' N ' HG23 ' A' ' 117' ' ' THR . 1.0 OUTLIER -79.73 -50.15 11.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.065 -1.022 . . . . 0.0 110.14 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -67.56 -13.1 61.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 109.618 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 116' ' ' LEU . 5.5 tt0 -97.5 -34.77 10.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.27 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.947 HG13 HD23 ' A' ' 105' ' ' LEU . 11.6 t -49.5 -51.75 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -41.14 -37.65 0.93 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 109.805 -179.534 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.522 ' HG2' ' HD2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -68.25 -57.51 5.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.158 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.533 ' SD ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -49.86 -22.73 1.58 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.158 179.557 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.682 HG23 HG23 ' A' ' 136' ' ' VAL . 3.4 mt -84.66 -38.65 13.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.63 0.729 . . . . 0.0 109.741 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.522 ' HD2' ' HG2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -62.02 -31.16 71.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.035 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.02 -9.51 53.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.106 -0.996 . . . . 0.0 109.113 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.57 -14.0 18.38 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.442 -0.786 . . . . 0.0 109.047 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.592 ' OD1' HG22 ' A' ' 136' ' ' VAL . 9.8 m-20 -92.63 164.27 13.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.433 -0.792 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.9 mt -86.16 -53.48 10.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.271 -0.893 . . . . 0.0 109.562 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.52 -46.58 46.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.495 -0.753 . . . . 0.0 109.673 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.79 30.71 4.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 135' ' ' GLN . 0.7 OUTLIER -79.85 -24.79 41.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -1.144 . . . . 0.0 109.596 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.39 16.91 9.77 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.561 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 1.5 mt-30 -128.65 147.53 50.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -1.088 . . . . 0.0 109.205 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.682 HG23 HG23 ' A' ' 125' ' ' ILE . 71.9 t -115.0 165.54 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.079 -1.013 . . . . 0.0 109.574 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.606 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -140.56 -168.05 2.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.582 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.975 ' O ' HG23 ' A' ' 142' ' ' VAL . 38.2 t80 -65.67 -52.64 50.05 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.715 -1.24 . . . . 0.0 110.689 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.465 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 2.6 mt-10 -58.44 -60.56 3.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.051 -1.03 . . . . 0.0 110.155 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 129' ' ' ASP . 13.5 mt-10 -52.14 -38.67 58.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 110.275 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.463 ' CE2' ' HA ' ' A' ' 89' ' ' PHE . 38.5 t80 -69.65 -29.22 66.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.981 -1.074 . . . . 0.0 109.81 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.975 HG23 ' O ' ' A' ' 138' ' ' TYR . 59.7 t -67.34 -39.36 82.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.444 -0.785 . . . . 0.0 109.875 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.749 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 9.3 mm100 -64.06 -32.09 73.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.6 tmm? -90.2 -21.47 22.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.019 . . . . 0.0 110.029 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -57.94 3.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.08 -1.012 . . . . 0.0 109.913 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.653 ' O ' HG22 ' A' ' 146' ' ' THR . 1.4 m -105.98 12.99 29.89 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.191 -0.943 . . . . 0.0 109.229 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -19.87 100.99 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.401 0.62 . . . . 0.0 111.36 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.587 -179.885 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -120.94 62.64 0.88 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.355 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -83.04 -12.86 56.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 79' ' ' THR . 14.5 t -168.24 49.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.146 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -41.99 108.13 0.09 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.451 -0.781 . . . . 0.0 109.664 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.464 ' O ' ' CD1' ' A' ' 85' ' ' ILE . 3.7 m -135.02 35.34 3.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.485 -0.759 . . . . 0.0 109.672 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -57.41 -88.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.918 . . . . 0.0 108.836 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -89.32 -5.24 57.69 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.687 -0.633 . . . . 0.0 109.296 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 81' ' ' SER . 0.7 OUTLIER -61.31 -13.29 18.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 109.687 -179.86 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.533 ' CG2' HG22 ' A' ' 142' ' ' VAL . 8.4 mt -86.71 -49.54 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.128 -0.983 . . . . 0.0 109.207 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.614 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.2 ttp180 -47.97 -29.26 3.27 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.254 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 88' ' ' ALA . 46.5 mt-10 -93.46 -53.25 4.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.92 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -45.82 -25.5 0.52 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.999 -1.063 . . . . 0.0 109.0 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 87.2 t80 -65.61 -56.25 13.24 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.441 -0.787 . . . . 0.0 109.604 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -62.08 -32.43 72.96 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.673 -0.642 . . . . 0.0 109.272 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 32.5 t -47.41 -31.08 2.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 64.4 m-85 -96.9 -33.71 11.52 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.453 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 25.8 t0 -92.57 108.15 19.76 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.539 ' HD3' ' CE1' ' A' ' 107' ' ' HIS . 0.1 OUTLIER -80.1 -26.56 39.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.113 -0.992 . . . . 0.0 110.128 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 97' ' ' ASN . 47.3 m-20 -79.15 2.67 20.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.3 -0.875 . . . . 0.0 108.934 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 34.53 34.56 0.04 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' ASP . 11.6 t-20 -87.32 -59.15 2.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -1.201 . . . . 0.0 109.836 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 137' ' ' ASN . . . 166.39 -24.15 0.14 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.647 ' CE2' ' HB3' ' A' ' 137' ' ' ASN . 15.4 m-85 -122.42 139.88 53.34 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.257 -1.143 . . . . 0.0 109.791 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.528 HG23 ' HB2' ' A' ' 104' ' ' GLU . 63.1 mt -100.47 141.98 16.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.447 ' OG ' ' HG3' ' A' ' 104' ' ' GLU . 88.9 p -109.91 -178.67 3.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.052 -1.03 . . . . 0.0 109.153 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 105' ' ' LEU . . . -62.38 -45.33 93.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 109.284 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.4 -46.43 88.71 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.37 -0.831 . . . . 0.0 109.539 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.528 ' HB2' HG23 ' A' ' 100' ' ' ILE . 28.5 mt-10 -62.97 -24.26 67.82 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.839 HD23 HG13 ' A' ' 121' ' ' VAL . 57.8 tp -71.28 -38.47 71.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.514 ' O ' ' CG ' ' A' ' 109' ' ' MET . 0.5 OUTLIER -70.92 -11.06 60.75 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.539 ' CE1' ' HD3' ' A' ' 94' ' ' LYS . 11.9 t-160 -57.82 -47.09 83.65 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.42 -0.8 . . . . 0.0 110.037 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' ' C ' ' A' ' 109' ' ' MET . 10.6 t -106.55 -5.66 10.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.243 -0.91 . . . . 0.0 110.103 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.525 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -39.12 -38.58 0.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 110.806 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.527 ' HA ' ' CA ' ' A' ' 114' ' ' GLU . 7.2 t -94.69 -34.65 12.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.869 -1.144 . . . . 0.0 110.226 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.433 ' HB2' HG13 ' A' ' 108' ' ' VAL . 15.6 m-80 -58.14 -18.54 26.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.929 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 mt -145.39 -20.37 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.043 -1.036 . . . . 0.0 111.222 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' MET . . . -124.14 18.54 7.41 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.203 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.527 ' CA ' ' HA ' ' A' ' 110' ' ' THR . 22.5 mt-10 58.1 179.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -1.223 . . . . 0.0 109.601 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 0.3 OUTLIER -54.64 133.57 46.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.912 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 0.4 OUTLIER -108.89 -164.8 0.97 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.198 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.516 ' OG1' ' HG3' ' A' ' 120' ' ' GLU . 3.0 p -149.47 -150.09 0.33 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.398 -0.814 . . . . 0.0 108.85 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.51 -49.31 7.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.44 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -68.96 -15.72 63.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 0.0 109.889 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.516 ' HG3' ' OG1' ' A' ' 117' ' ' THR . 0.1 OUTLIER -94.52 -37.1 11.55 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.109 -0.994 . . . . 0.0 108.996 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.839 HG13 HD23 ' A' ' 105' ' ' LEU . 29.3 t -72.0 -70.38 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.819 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -50.76 -27.65 7.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 0.0 109.434 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 79.1 tt0 -75.2 -39.15 60.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 0.0 108.703 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . 0.641 ' HB2' HD21 ' A' ' 105' ' ' LEU . 23.1 mtp -61.83 -29.84 70.44 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.8 mt -77.08 -40.81 30.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.5 mtp85 -57.77 -33.15 68.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.624 -0.672 . . . . 0.0 109.931 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -81.38 -20.09 41.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 108.9 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.478 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -97.46 -6.54 33.61 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.514 -0.741 . . . . 0.0 109.469 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.82 131.21 35.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.31 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.463 HD12 ' CD ' ' A' ' 140' ' ' GLU . 47.5 mt -104.9 -32.42 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.157 -0.965 . . . . 0.0 109.745 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.53 -41.86 6.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.767 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.23 36.21 2.0 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.3 p30 -79.16 -26.65 42.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.324 -1.104 . . . . 0.0 108.885 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 119.42 -40.75 2.15 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.47 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 15.3 pm0 -110.05 -177.39 3.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -1.164 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 137' ' ' ASN . 99.5 t -122.64 171.83 10.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.343 -0.848 . . . . 0.0 108.852 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.647 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 1.4 p-10 -148.57 -175.04 4.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.795 -1.191 . . . . 0.0 108.828 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.662 ' O ' HG23 ' A' ' 142' ' ' VAL . 52.5 t80 -71.75 -39.8 69.79 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.804 -1.185 . . . . 0.0 110.721 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.42 -48.5 75.13 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.992 -1.067 . . . . 0.0 109.985 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.482 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 1.3 mm-40 -71.83 -32.6 67.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.495 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 37.4 t80 -72.76 -25.78 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.868 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 138' ' ' TYR . 39.6 t -74.01 -51.16 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 51.6 mt-30 -59.81 -30.67 69.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.185 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 8.1 tpp -84.46 -29.98 25.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.009 -1.057 . . . . 0.0 109.924 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.495 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 3.1 tmm? -91.41 -5.14 54.86 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.184 -0.947 . . . . 0.0 110.217 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 142' ' ' VAL . 1.2 t -140.43 -43.9 0.41 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.98 -1.075 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -84.62 163.37 19.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.987 . . . . 0.0 109.671 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.493 ' OXT' ' CG ' ' A' ' 148' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.318 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 86' ' ' ARG . 1.3 mt-10 . . . . . 0 N--CA 1.486 1.362 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -43.7 -33.85 1.34 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 109.65 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.59 HG21 HG22 ' A' ' 142' ' ' VAL . 2.1 mp -93.17 -34.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.198 -0.939 . . . . 0.0 109.929 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.471 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 2.0 mmt85 -48.58 -37.91 19.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.641 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.7 mt-10 -87.01 -51.89 5.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.762 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.412 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -45.94 -25.06 0.48 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.994 -1.066 . . . . 0.0 109.11 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.442 ' HA ' ' CE2' ' A' ' 141' ' ' PHE . 77.6 t80 -66.5 -56.31 11.5 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.413 -0.804 . . . . 0.0 109.45 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.418 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 2.2 mtp180 -63.14 -27.51 69.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.295 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 108' ' ' VAL . 41.2 t -50.34 -28.99 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 62.4 m-85 -100.96 -36.19 9.12 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 27.1 t70 -83.94 82.58 8.28 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.581 -0.7 . . . . 0.0 109.254 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 4.7 mmtt -80.61 -20.43 43.25 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.301 -0.875 . . . . 0.0 110.157 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' GLY . 2.6 m-20 -78.12 1.56 20.82 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.98 48.15 1.96 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -109.09 -18.28 13.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -1.196 . . . . 0.0 109.812 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.461 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 120.09 -36.65 3.35 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.577 ' CD1' ' OE1' ' A' ' 135' ' ' GLN . 54.7 m-85 -116.38 142.08 47.32 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.374 -1.074 . . . . 0.0 109.59 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 97.0 mt -90.25 123.78 42.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 108.962 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.4 p -82.05 173.5 12.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.14 -0.975 . . . . 0.0 109.427 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -63.4 -42.1 98.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.414 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.468 ' HA ' ' NH2' ' A' ' 106' ' ' ARG . . . -63.46 -30.23 71.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 56.1 mm-40 -72.15 -22.51 61.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.149 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 109' ' ' MET . 4.1 tp -88.71 -31.83 18.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.6 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HE ' HG21 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.16 -9.59 52.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.164 -0.96 . . . . 0.0 109.175 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -88.31 -39.31 14.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.098 -1.001 . . . . 0.0 109.669 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 91' ' ' VAL . 57.3 t -88.62 -28.42 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 109.795 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 4.5 mtt -68.16 -20.98 64.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.238 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.518 ' CB ' ' O ' ' A' ' 114' ' ' GLU . 8.5 t -100.05 1.19 42.15 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.578 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 45.9 p-10 -57.51 -16.17 9.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 0.0 109.601 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.468 ' N ' ' OD1' ' A' ' 111' ' ' ASN . 1.2 mt -107.46 -20.93 13.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 109.641 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.6 -32.35 1.73 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 110' ' ' THR . 10.6 mt-10 -50.62 137.45 19.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.254 -1.145 . . . . 0.0 109.488 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 81.68 1.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.105 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.409 ' HB3' HG23 ' A' ' 121' ' ' VAL . 4.8 mp -63.91 136.29 57.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.0 t -90.81 -178.15 5.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 108.78 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -67.08 -54.98 16.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.892 -1.13 . . . . 0.0 110.178 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -60.73 -12.09 9.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.251 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 124' ' ' MET . 5.1 tp10 -97.46 -32.6 11.76 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.239 -0.913 . . . . 0.0 109.606 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.54 HG11 ' HB1' ' A' ' 102' ' ' ALA . 25.3 t -72.64 -54.43 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 0.0 109.787 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.69 -34.83 62.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.119 -0.988 . . . . 0.0 109.689 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 1.0 OUTLIER -76.08 -35.71 59.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.095 -1.003 . . . . 0.0 109.243 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 1.4 mmt -70.56 -21.05 62.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 108.716 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.499 HG21 ' O ' ' A' ' 134' ' ' GLY . 2.0 mt -84.87 -42.77 16.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -48.79 -31.61 7.32 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 109.898 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.84 -24.62 20.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.022 -1.049 . . . . 0.0 110.394 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.81 -44.98 54.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 109.838 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 135' ' ' GLN . 12.9 p-10 -86.39 177.06 7.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.349 -0.845 . . . . 0.0 109.668 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.0 mt -85.9 -66.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.414 -0.804 . . . . 0.0 109.567 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -177.47 57.83 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.512 -0.742 . . . . 0.0 109.49 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.22 -87.15 1.78 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.4 p-10 -139.11 -24.51 0.88 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.999 -0.707 . . . . 0.0 110.249 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.499 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 141.06 29.48 0.17 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.577 ' OE1' ' CD1' ' A' ' 99' ' ' TYR . 3.0 pt20 -119.63 166.85 12.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.263 . . . . 0.0 108.914 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 137' ' ' ASN . 69.9 t -119.41 162.87 17.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.517 ' N ' HG12 ' A' ' 136' ' ' VAL . 5.2 t-20 -141.29 -164.38 1.75 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.975 -1.078 . . . . 0.0 108.372 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 142' ' ' VAL . 60.9 t80 -77.31 -49.5 14.85 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.686 -1.259 . . . . 0.0 110.15 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.29 -29.06 69.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.967 -1.083 . . . . 0.0 109.593 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.509 ' HB3' ' HA ' ' A' ' 129' ' ' ASP . 19.6 mt-10 -84.65 -32.87 23.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.107 -0.995 . . . . 0.0 108.856 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 89' ' ' PHE . 42.8 t80 -71.66 -25.81 62.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.535 -0.728 . . . . 0.0 109.087 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.59 HG22 HG21 ' A' ' 85' ' ' ILE . 24.0 t -60.53 -47.07 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.444 -0.785 . . . . 0.0 109.511 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -64.42 -35.54 81.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 109.782 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -83.34 -12.54 56.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.781 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.518 ' HE3' ' HA ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -81.88 -67.84 0.75 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.299 -0.876 . . . . 0.0 109.247 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.412 -0.805 . . . . 0.0 109.285 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.484 1.275 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -47.83 84.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.576 HG21 HG22 ' A' ' 142' ' ' VAL . 5.1 mt -75.3 -37.35 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.614 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.599 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -52.52 -30.71 31.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.193 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 23.1 mm-40 -90.93 -52.11 5.02 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.377 -0.827 . . . . 0.0 109.473 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -47.19 -24.86 0.78 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.989 . . . . 0.0 109.159 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 92.6 t80 -67.51 -56.46 9.43 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -63.76 -24.31 67.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 24.4 t -52.73 -32.72 17.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.543 ' HA ' HG21 ' A' ' 108' ' ' VAL . 53.9 m-85 -95.32 -36.56 11.35 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.468 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 27.6 t0 -84.26 112.78 20.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.544 -0.722 . . . . 0.0 109.483 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -89.31 -24.42 22.03 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.095 -1.003 . . . . 0.0 109.825 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 97' ' ' ASN . 60.2 m-20 -78.6 1.41 22.77 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.571 -0.852 . . . . 0.0 108.748 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 36.32 31.41 0.04 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -88.16 -28.36 21.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.076 -1.249 . . . . 0.0 109.529 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.48 -19.76 5.03 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.614 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 2.0 m-30 -118.45 152.41 35.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -1.156 . . . . 0.0 109.562 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.468 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 52.3 mt -118.25 105.36 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.145 -0.972 . . . . 0.0 109.491 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 102' ' ' ALA . 2.3 p -74.17 151.79 39.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 0.0 109.258 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.509 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -43.79 -36.4 2.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.95 . . . . 0.0 109.771 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.34 -45.81 82.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.083 -1.011 . . . . 0.0 109.58 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.487 ' OE2' ' HB2' ' A' ' 94' ' ' LYS . 3.8 mm-40 -65.95 -21.44 66.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.118 -0.989 . . . . 0.0 108.785 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.536 ' O ' ' CG ' ' A' ' 109' ' ' MET . 10.6 tp -84.53 -25.14 28.99 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.459 -0.776 . . . . 0.0 109.581 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.415 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 4.5 ttm180 -77.79 -54.81 5.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.516 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.628 ' O ' HG22 ' A' ' 110' ' ' THR . 15.2 t60 -45.05 -45.4 10.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.954 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.543 HG21 ' HA ' ' A' ' 92' ' ' PHE . 98.2 t -82.88 -24.4 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 110.107 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.612 ' HB3' HD13 ' A' ' 116' ' ' LEU . 8.8 mmt -70.59 -14.06 62.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.071 -1.018 . . . . 0.0 109.256 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 107' ' ' HIS . 15.3 t -100.55 -6.32 25.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 109.686 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.45 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 1.2 t-20 -44.3 -51.97 7.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.228 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.45 ' HG ' ' C ' ' A' ' 111' ' ' ASN . 28.7 mt -145.83 13.46 1.32 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -129.11 22.6 5.06 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 2.8 mm-40 62.05 153.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.405 -1.056 . . . . 0.0 109.278 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 126.81 31.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 0.0 109.668 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.64 HD21 ' SD ' ' A' ' 124' ' ' MET . 10.2 mp -70.29 171.56 9.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.83 -170.23 2.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.301 -0.874 . . . . 0.0 108.835 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.03 -49.83 8.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.182 -0.949 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.81 -12.04 57.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.816 . . . . 0.0 109.41 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.468 ' HG2' HD23 ' A' ' 116' ' ' LEU . 1.9 tt0 -99.52 -41.64 7.28 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.362 -0.836 . . . . 0.0 109.75 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 117' ' ' THR . 29.4 t -56.51 -51.78 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.588 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.18 -27.42 54.41 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.183 -0.948 . . . . 0.0 109.733 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 85.4 mt-10 -79.12 -29.13 43.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.375 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.64 ' SD ' HD21 ' A' ' 116' ' ' LEU . 2.1 mtt -78.52 -24.85 45.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 108.542 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.589 HG23 HG23 ' A' ' 136' ' ' VAL . 5.7 mt -83.59 -39.27 14.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.563 0.697 . . . . 0.0 109.378 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.8 ptm180 -42.37 -21.87 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.735 -0.603 . . . . 0.0 111.494 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' ILE . 1.6 mt-10 -86.18 -42.51 13.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.579 -1.326 . . . . 0.0 108.918 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.36 7.56 42.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.457 ' CG ' HG22 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -69.0 132.71 47.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.548 0.69 . . . . 0.0 110.455 -179.008 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.527 ' HA ' ' HG3' ' A' ' 140' ' ' GLU . 12.3 mt -49.11 -43.6 15.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.565 -0.709 . . . . 0.0 109.645 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -156.67 -36.29 0.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.355 -0.841 . . . . 0.0 109.971 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 155.82 40.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -101.46 -23.35 14.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -1.153 . . . . 0.0 109.358 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 109.76 -17.44 30.28 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.456 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -103.05 169.13 8.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.076 -1.249 . . . . 0.0 109.728 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.633 HG12 ' N ' ' A' ' 137' ' ' ASN . 54.3 t -128.07 167.21 23.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.633 ' N ' HG12 ' A' ' 136' ' ' VAL . 5.3 p-10 -138.4 -173.89 3.66 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.818 ' O ' HG23 ' A' ' 142' ' ' VAL . 55.3 t80 -72.7 -43.02 63.59 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.682 -1.261 . . . . 0.0 111.657 -178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.409 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 7.5 tt0 -66.4 -32.42 73.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.785 -1.197 . . . . 0.0 110.743 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.564 ' CG ' ' OD1' ' A' ' 137' ' ' ASN . 41.5 mm-40 -86.4 -28.93 23.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.0 109.161 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.436 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 20.6 t80 -75.1 -24.09 58.05 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 138' ' ' TYR . 42.3 t -69.33 -44.89 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.515 -0.741 . . . . 0.0 109.996 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -51.77 -38.29 54.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.082 -1.012 . . . . 0.0 109.946 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.42 -42.67 24.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.192 -0.943 . . . . 0.0 109.842 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.42 ' SD ' HG12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -68.36 -10.02 52.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.255 -0.903 . . . . 0.0 109.919 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.46 ' O ' HG22 ' A' ' 146' ' ' THR . 2.6 m . . . . . 0 C--N 1.303 -1.422 0 O-C-N 121.164 -0.96 . . . . 0.0 109.299 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -59.96 -18.3 44.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.524 HG21 HG22 ' A' ' 142' ' ' VAL . 22.5 mm -71.94 -34.21 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.447 -0.783 . . . . 0.0 109.641 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.583 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -50.7 -39.34 51.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 109.304 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' PHE . 20.7 mt-10 -85.58 -50.68 7.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.181 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.86 -25.57 0.31 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.216 -0.927 . . . . 0.0 108.893 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 78.6 t80 -65.55 -56.65 11.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.283 -0.886 . . . . 0.0 109.2 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.445 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 5.3 mtp180 -61.23 -29.26 69.72 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 38.2 t -47.63 -35.02 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.516 ' HD2' HD12 ' A' ' 105' ' ' LEU . 61.3 m-85 -91.54 -37.84 12.88 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.485 ' HB2' HG12 ' A' ' 100' ' ' ILE . 44.1 t0 -89.78 90.12 8.06 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -78.58 -25.13 45.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 110.492 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.477 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 1.2 m-20 -79.84 7.07 9.45 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.165 -0.959 . . . . 0.0 109.33 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 40.21 38.9 1.43 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -87.92 -1.42 57.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.61 -21.94 23.43 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.656 ' CE1' ' CB ' ' A' ' 137' ' ' ASN . 1.5 m-85 -125.26 145.61 49.92 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.325 -1.103 . . . . 0.0 109.382 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.503 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 88.5 mt -103.04 101.16 11.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 109.592 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 p -73.29 -179.53 3.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -0.987 . . . . 0.0 109.223 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.16 90.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.59 -28.09 66.63 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.222 -0.924 . . . . 0.0 109.277 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' A' ' 95' ' ' ASP . 5.2 mm-40 -72.94 -31.6 64.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.112 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.516 HD12 ' HD2' ' A' ' 92' ' ' PHE . 16.2 tp -83.12 -27.57 30.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.313 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.438 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 2.2 ttt180 -65.26 -18.62 65.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.858 . . . . 0.0 108.82 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.471 ' CD2' HG23 ' A' ' 108' ' ' VAL . 33.9 t60 -82.76 -34.48 27.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.472 -0.767 . . . . 0.0 109.926 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 108' ' ' VAL . 74.1 t -123.38 26.37 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.012 -1.055 . . . . 0.0 110.155 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.672 ' HB2' HD21 ' A' ' 116' ' ' LEU . 9.2 ptt? -71.41 -21.58 61.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.067 -1.021 . . . . 0.0 108.815 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -88.84 -8.7 53.84 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.422 -0.799 . . . . 0.0 110.171 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.723 ' HB2' HG12 ' A' ' 108' ' ' VAL . 4.5 t-20 -36.44 -46.73 0.57 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.477 -0.764 . . . . 0.0 109.619 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 174.92 35.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.49 -0.756 . . . . 0.0 109.071 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -116.12 36.1 3.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 22.8 mt-10 72.31 -160.72 0.11 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -1.019 . . . . 0.0 109.071 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' A' ' 115' ' ' LYS . 26.8 mtmt -120.93 89.81 3.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 109.691 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 109' ' ' MET . 0.3 OUTLIER -84.16 170.94 13.28 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.353 -0.842 . . . . 0.0 109.905 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 121' ' ' VAL . 5.4 t -112.1 -155.92 0.58 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.379 -0.826 . . . . 0.0 109.345 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.629 ' N ' HG23 ' A' ' 117' ' ' THR . 2.9 m-20 -84.44 -58.7 2.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.958 -1.089 . . . . 0.0 109.671 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -54.58 -18.86 4.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.499 ' HG2' ' HB2' ' A' ' 116' ' ' LEU . 3.2 tt0 -91.13 -37.0 13.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.357 -0.839 . . . . 0.0 109.764 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 117' ' ' THR . 2.9 t -41.85 -53.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.33 -0.856 . . . . 0.0 109.99 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -37.42 77.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.073 -1.017 . . . . 0.0 109.795 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -72.09 -19.06 61.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 0.0 109.377 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.5 mmm -85.73 -23.23 27.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.976 . . . . 0.0 108.424 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.667 HG23 HG23 ' A' ' 136' ' ' VAL . 6.1 mt -84.32 -41.74 16.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.692 0.758 . . . . 0.0 109.164 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -61.44 -19.58 62.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 110.153 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -88.93 -31.77 18.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.01 . . . . 0.0 109.089 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.12 -5.83 51.96 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.608 -0.682 . . . . 0.0 109.394 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.465 ' OD2' ' OE1' ' A' ' 140' ' ' GLU . 1.2 t70 -100.23 166.59 10.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.451 ' N ' ' CG ' ' A' ' 129' ' ' ASP . 38.9 mm -86.78 -71.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.37 -0.831 . . . . 0.0 109.285 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 179.62 58.1 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.612 -0.68 . . . . 0.0 109.211 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.08 -89.5 1.92 Allowed Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -127.92 -25.84 3.0 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.69 0.757 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.446 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 136.55 30.01 0.3 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 5.9 pt20 -128.74 -170.62 2.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.293 . . . . 0.0 108.938 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.667 HG23 HG23 ' A' ' 125' ' ' ILE . 92.8 t -127.33 169.82 18.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.994 -1.066 . . . . 0.0 109.604 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.656 ' CB ' ' CE1' ' A' ' 99' ' ' TYR . 7.7 p30 -149.37 -168.02 2.99 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.583 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 55.3 t80 -66.12 -55.24 17.43 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.44 -1.412 . . . . 0.0 110.461 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.507 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -53.66 -57.9 9.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.102 -0.999 . . . . 0.0 110.373 -179.322 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.538 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 19.6 mt-10 -57.68 -39.22 76.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.058 -1.026 . . . . 0.0 109.883 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.6 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 59.9 t80 -63.58 -28.05 69.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.538 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 85' ' ' ILE . 35.7 t -65.91 -53.12 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.421 -0.799 . . . . 0.0 109.722 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -58.43 -30.21 66.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 0.0 110.051 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 144' ' ' MET . 0.6 OUTLIER -86.92 -20.68 27.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.963 . . . . 0.0 109.958 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.6 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -96.31 -7.54 35.06 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.16 -0.963 . . . . 0.0 109.977 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.087 -1.008 . . . . 0.0 110.029 -179.619 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 1.3 tt0 -60.97 -19.59 61.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.895 . . . . 0.0 109.086 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 mt -116.71 -48.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.308 -0.87 . . . . 0.0 109.328 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.514 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.2 OUTLIER -56.33 -43.25 78.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.275 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.8 mm-40 -82.63 -31.99 28.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.341 -0.849 . . . . 0.0 109.491 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.439 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -61.5 -26.51 67.96 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.414 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 85.5 t80 -66.06 -56.89 9.27 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.507 -0.746 . . . . 0.0 109.417 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -64.03 -25.54 68.16 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 87' ' ' GLU . 17.6 t -53.13 -30.34 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.56 ' CE1' HG11 ' A' ' 108' ' ' VAL . 68.7 m-85 -97.22 -32.36 11.96 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.466 ' HB2' HG12 ' A' ' 100' ' ' ILE . 11.7 t70 -99.08 94.18 6.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -75.58 -23.4 56.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.056 -1.028 . . . . 0.0 109.671 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 97' ' ' ASN . 51.4 m-20 -78.5 0.92 24.12 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.339 -0.851 . . . . 0.0 108.943 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 31.26 37.46 0.03 OUTLIER Glycine 0 N--CA 1.498 2.826 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.6 OUTLIER -84.14 -32.93 24.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.26 . . . . 0.0 109.708 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.49 -34.08 2.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.7 m-85 -114.58 145.53 41.86 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.36 -1.082 . . . . 0.0 109.096 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.466 HG12 ' HB2' ' A' ' 93' ' ' ASP . 27.9 mt -100.07 122.6 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.171 -0.956 . . . . 0.0 109.469 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.59 -178.1 5.74 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.291 -0.881 . . . . 0.0 109.114 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.36 -36.19 68.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.131 -0.981 . . . . 0.0 109.303 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.45 -30.29 71.06 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.329 -0.857 . . . . 0.0 109.747 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 33.6 mm-40 -75.95 -22.7 55.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.168 -0.958 . . . . 0.0 109.189 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.45 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 63.5 tp -95.61 -11.02 27.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -0.764 . . . . 0.0 109.339 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -87.73 -43.26 12.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.314 -0.866 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.711 ' O ' HG22 ' A' ' 110' ' ' THR . 3.2 t60 -61.69 -41.84 98.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.952 . . . . 0.0 109.431 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.56 HG11 ' CE1' ' A' ' 92' ' ' PHE . 1.3 t -73.05 -40.0 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.156 -0.965 . . . . 0.0 109.161 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.749 ' HB3' HD13 ' A' ' 116' ' ' LEU . 2.4 mmt -68.1 -16.79 64.16 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 107' ' ' HIS . 2.3 t -96.07 -20.95 18.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.845 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.478 ' OD1' ' O ' ' A' ' 108' ' ' VAL . 0.6 OUTLIER -52.18 -44.99 64.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 108.845 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 112' ' ' LEU . 33.1 mt -152.62 18.14 0.61 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.473 -0.767 . . . . 0.0 109.474 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -114.61 34.9 4.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 110' ' ' THR . 13.1 mm-40 62.09 -169.12 0.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.418 -1.048 . . . . 0.0 109.627 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.32 89.88 4.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.824 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.749 HD13 ' HB3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -57.39 131.31 49.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.542 HG23 ' H ' ' A' ' 120' ' ' GLU . 1.1 t -79.47 177.75 8.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.09 -1.006 . . . . 0.0 108.839 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.85 -63.09 1.26 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.92 -1.113 . . . . 0.0 109.994 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 14.4 pt-20 -47.07 -44.39 20.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.948 . . . . 0.0 109.934 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.542 ' H ' HG23 ' A' ' 117' ' ' THR . 39.8 tp10 -62.02 -41.15 97.78 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.757 -0.589 . . . . 0.0 110.454 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 117' ' ' THR . 46.9 t -65.89 -62.65 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.13 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -31.42 52.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.974 -1.079 . . . . 0.0 109.196 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -71.06 -34.65 71.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.0 108.955 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 124' ' ' MET . 2.9 mmt -70.89 -28.15 64.33 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.342 -0.849 . . . . 0.0 108.842 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.465 HG23 HG23 ' A' ' 136' ' ' VAL . 2.7 mt -75.75 -42.08 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.424 -0.798 . . . . 0.0 109.15 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -14.63 3.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.673 -0.642 . . . . 0.0 110.165 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.2 -32.37 21.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 108.981 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.64 -7.25 50.54 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.467 -0.77 . . . . 0.0 109.348 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 0.3 OUTLIER -76.99 145.14 38.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.867 . . . . 0.0 109.808 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.502 ' CG1' ' OE1' ' A' ' 140' ' ' GLU . 32.0 mm -81.68 -39.38 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.155 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.18 -43.62 3.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.704 -0.622 . . . . 0.0 109.618 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.84 39.0 0.67 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.412 ' CG ' ' OE1' ' A' ' 135' ' ' GLN . 1.5 p30 -78.62 -25.03 45.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.294 -1.121 . . . . 0.0 108.771 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.21 26.95 4.12 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.65 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.586 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -156.86 170.36 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.935 -1.332 . . . . 0.0 109.369 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 137' ' ' ASN . 85.5 t -130.74 168.2 24.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.18 -0.95 . . . . 0.0 109.572 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.605 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -140.27 -165.57 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.77 ' O ' HG23 ' A' ' 142' ' ' VAL . 57.9 t80 -80.96 -40.07 25.05 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.04 -1.037 . . . . 0.0 109.768 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -33.0 73.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.089 -1.007 . . . . 0.0 109.378 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.572 ' HG2' ' ND2' ' A' ' 137' ' ' ASN . 2.1 mm-40 -82.18 -38.92 23.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.045 -1.034 . . . . 0.0 108.98 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.583 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 31.3 t80 -67.41 -25.42 65.93 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 108.978 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 138' ' ' TYR . 40.0 t -70.71 -43.67 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.862 . . . . 0.0 109.713 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -61.58 -23.89 66.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 109.697 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.28 -31.47 16.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.638 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.583 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -93.03 -2.67 55.43 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.261 -0.9 . . . . 0.0 109.917 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.303 -1.446 0 O-C-N 121.263 -0.898 . . . . 0.0 108.992 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 22.8 tt0 -47.25 -24.58 0.76 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.57 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 mp -80.39 -43.39 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.321 -0.862 . . . . 0.0 109.667 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -39.0 57.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 109.355 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 17.7 pt-20 -81.03 -47.8 13.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 87' ' ' GLU . . . -45.47 -32.06 2.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 108.805 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.402 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 90.4 t80 -58.96 -56.29 24.22 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.393 -0.817 . . . . 0.0 109.582 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 3.2 mtp180 -63.42 -30.0 71.2 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.693 -0.629 . . . . 0.0 109.453 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 74.5 t -49.23 -28.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -102.14 -32.18 10.23 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD1' ' OE1' ' A' ' 104' ' ' GLU . 30.6 t70 -91.05 80.14 5.73 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.64 -0.663 . . . . 0.0 109.624 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -21.0 59.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.845 . . . . 0.0 109.817 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -78.58 1.9 21.08 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.72 -0.792 . . . . 0.0 108.994 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 34.62 39.44 0.15 Allowed Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 13.1 p-10 -94.42 -17.8 22.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.277 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.98 -38.19 2.94 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 137' ' ' ASN . 36.6 m-85 -115.36 140.47 49.1 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.291 -1.123 . . . . 0.0 109.32 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 72.1 mt -89.49 117.12 32.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.19 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.3 p -83.74 164.86 19.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.71 -35.3 72.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.522 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.44 -31.65 71.12 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.228 -0.92 . . . . 0.0 109.381 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' OE1' ' OD1' ' A' ' 93' ' ' ASP . 34.5 mt-10 -71.94 -24.22 61.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.202 -0.936 . . . . 0.0 108.948 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.5 tp -85.05 -33.96 22.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.259 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' A' ' 109' ' ' MET . 18.0 ttt180 -61.25 -28.49 69.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 108.657 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -65.89 -49.25 68.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.544 -0.722 . . . . 0.0 109.451 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 108' ' ' VAL . 23.8 t -103.16 41.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.892 ' HB2' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -92.39 -23.06 19.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.804 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.8 OUTLIER -100.55 -12.48 19.24 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.211 -0.931 . . . . 0.0 109.573 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.977 ' O ' HD23 ' A' ' 112' ' ' LEU . 19.7 p-10 -45.55 -44.87 13.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.044 -1.035 . . . . 0.0 108.915 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.977 HD23 ' O ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -159.5 22.69 0.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.306 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -123.72 45.02 1.22 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.5 mm-40 56.84 -141.18 0.81 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -1.234 . . . . 0.0 109.125 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -126.18 83.62 2.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.977 -1.077 . . . . 0.0 109.459 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.892 HD12 ' HB2' ' A' ' 109' ' ' MET . 35.2 mt -59.31 -160.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.138 -0.976 . . . . 0.0 109.587 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.831 ' O ' HG23 ' A' ' 121' ' ' VAL . 17.9 p -153.78 -161.58 1.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.39 -48.6 9.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.192 -0.943 . . . . 0.0 109.072 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.42 -16.18 60.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.285 -0.884 . . . . 0.0 108.796 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -88.81 -37.31 15.5 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 117' ' ' THR . 9.1 t -55.98 -52.54 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.418 -0.801 . . . . 0.0 109.014 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 3.5 m-20 -57.82 -23.35 52.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.173 -0.954 . . . . 0.0 109.327 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -81.37 -29.96 33.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.428 -0.795 . . . . 0.0 109.046 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.82 -25.85 49.14 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.627 HG21 ' O ' ' A' ' 134' ' ' GLY . 6.8 mt -84.65 -38.73 13.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.738 0.78 . . . . 0.0 109.031 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.2 ptm85 -54.33 -33.49 59.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.703 -0.623 . . . . 0.0 109.897 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 5.7 mt-10 -89.62 -18.09 27.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.064 -1.022 . . . . 0.0 109.336 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.35 -5.37 43.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.387 -0.821 . . . . 0.0 109.751 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.477 ' OD2' ' HA ' ' A' ' 126' ' ' ARG . 3.0 p30 -81.99 177.78 8.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.88 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.589 HD12 ' OE2' ' A' ' 140' ' ' GLU . 36.0 mt -81.13 -50.31 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.497 -0.752 . . . . 0.0 109.78 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -133.09 -24.32 1.88 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.32 -0.862 . . . . 0.0 110.55 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 137.78 40.79 0.11 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -78.97 -24.15 44.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -1.11 . . . . 0.0 108.74 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.627 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 102.06 -26.58 23.83 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -103.58 173.71 6.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -1.229 . . . . 0.0 109.451 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.603 HG23 HG23 ' A' ' 125' ' ' ILE . 55.6 t -124.26 162.62 25.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.576 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 4.6 t-20 -141.54 -165.55 2.01 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.867 -1.146 . . . . 0.0 108.215 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.966 ' O ' HG23 ' A' ' 142' ' ' VAL . 72.1 t80 -75.99 -39.22 56.28 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.844 -1.16 . . . . 0.0 109.843 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -70.56 -34.12 71.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.235 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.589 ' OE2' HD12 ' A' ' 130' ' ' ILE . 7.8 mt-10 -80.2 -28.91 38.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 108.778 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.402 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 43.1 t80 -78.88 -25.12 43.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.433 -0.792 . . . . 0.0 109.3 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 138' ' ' TYR . 48.1 t -58.86 -48.53 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 109.822 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -66.64 -26.37 67.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.001 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.2 ttp -81.93 -21.95 37.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.67 -65.51 1.01 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.245 -0.909 . . . . 0.0 109.756 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.333 -0.854 . . . . 0.0 109.657 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.376 0.608 . . . . 0.0 109.413 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -55.73 24.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.943 . . . . 0.0 109.495 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.81 -41.64 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.536 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.584 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 4.2 ttp180 -49.86 -31.35 11.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.066 -1.021 . . . . 0.0 109.03 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 77.9 mt-10 -86.15 -57.54 2.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 110.105 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.514 ' CB ' ' SD ' ' A' ' 145' ' ' MET . . . -41.07 -32.98 0.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 109.031 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.46 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 89.9 t80 -59.76 -56.96 15.35 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.493 -0.754 . . . . 0.0 109.194 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.474 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -59.94 -35.85 75.82 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.759 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 66.1 t -42.93 -32.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -98.57 -31.7 11.82 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.474 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 13.2 t70 -95.6 81.68 3.55 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.607 -0.683 . . . . 0.0 109.316 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -22.35 55.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 110.296 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 97' ' ' ASN . 59.1 m-20 -78.51 2.15 20.02 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.281 -0.887 . . . . 0.0 109.21 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.09 29.83 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 95' ' ' ASP . 1.9 t30 -78.51 -36.44 44.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.101 -1.235 . . . . 0.0 109.551 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.71 -52.73 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 11.8 m-30 -106.42 156.52 18.44 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.352 -1.087 . . . . 0.0 109.003 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.411 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 74.2 mt -97.24 108.33 21.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.453 -0.779 . . . . 0.0 109.273 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -78.19 -177.56 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.759 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.695 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -64.65 -45.14 88.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -0.856 . . . . 0.0 109.17 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.97 -23.9 67.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.434 -0.791 . . . . 0.0 109.698 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -76.99 -31.89 56.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.023 -1.048 . . . . 0.0 108.892 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.633 HD12 HG12 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -89.27 -13.23 38.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -0.842 . . . . 0.0 108.899 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.498 ' O ' ' CG2' ' A' ' 110' ' ' THR . 10.1 ttt180 -90.15 -14.03 34.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.377 -0.827 . . . . 0.0 108.793 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -77.79 -26.47 49.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 110.172 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.8 t -106.67 -50.86 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 110.492 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.664 ' HB3' HD11 ' A' ' 116' ' ' LEU . 2.4 mmt -56.2 -19.55 14.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 109.858 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 106' ' ' ARG . 12.9 t -88.26 -28.94 20.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.119 -0.988 . . . . 0.0 109.645 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -52.93 -47.09 68.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.37 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pp -132.85 -3.72 3.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 110.131 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 109' ' ' MET . . . -103.79 20.05 42.52 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 16.3 mt-10 63.49 141.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -1.124 . . . . 0.0 109.186 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HA ' ' OG1' ' A' ' 110' ' ' THR . 0.6 OUTLIER -50.39 100.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.752 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 109' ' ' MET . 29.0 mt -59.57 133.18 55.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 109.264 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -71.16 178.97 3.02 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.109 -0.994 . . . . 0.0 108.332 179.201 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.412 ' N ' ' OG1' ' A' ' 117' ' ' THR . 10.0 m-20 -60.52 -63.45 1.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.87 -1.144 . . . . 0.0 109.914 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 1.4 pt-20 -50.4 -42.19 53.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 109.947 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.48 ' H ' HG23 ' A' ' 117' ' ' THR . 12.7 tp10 -63.04 -34.99 78.75 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.586 -0.696 . . . . 0.0 110.156 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.695 HG11 ' HB1' ' A' ' 102' ' ' ALA . 28.7 t -71.65 -65.37 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.276 -0.89 . . . . 0.0 109.638 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -48.82 -30.66 6.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.087 -1.008 . . . . 0.0 109.158 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 0.5 OUTLIER -75.09 -38.94 61.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.166 179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.566 ' HG3' HD13 ' A' ' 116' ' ' LEU . 3.7 mmt -65.32 -23.89 67.13 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.689 HG23 HG23 ' A' ' 136' ' ' VAL . 3.2 mt -81.76 -38.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -47.97 -28.76 2.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.955 -0.466 . . . . 0.0 110.099 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 124' ' ' MET . 7.2 pt-20 -80.2 -37.39 33.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.887 -1.133 . . . . 0.0 108.589 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -78.47 -7.98 58.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.65 143.3 30.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.822 . . . . 0.0 109.255 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.8 -39.47 10.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 109.665 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.11 -44.81 7.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.455 -0.778 . . . . 0.0 109.956 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.19 39.94 1.09 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -79.08 -24.54 43.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -1.073 . . . . 0.0 108.776 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.522 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 117.22 -36.77 3.58 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -98.75 170.07 9.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.061 -1.258 . . . . 0.0 109.118 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.689 HG23 HG23 ' A' ' 125' ' ' ILE . 52.0 t -127.9 162.79 33.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.176 -0.952 . . . . 0.0 108.556 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -137.99 -169.76 2.63 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 109.094 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.97 ' O ' HG23 ' A' ' 142' ' ' VAL . 78.7 t80 -77.62 -34.9 53.19 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.701 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -49.62 70.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.262 -0.899 . . . . 0.0 109.322 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -69.3 -39.79 78.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.331 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.46 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 47.7 t80 -66.38 -24.34 66.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.812 . . . . 0.0 109.793 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.97 HG23 ' O ' ' A' ' 138' ' ' TYR . 40.8 t -70.29 -46.95 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.94 . . . . 0.0 109.963 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -70.28 -23.96 62.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 109.866 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -85.12 -23.77 28.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.514 ' SD ' ' CB ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -83.34 -51.63 7.25 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.0 109.994 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -58.42 -27.28 64.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.112 -0.993 . . . . 0.0 109.191 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.596 HG21 HG13 ' A' ' 142' ' ' VAL . 4.5 mm -76.07 -39.86 36.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.371 -0.83 . . . . 0.0 109.262 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.406 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -53.56 -43.66 68.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 109.584 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 9.9 pt-20 -78.8 -41.59 29.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.991 . . . . 0.0 109.607 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.505 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -52.16 -30.37 26.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.104 -0.998 . . . . 0.0 108.648 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.446 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 90.4 t80 -64.39 -52.95 55.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.0 109.622 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -64.51 -24.21 67.53 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 52.7 t -56.35 -22.8 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -104.97 -36.27 7.38 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.411 ' HB2' HG12 ' A' ' 100' ' ' ILE . 39.4 t0 -83.99 108.29 16.86 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -84.28 -26.49 28.55 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.079 -1.013 . . . . 0.0 110.088 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.485 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -79.46 3.04 19.74 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 108.903 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 36.32 36.74 0.16 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 95' ' ' ASP . 14.5 p-10 -93.71 -42.87 8.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -1.187 . . . . 0.0 109.875 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.42 -20.71 1.52 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.641 ' CE1' ' CB ' ' A' ' 137' ' ' ASN . 1.7 m-85 -120.72 144.44 48.24 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.216 -1.167 . . . . 0.0 109.71 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.411 HG12 ' HB2' ' A' ' 93' ' ' ASP . 68.5 mt -108.54 110.21 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.547 -0.721 . . . . 0.0 109.537 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.75 162.92 28.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.245 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.526 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -55.06 -36.85 66.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.975 . . . . 0.0 109.38 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.44 78.59 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.375 -0.828 . . . . 0.0 109.343 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -72.24 -22.54 61.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.339 -0.851 . . . . 0.0 108.895 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 109' ' ' MET . 17.8 tp -90.03 -23.16 21.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.378 -0.826 . . . . 0.0 109.512 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.433 ' HB2' HG21 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -84.44 -34.33 23.49 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.16 -0.962 . . . . 0.0 109.882 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.535 ' O ' HG22 ' A' ' 110' ' ' THR . 35.0 t60 -61.12 -41.53 96.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.033 -1.042 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 91' ' ' VAL . 46.9 t -86.64 -23.86 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.816 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.492 ' CG ' ' O ' ' A' ' 105' ' ' LEU . 4.4 mmt -73.25 -21.33 60.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 107' ' ' HIS . 9.3 t -89.55 -26.03 21.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.34 -0.85 . . . . 0.0 109.63 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.693 ' HB3' HD12 ' A' ' 112' ' ' LEU . 1.6 t30 -48.18 -57.49 5.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.445 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 111' ' ' ASN . 1.8 mp -125.22 3.63 7.84 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.354 -0.841 . . . . 0.0 109.64 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . -108.86 56.4 0.47 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.9 mt-10 45.45 -134.53 0.78 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -1.15 . . . . 0.0 108.861 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -148.44 78.1 1.41 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.76 -1.212 . . . . 0.0 109.564 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.751 ' H ' HD23 ' A' ' 116' ' ' LEU . 1.4 pt? -67.85 144.81 55.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.095 -1.003 . . . . 0.0 109.0 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.719 ' O ' HG23 ' A' ' 121' ' ' VAL . 21.9 p -77.55 -159.73 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.9 . . . . 0.0 109.956 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.21 -48.37 13.21 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.422 -0.799 . . . . 0.0 109.49 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.68 -21.96 20.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.137 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 23.6 mm-40 -87.5 -47.88 8.38 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 117' ' ' THR . 49.0 t -46.96 -49.99 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.445 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.45 -38.16 68.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.832 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 15.6 mt-10 -67.45 -38.26 84.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.935 . . . . 0.0 109.629 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 21.9 mmm -68.51 -30.38 69.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.103 -0.998 . . . . 0.0 108.893 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.462 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 3.0 mt -71.96 -40.36 67.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.419 -0.801 . . . . 0.0 108.849 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -61.28 -18.93 60.89 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.558 -0.714 . . . . 0.0 109.189 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 7.1 mm-40 -90.4 -21.48 21.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.337 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 144' ' ' MET . . . -92.59 -65.18 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 30.4 p-10 -76.16 177.47 7.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.462 -0.774 . . . . 0.0 109.069 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.499 HG12 ' OE2' ' A' ' 140' ' ' GLU . 7.4 mm -85.89 -66.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -0.908 . . . . 0.0 109.721 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 173.46 65.01 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.92 -87.51 1.77 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.93 -17.61 7.26 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.765 -0.844 . . . . 0.0 109.327 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 125.08 18.32 2.59 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.48 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 1.3 pt20 -118.68 171.37 8.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -1.184 . . . . 0.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 137' ' ' ASN . 84.1 t -125.43 169.41 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.141 -0.974 . . . . 0.0 109.862 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.641 ' CB ' ' CE1' ' A' ' 99' ' ' TYR . 1.8 p-10 -145.23 -173.21 4.04 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.693 ' O ' HG23 ' A' ' 142' ' ' VAL . 49.9 t80 -69.81 -45.21 68.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.392 -1.443 . . . . 0.0 111.671 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.454 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 0.3 OUTLIER -61.68 -47.82 83.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.902 -1.124 . . . . 0.0 110.651 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.527 ' HB3' ' HA ' ' A' ' 129' ' ' ASP . 0.8 OUTLIER -70.41 -36.52 74.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.892 -1.13 . . . . 0.0 109.78 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.597 ' CZ ' ' HG2' ' A' ' 145' ' ' MET . 6.2 t80 -67.66 -27.71 67.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.19 -0.943 . . . . 0.0 109.159 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 138' ' ' TYR . 75.8 t -79.32 -62.62 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.369 -0.832 . . . . 0.0 109.662 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.44 ' C ' ' O ' ' A' ' 142' ' ' VAL . 7.8 mm100 -39.38 -34.65 0.22 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.473 -0.767 . . . . 0.0 110.73 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 128' ' ' ALA . 29.6 mmt -90.45 -45.75 8.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.871 -1.143 . . . . 0.0 110.624 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.597 ' HG2' ' CZ ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -71.61 -0.61 11.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 0.0 110.549 -178.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.494 ' CG2' HG13 ' A' ' 85' ' ' ILE . 7.8 p . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.104 -0.997 . . . . 0.0 110.008 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -52.95 -23.15 6.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.474 -0.766 . . . . 0.0 109.401 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -81.81 -38.12 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.326 -0.859 . . . . 0.0 109.058 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.474 ' HG2' ' CZ ' ' A' ' 138' ' ' TYR . 9.9 mtt180 -61.19 -31.92 71.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.437 -0.79 . . . . 0.0 109.143 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -89.74 -34.99 16.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 109.136 179.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.494 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.56 -23.12 67.25 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.42 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 82.6 t80 -69.68 -54.31 14.46 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -63.54 -27.62 69.38 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 4.9 t -48.17 -31.11 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.498 ' CE1' ' HB ' ' A' ' 108' ' ' VAL . 83.3 m-85 -98.29 -37.59 9.59 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.468 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 43.2 t0 -87.39 92.32 9.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -84.0 -24.8 30.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.26 -0.9 . . . . 0.0 110.223 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -79.18 4.18 15.57 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.245 -0.91 . . . . 0.0 109.101 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 39.57 29.3 0.14 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 95' ' ' ASP . 15.4 p-10 -73.93 -39.0 64.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.116 . . . . 0.0 109.658 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.26 -48.34 0.68 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.488 ' CD2' ' HG3' ' A' ' 135' ' ' GLN . 8.7 m-30 -108.92 176.29 5.16 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.335 -1.097 . . . . 0.0 109.465 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.7 mt -119.31 115.3 47.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.643 -0.66 . . . . 0.0 109.424 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.5 p -80.29 159.11 25.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.651 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.465 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -51.93 -35.89 47.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 0.0 109.514 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.56 -41.21 88.99 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.152 -0.968 . . . . 0.0 109.117 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 13.6 mt-10 -65.84 -22.69 66.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.227 -0.921 . . . . 0.0 109.103 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 109' ' ' MET . 9.4 tp -85.54 -32.25 22.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.422 -0.799 . . . . 0.0 109.644 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -34.79 77.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.289 -0.882 . . . . 0.0 109.177 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -59.55 -27.15 65.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 109.985 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.498 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 17.5 t -102.33 -12.73 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.078 -1.014 . . . . 0.0 110.44 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.815 ' HB3' HD22 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -78.24 -11.18 59.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.909 -1.12 . . . . 0.0 109.618 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 111' ' ' ASN . 2.1 t -99.93 -30.72 11.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.07 -1.019 . . . . 0.0 110.123 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -43.92 -45.49 7.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 109.221 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.8 23.48 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.648 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -115.04 19.76 15.0 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 67.8 146.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -1.095 . . . . 0.0 109.223 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.42 81.5 1.42 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -0.963 . . . . 0.0 110.053 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' A' ' 109' ' ' MET . 2.7 pt? -63.33 151.75 39.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 109.008 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.509 ' OG1' ' HG2' ' A' ' 120' ' ' GLU . 44.4 p -84.45 -165.61 1.22 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.296 -0.877 . . . . 0.0 109.447 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -75.11 -46.57 33.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.712 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.439 ' O ' ' OE1' ' A' ' 123' ' ' GLU . 30.9 mt-10 -57.2 -16.42 8.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.763 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.509 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 5.2 mm-40 -95.17 -45.08 7.34 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.342 -0.849 . . . . 0.0 108.961 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.603 HG22 HD11 ' A' ' 116' ' ' LEU . 41.8 t -49.42 -55.72 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.89 -0.507 . . . . 0.0 110.599 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.34 -36.54 84.05 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.852 -1.155 . . . . 0.0 109.042 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 119' ' ' GLU . 87.0 mt-10 -70.79 -15.56 62.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.179 -0.951 . . . . 0.0 108.56 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.434 ' SD ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -85.32 -30.94 23.31 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.698 HG22 ' OD2' ' A' ' 129' ' ' ASP . 3.3 mt -74.42 -41.31 49.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.99 -15.23 3.23 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.706 -0.621 . . . . 0.0 110.007 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -87.33 -30.94 20.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.923 -1.111 . . . . 0.0 109.797 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.402 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -88.7 -58.48 2.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.337 -0.852 . . . . 0.0 109.506 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.698 ' OD2' HG22 ' A' ' 125' ' ' ILE . 8.6 p30 -53.05 155.49 2.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.713 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.8 mt -111.79 -44.39 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.295 -0.878 . . . . 0.0 109.703 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -72.51 -38.14 68.18 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.473 -0.767 . . . . 0.0 109.63 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.66 33.46 6.42 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -78.94 -26.28 43.6 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.318 -1.107 . . . . 0.0 108.681 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.587 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 124.22 -42.19 1.6 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.488 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -90.07 165.25 14.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.059 -1.26 . . . . 0.0 109.49 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 137' ' ' ASN . 53.1 t -118.23 161.49 17.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.521 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -134.16 -164.62 1.53 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.714 -1.241 . . . . 0.0 108.659 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.991 ' O ' HG23 ' A' ' 142' ' ' VAL . 64.9 t80 -78.49 -38.48 40.8 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.205 -0.934 . . . . 0.0 110.206 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -70.45 -33.08 70.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.995 -1.066 . . . . 0.0 109.417 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.48 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 15.5 mt-10 -82.12 -34.07 29.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.159 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.42 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 38.5 t80 -75.47 -25.65 57.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.519 -0.738 . . . . 0.0 109.671 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.991 HG23 ' O ' ' A' ' 138' ' ' TYR . 26.8 t -55.38 -48.98 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.786 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -65.9 -27.3 68.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.041 -1.037 . . . . 0.0 109.627 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -80.39 -19.33 46.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.198 -0.939 . . . . 0.0 109.691 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.442 ' HG3' ' HB3' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -77.47 -39.13 47.62 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.095 -1.003 . . . . 0.0 109.36 179.826 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 86' ' ' ARG . 4.9 tt0 . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 121.349 0.595 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -47.09 -26.94 1.2 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.312 -0.868 . . . . 0.0 110.116 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.6 mt -72.45 -44.67 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.042 -1.036 . . . . 0.0 109.641 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.584 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -46.24 -33.4 3.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.059 -1.025 . . . . 0.0 109.441 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 88' ' ' ALA . 1.9 mt-10 -87.17 -55.44 3.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 109.977 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -42.69 -28.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 108.901 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 87' ' ' GLU . 79.6 t80 -62.61 -57.52 10.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.481 -0.762 . . . . 0.0 109.419 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.461 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 6.0 mtp180 -61.1 -32.99 72.65 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.67 -0.644 . . . . 0.0 109.302 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.488 HG12 HG21 ' A' ' 108' ' ' VAL . 39.1 t -45.31 -32.45 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.706 ' CD1' HD12 ' A' ' 105' ' ' LEU . 85.8 m-85 -94.47 -49.79 5.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.487 ' CA ' HG12 ' A' ' 100' ' ' ILE . 65.7 t0 -65.36 91.37 0.11 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -90.32 -21.01 22.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 111.238 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.46 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 10.5 p-10 -78.2 7.53 6.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.938 -1.101 . . . . 0.0 109.876 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.75 49.66 1.92 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.425 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 1.8 t30 -110.17 -64.58 1.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -1.114 . . . . 0.0 109.207 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.19 -47.27 0.11 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.593 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 7.6 m-30 -110.06 150.38 28.64 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.53 -0.982 . . . . 0.0 109.204 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.487 HG12 ' CA ' ' A' ' 93' ' ' ASP . 55.6 mt -85.43 152.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.419 -0.801 . . . . 0.0 109.511 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.7 p -110.48 172.63 6.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.183 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.96 -53.7 49.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.828 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.24 62.72 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 71.4 mt-10 -75.24 -30.0 60.39 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.123 -0.986 . . . . 0.0 108.561 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.706 HD12 ' CD1' ' A' ' 92' ' ' PHE . 12.2 tp -81.18 -21.93 39.29 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.776 ' HB2' HG21 ' A' ' 121' ' ' VAL . 35.9 ttt-85 -78.86 -22.64 45.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.41 -0.806 . . . . 0.0 108.968 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -67.76 -38.49 83.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.468 -0.77 . . . . 0.0 110.427 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.488 HG21 HG12 ' A' ' 91' ' ' VAL . 92.4 t -99.17 -38.07 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.255 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.979 ' HB3' HD13 ' A' ' 116' ' ' LEU . 16.3 mmt -61.14 -13.34 16.88 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.32 -0.862 . . . . 0.0 109.615 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -94.73 -29.41 14.8 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.22 -0.925 . . . . 0.0 108.849 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -68.12 0.39 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.905 . . . . 0.0 109.258 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.7 mt -114.33 15.19 18.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 109.328 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 109' ' ' MET . . . -111.04 51.35 0.7 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 48.29 -145.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -1.083 . . . . 0.0 109.545 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.56 101.01 9.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.02 . . . . 0.0 109.788 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.979 HD13 ' HB3' ' A' ' 109' ' ' MET . 0.1 OUTLIER -102.6 111.5 23.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.41 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.905 HG22 ' HG2' ' A' ' 120' ' ' GLU . 6.3 t -82.71 -146.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 108.735 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.7 ' N ' HG23 ' A' ' 117' ' ' THR . 2.9 m-20 -90.11 -48.45 7.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.023 -1.048 . . . . 0.0 109.884 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -60.23 -17.83 44.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.869 . . . . 0.0 109.586 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.905 ' HG2' HG22 ' A' ' 117' ' ' THR . 11.9 mm-40 -94.1 -47.76 6.53 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 117' ' ' THR . 47.7 t -47.49 -62.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.599 -0.688 . . . . 0.0 109.905 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -31.68 11.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.982 -1.074 . . . . 0.0 109.646 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -68.49 -40.18 81.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.224 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.492 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 36.2 mmm -63.39 -32.68 74.18 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mt -71.03 -39.25 74.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.567 -0.708 . . . . 0.0 109.463 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -55.06 -27.55 45.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 110.263 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -89.33 -21.56 23.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.126 -0.984 . . . . 0.0 109.663 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -97.19 -5.82 36.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.824 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' HG22 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -97.45 133.32 42.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.7 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 57.0 mt -85.34 -50.23 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.358 -0.839 . . . . 0.0 109.426 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.1 -49.86 7.91 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.604 -0.685 . . . . 0.0 109.726 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.08 37.75 2.45 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -78.78 -25.19 44.33 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.317 -1.108 . . . . 0.0 108.821 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.19 28.96 1.88 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.485 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.593 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -159.18 165.85 32.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.068 -1.254 . . . . 0.0 109.256 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 137' ' ' ASN . 55.8 t -122.6 162.86 21.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.12 -0.987 . . . . 0.0 108.654 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.534 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -132.44 -164.01 1.41 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.908 -1.12 . . . . 0.0 108.517 179.424 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 1.013 ' O ' HG23 ' A' ' 142' ' ' VAL . 67.2 t80 -78.58 -49.59 13.01 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 110.323 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -59.84 -39.65 85.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.0 109.536 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.517 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 7.5 mt-10 -74.68 -38.96 62.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.049 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 39.0 t80 -65.64 -22.52 66.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.422 -0.798 . . . . 0.0 109.059 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 1.013 HG23 ' O ' ' A' ' 138' ' ' TYR . 89.7 t -70.68 -40.66 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.552 -0.718 . . . . 0.0 110.079 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -65.98 -27.82 68.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.068 -1.02 . . . . 0.0 110.188 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.6 ttp -90.34 -26.54 19.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.094 -1.004 . . . . 0.0 110.058 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -97.68 -62.69 1.21 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.005 -1.06 . . . . 0.0 109.99 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 O-C-N 121.159 -0.963 . . . . 0.0 109.348 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 121.033 0.444 . . . . 0.0 109.849 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.41 -39.42 15.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.961 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.66 HG23 ' CB ' ' A' ' 145' ' ' MET . 2.6 mt -91.72 -37.17 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.178 -0.952 . . . . 0.0 110.243 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.57 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 34.8 mtt180 -49.61 -28.91 6.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.005 . . . . 0.0 109.772 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -92.68 -54.02 3.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.078 -1.014 . . . . 0.0 109.478 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -44.51 -26.74 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.189 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 75.7 t80 -64.77 -55.9 16.94 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.111 -0.993 . . . . 0.0 109.403 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.411 ' CZ ' ' CB ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -62.88 -31.68 72.78 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.307 -179.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 108' ' ' VAL . 41.0 t -47.41 -28.24 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 64.7 m-85 -102.74 -31.69 10.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.472 ' HB2' HG12 ' A' ' 100' ' ' ILE . 34.3 t0 -93.62 92.83 7.72 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.583 -0.698 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.553 ' NZ ' ' CD2' ' A' ' 107' ' ' HIS . 1.6 mmmm -90.28 -23.13 21.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.222 -0.924 . . . . 0.0 109.927 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.492 ' O ' ' C ' ' A' ' 96' ' ' GLY . 15.8 t0 -78.79 1.95 21.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 109.186 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 33.55 37.8 0.07 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 95' ' ' ASP . 12.9 p-10 -88.0 -28.53 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -1.178 . . . . 0.0 109.768 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 143.37 -54.27 0.59 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 14.6 m-30 -109.59 157.28 19.2 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.486 -1.008 . . . . 0.0 109.124 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 84.3 mt -90.28 117.4 33.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 109.026 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.0 p -74.48 159.86 31.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.168 -0.958 . . . . 0.0 109.265 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.79 -31.12 66.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.418 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.78 -35.34 62.54 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.168 -0.958 . . . . 0.0 109.042 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 50.7 mm-40 -73.3 -22.8 60.27 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.276 -0.89 . . . . 0.0 108.967 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 125' ' ' ILE . 5.3 tp -90.78 -25.16 20.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 0.0 109.032 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.496 ' O ' ' OG1' ' A' ' 110' ' ' THR . 2.0 ttt180 -77.4 -30.4 53.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.271 -0.893 . . . . 0.0 109.01 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.553 ' CD2' ' NZ ' ' A' ' 94' ' ' LYS . 71.3 t60 -58.03 -45.11 87.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.906 . . . . 0.0 110.057 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 91' ' ' VAL . 25.9 t -91.65 -26.46 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.06 -1.025 . . . . 0.0 110.392 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.576 ' CE ' HD12 ' A' ' 116' ' ' LEU . 13.7 mtm -61.29 -42.63 98.98 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.102 -0.999 . . . . 0.0 109.038 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.937 HG23 ' HA ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -59.31 -26.67 65.2 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.207 -0.933 . . . . 0.0 109.253 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 110' ' ' THR . 7.9 t-20 39.02 -93.03 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.662 -0.648 . . . . 0.0 110.088 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.839 ' O ' HD12 ' A' ' 112' ' ' LEU . 1.3 pp -148.71 68.34 1.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.143 -0.973 . . . . 0.0 109.226 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.56 -17.55 11.14 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -83.75 43.41 0.91 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.228 -1.16 . . . . 0.0 109.826 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.937 ' HA ' HG23 ' A' ' 110' ' ' THR . 13.7 ttpp -64.98 126.52 28.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 0.0 109.344 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.576 HD12 ' CE ' ' A' ' 109' ' ' MET . 45.5 mt -104.08 140.6 37.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.48 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -66.98 -169.17 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.91 . . . . 0.0 108.71 179.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.47 -50.53 12.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.011 -1.055 . . . . 0.0 109.269 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -30.6 70.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.18 -0.95 . . . . 0.0 108.5 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.49 ' CG ' HD22 ' A' ' 116' ' ' LEU . 9.8 tp10 -70.56 -41.88 71.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 117' ' ' THR . 34.6 t -61.5 -36.63 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.14 -25.53 67.02 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -75.01 -45.86 38.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.481 -0.762 . . . . 0.0 109.017 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 7.6 mmt -60.66 -28.28 68.47 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.21 -0.931 . . . . 0.0 108.76 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.563 HG12 HD22 ' A' ' 105' ' ' LEU . 2.4 mt -82.09 -35.24 13.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.519 -0.738 . . . . 0.0 109.475 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -59.69 -31.24 69.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 110.35 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.42 -5.24 56.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.029 -1.045 . . . . 0.0 110.509 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.06 -29.85 11.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.986 -1.071 . . . . 0.0 109.747 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.33 149.87 23.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.287 -0.883 . . . . 0.0 109.641 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.818 HD12 ' OE1' ' A' ' 140' ' ' GLU . 16.9 mt -113.38 -29.02 2.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.18 -0.95 . . . . 0.0 109.374 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.427 ' HB3' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -61.73 -33.6 74.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.88 21.39 55.83 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' OD2' ' HB3' ' A' ' 131' ' ' ASP . 0.7 OUTLIER -83.51 -27.56 29.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -1.169 . . . . 0.0 109.609 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.84 28.03 4.65 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.457 ' CD ' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -146.61 163.07 37.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -1.204 . . . . 0.0 109.391 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 137' ' ' ASN . 94.2 t -117.78 168.2 9.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.327 -0.858 . . . . 0.0 109.188 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.599 ' N ' HG12 ' A' ' 136' ' ' VAL . 47.0 t30 -148.25 -166.29 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.888 ' O ' HG23 ' A' ' 142' ' ' VAL . 60.2 t80 -80.62 -41.79 23.31 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.583 -1.323 . . . . 0.0 110.117 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.49 -29.99 66.67 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.104 -0.998 . . . . 0.0 109.303 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.818 ' OE1' HD12 ' A' ' 130' ' ' ILE . 6.1 mm-40 -85.26 -35.41 21.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 26.1 t80 -71.22 -26.87 63.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.536 -0.727 . . . . 0.0 109.16 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 138' ' ' TYR . 20.3 t -55.37 -44.31 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.189 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -57.94 -31.59 66.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.708 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.493 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 34.5 ttp -75.98 -39.57 55.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.454 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.66 ' CB ' HG23 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -69.77 -20.17 63.49 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.2 p . . . . . 0 N--CA 1.488 1.44 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.705 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.053 0.454 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.01 -19.46 4.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.064 -1.022 . . . . 0.0 109.338 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' A' ' 142' ' ' VAL . 5.8 mt -74.92 -39.72 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.282 -0.886 . . . . 0.0 109.548 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.586 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -46.52 -31.79 2.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.934 -1.103 . . . . 0.0 109.214 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 88' ' ' ALA . 15.5 mt-10 -91.88 -50.28 5.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.454 -0.779 . . . . 0.0 109.168 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.488 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.78 -25.87 0.34 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -0.906 . . . . 0.0 108.761 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' N ' ' C ' ' A' ' 87' ' ' GLU . 82.9 t80 -63.51 -55.61 22.59 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.284 -0.885 . . . . 0.0 109.004 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.45 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -60.86 -36.13 78.37 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 34.4 t -43.32 -28.35 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 90' ' ' ARG . 92.0 m-85 -106.36 -31.37 8.62 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.45 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 10.8 t0 -89.34 79.7 6.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.602 -0.686 . . . . 0.0 109.369 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -89.19 -16.97 30.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.386 -0.821 . . . . 0.0 109.745 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.459 ' O ' ' C ' ' A' ' 96' ' ' GLY . 12.6 t70 -77.19 0.39 21.98 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.397 -0.815 . . . . 0.0 108.988 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.96 50.3 2.07 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -108.12 -31.83 7.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -1.176 . . . . 0.0 109.587 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.39 -50.02 0.82 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.636 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 10.9 m-30 -114.03 146.04 40.73 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.339 -1.095 . . . . 0.0 109.217 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 81.9 mt -81.96 132.56 31.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.398 -0.814 . . . . 0.0 109.389 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.6 p -98.26 178.04 5.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.547 ' CA ' HG11 ' A' ' 121' ' ' VAL . . . -65.7 -40.54 92.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 109.341 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.73 -31.1 70.8 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.267 -0.896 . . . . 0.0 109.407 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.53 -26.23 59.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.877 . . . . 0.0 108.667 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.904 ' O ' HD23 ' A' ' 105' ' ' LEU . 3.6 tt -82.11 -26.2 33.77 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.787 HH12 HG21 ' A' ' 110' ' ' THR . 0.0 OUTLIER -73.03 -47.33 45.84 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 106' ' ' ARG . 28.0 t60 -40.93 -38.4 0.95 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.48 -0.762 . . . . 0.0 110.347 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.449 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 36.2 t -97.97 -28.11 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.972 -1.08 . . . . 0.0 110.297 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.701 ' CG ' HD22 ' A' ' 116' ' ' LEU . 3.9 mmt -64.33 -17.34 63.6 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.725 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.787 HG21 HH12 ' A' ' 106' ' ' ARG . 1.1 t -88.7 -18.55 27.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.455 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.449 ' OD1' ' HA ' ' A' ' 108' ' ' VAL . 7.3 m120 -58.48 97.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.875 . . . . 0.0 109.552 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt 61.32 13.45 4.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -117.96 41.91 1.95 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 52.89 -125.76 2.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.236 -1.155 . . . . 0.0 109.12 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 135.67 32.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.634 -1.292 . . . . 0.0 109.991 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.859 HD21 ' SD ' ' A' ' 124' ' ' MET . 0.7 OUTLIER -103.94 116.46 32.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.297 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.467 HG23 ' H ' ' A' ' 120' ' ' GLU . 5.6 t -75.45 165.78 24.6 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.64 -52.67 63.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.845 -1.16 . . . . 0.0 110.237 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -59.41 -17.96 34.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.244 -0.91 . . . . 0.0 109.998 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.546 ' CG ' ' HG ' ' A' ' 116' ' ' LEU . 7.7 tp10 -87.18 -40.16 14.83 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.547 HG11 ' CA ' ' A' ' 102' ' ' ALA . 21.9 t -61.41 -46.74 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.304 -0.872 . . . . 0.0 109.079 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -46.92 -28.82 1.74 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.383 -0.823 . . . . 0.0 109.751 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -75.54 -51.41 12.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.142 -0.974 . . . . 0.0 109.426 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.859 ' SD ' HD21 ' A' ' 116' ' ' LEU . 1.2 mpt? -59.91 -21.14 60.71 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.222 -0.924 . . . . 0.0 109.559 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.547 HG12 HD12 ' A' ' 105' ' ' LEU . 2.3 mt -84.85 -42.97 16.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.3 -0.875 . . . . 0.0 109.659 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -22.68 1.02 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.38 -0.825 . . . . 0.0 110.588 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -90.87 -30.37 16.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.919 -1.113 . . . . 0.0 110.379 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.19 -49.65 16.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.838 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.407 ' OD2' HG22 ' A' ' 125' ' ' ILE . 1.9 p30 -80.44 150.91 29.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.5 mt -117.69 -34.48 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.334 -0.854 . . . . 0.0 109.214 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -61.75 -39.88 93.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.536 -0.727 . . . . 0.0 109.286 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.56 29.44 29.8 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.18 -25.64 39.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.386 -1.067 . . . . 0.0 108.77 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 115.3 26.54 3.42 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.636 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -160.27 162.54 33.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.045 -1.268 . . . . 0.0 109.517 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 137' ' ' ASN . 70.0 t -113.8 161.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.52 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -135.79 -166.46 1.86 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.97 -1.081 . . . . 0.0 108.619 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 142' ' ' VAL . 52.3 t80 -78.87 -37.44 40.27 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.415 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.423 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 5.2 tp10 -67.77 -38.99 84.15 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -77.09 -38.47 52.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.175 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 38.6 t80 -69.47 -23.49 63.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.394 -0.816 . . . . 0.0 109.456 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 138' ' ' TYR . 23.1 t -75.7 -54.01 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 109.84 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.423 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 2.8 mt-30 -63.34 -21.9 66.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.0 110.044 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -90.24 -32.82 16.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.076 -1.015 . . . . 0.0 109.941 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -93.25 -4.4 51.95 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.201 -0.937 . . . . 0.0 110.143 -179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 142' ' ' VAL . 12.5 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.044 -1.035 . . . . 0.0 109.587 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 121.351 0.596 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -23.74 60.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.206 -0.934 . . . . 0.0 109.709 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.9 HG12 HG23 ' A' ' 146' ' ' THR . 3.5 mp -82.64 -37.85 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.142 -0.974 . . . . 0.0 109.929 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -42.05 95.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.722 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -79.56 -30.14 41.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.148 -0.97 . . . . 0.0 109.442 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -67.38 -27.02 66.76 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 82.0 t80 -68.44 -54.61 15.93 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.652 0.739 . . . . 0.0 109.247 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -63.78 -27.91 69.51 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 87' ' ' GLU . 8.5 t -50.09 -30.1 6.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.48 ' HB2' HD13 ' A' ' 100' ' ' ILE . 87.1 m-85 -98.02 -35.42 10.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -90.13 95.71 10.33 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -89.98 -26.02 20.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.207 -0.933 . . . . 0.0 110.841 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -78.99 5.26 12.12 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.062 -1.024 . . . . 0.0 109.055 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 40.94 33.12 0.62 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -75.81 -70.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -1.117 . . . . 0.0 109.081 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.19 -53.98 0.09 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.629 ' CE2' ' NE2' ' A' ' 135' ' ' GLN . 9.7 m-30 -107.95 152.15 24.84 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.488 -1.007 . . . . 0.0 109.047 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.488 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 86.0 mt -88.63 128.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 109.911 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.9 p -90.36 -176.58 4.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.327 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.664 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -67.51 -50.71 57.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.74 -29.52 69.43 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.382 -0.824 . . . . 0.0 109.526 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 28.5 mt-10 -73.64 -30.79 63.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.16 -0.962 . . . . 0.0 108.953 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 109' ' ' MET . 2.2 tp -91.06 -9.21 46.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.46 -0.775 . . . . 0.0 109.211 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -91.53 -40.24 11.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.383 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.579 ' O ' HG22 ' A' ' 110' ' ' THR . 24.4 t60 -54.83 -35.22 63.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.627 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 91' ' ' VAL . 71.1 t -88.85 -44.64 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.118 -0.989 . . . . 0.0 110.056 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.551 ' HB3' HD13 ' A' ' 116' ' ' LEU . 97.1 mmm -68.13 -7.65 31.64 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 109.188 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 107' ' ' HIS . 6.6 t -98.86 -19.54 17.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.125 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.636 ' O ' HD23 ' A' ' 112' ' ' LEU . 3.3 m120 -89.23 31.3 0.9 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.129 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER 161.03 -19.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.585 -0.697 . . . . 0.0 109.725 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -85.83 20.86 17.38 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.506 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.529 ' O ' ' O ' ' A' ' 115' ' ' LYS . 13.3 mt-10 62.08 40.61 11.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.112 -1.228 . . . . 0.0 110.125 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 114' ' ' GLU . 3.1 ttpp 50.0 115.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.767 0.794 . . . . 0.0 111.45 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' A' ' 124' ' ' MET . 0.7 OUTLIER -95.36 159.26 15.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 109.356 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 121' ' ' VAL . 21.7 p -92.41 -171.64 2.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 109.774 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.87 -47.82 8.3 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.465 -0.772 . . . . 0.0 109.025 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.42 -13.18 62.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 108.838 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 23.9 tp10 -93.46 -42.23 9.37 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.475 -0.766 . . . . 0.0 109.137 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.664 HG11 ' HB1' ' A' ' 102' ' ' ALA . 6.9 t -53.87 -61.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.422 -0.798 . . . . 0.0 109.775 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -48.1 -27.73 2.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.987 . . . . 0.0 109.952 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -77.33 -39.74 46.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.196 -0.94 . . . . 0.0 109.326 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.553 ' HG3' HD21 ' A' ' 116' ' ' LEU . 25.1 mmm -66.38 -22.3 66.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.872 -1.142 . . . . 0.0 108.586 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.636 HG23 HG23 ' A' ' 136' ' ' VAL . 3.2 mt -86.91 -38.3 12.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -55.88 -22.82 27.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.636 -0.665 . . . . 0.0 110.062 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.488 ' HG2' ' HG3' ' A' ' 126' ' ' ARG . 3.1 mt-10 -90.41 -34.57 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 0.0 109.75 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.24 -13.49 60.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.917 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.844 ' OD1' HG22 ' A' ' 136' ' ' VAL . 7.1 m-20 -94.68 142.45 27.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.615 HD12 ' OE2' ' A' ' 140' ' ' GLU . 73.2 mt -89.26 -37.15 9.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.324 -0.86 . . . . 0.0 109.22 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -39.09 24.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.514 -0.741 . . . . 0.0 109.439 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.36 29.94 13.3 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.14 -25.43 42.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -1.072 . . . . 0.0 109.09 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 117.48 5.77 14.01 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.629 ' NE2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -129.27 157.64 41.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.892 -1.357 . . . . 0.0 109.434 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.844 HG22 ' OD1' ' A' ' 129' ' ' ASP . 77.9 t -116.27 165.28 11.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.192 -0.943 . . . . 0.0 108.61 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -141.39 -164.19 1.71 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.925 -1.109 . . . . 0.0 108.512 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.501 ' O ' HG23 ' A' ' 142' ' ' VAL . 65.1 t80 -81.45 -42.17 20.73 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.126 -0.984 . . . . 0.0 109.182 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -68.34 -29.43 68.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.392 -0.817 . . . . 0.0 109.199 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.615 ' OE2' HD12 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -86.27 -33.91 20.54 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.418 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 60.1 t80 -70.94 -24.43 62.44 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.561 -0.712 . . . . 0.0 109.293 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.683 HG13 ' OG1' ' A' ' 146' ' ' THR . 3.8 t -66.01 -51.64 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.498 -0.751 . . . . 0.0 109.991 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -59.79 -26.03 65.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.115 -0.991 . . . . 0.0 110.662 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -28.37 19.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.854 -1.154 . . . . 0.0 110.742 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.4 tpt -102.57 -61.86 1.34 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.012 -1.055 . . . . 0.0 109.801 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.9 HG23 HG12 ' A' ' 85' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.302 -1.5 0 O-C-N 121.486 -0.759 . . . . 0.0 109.88 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 2.2 tm-20 -65.73 -35.8 81.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.416 -0.802 . . . . 0.0 109.531 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.603 HG21 ' HA ' ' A' ' 142' ' ' VAL . 2.8 mp -80.3 -37.65 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.271 -0.893 . . . . 0.0 110.026 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.483 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 5.7 ttp180 -48.53 -39.72 24.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.062 -1.024 . . . . 0.0 109.715 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 11.3 pt-20 -82.26 -50.74 8.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.111 -0.993 . . . . 0.0 109.875 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -45.59 -27.23 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.002 -1.061 . . . . 0.0 108.922 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.416 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 91.4 t80 -63.51 -56.99 11.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.419 -0.8 . . . . 0.0 109.753 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -62.03 -32.07 72.53 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.529 -0.732 . . . . 0.0 109.112 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 55.1 t -44.56 -30.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -99.44 -35.48 9.89 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.457 ' HB2' HG12 ' A' ' 100' ' ' ILE . 10.1 t0 -91.55 98.88 11.93 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.505 -0.747 . . . . 0.0 109.377 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.418 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 0.0 OUTLIER -90.32 -23.61 21.1 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.245 -0.909 . . . . 0.0 110.262 -179.487 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -79.01 3.68 16.54 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 109.337 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.61 31.76 0.09 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 95' ' ' ASP . 11.4 p-10 -80.47 -24.03 39.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.071 -1.252 . . . . 0.0 109.87 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.509 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 126.33 -44.64 1.23 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 52.3 m-85 -110.4 145.03 38.27 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.495 -1.003 . . . . 0.0 109.629 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 71.6 mt -90.43 94.31 4.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.453 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -66.58 158.61 29.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.106 -0.996 . . . . 0.0 109.208 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.552 ' HA ' HG11 ' A' ' 121' ' ' VAL . . . -45.49 -42.38 10.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.108 -0.995 . . . . 0.0 109.266 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.26 99.17 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.311 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.455 ' OE1' ' HB2' ' A' ' 95' ' ' ASP . 1.5 mm-40 -64.47 -24.15 67.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 0.0 109.199 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.481 HD23 HG13 ' A' ' 121' ' ' VAL . 34.7 tp -88.83 -16.83 31.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.747 ' O ' HG22 ' A' ' 110' ' ' THR . 5.6 ttt-85 -83.44 -35.23 25.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.505 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.418 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 23.3 t60 -42.24 -49.9 4.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.667 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.7 t -95.59 -24.77 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.987 -1.071 . . . . 0.0 110.717 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.521 ' HB2' ' HA ' ' A' ' 106' ' ' ARG . 8.3 mmt -64.17 -23.49 67.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.05 -1.031 . . . . 0.0 109.758 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -82.1 -31.13 30.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 109.795 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.405 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 22.5 t-20 -56.88 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.456 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 112' ' ' LEU . 1.5 mt 56.92 24.11 8.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.478 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -117.67 51.94 0.71 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 57.4 178.87 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -1.165 . . . . 0.0 109.346 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -112.98 79.79 1.27 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.331 -0.856 . . . . 0.0 109.215 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.584 HD11 HG22 ' A' ' 121' ' ' VAL . 1.0 OUTLIER -94.21 133.84 37.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.972 . . . . 0.0 109.378 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.901 ' O ' HG23 ' A' ' 121' ' ' VAL . 5.3 t -92.08 -146.14 0.21 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.363 -0.836 . . . . 0.0 109.237 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.778 ' N ' HG23 ' A' ' 117' ' ' THR . 3.9 m-20 -78.63 -48.85 14.28 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.552 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 117' ' ' THR . 20.8 mt-10 -54.48 -24.99 22.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 109.709 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.597 ' HG2' HG22 ' A' ' 117' ' ' THR . 18.1 mm-40 -86.96 -47.98 8.52 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 117' ' ' THR . 92.5 t -54.81 -26.15 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.72 -0.613 . . . . 0.0 109.568 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -68.36 -34.89 76.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -79.95 -19.0 49.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.948 -1.095 . . . . 0.0 108.598 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 15.2 mmt -88.91 -20.78 24.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.681 HG23 HG23 ' A' ' 136' ' ' VAL . 7.6 mt -92.43 -45.6 14.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.73 0.776 . . . . 0.0 109.718 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.7 -26.35 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.682 -0.636 . . . . 0.0 110.723 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -90.35 -37.15 14.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.985 -1.072 . . . . 0.0 109.749 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.43 ' HB2' ' CE ' ' A' ' 144' ' ' MET . . . -80.09 -4.36 52.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.852 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -96.67 176.75 5.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 3.7 mt -69.92 -69.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.362 -0.836 . . . . 0.0 109.437 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 130' ' ' ILE . 3.0 p-10 -179.24 32.95 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.44 -0.788 . . . . 0.0 110.533 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 146.93 49.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.068 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 129' ' ' ASP . 2.2 p30 -112.55 -24.65 9.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -1.119 . . . . 0.0 109.035 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.29 -10.2 55.2 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.448 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 4.3 pt20 -144.91 -170.35 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -1.154 . . . . 0.0 109.133 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.681 HG23 HG23 ' A' ' 125' ' ' ILE . 53.6 t -126.33 160.4 33.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.607 ' HB3' ' OE1' ' A' ' 140' ' ' GLU . 3.9 t-20 -141.53 -166.48 2.21 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.755 ' O ' HG23 ' A' ' 142' ' ' VAL . 88.4 t80 -78.19 -31.07 49.31 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.563 -1.336 . . . . 0.0 112.106 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -15.43 60.07 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.462 -1.399 . . . . 0.0 110.321 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.607 ' OE1' ' HB3' ' A' ' 137' ' ' ASN . 3.8 mp0 -100.57 -34.64 9.82 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.416 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 50.9 t80 -71.88 -25.28 61.87 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 138' ' ' TYR . 9.9 t -60.43 -55.27 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -65.44 -21.05 66.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.762 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.43 ' CE ' ' HB2' ' A' ' 128' ' ' ALA . 3.1 tpt -85.16 -20.55 30.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 0.0 109.726 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -39.64 20.58 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.141 -0.975 . . . . 0.0 109.482 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.929 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 86' ' ' ARG . 15.9 tt0 . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 121.318 0.58 . . . . 0.0 109.807 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -46.38 -27.52 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 110.095 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.826 HG21 HG22 ' A' ' 142' ' ' VAL . 5.1 mm -77.4 -47.45 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.17 -0.956 . . . . 0.0 110.446 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.476 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 5.3 mmm180 -47.73 -45.07 28.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.101 -0.999 . . . . 0.0 109.908 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 10.4 pt-20 -79.99 -39.79 29.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.059 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.539 ' N ' ' HG3' ' A' ' 87' ' ' GLU . . . -57.88 -19.54 30.23 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.912 -1.117 . . . . 0.0 108.48 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 82.4 t80 -71.53 -55.44 7.82 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.451 -0.78 . . . . 0.0 109.326 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -63.77 -27.45 69.2 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.513 HG12 HG21 ' A' ' 108' ' ' VAL . 24.3 t -50.14 -30.72 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.6 ' CE2' ' HB ' ' A' ' 108' ' ' VAL . 65.1 m-85 -96.88 -33.91 11.45 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.467 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 23.3 t0 -97.83 91.94 5.6 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.773 -0.58 . . . . 0.0 109.649 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 94' ' ' LYS . 19.4 mmmt -90.19 -19.34 24.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.285 -0.884 . . . . 0.0 110.013 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -77.94 2.43 17.53 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.344 -0.848 . . . . 0.0 109.386 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 39.57 37.54 0.86 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -85.86 -25.65 26.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -1.194 . . . . 0.0 109.556 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.18 -48.1 0.98 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.487 ' HB3' ' O ' ' A' ' 136' ' ' VAL . 13.5 m-30 -112.85 178.4 4.3 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.564 -0.962 . . . . 0.0 108.786 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.467 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 54.2 mt -113.04 128.29 69.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.471 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -87.37 -178.96 6.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.838 . . . . 0.0 109.8 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.596 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -67.4 -47.28 70.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 0.0 109.181 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.81 -31.76 72.82 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.368 -0.832 . . . . 0.0 109.027 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 65.2 mm-40 -70.67 -23.1 62.44 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 1.05 HD22 ' CE ' ' A' ' 109' ' ' MET . 0.5 OUTLIER -82.64 -36.43 26.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.474 -0.766 . . . . 0.0 109.324 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -9.61 58.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.117 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -75.99 -34.65 59.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.83 . . . . 0.0 110.392 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.6 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 52.2 t -111.36 -42.79 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.919 -1.113 . . . . 0.0 110.582 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 1.05 ' CE ' HD22 ' A' ' 105' ' ' LEU . 4.4 mtm -55.03 -16.57 2.95 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.111 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.35 -34.84 23.56 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.851 -1.155 . . . . 0.0 108.938 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.782 ' HB3' HD23 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -56.26 -55.86 28.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.829 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.782 HD23 ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -135.47 7.74 3.33 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.968 . . . . 0.0 110.025 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.483 ' CA ' ' O ' ' A' ' 109' ' ' MET . . . -103.23 36.79 4.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.56 ' O ' HD23 ' A' ' 116' ' ' LEU . 41.0 mt-10 64.85 114.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.439 -1.036 . . . . 0.0 108.789 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.63 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.447 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.701 ' H ' HD23 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -93.97 174.12 7.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 108.779 179.093 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 121' ' ' VAL . 1.4 t -120.32 171.89 8.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 0.0 108.588 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 119' ' ' GLU . 1.1 m-20 -48.67 -48.35 40.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.073 -1.017 . . . . 0.0 110.615 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -41.81 -38.78 1.58 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.24 -0.912 . . . . 0.0 110.332 -179.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 121' ' ' VAL . 3.0 mt-10 -87.72 -46.6 9.34 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.391 -0.818 . . . . 0.0 110.086 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.596 HG11 ' HB1' ' A' ' 102' ' ' ALA . 71.1 t -32.83 -50.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.668 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -50.78 72.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.761 -1.212 . . . . 0.0 109.418 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.58 -13.4 61.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 108.794 179.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.432 ' HG3' HD13 ' A' ' 116' ' ' LEU . 5.8 mmt -89.35 -22.42 22.62 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.932 HG21 ' O ' ' A' ' 134' ' ' GLY . 4.0 mt -80.1 -42.99 22.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.19 -19.12 18.8 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.659 -0.651 . . . . 0.0 109.98 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 20.4 mm-40 -90.6 -24.56 20.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.133 -0.979 . . . . 0.0 110.018 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.41 -59.82 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.359 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 43.5 p30 -47.46 154.86 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.7 mt -102.05 -40.58 7.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.187 -0.946 . . . . 0.0 109.754 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.27 -40.77 36.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.52 -0.737 . . . . 0.0 109.641 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.53 33.37 5.11 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.07 -23.04 44.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -1.084 . . . . 0.0 109.099 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.932 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 117.21 -30.06 6.45 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.75 167.51 10.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -1.199 . . . . 0.0 109.277 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 68.6 t -119.98 160.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.2 -0.938 . . . . 0.0 108.666 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.5 ' ND2' ' HG3' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -135.99 -164.41 1.55 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.63 -1.294 . . . . 0.0 108.648 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.547 ' O ' HG23 ' A' ' 142' ' ' VAL . 64.9 t80 -75.66 -42.07 52.32 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.973 -1.079 . . . . 0.0 109.817 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -65.15 -47.8 75.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.117 -0.989 . . . . 0.0 109.432 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.5 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 55.8 mt-10 -69.84 -36.77 75.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.126 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 145' ' ' MET . 44.0 t80 -64.72 -27.62 69.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.844 . . . . 0.0 109.081 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.826 HG22 HG21 ' A' ' 85' ' ' ILE . 4.6 t -61.28 -47.83 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.837 . . . . 0.0 109.859 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -53.23 -37.75 62.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -0.978 . . . . 0.0 110.482 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.11 -23.31 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.055 -1.028 . . . . 0.0 110.022 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.52 ' CG ' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -86.08 -11.06 53.75 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.092 -1.005 . . . . 0.0 109.849 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.129 -0.982 . . . . 0.0 109.615 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 1.4 tt0 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.59 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 6.7 tt0 -79.17 7.96 6.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.536 -0.728 . . . . 0.0 109.612 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.5 mm -117.89 -42.98 2.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.111 -0.993 . . . . 0.0 109.722 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.451 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 4.6 mtp180 -66.83 -33.32 75.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -0.981 . . . . 0.0 109.08 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.689 ' O ' HG23 ' A' ' 91' ' ' VAL . 18.5 pt-20 -96.57 -26.77 15.12 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.24 -0.913 . . . . 0.0 109.106 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -67.64 -29.52 68.85 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 84.6 t80 -62.07 -56.05 22.84 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.568 -0.708 . . . . 0.0 109.196 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -33.35 74.98 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.253 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.751 ' O ' HG21 ' A' ' 108' ' ' VAL . 23.7 t -47.91 -33.77 3.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.499 ' CD1' ' HB ' ' A' ' 108' ' ' VAL . 66.7 m-85 -92.33 -30.9 15.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.496 ' HB2' HG12 ' A' ' 100' ' ' ILE . 26.2 t0 -100.33 83.04 2.58 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -73.32 -21.12 60.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 110.248 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -77.87 0.52 23.68 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.251 -0.906 . . . . 0.0 109.012 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.42 50.68 1.78 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 7.8 p-10 -107.49 -14.26 14.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 109.802 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.39 -26.48 11.05 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.671 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.2 m-85 -121.12 146.66 46.51 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.377 -1.072 . . . . 0.0 109.262 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.496 HG12 ' HB2' ' A' ' 93' ' ' ASP . 76.6 mt -103.54 120.85 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.429 -0.794 . . . . 0.0 109.54 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.6 p -81.96 170.78 15.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.095 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.829 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -59.55 -45.8 90.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.046 -1.034 . . . . 0.0 109.475 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.37 83.45 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.219 -0.926 . . . . 0.0 109.462 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -73.28 -20.9 60.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.18 -0.95 . . . . 0.0 108.586 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 105' ' ' LEU . 15.4 tp -87.21 -23.69 24.67 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.47 -0.769 . . . . 0.0 109.534 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.488 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 23.3 ttt180 -82.97 -39.5 21.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -50.1 -30.51 11.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 110.403 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.751 HG21 ' O ' ' A' ' 91' ' ' VAL . 98.9 t -110.17 -26.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.001 -1.062 . . . . 0.0 110.173 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.659 ' HB3' HD21 ' A' ' 116' ' ' LEU . 2.3 mmt -61.95 -14.39 34.33 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.339 -0.851 . . . . 0.0 109.656 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -82.6 -35.26 27.22 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.283 -0.886 . . . . 0.0 109.655 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 110' ' ' THR . 10.7 m120 -43.43 -59.14 2.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.461 ' C ' HD12 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -144.29 16.8 1.7 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.407 -0.808 . . . . 0.0 109.134 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.487 ' O ' HD23 ' A' ' 116' ' ' LEU . . . -94.97 30.84 7.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.431 ' HG2' ' C ' ' A' ' 113' ' ' GLY . 23.9 mm-40 71.1 167.28 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -1.179 . . . . 0.0 109.703 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -90.6 73.33 6.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.659 HD21 ' HB3' ' A' ' 109' ' ' MET . 0.7 OUTLIER -97.97 153.55 18.29 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.584 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.896 ' O ' HG23 ' A' ' 121' ' ' VAL . 1.7 p -101.05 -150.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.141 -0.974 . . . . 0.0 109.776 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 4.1 m-20 -77.86 -54.07 6.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.0 109.853 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.432 ' HG3' ' OE1' ' A' ' 120' ' ' GLU . 10.9 pt-20 -48.98 -38.23 22.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 0.0 109.125 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 2.6 mm-40 -71.5 -46.64 59.2 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 117' ' ' THR . 21.3 t -37.64 -51.82 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.105 0.479 . . . . 0.0 110.109 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 122' ' ' ASP . 37.7 t0 -54.26 -46.9 72.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.109 -0.995 . . . . 0.0 109.844 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -63.37 -31.69 72.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.979 . . . . 0.0 109.75 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 18.2 mmt -73.06 -26.17 61.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.93 -1.106 . . . . 0.0 108.293 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 105' ' ' LEU . 7.1 mt -76.28 -37.14 31.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -57.07 -14.28 3.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.845 -0.534 . . . . 0.0 110.206 -179.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -89.37 -30.14 18.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 0.0 109.277 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -102.96 -0.69 30.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.565 -0.71 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.446 ' CG ' HG22 ' A' ' 125' ' ' ILE . 7.5 m-20 -82.72 143.72 30.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.852 . . . . 0.0 110.01 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.529 HG12 ' CG ' ' A' ' 140' ' ' GLU . 33.0 mm -108.66 -32.9 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.323 -0.861 . . . . 0.0 109.139 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -97.6 -33.91 11.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.608 -0.683 . . . . 0.0 109.23 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.11 26.41 18.97 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.06 -28.25 39.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -1.142 . . . . 0.0 109.219 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.11 33.96 2.07 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.438 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -154.31 150.82 28.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.425 -1.044 . . . . 0.0 109.361 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.621 HG12 ' N ' ' A' ' 137' ' ' ASN . 89.6 t -112.86 167.1 6.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.186 -0.946 . . . . 0.0 109.318 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.671 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 7.5 p30 -150.6 -172.5 4.2 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.762 ' O ' HG23 ' A' ' 142' ' ' VAL . 51.7 t80 -68.53 -48.78 63.46 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.413 -1.429 . . . . 0.0 110.804 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 7.0 mp0 -54.86 -55.51 29.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.986 -1.071 . . . . 0.0 110.845 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.536 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 22.4 mt-10 -63.3 -41.91 99.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.863 -1.148 . . . . 0.0 109.904 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.441 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 51.8 t80 -64.68 -23.05 67.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 109.978 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 138' ' ' TYR . 43.2 t -76.37 -44.08 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.841 . . . . 0.0 110.47 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -64.47 -32.36 73.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.129 -0.982 . . . . 0.0 110.605 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -21.74 24.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.927 -1.108 . . . . 0.0 110.283 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.3 tpt -98.59 -6.63 29.61 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.897 -1.127 . . . . 0.0 110.649 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 O-C-N 120.678 -1.264 . . . . 0.0 110.733 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 121.123 0.487 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -30.14 65.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.973 . . . . 0.0 109.639 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mt -83.88 -40.72 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.916 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.8 mtt85 -58.64 -35.29 72.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.608 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.46 ' OE2' ' N ' ' A' ' 88' ' ' ALA . 0.8 OUTLIER -87.08 -31.68 20.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.577 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.5 -28.94 70.29 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.152 -0.967 . . . . 0.0 108.443 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.451 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 87.6 t80 -66.9 -53.0 36.42 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.408 -0.807 . . . . 0.0 109.507 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 1.8 mtp180 -66.2 -25.07 66.76 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 2.7 t -52.7 -24.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.501 ' CE1' ' HB ' ' A' ' 108' ' ' VAL . 75.5 m-85 -108.34 -30.08 8.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 39.0 t0 -95.25 76.06 3.42 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.447 ' HB2' ' OE1' ' A' ' 104' ' ' GLU . 11.3 mmmt -79.86 -16.75 54.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 96' ' ' GLY . 18.8 m-20 -78.32 5.5 10.33 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.984 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.14 38.11 0.32 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -93.66 -69.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.401 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.9 -50.85 0.11 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.625 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 11.3 m-30 -109.66 155.37 21.57 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.413 -1.051 . . . . 0.0 108.784 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.497 HD13 ' CB ' ' A' ' 92' ' ' PHE . 94.1 mt -90.51 122.37 41.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 109.597 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.2 p -85.38 174.14 9.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.401 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.548 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -66.0 -33.04 74.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.132 -0.98 . . . . 0.0 109.447 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.4 68.44 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.228 -0.92 . . . . 0.0 109.565 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 60.3 mm-40 -78.71 -20.96 48.87 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.578 HD22 HG12 ' A' ' 125' ' ' ILE . 3.2 tp -93.25 -17.49 23.59 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.581 -0.699 . . . . 0.0 109.277 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.429 ' O ' ' OG1' ' A' ' 110' ' ' THR . 15.1 ttt-85 -80.58 -21.99 41.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.198 -0.939 . . . . 0.0 109.251 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -70.55 -27.79 64.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.307 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.501 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 79.4 t -111.07 -21.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.917 -1.114 . . . . 0.0 110.122 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.502 ' HB3' HD21 ' A' ' 116' ' ' LEU . 10.5 mmt -67.48 -41.04 85.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.016 -1.052 . . . . 0.0 109.18 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -73.69 -15.99 61.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.377 -0.827 . . . . 0.0 109.867 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.838 ' C ' HD23 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -59.09 87.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.899 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.838 HD23 ' C ' ' A' ' 111' ' ' ASN . 1.4 pt? 36.29 29.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.637 -0.664 . . . . 0.0 110.835 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -96.03 -12.57 52.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 1.025 ' HG3' HD23 ' A' ' 116' ' ' LEU . 0.4 OUTLIER 151.27 -167.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 65.2 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.007 . . . . 0.0 109.167 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.025 HD23 ' HG3' ' A' ' 114' ' ' GLU . 1.7 pp -105.77 121.76 44.69 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.583 -0.698 . . . . 0.0 109.431 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.81 HG23 ' N ' ' A' ' 118' ' ' ASP . 4.5 t -86.5 -146.89 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.623 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.81 ' N ' HG23 ' A' ' 117' ' ' THR . 1.2 m-20 -73.4 -57.58 3.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.853 . . . . 0.0 109.873 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -20.41 2.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.847 . . . . 0.0 110.014 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.675 ' HG2' HG22 ' A' ' 117' ' ' THR . 27.4 mm-40 -89.77 -39.79 12.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 117' ' ' THR . 22.4 t -47.67 -61.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.185 0.517 . . . . 0.0 109.652 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 121' ' ' VAL . 49.4 t0 -41.75 -34.0 0.57 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.293 -0.879 . . . . 0.0 109.878 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -45.14 49.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 108.96 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.549 ' HE2' HD22 ' A' ' 116' ' ' LEU . 65.7 mmm -60.87 -20.67 62.27 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.18 -0.95 . . . . 0.0 108.723 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.578 HG12 HD22 ' A' ' 105' ' ' LEU . 3.0 mt -87.47 -38.81 12.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -19.22 4.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.816 -0.552 . . . . 0.0 109.657 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -89.29 -31.95 17.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 109.049 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 144' ' ' MET . . . -90.08 -5.0 57.03 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.409 -0.807 . . . . 0.0 109.255 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 125' ' ' ILE . 1.8 m-20 -95.18 133.72 38.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.313 -0.867 . . . . 0.0 109.382 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.493 HG13 ' OE1' ' A' ' 140' ' ' GLU . 41.3 mm -83.78 -49.74 16.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.142 -0.974 . . . . 0.0 109.383 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.45 -45.09 23.04 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.571 -0.706 . . . . 0.0 109.168 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.62 31.95 3.79 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.47 -27.36 41.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -1.038 . . . . 0.0 109.429 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.501 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 121.72 -16.21 8.97 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.847 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.625 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -109.18 164.59 12.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.739 -1.448 . . . . 0.0 109.587 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.559 HG23 HG23 ' A' ' 125' ' ' ILE . 53.8 t -121.87 163.65 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.257 -0.902 . . . . 0.0 108.707 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.567 ' ND2' ' HG2' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -135.1 -168.72 2.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.928 -1.108 . . . . 0.0 108.707 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.895 ' O ' HG23 ' A' ' 142' ' ' VAL . 73.0 t80 -80.47 -36.59 33.24 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.089 -1.007 . . . . 0.0 110.146 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -68.26 -34.26 75.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.567 ' HG2' ' ND2' ' A' ' 137' ' ' ASN . 4.1 mm-40 -83.52 -34.75 25.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 108.921 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.576 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 14.3 t80 -72.26 -23.17 61.16 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.45 -0.781 . . . . 0.0 109.158 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 138' ' ' TYR . 48.4 t -74.99 -59.51 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 0.0 109.694 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 12.4 mt-30 -53.34 -24.11 11.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.825 . . . . 0.0 110.538 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -90.7 -37.08 13.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.036 -1.04 . . . . 0.0 110.96 -178.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -84.8 -8.68 58.72 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.978 -1.077 . . . . 0.0 110.838 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 O-C-N 120.912 -1.118 . . . . 0.0 109.061 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -60.94 -19.51 60.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.716 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.47 HG21 ' HA ' ' A' ' 142' ' ' VAL . 3.5 mt -97.74 -38.13 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.185 -0.947 . . . . 0.0 110.047 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.535 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 2.9 ttt-85 -49.58 -32.13 12.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.041 -1.037 . . . . 0.0 109.49 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.1 mt-10 -91.01 -53.94 4.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 109.735 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -43.98 -27.03 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.0 108.79 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 138' ' ' TYR . 70.3 t80 -62.37 -58.08 8.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.411 -0.806 . . . . 0.0 109.141 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -60.04 -37.49 79.97 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.385 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.629 ' O ' HG21 ' A' ' 108' ' ' VAL . 59.5 t -42.9 -32.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.495 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 56.0 m-85 -95.93 -35.12 11.56 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.477 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 28.3 t0 -91.06 88.89 7.16 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -77.53 -21.16 53.08 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 110.229 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 96' ' ' GLY . 67.2 m-20 -78.21 0.4 25.24 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 109.133 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 35.47 49.25 0.94 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -106.79 -22.82 12.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.249 . . . . 0.0 109.666 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.36 -27.97 5.15 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.638 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.7 m-85 -121.61 145.46 47.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.412 -1.052 . . . . 0.0 108.985 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.477 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 56.8 mt -96.17 133.94 35.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.236 -0.915 . . . . 0.0 109.358 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.59 170.9 9.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.41 94.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 109.281 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.89 -35.83 77.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.391 -0.818 . . . . 0.0 109.703 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.57 ' O ' ' CE1' ' A' ' 107' ' ' HIS . 64.6 mm-40 -71.61 -21.86 61.79 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.174 -0.954 . . . . 0.0 108.495 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.505 ' HG ' ' CG ' ' A' ' 109' ' ' MET . 1.6 tp -99.73 4.49 45.49 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.585 -0.697 . . . . 0.0 109.212 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -96.92 -30.89 12.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.127 -0.983 . . . . 0.0 109.978 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.95 ' CD2' HG23 ' A' ' 108' ' ' VAL . 45.5 p-80 -88.07 -53.3 4.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 111.802 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.95 HG23 ' CD2' ' A' ' 107' ' ' HIS . 18.9 t -68.43 -54.14 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.168 -0.957 . . . . 0.0 110.968 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.505 ' CG ' ' HG ' ' A' ' 105' ' ' LEU . 1.5 mmt -35.98 -45.33 0.41 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.611 -0.681 . . . . 0.0 110.786 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.658 HG21 ' HA ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -88.88 -33.31 17.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.992 -1.067 . . . . 0.0 109.994 -179.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.459 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER 41.19 51.49 3.46 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.275 -0.891 . . . . 0.0 109.864 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER 56.33 41.26 29.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.351 -0.843 . . . . 0.0 110.115 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -141.63 8.1 2.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 0.3 OUTLIER 155.1 57.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.752 -0.852 . . . . 0.0 108.999 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.658 ' HA ' HG21 ' A' ' 110' ' ' THR . 3.1 ptpt -46.6 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.844 . . . . 0.0 110.318 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -70.59 156.81 38.96 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.146 -0.971 . . . . 0.0 108.794 179.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.978 ' O ' HG23 ' A' ' 121' ' ' VAL . 2.0 t -82.0 -174.78 5.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 109.486 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.16 -57.65 3.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 109.281 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.56 -24.04 4.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 108.887 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.429 ' CB ' HG22 ' A' ' 117' ' ' THR . 16.0 tp10 -81.11 -40.88 23.36 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 117' ' ' THR . 58.0 t -54.73 -48.39 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -31.54 29.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.842 . . . . 0.0 109.249 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 26.1 mm-40 -73.92 -39.58 63.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 109.042 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.9 mtt -67.33 -23.91 65.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.041 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.08 -40.03 15.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.441 -0.787 . . . . 0.0 109.805 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -15.41 6.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.511 -0.743 . . . . 0.0 110.359 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 4.1 mt-10 -90.16 -27.41 19.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.009 -1.057 . . . . 0.0 109.582 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.09 -58.45 2.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.918 . . . . 0.0 109.6 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 129' ' ' ASP . 40.2 p-10 -45.25 123.94 4.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.645 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.2 mt -91.89 -38.32 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.27 -0.894 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -76.23 -37.3 57.86 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.454 -0.779 . . . . 0.0 109.722 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.88 32.32 4.46 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.46 ' OD1' ' HG2' ' A' ' 135' ' ' GLN . 2.3 p30 -79.54 -24.56 42.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -1.075 . . . . 0.0 109.638 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.2 28.87 5.94 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.46 ' HG2' ' OD1' ' A' ' 133' ' ' ASP . 3.1 pt20 -160.23 -169.28 2.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -1.181 . . . . 0.0 108.993 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.619 HG12 ' N ' ' A' ' 137' ' ' ASN . 57.5 t -136.47 169.07 20.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.989 -1.07 . . . . 0.0 110.129 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.638 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -143.63 -167.92 2.7 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.252 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.888 ' O ' HG23 ' A' ' 142' ' ' VAL . 50.6 t80 -74.5 -38.36 62.87 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.805 -1.184 . . . . 0.0 109.497 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -49.68 68.02 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.308 -0.87 . . . . 0.0 109.701 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.508 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 50.2 mt-10 -68.23 -36.92 80.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.678 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.566 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 34.6 t80 -69.21 -26.91 65.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -0.921 . . . . 0.0 109.686 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 138' ' ' TYR . 48.1 t -68.12 -43.3 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.619 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -72.44 -21.99 61.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 0.0 109.878 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.43 -22.32 22.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.566 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.6 tpt -92.34 -59.15 2.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.078 -1.014 . . . . 0.0 109.787 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 142' ' ' VAL . 4.8 t . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.367 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.49 -47.56 81.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 0.0 110.109 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.679 ' CG2' HG22 ' A' ' 142' ' ' VAL . 3.2 mt -65.07 -36.85 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.155 -0.965 . . . . 0.0 110.159 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.587 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.4 mtp85 -50.67 -34.29 25.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.112 -0.992 . . . . 0.0 109.372 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 88' ' ' ALA . 3.4 mt-10 -87.73 -52.73 5.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 109.742 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.64 -26.83 0.41 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 108.635 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.54 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 88.0 t80 -62.77 -57.64 10.22 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.43 -0.794 . . . . 0.0 109.572 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.467 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -61.06 -31.66 71.32 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 109.04 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 70.4 t -46.66 -35.48 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.933 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 28.0 m-85 -87.29 -47.71 8.6 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 57.5 t0 -72.97 116.75 13.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.69 -25.29 21.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.142 -0.973 . . . . 0.0 110.125 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.9 OUTLIER -78.94 2.61 19.65 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 108.983 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.471 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.04 47.56 1.35 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -108.26 -38.63 5.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -1.202 . . . . 0.0 109.748 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.14 -10.44 2.27 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -130.26 151.06 51.18 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.165 -1.197 . . . . 0.0 109.946 -179.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.417 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 62.9 mt -114.0 141.18 31.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.24 -0.913 . . . . 0.0 109.339 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -100.44 -178.29 3.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.456 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -67.76 -46.17 72.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.338 -0.851 . . . . 0.0 109.242 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.49 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . . . -56.47 -47.12 79.86 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.373 -0.829 . . . . 0.0 109.343 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.451 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 97.7 mt-10 -65.75 -22.88 66.63 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD2' ' CG ' ' A' ' 109' ' ' MET . 0.6 OUTLIER -77.86 -25.19 48.51 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.521 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.835 ' HG2' HG21 ' A' ' 121' ' ' VAL . 8.9 mtm-85 -77.74 -45.71 23.9 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.216 -0.928 . . . . 0.0 108.55 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -48.09 -27.22 2.19 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.454 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.933 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 98.8 t -112.82 -39.26 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.612 -1.305 . . . . 0.0 111.309 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.587 ' CG ' ' CD2' ' A' ' 105' ' ' LEU . 10.6 mmt -61.76 -15.89 44.9 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 109.727 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.7 t -85.53 -25.12 26.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 109.34 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -54.75 -34.77 62.99 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.282 -0.886 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.47 ' H ' HD12 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -135.15 1.95 3.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.795 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -110.74 30.52 8.05 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 2.2 mt-10 59.06 -95.53 0.06 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.329 -1.1 . . . . 0.0 109.304 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -139.94 136.21 33.59 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.07 -1.019 . . . . 0.0 109.601 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.72 HD13 ' HG2' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -115.04 108.76 17.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.935 . . . . 0.0 109.544 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -72.53 -170.21 0.64 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.078 -1.014 . . . . 0.0 108.294 179.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -80.49 -54.96 5.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.915 -1.116 . . . . 0.0 108.882 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -22.62 65.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 108.838 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.72 ' HG2' HD13 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -77.61 -47.07 20.25 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.835 HG21 ' HG2' ' A' ' 106' ' ' ARG . 44.2 t -52.7 -46.5 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.488 -0.757 . . . . 0.0 110.087 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -48.64 -33.91 10.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 0.0 109.871 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -71.83 -37.96 70.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.404 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.428 ' SD ' HD11 ' A' ' 116' ' ' LEU . 2.6 mtt -68.54 -27.53 66.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.091 -1.006 . . . . 0.0 108.98 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 134' ' ' GLY . 6.0 mt -78.19 -37.47 22.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -57.82 -27.08 62.84 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.83 -0.544 . . . . 0.0 110.235 -179.417 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 126' ' ' ARG . 3.5 mt-10 -91.24 -16.95 26.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.021 -1.049 . . . . 0.0 109.859 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.534 ' O ' ' HE2' ' A' ' 144' ' ' MET . . . -99.15 -66.36 0.91 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.114 -0.991 . . . . 0.0 109.794 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 128' ' ' ALA . 6.8 t70 -46.12 154.74 0.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.37 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.5 mm -88.89 -65.22 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.715 0.769 . . . . 0.0 109.268 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -176.91 57.09 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.564 -0.71 . . . . 0.0 109.342 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -104.32 -89.63 2.12 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -129.46 -19.54 3.41 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.73 -0.865 . . . . 0.0 110.128 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.558 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 125.81 16.75 2.67 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 1.6 tt0 -112.56 163.38 14.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.23 -1.159 . . . . 0.0 108.674 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.576 HG12 ' N ' ' A' ' 137' ' ' ASN . 96.5 t -106.18 165.85 3.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 120.923 -1.11 . . . . 0.0 109.492 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.606 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -149.62 -171.31 3.86 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.893 ' O ' HG23 ' A' ' 142' ' ' VAL . 62.9 t80 -69.0 -37.7 78.86 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.607 -1.308 . . . . 0.0 111.337 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.41 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -68.88 -40.38 79.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.053 . . . . 0.0 110.377 -179.153 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.517 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 26.8 mt-10 -81.04 -23.04 38.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.933 -1.105 . . . . 0.0 109.192 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 145' ' ' MET . 28.4 t80 -84.28 -23.62 30.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.38 -0.825 . . . . 0.0 109.607 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 138' ' ' TYR . 52.2 t -73.97 -63.13 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.312 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -56.58 -24.54 48.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.534 ' HE2' ' O ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -90.23 -31.8 16.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.906 -1.121 . . . . 0.0 110.029 -179.506 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 141' ' ' PHE . 2.1 ttp -77.04 -16.87 59.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.086 -1.009 . . . . 0.0 109.784 -179.879 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.355 0.597 . . . . 0.0 109.922 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.611 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -100.22 -18.65 16.77 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.748 HG21 HG13 ' A' ' 142' ' ' VAL . 2.7 mp -83.5 -35.11 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.595 -0.691 . . . . 0.0 109.665 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.37 -45.89 90.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.111 -0.993 . . . . 0.0 109.344 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.67 -31.66 24.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.14 -0.975 . . . . 0.0 109.069 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -61.57 -24.01 66.36 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 138' ' ' TYR . 73.6 t80 -66.31 -55.47 15.84 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.418 -0.801 . . . . 0.0 109.279 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -28.84 70.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.223 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 4.8 t -48.18 -29.04 2.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.586 ' CE2' ' HB ' ' A' ' 108' ' ' VAL . 78.6 m-85 -100.32 -35.94 9.43 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.437 ' HB2' HG12 ' A' ' 100' ' ' ILE . 41.5 t0 -90.36 87.16 6.69 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -77.25 -18.48 57.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.836 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ASN . 10.3 t70 -78.02 2.32 18.11 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.405 -0.81 . . . . 0.0 109.252 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.39 29.92 0.05 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' ASP . 4.0 t30 -88.93 -36.94 15.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.089 -1.242 . . . . 0.0 109.467 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.54 -14.17 4.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -128.37 146.55 50.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.25 -1.147 . . . . 0.0 109.746 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 93' ' ' ASP . 87.0 mt -105.05 131.63 53.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.566 -0.709 . . . . 0.0 109.448 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.51 172.25 8.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.189 -0.944 . . . . 0.0 109.574 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.85 81.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 109.399 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.89 -35.89 75.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.362 -0.836 . . . . 0.0 109.332 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 66.1 mm-40 -70.64 -23.41 62.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.151 -0.968 . . . . 0.0 108.861 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.947 HD23 HG13 ' A' ' 121' ' ' VAL . 55.8 tp -83.9 -25.15 30.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.546 -0.722 . . . . 0.0 109.301 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.03 -24.95 43.28 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.246 -0.909 . . . . 0.0 108.967 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -59.91 -29.61 68.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 110.297 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.586 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 95.5 t -111.23 -46.62 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.887 -1.133 . . . . 0.0 110.203 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -52.69 -58.98 5.08 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.451 -0.78 . . . . 0.0 109.241 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -91.16 13.09 18.0 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.412 -0.805 . . . . 0.0 110.137 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.517 ' HB3' ' HA ' ' A' ' 108' ' ' VAL . 3.0 p-10 -43.41 -48.44 7.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 0.0 109.785 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 111' ' ' ASN . 20.1 mt -152.53 14.67 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.013 . . . . 0.0 109.94 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -106.3 -14.51 20.11 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.743 ' HA ' HG22 ' A' ' 110' ' ' THR . 37.1 mt-10 54.55 30.43 13.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.412 -1.052 . . . . 0.0 109.24 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -79.31 161.01 26.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.763 HD13 HG23 ' A' ' 121' ' ' VAL . 3.6 pp 31.95 -157.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.499 0.666 . . . . 0.0 111.391 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.881 ' O ' HG23 ' A' ' 121' ' ' VAL . 4.0 t -152.19 -161.79 1.38 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.189 -0.945 . . . . 0.0 108.913 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.57 ' N ' HG23 ' A' ' 117' ' ' THR . 1.0 OUTLIER -79.73 -50.15 11.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.065 -1.022 . . . . 0.0 110.14 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -67.56 -13.1 61.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 109.618 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 116' ' ' LEU . 5.5 tt0 -97.5 -34.77 10.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.27 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.947 HG13 HD23 ' A' ' 105' ' ' LEU . 11.6 t -49.5 -51.75 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -41.14 -37.65 0.93 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 109.805 -179.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.522 ' HG2' ' HD2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -68.25 -57.51 5.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.158 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.533 ' SD ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -49.86 -22.73 1.58 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.158 179.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.682 HG23 HG23 ' A' ' 136' ' ' VAL . 3.4 mt -84.66 -38.65 13.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.63 0.729 . . . . 0.0 109.741 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.522 ' HD2' ' HG2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -62.02 -31.16 71.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.035 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.02 -9.51 53.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.106 -0.996 . . . . 0.0 109.113 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.57 -14.0 18.38 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.442 -0.786 . . . . 0.0 109.047 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.592 ' OD1' HG22 ' A' ' 136' ' ' VAL . 9.8 m-20 -92.63 164.27 13.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.433 -0.792 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.9 mt -86.16 -53.48 10.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.271 -0.893 . . . . 0.0 109.562 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.52 -46.58 46.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.495 -0.753 . . . . 0.0 109.673 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.79 30.71 4.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 135' ' ' GLN . 0.7 OUTLIER -79.85 -24.79 41.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -1.144 . . . . 0.0 109.596 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.39 16.91 9.77 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.561 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -128.65 147.53 50.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -1.088 . . . . 0.0 109.205 -179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.682 HG23 HG23 ' A' ' 125' ' ' ILE . 71.9 t -115.0 165.54 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.079 -1.013 . . . . 0.0 109.574 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.606 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -140.56 -168.05 2.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.975 ' O ' HG23 ' A' ' 142' ' ' VAL . 38.2 t80 -65.67 -52.64 50.05 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.715 -1.24 . . . . 0.0 110.689 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.465 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 2.6 mt-10 -58.44 -60.56 3.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.051 -1.03 . . . . 0.0 110.155 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 129' ' ' ASP . 13.5 mt-10 -52.14 -38.67 58.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 110.275 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.463 ' CE2' ' HA ' ' A' ' 89' ' ' PHE . 38.5 t80 -69.65 -29.22 66.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.981 -1.074 . . . . 0.0 109.81 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.975 HG23 ' O ' ' A' ' 138' ' ' TYR . 59.7 t -67.34 -39.36 82.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.444 -0.785 . . . . 0.0 109.875 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -64.06 -32.09 73.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.6 tmm? -90.2 -21.47 22.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.019 . . . . 0.0 110.029 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -57.94 3.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.08 -1.012 . . . . 0.0 109.913 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.653 ' O ' HG22 ' A' ' 146' ' ' THR . 1.4 m . . . . . 0 C--N 1.305 -1.334 0 O-C-N 121.191 -0.943 . . . . 0.0 109.229 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 N--CA 1.485 1.293 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.31 -13.29 18.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 109.687 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.533 ' CG2' HG22 ' A' ' 142' ' ' VAL . 8.4 mt -86.71 -49.54 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.128 -0.983 . . . . 0.0 109.207 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.614 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.2 ttp180 -47.97 -29.26 3.27 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.254 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 88' ' ' ALA . 46.5 mt-10 -93.46 -53.25 4.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.92 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -45.82 -25.5 0.52 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.999 -1.063 . . . . 0.0 109.0 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 87.2 t80 -65.61 -56.25 13.24 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.441 -0.787 . . . . 0.0 109.604 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -62.08 -32.43 72.96 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.673 -0.642 . . . . 0.0 109.272 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 32.5 t -47.41 -31.08 2.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 64.4 m-85 -96.9 -33.71 11.52 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.453 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 25.8 t0 -92.57 108.15 19.76 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.539 ' HD3' ' CE1' ' A' ' 107' ' ' HIS . 0.1 OUTLIER -80.1 -26.56 39.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.113 -0.992 . . . . 0.0 110.128 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 97' ' ' ASN . 47.3 m-20 -79.15 2.67 20.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.3 -0.875 . . . . 0.0 108.934 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 34.53 34.56 0.04 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' ASP . 3.5 t30 -87.32 -59.15 2.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -1.201 . . . . 0.0 109.836 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 137' ' ' ASN . . . 166.39 -24.15 0.14 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.647 ' CE2' ' HB3' ' A' ' 137' ' ' ASN . 15.4 m-85 -122.42 139.88 53.34 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.257 -1.143 . . . . 0.0 109.791 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.528 HG23 ' HB2' ' A' ' 104' ' ' GLU . 63.1 mt -100.47 141.98 16.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.447 ' OG ' ' HG3' ' A' ' 104' ' ' GLU . 88.9 p -109.91 -178.67 3.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.052 -1.03 . . . . 0.0 109.153 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 105' ' ' LEU . . . -62.38 -45.33 93.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 109.284 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.4 -46.43 88.71 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.37 -0.831 . . . . 0.0 109.539 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.528 ' HB2' HG23 ' A' ' 100' ' ' ILE . 28.5 mt-10 -62.97 -24.26 67.82 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.839 HD23 HG13 ' A' ' 121' ' ' VAL . 57.8 tp -71.28 -38.47 71.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.514 ' O ' ' CG ' ' A' ' 109' ' ' MET . 0.5 OUTLIER -70.92 -11.06 60.75 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.539 ' CE1' ' HD3' ' A' ' 94' ' ' LYS . 11.9 t-160 -57.82 -47.09 83.65 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.42 -0.8 . . . . 0.0 110.037 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' ' C ' ' A' ' 109' ' ' MET . 10.6 t -106.55 -5.66 10.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.243 -0.91 . . . . 0.0 110.103 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.525 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -39.12 -38.58 0.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 110.806 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.527 ' HA ' ' CA ' ' A' ' 114' ' ' GLU . 7.2 t -94.69 -34.65 12.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.869 -1.144 . . . . 0.0 110.226 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.433 ' HB2' HG13 ' A' ' 108' ' ' VAL . 15.6 m-80 -58.14 -18.54 26.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.929 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 mt -145.39 -20.37 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.043 -1.036 . . . . 0.0 111.222 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' MET . . . -124.14 18.54 7.41 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.203 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.527 ' CA ' ' HA ' ' A' ' 110' ' ' THR . 22.5 mt-10 58.1 179.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -1.223 . . . . 0.0 109.601 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 0.3 OUTLIER -54.64 133.57 46.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.912 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 0.4 OUTLIER -108.89 -164.8 0.97 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.198 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.516 ' OG1' ' HG3' ' A' ' 120' ' ' GLU . 3.0 p -149.47 -150.09 0.33 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.398 -0.814 . . . . 0.0 108.85 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.51 -49.31 7.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.44 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -68.96 -15.72 63.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 0.0 109.889 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.516 ' HG3' ' OG1' ' A' ' 117' ' ' THR . 0.1 OUTLIER -94.52 -37.1 11.55 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.109 -0.994 . . . . 0.0 108.996 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.839 HG13 HD23 ' A' ' 105' ' ' LEU . 29.3 t -72.0 -70.38 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.819 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -50.76 -27.65 7.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 0.0 109.434 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 79.1 tt0 -75.2 -39.15 60.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 0.0 108.703 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . 0.641 ' HB2' HD21 ' A' ' 105' ' ' LEU . 23.1 mtp -61.83 -29.84 70.44 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.8 mt -77.08 -40.81 30.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.5 mtp85 -57.77 -33.15 68.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.624 -0.672 . . . . 0.0 109.931 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -81.38 -20.09 41.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 108.9 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.478 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -97.46 -6.54 33.61 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.514 -0.741 . . . . 0.0 109.469 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.82 131.21 35.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.31 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.463 HD12 ' CD ' ' A' ' 140' ' ' GLU . 47.5 mt -104.9 -32.42 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.157 -0.965 . . . . 0.0 109.745 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.53 -41.86 6.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.767 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.23 36.21 2.0 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.3 p30 -79.16 -26.65 42.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.324 -1.104 . . . . 0.0 108.885 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 119.42 -40.75 2.15 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.47 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 15.3 pm0 -110.05 -177.39 3.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -1.164 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 137' ' ' ASN . 99.5 t -122.64 171.83 10.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.343 -0.848 . . . . 0.0 108.852 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.647 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 1.4 p-10 -148.57 -175.04 4.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.795 -1.191 . . . . 0.0 108.828 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.662 ' O ' HG23 ' A' ' 142' ' ' VAL . 52.5 t80 -71.75 -39.8 69.79 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.804 -1.185 . . . . 0.0 110.721 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.42 -48.5 75.13 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.992 -1.067 . . . . 0.0 109.985 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.482 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 1.3 mm-40 -71.83 -32.6 67.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.495 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 37.4 t80 -72.76 -25.78 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.868 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 138' ' ' TYR . 39.6 t -74.01 -51.16 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -59.81 -30.67 69.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.185 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 8.1 tpp -84.46 -29.98 25.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.009 -1.057 . . . . 0.0 109.924 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.495 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 3.1 tmm? -91.41 -5.14 54.86 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.184 -0.947 . . . . 0.0 110.217 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 142' ' ' VAL . 1.2 t . . . . . 0 N--CA 1.494 1.767 0 O-C-N 120.98 -1.075 . . . . 0.0 110.206 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.428 ' O ' ' CG ' ' A' ' 78' ' ' ASP . 0.2 OUTLIER 173.01 132.18 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 77' ' ' LYS . 0.9 OUTLIER 40.66 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.551 -0.718 . . . . 0.0 109.881 179.92 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 4.3 t -169.73 163.82 9.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.509 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.57 6.25 11.68 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.335 -0.853 . . . . 0.0 109.478 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.45 104.22 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.286 -0.884 . . . . 0.0 109.43 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -64.31 -13.57 50.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.207 -0.933 . . . . 0.0 108.95 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.436 ' HA ' ' HB2' ' A' ' 86' ' ' ARG . 1.3 mt-10 -75.8 -29.33 58.67 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.443 -0.786 . . . . 0.0 109.095 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -43.7 -33.85 1.34 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 0.0 109.65 -179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.59 HG21 HG22 ' A' ' 142' ' ' VAL . 2.1 mp -93.17 -34.88 6.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.198 -0.939 . . . . 0.0 109.929 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.471 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 2.0 mmt85 -48.58 -37.91 19.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.13 -0.981 . . . . 0.0 109.641 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.7 mt-10 -87.01 -51.89 5.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.762 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.412 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -45.94 -25.06 0.48 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.994 -1.066 . . . . 0.0 109.11 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.442 ' HA ' ' CE2' ' A' ' 141' ' ' PHE . 77.6 t80 -66.5 -56.31 11.5 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.413 -0.804 . . . . 0.0 109.45 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.418 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 2.2 mtp180 -63.14 -27.51 69.42 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.641 -0.662 . . . . 0.0 109.295 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 108' ' ' VAL . 41.2 t -50.34 -28.99 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 62.4 m-85 -100.96 -36.19 9.12 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.418 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 27.1 t70 -83.94 82.58 8.28 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.581 -0.7 . . . . 0.0 109.254 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 4.7 mmtt -80.61 -20.43 43.25 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.301 -0.875 . . . . 0.0 110.157 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 96' ' ' GLY . 2.6 m-20 -78.12 1.56 20.82 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.98 48.15 1.96 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -109.09 -18.28 13.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -1.196 . . . . 0.0 109.812 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.461 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 120.09 -36.65 3.35 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.577 ' CD1' ' OE1' ' A' ' 135' ' ' GLN . 54.7 m-85 -116.38 142.08 47.32 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.374 -1.074 . . . . 0.0 109.59 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 97.0 mt -90.25 123.78 42.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 108.962 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.4 p -82.05 173.5 12.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.14 -0.975 . . . . 0.0 109.427 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.54 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -63.4 -42.1 98.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.414 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.468 ' HA ' ' NH2' ' A' ' 106' ' ' ARG . . . -63.46 -30.23 71.38 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.461 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 56.1 mm-40 -72.15 -22.51 61.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.22 -0.925 . . . . 0.0 109.149 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 109' ' ' MET . 4.1 tp -88.71 -31.83 18.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.436 -0.79 . . . . 0.0 109.6 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.528 ' HE ' HG21 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -88.16 -9.59 52.66 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.164 -0.96 . . . . 0.0 109.175 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -88.31 -39.31 14.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.098 -1.001 . . . . 0.0 109.669 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 91' ' ' VAL . 57.3 t -88.62 -28.42 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 109.795 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 4.5 mtt -68.16 -20.98 64.93 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.316 -0.865 . . . . 0.0 109.238 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.518 ' CB ' ' O ' ' A' ' 114' ' ' GLU . 8.5 t -100.05 1.19 42.15 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.578 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.468 ' OD1' ' N ' ' A' ' 112' ' ' LEU . 45.9 p-10 -57.51 -16.17 9.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.321 -0.862 . . . . 0.0 109.601 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.468 ' N ' ' OD1' ' A' ' 111' ' ' ASN . 1.2 mt -107.46 -20.93 13.1 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 109.641 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 144.6 -32.35 1.73 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 110' ' ' THR . 10.6 mt-10 -50.62 137.45 19.68 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.254 -1.145 . . . . 0.0 109.488 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.18 81.68 1.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 0.0 109.105 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.409 ' HB3' HG23 ' A' ' 121' ' ' VAL . 4.8 mp -63.91 136.29 57.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.567 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 5.0 t -90.81 -178.15 5.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 108.78 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -67.08 -54.98 16.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.892 -1.13 . . . . 0.0 110.178 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -60.73 -12.09 9.49 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.251 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' A' ' 124' ' ' MET . 5.1 tp10 -97.46 -32.6 11.76 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.239 -0.913 . . . . 0.0 109.606 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.54 HG11 ' HB1' ' A' ' 102' ' ' ALA . 25.3 t -72.64 -54.43 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.39 -0.819 . . . . 0.0 109.787 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.69 -34.83 62.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.119 -0.988 . . . . 0.0 109.689 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 1.0 OUTLIER -76.08 -35.71 59.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.095 -1.003 . . . . 0.0 109.243 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 120' ' ' GLU . 1.4 mmt -70.56 -21.05 62.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 108.716 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.499 HG21 ' O ' ' A' ' 134' ' ' GLY . 2.0 mt -84.87 -42.77 16.77 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -48.79 -31.61 7.32 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 109.898 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -90.84 -24.62 20.21 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.022 -1.049 . . . . 0.0 110.394 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.81 -44.98 54.13 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 0.0 109.838 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.526 ' HB3' ' O ' ' A' ' 135' ' ' GLN . 12.9 p-10 -86.39 177.06 7.56 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.349 -0.845 . . . . 0.0 109.668 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.0 mt -85.9 -66.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.414 -0.804 . . . . 0.0 109.567 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -177.47 57.83 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.512 -0.742 . . . . 0.0 109.49 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -96.22 -87.15 1.78 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 2.4 p-10 -139.11 -24.51 0.88 Allowed 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.999 -0.707 . . . . 0.0 110.249 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.499 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 141.06 29.48 0.17 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.577 ' OE1' ' CD1' ' A' ' 99' ' ' TYR . 3.0 pt20 -119.63 166.85 12.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.053 -1.263 . . . . 0.0 108.914 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 137' ' ' ASN . 69.9 t -119.41 162.87 17.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.517 ' N ' HG12 ' A' ' 136' ' ' VAL . 5.2 t-20 -141.29 -164.38 1.75 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.975 -1.078 . . . . 0.0 108.372 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.578 ' O ' HG23 ' A' ' 142' ' ' VAL . 60.9 t80 -77.31 -49.5 14.85 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.686 -1.259 . . . . 0.0 110.15 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.29 -29.06 69.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.967 -1.083 . . . . 0.0 109.593 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.509 ' HB3' ' HA ' ' A' ' 129' ' ' ASP . 19.6 mt-10 -84.65 -32.87 23.41 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.107 -0.995 . . . . 0.0 108.856 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 89' ' ' PHE . 42.8 t80 -71.66 -25.81 62.28 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.535 -0.728 . . . . 0.0 109.087 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.59 HG22 HG21 ' A' ' 85' ' ' ILE . 24.0 t -60.53 -47.07 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.444 -0.785 . . . . 0.0 109.511 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -64.42 -35.54 81.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 109.782 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -83.34 -12.54 56.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.243 -0.911 . . . . 0.0 109.781 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.518 ' HE3' ' HA ' ' A' ' 85' ' ' ILE . 0.5 OUTLIER -81.88 -67.84 0.75 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.299 -0.876 . . . . 0.0 109.247 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -61.2 -85.78 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.412 -0.805 . . . . 0.0 109.285 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.31 167.21 2.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.355 -0.841 . . . . 0.0 109.586 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.587 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -66.33 176.75 1.69 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.355 -0.84 . . . . 0.0 109.832 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 62.76 21.77 12.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.318 -0.864 . . . . 0.0 109.318 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 52.73 -173.16 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.979 . . . . 0.0 109.224 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.454 ' O ' ' OG ' ' A' ' 81' ' ' SER . 7.3 m-20 -144.18 -64.97 0.36 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.151 -0.968 . . . . 0.0 109.573 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 80' ' ' ASP . 5.8 p 47.59 22.99 0.35 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.339 -0.851 . . . . 0.0 110.193 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -73.55 -23.49 59.99 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.355 -0.841 . . . . 0.0 109.279 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.3 OUTLIER -89.59 -27.36 20.27 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.457 -0.777 . . . . 0.0 109.112 179.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -47.83 84.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.576 HG21 HG22 ' A' ' 142' ' ' VAL . 5.1 mt -75.3 -37.35 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.614 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.599 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -52.52 -30.71 31.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.193 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 23.1 mm-40 -90.93 -52.11 5.02 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.377 -0.827 . . . . 0.0 109.473 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.466 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -47.19 -24.86 0.78 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.118 -0.989 . . . . 0.0 109.159 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.437 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 92.6 t80 -67.51 -56.46 9.43 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -63.76 -24.31 67.71 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 24.4 t -52.73 -32.72 17.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.543 ' HA ' HG21 ' A' ' 108' ' ' VAL . 53.9 m-85 -95.32 -36.56 11.35 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.468 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 27.6 t0 -84.26 112.78 20.6 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.544 -0.722 . . . . 0.0 109.483 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 0.1 OUTLIER -89.31 -24.42 22.03 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.095 -1.003 . . . . 0.0 109.825 179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.501 ' O ' ' N ' ' A' ' 97' ' ' ASN . 60.2 m-20 -78.6 1.41 22.77 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.571 -0.852 . . . . 0.0 108.748 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 36.32 31.41 0.04 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.1 OUTLIER -88.16 -28.36 21.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.076 -1.249 . . . . 0.0 109.529 -179.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.48 -19.76 5.03 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.614 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 2.0 m-30 -118.45 152.41 35.95 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.235 -1.156 . . . . 0.0 109.562 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.468 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 52.3 mt -118.25 105.36 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.145 -0.972 . . . . 0.0 109.491 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.418 ' O ' ' C ' ' A' ' 102' ' ' ALA . 2.3 p -74.17 151.79 39.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.069 -1.019 . . . . 0.0 109.258 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.509 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -43.79 -36.4 2.28 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.179 -0.95 . . . . 0.0 109.771 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.34 -45.81 82.75 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.083 -1.011 . . . . 0.0 109.58 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.487 ' OE2' ' HB2' ' A' ' 94' ' ' LYS . 3.8 mm-40 -65.95 -21.44 66.42 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.118 -0.989 . . . . 0.0 108.785 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.536 ' O ' ' CG ' ' A' ' 109' ' ' MET . 10.6 tp -84.53 -25.14 28.99 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.459 -0.776 . . . . 0.0 109.581 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.415 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 4.5 ttm180 -77.79 -54.81 5.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.216 -0.928 . . . . 0.0 109.516 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.628 ' O ' HG22 ' A' ' 110' ' ' THR . 15.2 t60 -45.05 -45.4 10.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.322 -0.861 . . . . 0.0 109.954 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.543 HG21 ' HA ' ' A' ' 92' ' ' PHE . 98.2 t -82.88 -24.4 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.16 -0.962 . . . . 0.0 110.107 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.612 ' HB3' HD13 ' A' ' 116' ' ' LEU . 8.8 mmt -70.59 -14.06 62.34 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.071 -1.018 . . . . 0.0 109.256 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.628 HG22 ' O ' ' A' ' 107' ' ' HIS . 15.3 t -100.55 -6.32 25.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.145 -0.972 . . . . 0.0 109.686 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.45 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 1.2 t-20 -44.3 -51.97 7.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.228 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.45 ' HG ' ' C ' ' A' ' 111' ' ' ASN . 28.7 mt -145.83 13.46 1.32 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.519 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -129.11 22.6 5.06 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 2.8 mm-40 62.05 153.67 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.405 -1.056 . . . . 0.0 109.278 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.16 126.81 31.56 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.981 . . . . 0.0 109.668 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.64 HD21 ' SD ' ' A' ' 124' ' ' MET . 10.2 mp -70.29 171.56 9.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.301 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.718 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.3 OUTLIER -90.83 -170.23 2.62 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.301 -0.874 . . . . 0.0 108.835 179.6 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -84.03 -49.83 8.56 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.182 -0.949 . . . . 0.0 109.349 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.81 -12.04 57.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.395 -0.816 . . . . 0.0 109.41 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.468 ' HG2' HD23 ' A' ' 116' ' ' LEU . 1.9 tt0 -99.52 -41.64 7.28 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.362 -0.836 . . . . 0.0 109.75 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 117' ' ' THR . 29.4 t -56.51 -51.78 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.588 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -56.18 -27.42 54.41 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.183 -0.948 . . . . 0.0 109.733 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 85.4 mt-10 -79.12 -29.13 43.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.375 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.64 ' SD ' HD21 ' A' ' 116' ' ' LEU . 2.1 mtt -78.52 -24.85 45.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.182 -0.949 . . . . 0.0 108.542 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.589 HG23 HG23 ' A' ' 136' ' ' VAL . 5.7 mt -83.59 -39.27 14.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.563 0.697 . . . . 0.0 109.378 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.8 ptm180 -42.37 -21.87 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.735 -0.603 . . . . 0.0 111.494 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 125' ' ' ILE . 1.6 mt-10 -86.18 -42.51 13.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.579 -1.326 . . . . 0.0 108.918 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.36 7.56 42.37 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.457 ' CG ' HG22 ' A' ' 125' ' ' ILE . 0.4 OUTLIER -69.0 132.71 47.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.548 0.69 . . . . 0.0 110.455 -179.008 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.527 ' HA ' ' HG3' ' A' ' 140' ' ' GLU . 12.3 mt -49.11 -43.6 15.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.565 -0.709 . . . . 0.0 109.645 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -156.67 -36.29 0.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.355 -0.841 . . . . 0.0 109.971 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 155.82 40.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -101.46 -23.35 14.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -1.153 . . . . 0.0 109.358 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 109.76 -17.44 30.28 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.456 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -103.05 169.13 8.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.076 -1.249 . . . . 0.0 109.728 -179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.633 HG12 ' N ' ' A' ' 137' ' ' ASN . 54.3 t -128.07 167.21 23.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.319 -0.863 . . . . 0.0 109.553 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.633 ' N ' HG12 ' A' ' 136' ' ' VAL . 5.3 p-10 -138.4 -173.89 3.66 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.818 ' O ' HG23 ' A' ' 142' ' ' VAL . 55.3 t80 -72.7 -43.02 63.59 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 120.682 -1.261 . . . . 0.0 111.657 -178.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.409 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 7.5 tt0 -66.4 -32.42 73.78 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.785 -1.197 . . . . 0.0 110.743 -178.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.564 ' CG ' ' OD1' ' A' ' 137' ' ' ASN . 41.5 mm-40 -86.4 -28.93 23.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.0 109.161 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.436 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 20.6 t80 -75.1 -24.09 58.05 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 138' ' ' TYR . 42.3 t -69.33 -44.89 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.515 -0.741 . . . . 0.0 109.996 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -51.77 -38.29 54.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.082 -1.012 . . . . 0.0 109.946 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.42 -42.67 24.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.192 -0.943 . . . . 0.0 109.842 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.42 ' SD ' HG12 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -68.36 -10.02 52.13 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.255 -0.903 . . . . 0.0 109.919 -179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.46 ' O ' HG22 ' A' ' 146' ' ' THR . 2.6 m -105.03 -5.94 20.46 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.164 -0.96 . . . . 0.0 109.299 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -51.3 126.64 17.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.13 -0.981 . . . . 0.0 109.689 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.32 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.57 77.85 1.52 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.948 . . . . 0.0 109.615 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -101.7 -175.53 2.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.25 -0.906 . . . . 0.0 109.591 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 58.51 97.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.376 -0.828 . . . . 0.0 109.667 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -105.23 114.57 28.83 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.336 -0.853 . . . . 0.0 109.137 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.9 m -83.87 11.6 7.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.392 -0.817 . . . . 0.0 109.66 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -75.49 -24.46 56.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 108.793 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -73.24 -13.58 61.17 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -59.96 -18.3 44.44 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.31 -0.869 . . . . 0.0 108.908 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.524 HG21 HG22 ' A' ' 142' ' ' VAL . 22.5 mm -71.94 -34.21 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.447 -0.783 . . . . 0.0 109.641 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.583 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -50.7 -39.34 51.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.208 -0.932 . . . . 0.0 109.304 179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' PHE . 20.7 mt-10 -85.58 -50.68 7.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.255 -0.903 . . . . 0.0 109.181 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.86 -25.57 0.31 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.216 -0.927 . . . . 0.0 108.893 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 78.6 t80 -65.55 -56.65 11.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.283 -0.886 . . . . 0.0 109.2 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.445 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 5.3 mtp180 -61.23 -29.26 69.72 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 38.2 t -47.63 -35.02 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.516 ' HD2' HD12 ' A' ' 105' ' ' LEU . 61.3 m-85 -91.54 -37.84 12.88 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.485 ' HB2' HG12 ' A' ' 100' ' ' ILE . 44.1 t0 -89.78 90.12 8.06 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -78.58 -25.13 45.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.238 -0.913 . . . . 0.0 110.492 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.477 ' HB2' ' OE2' ' A' ' 104' ' ' GLU . 1.2 m-20 -79.84 7.07 9.45 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.165 -0.959 . . . . 0.0 109.33 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 40.21 38.9 1.43 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -87.92 -1.42 57.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.187 -1.184 . . . . 0.0 109.484 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.61 -21.94 23.43 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.656 ' CE1' ' CB ' ' A' ' 137' ' ' ASN . 1.5 m-85 -125.26 145.61 49.92 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.325 -1.103 . . . . 0.0 109.382 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.503 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 88.5 mt -103.04 101.16 11.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.382 -0.824 . . . . 0.0 109.592 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.6 p -73.29 -179.53 3.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.121 -0.987 . . . . 0.0 109.223 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.16 90.06 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.178 -0.951 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.59 -28.09 66.63 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.222 -0.924 . . . . 0.0 109.277 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.477 ' OE2' ' HB2' ' A' ' 95' ' ' ASP . 5.2 mm-40 -72.94 -31.6 64.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.112 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.516 HD12 ' HD2' ' A' ' 92' ' ' PHE . 16.2 tp -83.12 -27.57 30.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.297 -0.877 . . . . 0.0 109.313 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.438 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 2.2 ttt180 -65.26 -18.62 65.45 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.858 . . . . 0.0 108.82 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.471 ' CD2' HG23 ' A' ' 108' ' ' VAL . 33.9 t60 -82.76 -34.48 27.09 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.472 -0.767 . . . . 0.0 109.926 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 108' ' ' VAL . 74.1 t -123.38 26.37 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.012 -1.055 . . . . 0.0 110.155 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.672 ' HB2' HD21 ' A' ' 116' ' ' LEU . 9.2 ptt? -71.41 -21.58 61.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.067 -1.021 . . . . 0.0 108.815 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -88.84 -8.7 53.84 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.422 -0.799 . . . . 0.0 110.171 -179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.723 ' HB2' HG12 ' A' ' 108' ' ' VAL . 4.5 t-20 -36.44 -46.73 0.57 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.477 -0.764 . . . . 0.0 109.619 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 174.92 35.7 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.49 -0.756 . . . . 0.0 109.071 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -116.12 36.1 3.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 22.8 mt-10 72.31 -160.72 0.11 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.467 -1.019 . . . . 0.0 109.071 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' A' ' 115' ' ' LYS . 26.8 mtmt -120.93 89.81 3.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 109.691 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 109' ' ' MET . 0.3 OUTLIER -84.16 170.94 13.28 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.353 -0.842 . . . . 0.0 109.905 -179.807 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 121' ' ' VAL . 5.4 t -112.1 -155.92 0.58 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.379 -0.826 . . . . 0.0 109.345 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.629 ' N ' HG23 ' A' ' 117' ' ' THR . 2.9 m-20 -84.44 -58.7 2.63 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.958 -1.089 . . . . 0.0 109.671 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -54.58 -18.86 4.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.0 109.629 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.499 ' HG2' ' HB2' ' A' ' 116' ' ' LEU . 3.2 tt0 -91.13 -37.0 13.66 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.357 -0.839 . . . . 0.0 109.764 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 117' ' ' THR . 2.9 t -41.85 -53.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.33 -0.856 . . . . 0.0 109.99 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.4 -37.42 77.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.073 -1.017 . . . . 0.0 109.795 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -72.09 -19.06 61.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.085 -1.009 . . . . 0.0 109.377 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 32.5 mmm -85.73 -23.23 27.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.139 -0.976 . . . . 0.0 108.424 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.667 HG23 HG23 ' A' ' 136' ' ' VAL . 6.1 mt -84.32 -41.74 16.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.692 0.758 . . . . 0.0 109.164 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -61.44 -19.58 62.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.623 -0.673 . . . . 0.0 110.153 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -88.93 -31.77 18.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.085 -1.01 . . . . 0.0 109.089 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.12 -5.83 51.96 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.608 -0.682 . . . . 0.0 109.394 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.465 ' OD2' ' OE1' ' A' ' 140' ' ' GLU . 1.2 t70 -100.23 166.59 10.92 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.265 -0.897 . . . . 0.0 109.656 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.451 ' N ' ' CG ' ' A' ' 129' ' ' ASP . 38.9 mm -86.78 -71.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.37 -0.831 . . . . 0.0 109.285 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 179.62 58.1 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.612 -0.68 . . . . 0.0 109.211 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -98.08 -89.5 1.92 Allowed Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -127.92 -25.84 3.0 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.69 0.757 . . . . 0.0 109.441 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.446 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 136.55 30.01 0.3 Allowed Glycine 0 N--CA 1.489 2.193 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.432 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 5.9 pt20 -128.74 -170.62 2.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.001 -1.293 . . . . 0.0 108.938 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.667 HG23 HG23 ' A' ' 125' ' ' ILE . 92.8 t -127.33 169.82 18.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.994 -1.066 . . . . 0.0 109.604 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.656 ' CB ' ' CE1' ' A' ' 99' ' ' TYR . 7.7 p30 -149.37 -168.02 2.99 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.583 ' CE1' ' HA ' ' A' ' 86' ' ' ARG . 55.3 t80 -66.12 -55.24 17.43 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.44 -1.412 . . . . 0.0 110.461 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.507 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -53.66 -57.9 9.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.102 -0.999 . . . . 0.0 110.373 -179.322 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.538 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 19.6 mt-10 -57.68 -39.22 76.62 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.058 -1.026 . . . . 0.0 109.883 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.6 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 59.9 t80 -63.58 -28.05 69.67 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.319 -0.863 . . . . 0.0 109.538 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.524 HG22 HG21 ' A' ' 85' ' ' ILE . 35.7 t -65.91 -53.12 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.421 -0.799 . . . . 0.0 109.722 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -58.43 -30.21 66.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 0.0 110.051 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.432 ' O ' ' HG2' ' A' ' 144' ' ' MET . 0.6 OUTLIER -86.92 -20.68 27.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.16 -0.963 . . . . 0.0 109.958 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.6 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -96.31 -7.54 35.06 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.16 -0.963 . . . . 0.0 109.977 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.2 p -115.37 -42.6 3.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.087 -1.008 . . . . 0.0 110.029 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -59.29 97.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.117 -0.989 . . . . 0.0 109.75 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.678 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.474 ' O ' ' HB3' ' A' ' 77' ' ' LYS . 5.0 mtt . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 76' ' ' MET . 22.8 ttpp 67.43 93.58 0.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.879 . . . . 0.0 109.49 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -179.13 165.19 1.47 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 109.565 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.574 ' O ' ' N ' ' A' ' 81' ' ' SER . 0.6 OUTLIER -69.63 162.8 26.93 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.284 -0.885 . . . . 0.0 109.207 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 79' ' ' THR . 0.2 OUTLIER 39.48 -88.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.615 -0.678 . . . . 0.0 110.575 179.646 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.574 ' N ' ' O ' ' A' ' 79' ' ' THR . 0.1 OUTLIER 177.51 111.32 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.89 -1.131 . . . . 0.0 109.461 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 12.4 pt-20 -65.18 -14.94 61.81 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.163 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -84.72 -21.6 30.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.44 -0.787 . . . . 0.0 109.47 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 1.3 tt0 -60.97 -19.59 61.24 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.269 -0.895 . . . . 0.0 109.086 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 mt -116.71 -48.04 4.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 O-C-N 121.308 -0.87 . . . . 0.0 109.328 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.514 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.2 OUTLIER -56.33 -43.25 78.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.275 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 91' ' ' VAL . 2.8 mm-40 -82.63 -31.99 28.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.341 -0.849 . . . . 0.0 109.491 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.439 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -61.5 -26.51 67.96 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.414 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 85.5 t80 -66.06 -56.89 9.27 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.507 -0.746 . . . . 0.0 109.417 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -64.03 -25.54 68.16 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 87' ' ' GLU . 17.6 t -53.13 -30.34 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.56 ' CE1' HG11 ' A' ' 108' ' ' VAL . 68.7 m-85 -97.22 -32.36 11.96 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.466 ' HB2' HG12 ' A' ' 100' ' ' ILE . 11.7 t70 -99.08 94.18 6.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' CD ' ' N ' ' A' ' 94' ' ' LYS . 0.4 OUTLIER -75.58 -23.4 56.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.056 -1.028 . . . . 0.0 109.671 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 97' ' ' ASN . 51.4 m-20 -78.5 0.92 24.12 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.339 -0.851 . . . . 0.0 108.943 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 31.26 37.46 0.03 OUTLIER Glycine 0 N--CA 1.498 2.826 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.6 OUTLIER -84.14 -32.93 24.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.26 . . . . 0.0 109.708 -179.723 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 136.49 -34.08 2.28 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.604 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.7 m-85 -114.58 145.53 41.86 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.36 -1.082 . . . . 0.0 109.096 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.466 HG12 ' HB2' ' A' ' 93' ' ' ASP . 27.9 mt -100.07 122.6 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.171 -0.956 . . . . 0.0 109.469 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -88.59 -178.1 5.74 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.291 -0.881 . . . . 0.0 109.114 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.36 -36.19 68.7 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.131 -0.981 . . . . 0.0 109.303 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.45 -30.29 71.06 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.329 -0.857 . . . . 0.0 109.747 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 33.6 mm-40 -75.95 -22.7 55.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.168 -0.958 . . . . 0.0 109.189 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.45 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 63.5 tp -95.61 -11.02 27.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -0.764 . . . . 0.0 109.339 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -87.73 -43.26 12.03 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.314 -0.866 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.711 ' O ' HG22 ' A' ' 110' ' ' THR . 3.2 t60 -61.69 -41.84 98.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.178 -0.952 . . . . 0.0 109.431 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.56 HG11 ' CE1' ' A' ' 92' ' ' PHE . 1.3 t -73.05 -40.0 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.156 -0.965 . . . . 0.0 109.161 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.749 ' HB3' HD13 ' A' ' 116' ' ' LEU . 2.4 mmt -68.1 -16.79 64.16 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 107' ' ' HIS . 2.3 t -96.07 -20.95 18.27 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.097 -1.002 . . . . 0.0 109.845 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.478 ' OD1' ' O ' ' A' ' 108' ' ' VAL . 0.6 OUTLIER -52.18 -44.99 64.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 108.845 179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 112' ' ' LEU . 33.1 mt -152.62 18.14 0.61 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.473 -0.767 . . . . 0.0 109.474 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -114.61 34.9 4.67 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 110' ' ' THR . 13.1 mm-40 62.09 -169.12 0.18 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.418 -1.048 . . . . 0.0 109.627 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.32 89.88 4.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.824 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.749 HD13 ' HB3' ' A' ' 109' ' ' MET . 0.8 OUTLIER -57.39 131.31 49.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.322 -0.861 . . . . 0.0 109.366 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.542 HG23 ' H ' ' A' ' 120' ' ' GLU . 1.1 t -79.47 177.75 8.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.09 -1.006 . . . . 0.0 108.839 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.85 -63.09 1.26 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.92 -1.113 . . . . 0.0 109.994 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.514 ' CG ' ' N ' ' A' ' 120' ' ' GLU . 14.4 pt-20 -47.07 -44.39 20.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.948 . . . . 0.0 109.934 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.542 ' H ' HG23 ' A' ' 117' ' ' THR . 39.8 tp10 -62.02 -41.15 97.78 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.757 -0.589 . . . . 0.0 110.454 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 117' ' ' THR . 46.9 t -65.89 -62.65 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 0.0 110.13 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.18 -31.42 52.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.974 -1.079 . . . . 0.0 109.196 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -71.06 -34.65 71.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.307 -0.871 . . . . 0.0 108.955 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.403 ' CE ' ' HA ' ' A' ' 124' ' ' MET . 2.9 mmt -70.89 -28.15 64.33 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.342 -0.849 . . . . 0.0 108.842 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.465 HG23 HG23 ' A' ' 136' ' ' VAL . 2.7 mt -75.75 -42.08 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.424 -0.798 . . . . 0.0 109.15 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -14.63 3.75 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.673 -0.642 . . . . 0.0 110.165 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -86.2 -32.37 21.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.025 -1.047 . . . . 0.0 108.981 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.64 -7.25 50.54 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.467 -0.77 . . . . 0.0 109.348 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 135' ' ' GLN . 0.3 OUTLIER -76.99 145.14 38.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.312 -0.867 . . . . 0.0 109.808 -179.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.502 ' CG1' ' OE1' ' A' ' 140' ' ' GLU . 32.0 mm -81.68 -39.38 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.503 -0.748 . . . . 0.0 109.155 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.18 -43.62 3.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.704 -0.622 . . . . 0.0 109.618 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 119.84 39.0 0.67 Allowed Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.412 ' CG ' ' OE1' ' A' ' 135' ' ' GLN . 1.5 p30 -78.62 -25.03 45.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.294 -1.121 . . . . 0.0 108.771 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.21 26.95 4.12 Favored Glycine 0 N--CA 1.493 2.467 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.65 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.586 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.8 OUTLIER -156.86 170.36 22.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.935 -1.332 . . . . 0.0 109.369 179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.605 HG12 ' N ' ' A' ' 137' ' ' ASN . 85.5 t -130.74 168.2 24.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.18 -0.95 . . . . 0.0 109.572 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.605 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -140.27 -165.57 1.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.77 ' O ' HG23 ' A' ' 142' ' ' VAL . 57.9 t80 -80.96 -40.07 25.05 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.04 -1.037 . . . . 0.0 109.768 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -33.0 73.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.089 -1.007 . . . . 0.0 109.378 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.572 ' HG2' ' ND2' ' A' ' 137' ' ' ASN . 2.1 mm-40 -82.18 -38.92 23.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.045 -1.034 . . . . 0.0 108.98 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.583 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 31.3 t80 -67.41 -25.42 65.93 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 108.978 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 138' ' ' TYR . 40.0 t -70.71 -43.67 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.32 -0.862 . . . . 0.0 109.713 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.511 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 69.7 mt-30 -61.58 -23.89 66.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.093 -1.004 . . . . 0.0 109.697 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.403 ' HA ' ' OXT' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -90.28 -31.47 16.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.638 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.583 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -93.03 -2.67 55.43 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.261 -0.9 . . . . 0.0 109.917 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -130.87 -46.54 1.03 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.263 -0.898 . . . . 0.0 108.992 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -93.92 48.8 1.29 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.301 -0.874 . . . . 0.0 109.571 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.403 ' OXT' ' HA ' ' A' ' 144' ' ' MET . 17.3 mmtp . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.402 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.74 ' N ' ' HG1' ' A' ' 79' ' ' THR . 4.6 ptm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.558 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 2.1 ttpm? 56.22 62.62 2.28 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 109.373 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.558 ' CB ' ' O ' ' A' ' 77' ' ' LYS . 1.3 t0 82.74 -47.58 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.741 -0.599 . . . . 0.0 110.067 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.74 ' HG1' ' N ' ' A' ' 76' ' ' MET . 0.2 OUTLIER 60.13 -166.95 0.18 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.037 -1.04 . . . . 0.0 109.285 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.6 t70 56.85 14.25 1.77 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.293 -0.879 . . . . 0.0 110.47 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.6 m -79.54 -27.42 41.31 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.988 -1.07 . . . . 0.0 109.273 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -91.62 -27.82 17.9 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.568 0.699 . . . . 0.0 109.336 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -85.79 8.89 18.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.601 -0.687 . . . . 0.0 109.444 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' HA ' ' OE2' ' A' ' 87' ' ' GLU . 22.8 tt0 -47.25 -24.58 0.76 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -0.868 . . . . 0.0 109.57 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 2.7 mp -80.39 -43.39 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.321 -0.862 . . . . 0.0 109.667 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.57 -39.0 57.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.074 -1.016 . . . . 0.0 109.355 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.535 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 17.7 pt-20 -81.03 -47.8 13.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.535 ' N ' ' HG3' ' A' ' 87' ' ' GLU . . . -45.47 -32.06 2.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 108.805 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.402 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 90.4 t80 -58.96 -56.29 24.22 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.393 -0.817 . . . . 0.0 109.582 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.414 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 3.2 mtp180 -63.42 -30.0 71.2 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.693 -0.629 . . . . 0.0 109.453 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.47 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 74.5 t -49.23 -28.55 2.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -102.14 -32.18 10.23 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD1' ' OE1' ' A' ' 104' ' ' GLU . 30.6 t70 -91.05 80.14 5.73 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.64 -0.663 . . . . 0.0 109.624 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -21.0 59.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.845 . . . . 0.0 109.817 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -78.58 1.9 21.08 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.72 -0.792 . . . . 0.0 108.994 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 34.62 39.44 0.15 Allowed Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 13.1 p-10 -94.42 -17.8 22.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.029 -1.277 . . . . 0.0 109.686 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.98 -38.19 2.94 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 137' ' ' ASN . 36.6 m-85 -115.36 140.47 49.1 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.291 -1.123 . . . . 0.0 109.32 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.516 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 72.1 mt -89.49 117.12 32.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.177 -0.952 . . . . 0.0 109.19 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 79.3 p -83.74 164.86 19.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.26 -0.9 . . . . 0.0 109.484 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.71 -35.3 72.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.522 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.44 -31.65 71.12 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.228 -0.92 . . . . 0.0 109.381 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' OE1' ' OD1' ' A' ' 93' ' ' ASP . 34.5 mt-10 -71.94 -24.22 61.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.202 -0.936 . . . . 0.0 108.948 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.5 tp -85.05 -33.96 22.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.259 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.417 ' O ' ' HG2' ' A' ' 109' ' ' MET . 18.0 ttt180 -61.25 -28.49 69.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 108.657 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -65.89 -49.25 68.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.544 -0.722 . . . . 0.0 109.451 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 108' ' ' VAL . 23.8 t -103.16 41.02 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.258 -0.901 . . . . 0.0 109.593 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.892 ' HB2' HD12 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -92.39 -23.06 19.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 0.0 109.804 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 114' ' ' GLU . 0.8 OUTLIER -100.55 -12.48 19.24 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.211 -0.931 . . . . 0.0 109.573 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.977 ' O ' HD23 ' A' ' 112' ' ' LEU . 19.7 p-10 -45.55 -44.87 13.12 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.044 -1.035 . . . . 0.0 108.915 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.977 HD23 ' O ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -159.5 22.69 0.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.377 -0.827 . . . . 0.0 109.306 179.66 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -123.72 45.02 1.22 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.499 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.5 mm-40 56.84 -141.18 0.81 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.102 -1.234 . . . . 0.0 109.125 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.0 ttmt -126.18 83.62 2.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.977 -1.077 . . . . 0.0 109.459 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.892 HD12 ' HB2' ' A' ' 109' ' ' MET . 35.2 mt -59.31 -160.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.138 -0.976 . . . . 0.0 109.587 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.831 ' O ' HG23 ' A' ' 121' ' ' VAL . 17.9 p -153.78 -161.58 1.28 Allowed 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.39 -48.6 9.5 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.192 -0.943 . . . . 0.0 109.072 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.42 -16.18 60.37 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.285 -0.884 . . . . 0.0 108.796 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -88.81 -37.31 15.5 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.831 HG23 ' O ' ' A' ' 117' ' ' THR . 9.1 t -55.98 -52.54 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.418 -0.801 . . . . 0.0 109.014 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.403 ' O ' ' HB3' ' A' ' 126' ' ' ARG . 3.5 m-20 -57.82 -23.35 52.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.173 -0.954 . . . . 0.0 109.327 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -81.37 -29.96 33.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.428 -0.795 . . . . 0.0 109.046 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.82 -25.85 49.14 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.627 HG21 ' O ' ' A' ' 134' ' ' GLY . 6.8 mt -84.65 -38.73 13.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-O 121.738 0.78 . . . . 0.0 109.031 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 2.2 ptm85 -54.33 -33.49 59.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.703 -0.623 . . . . 0.0 109.897 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 5.7 mt-10 -89.62 -18.09 27.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.064 -1.022 . . . . 0.0 109.336 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.35 -5.37 43.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.387 -0.821 . . . . 0.0 109.751 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.477 ' OD2' ' HA ' ' A' ' 126' ' ' ARG . 3.0 p30 -81.99 177.78 8.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 109.88 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.589 HD12 ' OE2' ' A' ' 140' ' ' GLU . 36.0 mt -81.13 -50.31 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.497 -0.752 . . . . 0.0 109.78 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -133.09 -24.32 1.88 Allowed 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.32 -0.862 . . . . 0.0 110.55 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 137.78 40.79 0.11 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -78.97 -24.15 44.03 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -1.11 . . . . 0.0 108.74 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.627 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 102.06 -26.58 23.83 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -103.58 173.71 6.19 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -1.229 . . . . 0.0 109.451 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.603 HG23 HG23 ' A' ' 125' ' ' ILE . 55.6 t -124.26 162.62 25.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.576 ' HB2' ' CE2' ' A' ' 99' ' ' TYR . 4.6 t-20 -141.54 -165.55 2.01 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.867 -1.146 . . . . 0.0 108.215 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.966 ' O ' HG23 ' A' ' 142' ' ' VAL . 72.1 t80 -75.99 -39.22 56.28 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.844 -1.16 . . . . 0.0 109.843 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -70.56 -34.12 71.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.081 -1.012 . . . . 0.0 109.235 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.589 ' OE2' HD12 ' A' ' 130' ' ' ILE . 7.8 mt-10 -80.2 -28.91 38.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.274 -0.891 . . . . 0.0 108.778 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.402 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 43.1 t80 -78.88 -25.12 43.87 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.433 -0.792 . . . . 0.0 109.3 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 138' ' ' TYR . 48.1 t -58.86 -48.53 86.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.465 -0.772 . . . . 0.0 109.822 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.555 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 4.6 mt-30 -66.64 -26.37 67.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.001 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 48.2 ttp -81.93 -21.95 37.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.469 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.67 -65.51 1.01 Allowed 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.245 -0.909 . . . . 0.0 109.756 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.6 -45.38 45.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.333 -0.854 . . . . 0.0 109.657 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -93.62 174.95 6.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 0.0 109.607 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 117.92 -1.038 . . . . 0.0 109.311 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.28 0.562 . . . . 0.0 109.599 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 65.88 156.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.304 -0.872 . . . . 0.0 109.569 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 54.7 68.14 0.91 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.319 -0.863 . . . . 0.0 109.484 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 25.8 m -90.91 91.08 8.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.262 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.493 ' O ' ' CB ' ' A' ' 81' ' ' SER . 0.4 OUTLIER -117.44 -75.89 0.58 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.195 -0.941 . . . . 0.0 109.753 -179.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 80' ' ' ASP . 0.3 OUTLIER 165.67 117.27 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.337 -0.852 . . . . 0.0 109.075 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -67.02 -15.13 63.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -86.39 -15.47 40.29 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.421 -0.799 . . . . 0.0 109.413 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -55.73 24.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.943 . . . . 0.0 109.495 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.81 -41.64 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -0.982 . . . . 0.0 109.536 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.584 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 4.2 ttp180 -49.86 -31.35 11.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.066 -1.021 . . . . 0.0 109.03 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 83' ' ' GLU . 77.9 mt-10 -86.15 -57.54 2.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.455 -0.778 . . . . 0.0 110.105 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.514 ' CB ' ' SD ' ' A' ' 145' ' ' MET . . . -41.07 -32.98 0.28 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 0.0 109.031 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.46 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 89.9 t80 -59.76 -56.96 15.35 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.493 -0.754 . . . . 0.0 109.194 179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.474 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -59.94 -35.85 75.82 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.745 -0.597 . . . . 0.0 109.759 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 66.1 t -42.93 -32.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -98.57 -31.7 11.82 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.474 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 13.2 t70 -95.6 81.68 3.55 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.607 -0.683 . . . . 0.0 109.316 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.98 -22.35 55.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.322 -0.861 . . . . 0.0 110.296 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 97' ' ' ASN . 59.1 m-20 -78.51 2.15 20.02 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.281 -0.887 . . . . 0.0 109.21 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.476 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.09 29.83 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 95' ' ' ASP . 1.9 t30 -78.51 -36.44 44.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.101 -1.235 . . . . 0.0 109.551 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.71 -52.73 0.63 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 11.8 m-30 -106.42 156.52 18.44 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.352 -1.087 . . . . 0.0 109.003 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.411 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 74.2 mt -97.24 108.33 21.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 O-C-N 121.453 -0.779 . . . . 0.0 109.273 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 9.4 p -78.19 -177.56 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.759 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.695 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -64.65 -45.14 88.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.331 -0.856 . . . . 0.0 109.17 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.97 -23.9 67.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.434 -0.791 . . . . 0.0 109.698 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -76.99 -31.89 56.83 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.023 -1.048 . . . . 0.0 108.892 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.633 HD12 HG12 ' A' ' 125' ' ' ILE . 0.7 OUTLIER -89.27 -13.23 38.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.353 -0.842 . . . . 0.0 108.899 179.288 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.498 ' O ' ' CG2' ' A' ' 110' ' ' THR . 10.1 ttt180 -90.15 -14.03 34.43 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.377 -0.827 . . . . 0.0 108.793 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -77.79 -26.47 49.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.459 -0.776 . . . . 0.0 110.172 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 69.8 t -106.67 -50.86 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.948 -1.095 . . . . 0.0 110.492 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.664 ' HB3' HD11 ' A' ' 116' ' ' LEU . 2.4 mmt -56.2 -19.55 14.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.303 -0.873 . . . . 0.0 109.858 -179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 106' ' ' ARG . 12.9 t -88.26 -28.94 20.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.119 -0.988 . . . . 0.0 109.645 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -52.93 -47.09 68.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.37 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pp -132.85 -3.72 3.22 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 110.131 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.522 ' CA ' ' O ' ' A' ' 109' ' ' MET . . . -103.79 20.05 42.52 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 16.3 mt-10 63.49 141.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -1.124 . . . . 0.0 109.186 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.474 ' HA ' ' OG1' ' A' ' 110' ' ' THR . 0.6 OUTLIER -50.39 100.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.821 . . . . 0.0 109.752 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 109' ' ' MET . 29.0 mt -59.57 133.18 55.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.897 . . . . 0.0 109.264 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -71.16 178.97 3.02 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.109 -0.994 . . . . 0.0 108.332 179.201 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.412 ' N ' ' OG1' ' A' ' 117' ' ' THR . 10.0 m-20 -60.52 -63.45 1.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.87 -1.144 . . . . 0.0 109.914 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 1.4 pt-20 -50.4 -42.19 53.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.191 -0.943 . . . . 0.0 109.947 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.48 ' H ' HG23 ' A' ' 117' ' ' THR . 12.7 tp10 -63.04 -34.99 78.75 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.586 -0.696 . . . . 0.0 110.156 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.695 HG11 ' HB1' ' A' ' 102' ' ' ALA . 28.7 t -71.65 -65.37 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.276 -0.89 . . . . 0.0 109.638 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -48.82 -30.66 6.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.087 -1.008 . . . . 0.0 109.158 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 0.5 OUTLIER -75.09 -38.94 61.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.869 . . . . 0.0 109.166 179.636 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.566 ' HG3' HD13 ' A' ' 116' ' ' LEU . 3.7 mmt -65.32 -23.89 67.13 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.689 HG23 HG23 ' A' ' 136' ' ' VAL . 3.2 mt -81.76 -38.82 16.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 1.3 mtp180 -47.97 -28.76 2.91 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.955 -0.466 . . . . 0.0 110.099 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.534 ' CG ' ' O ' ' A' ' 124' ' ' MET . 7.2 pt-20 -80.2 -37.39 33.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.887 -1.133 . . . . 0.0 108.589 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -78.47 -7.98 58.03 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.65 143.3 30.98 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.384 -0.822 . . . . 0.0 109.255 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.8 -39.47 10.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.185 -0.947 . . . . 0.0 109.665 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.11 -44.81 7.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.455 -0.778 . . . . 0.0 109.956 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 113.19 39.94 1.09 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -79.08 -24.54 43.41 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.376 -1.073 . . . . 0.0 108.776 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.522 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 117.22 -36.77 3.58 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -98.75 170.07 9.03 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.061 -1.258 . . . . 0.0 109.118 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.689 HG23 HG23 ' A' ' 125' ' ' ILE . 52.0 t -127.9 162.79 33.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.176 -0.952 . . . . 0.0 108.556 179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.545 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.1 OUTLIER -137.99 -169.76 2.63 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 109.094 179.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.97 ' O ' HG23 ' A' ' 142' ' ' VAL . 78.7 t80 -77.62 -34.9 53.19 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.744 -0.783 . . . . 0.0 109.701 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -49.62 70.1 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.262 -0.899 . . . . 0.0 109.322 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -69.3 -39.79 78.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 109.331 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.46 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 47.7 t80 -66.38 -24.34 66.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.4 -0.812 . . . . 0.0 109.793 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.97 HG23 ' O ' ' A' ' 138' ' ' TYR . 40.8 t -70.29 -46.95 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.197 -0.94 . . . . 0.0 109.963 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 22.5 mm100 -70.28 -23.96 62.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.012 -1.055 . . . . 0.0 109.866 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -85.12 -23.77 28.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.496 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.514 ' SD ' ' CB ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -83.34 -51.63 7.25 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.227 -0.921 . . . . 0.0 110.136 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.91 -62.46 1.41 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.066 -1.021 . . . . 0.0 109.994 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -65.68 176.17 1.63 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.761 -179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 pttt . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.952 -1.023 . . . . 0.0 109.546 -179.985 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.7 ptt? . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.332 0.587 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.93 125.3 10.14 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.185 -0.947 . . . . 0.0 109.732 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -104.78 -51.06 3.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.309 -0.87 . . . . 0.0 109.351 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.4 173.59 11.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.243 -0.911 . . . . 0.0 109.575 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.68 -59.88 1.19 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -0.944 . . . . 0.0 109.735 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 6.7 t 60.91 16.79 7.21 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.181 -0.949 . . . . 0.0 109.481 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -79.98 -89.13 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 109.387 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.4 mp0 -80.62 -1.2 41.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.499 -0.751 . . . . 0.0 109.584 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.8 OUTLIER -58.42 -27.28 64.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.112 -0.993 . . . . 0.0 109.191 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.596 HG21 HG13 ' A' ' 142' ' ' VAL . 4.5 mm -76.07 -39.86 36.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.371 -0.83 . . . . 0.0 109.262 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.406 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.1 OUTLIER -53.56 -43.66 68.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.408 -0.807 . . . . 0.0 109.584 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 9.9 pt-20 -78.8 -41.59 29.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.114 -0.991 . . . . 0.0 109.607 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.505 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -52.16 -30.37 26.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.104 -0.998 . . . . 0.0 108.648 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.446 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 90.4 t80 -64.39 -52.95 55.67 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.384 -0.822 . . . . 0.0 109.622 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -64.51 -24.21 67.53 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 52.7 t -56.35 -22.8 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -104.97 -36.27 7.38 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.411 ' HB2' HG12 ' A' ' 100' ' ' ILE . 39.4 t0 -83.99 108.29 16.86 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -84.28 -26.49 28.55 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.079 -1.013 . . . . 0.0 110.088 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.485 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -79.46 3.04 19.74 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.184 -0.947 . . . . 0.0 108.903 179.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.485 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 36.32 36.74 0.16 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 95' ' ' ASP . 14.5 p-10 -93.71 -42.87 8.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.181 -1.187 . . . . 0.0 109.875 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 147.42 -20.71 1.52 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.641 ' CE1' ' CB ' ' A' ' 137' ' ' ASN . 1.7 m-85 -120.72 144.44 48.24 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.216 -1.167 . . . . 0.0 109.71 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.411 HG12 ' HB2' ' A' ' 93' ' ' ASP . 68.5 mt -108.54 110.21 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.547 -0.721 . . . . 0.0 109.537 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.75 162.92 28.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 109.245 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.526 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -55.06 -36.85 66.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.139 -0.975 . . . . 0.0 109.38 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.65 -36.44 78.59 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.375 -0.828 . . . . 0.0 109.343 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 -72.24 -22.54 61.23 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.339 -0.851 . . . . 0.0 108.895 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.492 ' O ' ' CG ' ' A' ' 109' ' ' MET . 17.8 tp -90.03 -23.16 21.54 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.378 -0.826 . . . . 0.0 109.512 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.433 ' HB2' HG21 ' A' ' 121' ' ' VAL . 0.2 OUTLIER -84.44 -34.33 23.49 Favored 'General case' 0 C--N 1.306 -1.286 0 O-C-N 121.16 -0.962 . . . . 0.0 109.882 -179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.535 ' O ' HG22 ' A' ' 110' ' ' THR . 35.0 t60 -61.12 -41.53 96.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.033 -1.042 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.447 HG21 ' O ' ' A' ' 91' ' ' VAL . 46.9 t -86.64 -23.86 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.22 -0.925 . . . . 0.0 109.816 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.492 ' CG ' ' O ' ' A' ' 105' ' ' LEU . 4.4 mmt -73.25 -21.33 60.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.319 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 107' ' ' HIS . 9.3 t -89.55 -26.03 21.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.34 -0.85 . . . . 0.0 109.63 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.693 ' HB3' HD12 ' A' ' 112' ' ' LEU . 1.6 t30 -48.18 -57.49 5.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.445 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.693 HD12 ' HB3' ' A' ' 111' ' ' ASN . 1.8 mp -125.22 3.63 7.84 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.354 -0.841 . . . . 0.0 109.64 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 114' ' ' GLU . . . -108.86 56.4 0.47 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 110' ' ' THR . 1.9 mt-10 45.45 -134.53 0.78 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.245 -1.15 . . . . 0.0 108.861 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.7 ttpp -148.44 78.1 1.41 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.76 -1.212 . . . . 0.0 109.564 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.751 ' H ' HD23 ' A' ' 116' ' ' LEU . 1.4 pt? -67.85 144.81 55.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.095 -1.003 . . . . 0.0 109.0 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.719 ' O ' HG23 ' A' ' 121' ' ' VAL . 21.9 p -77.55 -159.73 0.15 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.261 -0.9 . . . . 0.0 109.956 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.21 -48.37 13.21 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.422 -0.799 . . . . 0.0 109.49 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.68 -21.96 20.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.137 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 23.6 mm-40 -87.5 -47.88 8.38 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 117' ' ' THR . 49.0 t -46.96 -49.99 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.445 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.45 -38.16 68.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.342 -0.849 . . . . 0.0 109.832 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 15.6 mt-10 -67.45 -38.26 84.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.205 -0.935 . . . . 0.0 109.629 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 21.9 mmm -68.51 -30.38 69.19 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.103 -0.998 . . . . 0.0 108.893 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.462 ' O ' ' OD1' ' A' ' 129' ' ' ASP . 3.0 mt -71.96 -40.36 67.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.419 -0.801 . . . . 0.0 108.849 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -61.28 -18.93 60.89 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.558 -0.714 . . . . 0.0 109.189 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 7.1 mm-40 -90.4 -21.48 21.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.263 -0.898 . . . . 0.0 109.337 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 144' ' ' MET . . . -92.59 -65.18 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.527 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 30.4 p-10 -76.16 177.47 7.15 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.462 -0.774 . . . . 0.0 109.069 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.499 HG12 ' OE2' ' A' ' 140' ' ' GLU . 7.4 mm -85.89 -66.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.247 -0.908 . . . . 0.0 109.721 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 173.46 65.01 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -95.92 -87.51 1.77 Allowed Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.93 -17.61 7.26 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.765 -0.844 . . . . 0.0 109.327 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 125.08 18.32 2.59 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.48 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 1.3 pt20 -118.68 171.37 8.24 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -1.184 . . . . 0.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 137' ' ' ASN . 84.1 t -125.43 169.41 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.141 -0.974 . . . . 0.0 109.862 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.641 ' CB ' ' CE1' ' A' ' 99' ' ' TYR . 1.8 p-10 -145.23 -173.21 4.04 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.693 ' O ' HG23 ' A' ' 142' ' ' VAL . 49.9 t80 -69.81 -45.21 68.41 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.392 -1.443 . . . . 0.0 111.671 -177.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.454 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 0.3 OUTLIER -61.68 -47.82 83.58 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.902 -1.124 . . . . 0.0 110.651 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.527 ' HB3' ' HA ' ' A' ' 129' ' ' ASP . 0.8 OUTLIER -70.41 -36.52 74.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.892 -1.13 . . . . 0.0 109.78 -179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.597 ' CZ ' ' HG2' ' A' ' 145' ' ' MET . 6.2 t80 -67.66 -27.71 67.08 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.19 -0.943 . . . . 0.0 109.159 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 138' ' ' TYR . 75.8 t -79.32 -62.62 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.369 -0.832 . . . . 0.0 109.662 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.44 ' C ' ' O ' ' A' ' 142' ' ' VAL . 7.8 mm100 -39.38 -34.65 0.22 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.473 -0.767 . . . . 0.0 110.73 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.461 ' HG3' ' O ' ' A' ' 128' ' ' ALA . 29.6 mmt -90.45 -45.75 8.78 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.871 -1.143 . . . . 0.0 110.624 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.597 ' HG2' ' CZ ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -71.61 -0.61 11.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 0.0 110.549 -178.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.494 ' CG2' HG13 ' A' ' 85' ' ' ILE . 7.8 p -125.24 -89.27 0.58 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.104 -0.997 . . . . 0.0 110.008 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' A' ' 148' ' ' LYS . . . -83.75 -175.38 5.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.079 -1.013 . . . . 0.0 110.202 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 147' ' ' ALA . 11.5 mptt . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.159 -0.924 . . . . 0.0 109.67 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 3.8 tpt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.66 78.84 0.11 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.272 -0.893 . . . . 0.0 109.631 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -94.25 -168.62 1.89 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.17 -0.956 . . . . 0.0 109.551 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -60.68 108.13 0.79 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -0.9 . . . . 0.0 109.757 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.523 ' CB ' ' OE2' ' A' ' 82' ' ' GLU . 73.7 m-20 -113.21 -29.95 7.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.125 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.453 ' O ' ' OG ' ' A' ' 81' ' ' SER . 0.2 OUTLIER 66.32 13.7 9.33 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.348 -0.845 . . . . 0.0 109.743 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.523 ' OE2' ' CB ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -88.6 -16.77 31.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.251 -0.906 . . . . 0.0 109.098 179.434 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -89.95 -30.21 17.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 87' ' ' GLU . 0.4 OUTLIER -52.95 -23.15 6.62 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.474 -0.766 . . . . 0.0 109.401 179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.6 mt -81.81 -38.12 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.326 -0.859 . . . . 0.0 109.058 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.474 ' HG2' ' CZ ' ' A' ' 138' ' ' TYR . 9.9 mtt180 -61.19 -31.92 71.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.437 -0.79 . . . . 0.0 109.143 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.469 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -89.74 -34.99 16.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.227 -0.921 . . . . 0.0 109.136 179.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.494 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.56 -23.12 67.25 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.42 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 82.6 t80 -69.68 -54.31 14.46 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -63.54 -27.62 69.38 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.494 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 4.9 t -48.17 -31.11 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.498 ' CE1' ' HB ' ' A' ' 108' ' ' VAL . 83.3 m-85 -98.29 -37.59 9.59 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.468 ' HA ' ' OE1' ' A' ' 104' ' ' GLU . 43.2 t0 -87.39 92.32 9.04 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -84.0 -24.8 30.4 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.26 -0.9 . . . . 0.0 110.223 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 97' ' ' ASN . 0.2 OUTLIER -79.18 4.18 15.57 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.245 -0.91 . . . . 0.0 109.101 179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 39.57 29.3 0.14 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' N ' ' O ' ' A' ' 95' ' ' ASP . 15.4 p-10 -73.93 -39.0 64.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.304 -1.116 . . . . 0.0 109.658 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.26 -48.34 0.68 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.488 ' CD2' ' HG3' ' A' ' 135' ' ' GLN . 8.7 m-30 -108.92 176.29 5.16 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.335 -1.097 . . . . 0.0 109.465 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 49.7 mt -119.31 115.3 47.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.643 -0.66 . . . . 0.0 109.424 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.5 p -80.29 159.11 25.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.161 -0.962 . . . . 0.0 109.651 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.465 ' HB1' ' CG1' ' A' ' 121' ' ' VAL . . . -51.93 -35.89 47.28 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 0.0 109.514 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.56 -41.21 88.99 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.152 -0.968 . . . . 0.0 109.117 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 93' ' ' ASP . 13.6 mt-10 -65.84 -22.69 66.56 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.227 -0.921 . . . . 0.0 109.103 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 109' ' ' MET . 9.4 tp -85.54 -32.25 22.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.422 -0.799 . . . . 0.0 109.644 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -34.79 77.64 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.289 -0.882 . . . . 0.0 109.177 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -59.55 -27.15 65.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 0.0 109.985 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.498 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 17.5 t -102.33 -12.73 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.078 -1.014 . . . . 0.0 110.44 -179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.815 ' HB3' HD22 ' A' ' 116' ' ' LEU . 0.5 OUTLIER -78.24 -11.18 59.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.909 -1.12 . . . . 0.0 109.618 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 111' ' ' ASN . 2.1 t -99.93 -30.72 11.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.07 -1.019 . . . . 0.0 110.123 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.42 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -43.92 -45.49 7.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 109.221 179.996 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.8 23.48 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.286 -0.884 . . . . 0.0 109.648 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -115.04 19.76 15.0 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 67.8 146.39 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -1.095 . . . . 0.0 109.223 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.42 81.5 1.42 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.159 -0.963 . . . . 0.0 110.053 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' A' ' 109' ' ' MET . 2.7 pt? -63.33 151.75 39.87 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 0.0 109.008 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.509 ' OG1' ' HG2' ' A' ' 120' ' ' GLU . 44.4 p -84.45 -165.61 1.22 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.296 -0.877 . . . . 0.0 109.447 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -75.11 -46.57 33.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.38 -0.825 . . . . 0.0 109.712 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.439 ' O ' ' OE1' ' A' ' 123' ' ' GLU . 30.9 mt-10 -57.2 -16.42 8.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.763 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.509 ' HG2' ' OG1' ' A' ' 117' ' ' THR . 5.2 mm-40 -95.17 -45.08 7.34 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.342 -0.849 . . . . 0.0 108.961 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.603 HG22 HD11 ' A' ' 116' ' ' LEU . 41.8 t -49.42 -55.72 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.89 -0.507 . . . . 0.0 110.599 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.34 -36.54 84.05 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.852 -1.155 . . . . 0.0 109.042 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 119' ' ' GLU . 87.0 mt-10 -70.79 -15.56 62.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.179 -0.951 . . . . 0.0 108.56 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.434 ' SD ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -85.32 -30.94 23.31 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.698 HG22 ' OD2' ' A' ' 129' ' ' ASP . 3.3 mt -74.42 -41.31 49.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.99 -15.23 3.23 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.706 -0.621 . . . . 0.0 110.007 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -87.33 -30.94 20.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.923 -1.111 . . . . 0.0 109.797 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.402 ' HB2' ' SD ' ' A' ' 144' ' ' MET . . . -88.7 -58.48 2.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.337 -0.852 . . . . 0.0 109.506 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.698 ' OD2' HG22 ' A' ' 125' ' ' ILE . 8.6 p30 -53.05 155.49 2.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.713 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.8 mt -111.79 -44.39 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.295 -0.878 . . . . 0.0 109.703 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -72.51 -38.14 68.18 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.473 -0.767 . . . . 0.0 109.63 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 95.66 33.46 6.42 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -78.94 -26.28 43.6 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.318 -1.107 . . . . 0.0 108.681 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.587 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 124.22 -42.19 1.6 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.488 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -90.07 165.25 14.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.059 -1.26 . . . . 0.0 109.49 -179.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 137' ' ' ASN . 53.1 t -118.23 161.49 17.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.521 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -134.16 -164.62 1.53 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.714 -1.241 . . . . 0.0 108.659 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.991 ' O ' HG23 ' A' ' 142' ' ' VAL . 64.9 t80 -78.49 -38.48 40.8 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.205 -0.934 . . . . 0.0 110.206 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -70.45 -33.08 70.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.995 -1.066 . . . . 0.0 109.417 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.48 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 15.5 mt-10 -82.12 -34.07 29.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.159 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.42 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 38.5 t80 -75.47 -25.65 57.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.519 -0.738 . . . . 0.0 109.671 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.991 HG23 ' O ' ' A' ' 138' ' ' TYR . 26.8 t -55.38 -48.98 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.786 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -65.9 -27.3 68.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.041 -1.037 . . . . 0.0 109.627 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.402 ' SD ' ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -80.39 -19.33 46.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.198 -0.939 . . . . 0.0 109.691 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.442 ' HG3' ' HB3' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -77.47 -39.13 47.62 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.0 p -56.7 -30.83 63.87 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.095 -1.003 . . . . 0.0 109.36 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.405 ' O ' ' OXT' ' A' ' 148' ' ' LYS . . . -73.62 168.08 20.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.299 -0.876 . . . . 0.0 109.338 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.405 ' OXT' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.385 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.23 0.538 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -78.7 113.03 16.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.259 -0.901 . . . . 0.0 109.166 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -59.33 176.63 0.23 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.273 -0.892 . . . . 0.0 109.681 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.6 t -139.08 154.0 48.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 109.413 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -151.39 -33.38 0.15 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.166 -0.959 . . . . 0.0 110.187 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.75 10.56 7.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.882 -1.136 . . . . 0.0 110.039 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.401 ' O ' HD12 ' A' ' 85' ' ' ILE . 4.5 mm-40 -89.49 -37.99 14.36 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 108.856 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 86' ' ' ARG . 4.9 tt0 -90.6 -9.24 47.78 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.349 0.595 . . . . 0.0 109.469 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -47.09 -26.94 1.2 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.312 -0.868 . . . . 0.0 110.116 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 82' ' ' GLU . 2.6 mt -72.45 -44.67 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.042 -1.036 . . . . 0.0 109.641 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.584 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -46.24 -33.4 3.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.059 -1.025 . . . . 0.0 109.441 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 88' ' ' ALA . 1.9 mt-10 -87.17 -55.44 3.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.338 -0.851 . . . . 0.0 109.977 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -42.69 -28.34 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.326 -0.859 . . . . 0.0 108.901 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 87' ' ' GLU . 79.6 t80 -62.61 -57.52 10.77 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.481 -0.762 . . . . 0.0 109.419 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.461 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 6.0 mtp180 -61.1 -32.99 72.65 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.67 -0.644 . . . . 0.0 109.302 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.488 HG12 HG21 ' A' ' 108' ' ' VAL . 39.1 t -45.31 -32.45 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.706 ' CD1' HD12 ' A' ' 105' ' ' LEU . 85.8 m-85 -94.47 -49.79 5.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.487 ' CA ' HG12 ' A' ' 100' ' ' ILE . 65.7 t0 -65.36 91.37 0.11 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -90.32 -21.01 22.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 111.238 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.46 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 10.5 p-10 -78.2 7.53 6.2 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.938 -1.101 . . . . 0.0 109.876 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.75 49.66 1.92 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.425 ' HB3' ' OD2' ' A' ' 95' ' ' ASP . 1.8 t30 -110.17 -64.58 1.25 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.306 -1.114 . . . . 0.0 109.207 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.19 -47.27 0.11 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.593 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 7.6 m-30 -110.06 150.38 28.64 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.53 -0.982 . . . . 0.0 109.204 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.487 HG12 ' CA ' ' A' ' 93' ' ' ASP . 55.6 mt -85.43 152.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 121.419 -0.801 . . . . 0.0 109.511 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.7 p -110.48 172.63 6.75 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.391 -0.818 . . . . 0.0 109.183 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.96 -53.7 49.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.828 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -57.68 -27.24 62.72 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.843 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 71.4 mt-10 -75.24 -30.0 60.39 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.123 -0.986 . . . . 0.0 108.561 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.706 HD12 ' CD1' ' A' ' 92' ' ' PHE . 12.2 tp -81.18 -21.93 39.29 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.776 ' HB2' HG21 ' A' ' 121' ' ' VAL . 35.9 ttt-85 -78.86 -22.64 45.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.41 -0.806 . . . . 0.0 108.968 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -67.76 -38.49 83.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.468 -0.77 . . . . 0.0 110.427 -179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.488 HG21 HG12 ' A' ' 91' ' ' VAL . 92.4 t -99.17 -38.07 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.025 -1.047 . . . . 0.0 110.255 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.979 ' HB3' HD13 ' A' ' 116' ' ' LEU . 16.3 mmt -61.14 -13.34 16.88 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.32 -0.862 . . . . 0.0 109.615 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -94.73 -29.41 14.8 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.22 -0.925 . . . . 0.0 108.849 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -68.12 0.39 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.905 . . . . 0.0 109.258 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 6.7 mt -114.33 15.19 18.07 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.264 -0.897 . . . . 0.0 109.328 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 109' ' ' MET . . . -111.04 51.35 0.7 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 48.29 -145.35 0.35 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -1.083 . . . . 0.0 109.545 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.56 101.01 9.71 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.067 -1.02 . . . . 0.0 109.788 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.979 HD13 ' HB3' ' A' ' 109' ' ' MET . 0.1 OUTLIER -102.6 111.5 23.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.16 -0.963 . . . . 0.0 109.41 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.905 HG22 ' HG2' ' A' ' 120' ' ' GLU . 6.3 t -82.71 -146.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.174 -0.954 . . . . 0.0 108.735 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.7 ' N ' HG23 ' A' ' 117' ' ' THR . 2.9 m-20 -90.11 -48.45 7.17 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.023 -1.048 . . . . 0.0 109.884 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.3 mp0 -60.23 -17.83 44.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.31 -0.869 . . . . 0.0 109.586 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.905 ' HG2' HG22 ' A' ' 117' ' ' THR . 11.9 mm-40 -94.1 -47.76 6.53 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 117' ' ' THR . 47.7 t -47.49 -62.02 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.599 -0.688 . . . . 0.0 109.905 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.73 -31.68 11.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.982 -1.074 . . . . 0.0 109.646 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 0.9 OUTLIER -68.49 -40.18 81.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.181 -0.949 . . . . 0.0 109.224 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.492 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 36.2 mmm -63.39 -32.68 74.18 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mt -71.03 -39.25 74.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.567 -0.708 . . . . 0.0 109.463 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -55.06 -27.55 45.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.578 -0.701 . . . . 0.0 110.263 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -89.33 -21.56 23.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.126 -0.984 . . . . 0.0 109.663 -179.479 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.502 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -97.19 -5.82 36.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.824 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD1' HG22 ' A' ' 136' ' ' VAL . 1.0 OUTLIER -97.45 133.32 42.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.931 . . . . 0.0 109.7 -179.582 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 57.0 mt -85.34 -50.23 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.358 -0.839 . . . . 0.0 109.426 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.1 -49.86 7.91 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.604 -0.685 . . . . 0.0 109.726 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.08 37.75 2.45 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -78.78 -25.19 44.33 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.317 -1.108 . . . . 0.0 108.821 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 119.19 28.96 1.88 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.905 -1.141 . . . . 0.0 110.485 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.593 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -159.18 165.85 32.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.068 -1.254 . . . . 0.0 109.256 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 137' ' ' ASN . 55.8 t -122.6 162.86 21.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.12 -0.987 . . . . 0.0 108.654 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.534 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.0 OUTLIER -132.44 -164.01 1.41 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.908 -1.12 . . . . 0.0 108.517 179.424 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 1.013 ' O ' HG23 ' A' ' 142' ' ' VAL . 67.2 t80 -78.58 -49.59 13.01 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.156 -0.965 . . . . 0.0 110.323 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -59.84 -39.65 85.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.048 -1.032 . . . . 0.0 109.536 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.517 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 7.5 mt-10 -74.68 -38.96 62.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.049 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.593 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 39.0 t80 -65.64 -22.52 66.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.422 -0.798 . . . . 0.0 109.059 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 1.013 HG23 ' O ' ' A' ' 138' ' ' TYR . 89.7 t -70.68 -40.66 77.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.552 -0.718 . . . . 0.0 110.079 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 7.6 mt-30 -65.98 -27.82 68.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.068 -1.02 . . . . 0.0 110.188 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.6 ttp -90.34 -26.54 19.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.094 -1.004 . . . . 0.0 110.058 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.593 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -97.68 -62.69 1.21 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.005 -1.06 . . . . 0.0 109.99 -179.736 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 142' ' ' VAL . 0.6 OUTLIER -52.53 -31.61 36.41 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.159 -0.963 . . . . 0.0 109.348 -179.735 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -50.76 101.75 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.069 -1.02 . . . . 0.0 109.492 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.2 mttm . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.367 179.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.33 0.586 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 65.37 164.76 0.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.587 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.07 -38.28 2.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.84 . . . . 0.0 109.709 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.77 171.25 18.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.948 . . . . 0.0 109.778 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -114.04 -84.07 0.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.298 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 m -169.66 105.95 0.36 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.398 -0.814 . . . . 0.0 109.144 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.97 -13.05 21.76 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.264 -0.898 . . . . 0.0 109.443 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -71.2 -31.07 67.17 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.34 -0.85 . . . . 0.0 109.849 -179.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.41 -39.42 15.41 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.077 -1.014 . . . . 0.0 109.961 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.66 HG23 ' CB ' ' A' ' 145' ' ' MET . 2.6 mt -91.72 -37.17 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.178 -0.952 . . . . 0.0 110.243 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.57 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 34.8 mtt180 -49.61 -28.91 6.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.091 -1.005 . . . . 0.0 109.772 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -92.68 -54.02 3.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.078 -1.014 . . . . 0.0 109.478 179.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -44.51 -26.74 0.39 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.189 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 75.7 t80 -64.77 -55.9 16.94 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.111 -0.993 . . . . 0.0 109.403 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.411 ' CZ ' ' CB ' ' A' ' 90' ' ' ARG . 0.1 OUTLIER -62.88 -31.68 72.78 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.307 -179.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.44 ' O ' HG21 ' A' ' 108' ' ' VAL . 41.0 t -47.41 -28.24 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.474 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 64.7 m-85 -102.74 -31.69 10.2 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.472 ' HB2' HG12 ' A' ' 100' ' ' ILE . 34.3 t0 -93.62 92.83 7.72 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.583 -0.698 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.553 ' NZ ' ' CD2' ' A' ' 107' ' ' HIS . 1.6 mmmm -90.28 -23.13 21.27 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.222 -0.924 . . . . 0.0 109.927 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.492 ' O ' ' C ' ' A' ' 96' ' ' GLY . 15.8 t0 -78.79 1.95 21.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.29 -0.881 . . . . 0.0 109.186 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.492 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 33.55 37.8 0.07 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 95' ' ' ASP . 12.9 p-10 -88.0 -28.53 21.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.197 -1.178 . . . . 0.0 109.768 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.462 ' O ' ' OD1' ' A' ' 137' ' ' ASN . . . 143.37 -54.27 0.59 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.512 ' HA ' ' O ' ' A' ' 136' ' ' VAL . 14.6 m-30 -109.59 157.28 19.2 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.486 -1.008 . . . . 0.0 109.124 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.484 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 84.3 mt -90.28 117.4 33.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.336 -0.852 . . . . 0.0 109.026 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 65.0 p -74.48 159.86 31.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.168 -0.958 . . . . 0.0 109.265 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.79 -31.12 66.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.279 -0.888 . . . . 0.0 109.418 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.78 -35.34 62.54 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.168 -0.958 . . . . 0.0 109.042 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 50.7 mm-40 -73.3 -22.8 60.27 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.276 -0.89 . . . . 0.0 108.967 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 125' ' ' ILE . 5.3 tp -90.78 -25.16 20.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 0.0 109.032 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.496 ' O ' ' OG1' ' A' ' 110' ' ' THR . 2.0 ttt180 -77.4 -30.4 53.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.271 -0.893 . . . . 0.0 109.01 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.553 ' CD2' ' NZ ' ' A' ' 94' ' ' LYS . 71.3 t60 -58.03 -45.11 87.47 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.906 . . . . 0.0 110.057 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 91' ' ' VAL . 25.9 t -91.65 -26.46 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.06 -1.025 . . . . 0.0 110.392 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.576 ' CE ' HD12 ' A' ' 116' ' ' LEU . 13.7 mtm -61.29 -42.63 98.98 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.102 -0.999 . . . . 0.0 109.038 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.937 HG23 ' HA ' ' A' ' 115' ' ' LYS . 0.2 OUTLIER -59.31 -26.67 65.2 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.207 -0.933 . . . . 0.0 109.253 179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 110' ' ' THR . 7.9 t-20 39.02 -93.03 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.662 -0.648 . . . . 0.0 110.088 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.839 ' O ' HD12 ' A' ' 112' ' ' LEU . 1.3 pp -148.71 68.34 1.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.143 -0.973 . . . . 0.0 109.226 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 118.56 -17.55 11.14 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -83.75 43.41 0.91 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.228 -1.16 . . . . 0.0 109.826 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.937 ' HA ' HG23 ' A' ' 110' ' ' THR . 13.7 ttpp -64.98 126.52 28.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 0.0 109.344 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.576 HD12 ' CE ' ' A' ' 109' ' ' MET . 45.5 mt -104.08 140.6 37.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.48 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.611 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.1 OUTLIER -66.98 -169.17 0.08 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.243 -0.91 . . . . 0.0 108.71 179.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.47 -50.53 12.47 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.011 -1.055 . . . . 0.0 109.269 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -30.6 70.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.18 -0.95 . . . . 0.0 108.5 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.49 ' CG ' HD22 ' A' ' 116' ' ' LEU . 9.8 tp10 -70.56 -41.88 71.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 117' ' ' THR . 34.6 t -61.5 -36.63 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.14 -25.53 67.02 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -75.01 -45.86 38.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.481 -0.762 . . . . 0.0 109.017 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 7.6 mmt -60.66 -28.28 68.47 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.21 -0.931 . . . . 0.0 108.76 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.563 HG12 HD22 ' A' ' 105' ' ' LEU . 2.4 mt -82.09 -35.24 13.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.519 -0.738 . . . . 0.0 109.475 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -59.69 -31.24 69.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.61 -0.681 . . . . 0.0 110.35 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.42 -5.24 56.35 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.029 -1.045 . . . . 0.0 110.509 -179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.06 -29.85 11.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.986 -1.071 . . . . 0.0 109.747 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -100.33 149.87 23.17 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.287 -0.883 . . . . 0.0 109.641 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.818 HD12 ' OE1' ' A' ' 140' ' ' GLU . 16.9 mt -113.38 -29.02 2.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.18 -0.95 . . . . 0.0 109.374 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.427 ' HB3' ' OD2' ' A' ' 133' ' ' ASP . 0.2 OUTLIER -61.73 -33.6 74.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.503 -0.748 . . . . 0.0 109.523 -179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.88 21.39 55.83 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' OD2' ' HB3' ' A' ' 131' ' ' ASP . 0.7 OUTLIER -83.51 -27.56 29.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -1.169 . . . . 0.0 109.609 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 108.84 28.03 4.65 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.457 ' CD ' ' CD2' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -146.61 163.07 37.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -1.204 . . . . 0.0 109.391 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.599 HG12 ' N ' ' A' ' 137' ' ' ASN . 94.2 t -117.78 168.2 9.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.327 -0.858 . . . . 0.0 109.188 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.599 ' N ' HG12 ' A' ' 136' ' ' VAL . 47.0 t30 -148.25 -166.29 2.5 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.888 ' O ' HG23 ' A' ' 142' ' ' VAL . 60.2 t80 -80.62 -41.79 23.31 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.583 -1.323 . . . . 0.0 110.117 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.49 -29.99 66.67 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.104 -0.998 . . . . 0.0 109.303 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.818 ' OE1' HD12 ' A' ' 130' ' ' ILE . 6.1 mm-40 -85.26 -35.41 21.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.498 ' HB3' ' O ' ' A' ' 137' ' ' ASN . 26.1 t80 -71.22 -26.87 63.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.536 -0.727 . . . . 0.0 109.16 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 138' ' ' TYR . 20.3 t -55.37 -44.31 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.434 -0.791 . . . . 0.0 109.189 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -57.94 -31.59 66.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.331 -0.855 . . . . 0.0 109.708 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.493 ' HE3' ' CE1' ' A' ' 141' ' ' PHE . 34.5 ttp -75.98 -39.57 55.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.203 -0.935 . . . . 0.0 109.454 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.66 ' CB ' HG23 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -69.77 -20.17 63.49 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.366 -0.834 . . . . 0.0 109.527 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 26.2 p -154.07 94.71 1.77 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.218 -0.926 . . . . 0.0 109.518 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -101.33 85.93 2.89 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.665 -0.647 . . . . 0.0 109.412 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.385 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.287 0.565 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.0 146.92 41.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.188 -0.945 . . . . 0.0 109.393 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -56.89 137.77 54.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.978 . . . . 0.0 109.2 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 80' ' ' ASP . 9.5 t -144.99 139.9 27.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.207 -0.933 . . . . 0.0 109.519 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 79' ' ' THR . 3.0 t0 80.92 -55.67 0.31 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.902 -0.499 . . . . 0.0 110.251 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.41 20.43 1.99 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.92 -1.112 . . . . 0.0 109.527 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.44 -90.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.247 -0.908 . . . . 0.0 109.61 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -74.39 2.31 9.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.502 -0.749 . . . . 0.0 109.993 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.01 -19.46 4.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.064 -1.022 . . . . 0.0 109.338 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.521 HG21 ' HA ' ' A' ' 142' ' ' VAL . 5.8 mt -74.92 -39.72 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.282 -0.886 . . . . 0.0 109.548 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.586 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 0.0 OUTLIER -46.52 -31.79 2.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.934 -1.103 . . . . 0.0 109.214 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 88' ' ' ALA . 15.5 mt-10 -91.88 -50.28 5.8 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.454 -0.779 . . . . 0.0 109.168 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.488 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.78 -25.87 0.34 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -0.906 . . . . 0.0 108.761 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' N ' ' C ' ' A' ' 87' ' ' GLU . 82.9 t80 -63.51 -55.61 22.59 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.284 -0.885 . . . . 0.0 109.004 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.45 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -60.86 -36.13 78.37 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 34.4 t -43.32 -28.35 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 90' ' ' ARG . 92.0 m-85 -106.36 -31.37 8.62 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.45 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 10.8 t0 -89.34 79.7 6.97 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.602 -0.686 . . . . 0.0 109.369 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HA ' ' HD2' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -89.19 -16.97 30.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.386 -0.821 . . . . 0.0 109.745 -179.456 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.459 ' O ' ' C ' ' A' ' 96' ' ' GLY . 12.6 t70 -77.19 0.39 21.98 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.397 -0.815 . . . . 0.0 108.988 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.96 50.3 2.07 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -108.12 -31.83 7.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -1.176 . . . . 0.0 109.587 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 138.39 -50.02 0.82 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.224 -1.551 . . . . 0.0 109.224 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.636 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 10.9 m-30 -114.03 146.04 40.73 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.339 -1.095 . . . . 0.0 109.217 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.477 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 81.9 mt -81.96 132.56 31.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.398 -0.814 . . . . 0.0 109.389 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.6 p -98.26 178.04 5.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.3 -0.875 . . . . 0.0 109.221 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.547 ' CA ' HG11 ' A' ' 121' ' ' VAL . . . -65.7 -40.54 92.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.936 . . . . 0.0 109.341 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.73 -31.1 70.8 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.267 -0.896 . . . . 0.0 109.407 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -74.53 -26.23 59.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.296 -0.877 . . . . 0.0 108.667 179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.904 ' O ' HD23 ' A' ' 105' ' ' LEU . 3.6 tt -82.11 -26.2 33.77 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.787 HH12 HG21 ' A' ' 110' ' ' THR . 0.0 OUTLIER -73.03 -47.33 45.84 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 106' ' ' ARG . 28.0 t60 -40.93 -38.4 0.95 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.48 -0.762 . . . . 0.0 110.347 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.449 ' HA ' ' OD1' ' A' ' 111' ' ' ASN . 36.2 t -97.97 -28.11 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.972 -1.08 . . . . 0.0 110.297 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.701 ' CG ' HD22 ' A' ' 116' ' ' LEU . 3.9 mmt -64.33 -17.34 63.6 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.229 -0.919 . . . . 0.0 109.725 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.787 HG21 HH12 ' A' ' 106' ' ' ARG . 1.1 t -88.7 -18.55 27.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.179 -0.951 . . . . 0.0 109.455 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.449 ' OD1' ' HA ' ' A' ' 108' ' ' VAL . 7.3 m120 -58.48 97.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.875 . . . . 0.0 109.552 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mt 61.32 13.45 4.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -0.899 . . . . 0.0 109.625 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -117.96 41.91 1.95 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 52.89 -125.76 2.4 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.236 -1.155 . . . . 0.0 109.12 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.03 135.67 32.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.634 -1.292 . . . . 0.0 109.991 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.859 HD21 ' SD ' ' A' ' 124' ' ' MET . 0.7 OUTLIER -103.94 116.46 32.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.0 109.297 179.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.467 HG23 ' H ' ' A' ' 120' ' ' GLU . 5.6 t -75.45 165.78 24.6 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.64 -52.67 63.99 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.845 -1.16 . . . . 0.0 110.237 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -59.41 -17.96 34.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.244 -0.91 . . . . 0.0 109.998 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.546 ' CG ' ' HG ' ' A' ' 116' ' ' LEU . 7.7 tp10 -87.18 -40.16 14.83 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.547 HG11 ' CA ' ' A' ' 102' ' ' ALA . 21.9 t -61.41 -46.74 95.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.304 -0.872 . . . . 0.0 109.079 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -46.92 -28.82 1.74 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.383 -0.823 . . . . 0.0 109.751 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -75.54 -51.41 12.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.142 -0.974 . . . . 0.0 109.426 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.859 ' SD ' HD21 ' A' ' 116' ' ' LEU . 1.2 mpt? -59.91 -21.14 60.71 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.222 -0.924 . . . . 0.0 109.559 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.547 HG12 HD12 ' A' ' 105' ' ' LEU . 2.3 mt -84.85 -42.97 16.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.3 -0.875 . . . . 0.0 109.659 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.15 -22.68 1.02 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.38 -0.825 . . . . 0.0 110.588 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -90.87 -30.37 16.97 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.919 -1.113 . . . . 0.0 110.379 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.19 -49.65 16.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.838 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.407 ' OD2' HG22 ' A' ' 125' ' ' ILE . 1.9 p30 -80.44 150.91 29.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 110.0 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 33.5 mt -117.69 -34.48 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.334 -0.854 . . . . 0.0 109.214 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -61.75 -39.88 93.17 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.536 -0.727 . . . . 0.0 109.286 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 84.56 29.44 29.8 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.18 -25.64 39.64 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.386 -1.067 . . . . 0.0 108.77 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 115.3 26.54 3.42 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.636 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -160.27 162.54 33.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.045 -1.268 . . . . 0.0 109.517 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 137' ' ' ASN . 70.0 t -113.8 161.23 12.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.52 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -135.79 -166.46 1.86 Allowed 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.97 -1.081 . . . . 0.0 108.619 179.113 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.705 ' O ' HG23 ' A' ' 142' ' ' VAL . 52.3 t80 -78.87 -37.44 40.27 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.415 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.423 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 5.2 tp10 -67.77 -38.99 84.15 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.217 -0.927 . . . . 0.0 109.28 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -77.09 -38.47 52.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.246 -0.909 . . . . 0.0 109.175 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.563 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 38.6 t80 -69.47 -23.49 63.65 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.394 -0.816 . . . . 0.0 109.456 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 138' ' ' TYR . 23.1 t -75.7 -54.01 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 109.84 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.423 ' OE1' ' O ' ' A' ' 139' ' ' GLU . 2.8 mt-30 -63.34 -21.9 66.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.0 110.044 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -90.24 -32.82 16.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.076 -1.015 . . . . 0.0 109.941 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.563 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -93.25 -4.4 51.95 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.201 -0.937 . . . . 0.0 110.143 -179.326 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.595 HG23 ' N ' ' A' ' 147' ' ' ALA . 12.5 t -98.14 -45.47 6.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.044 -1.035 . . . . 0.0 109.587 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.595 ' N ' HG23 ' A' ' 146' ' ' THR . . . -43.36 159.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.923 . . . . 0.0 109.608 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.078 -0.963 . . . . 0.0 109.649 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.269 0.557 . . . . 0.0 109.507 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt 66.86 154.76 0.09 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -0.926 . . . . 0.0 109.461 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.23 1.56 12.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.91 . . . . 0.0 109.506 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 61.4 p 45.91 -158.84 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.169 -0.957 . . . . 0.0 109.265 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -119.14 -1.44 10.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.934 . . . . 0.0 109.903 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 29.5 t -72.56 -17.36 61.72 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.041 -1.037 . . . . 0.0 109.764 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.63 -22.74 20.12 Favored 'General case' 0 C--N 1.293 -1.872 0 O-C-N 121.675 -0.641 . . . . 0.0 109.544 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.92 11.45 20.38 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.603 -0.686 . . . . 0.0 109.617 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -23.74 60.78 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.206 -0.934 . . . . 0.0 109.709 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.9 HG12 HG23 ' A' ' 146' ' ' THR . 3.5 mp -82.64 -37.85 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.142 -0.974 . . . . 0.0 109.929 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -42.05 95.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.722 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.722 ' O ' HG23 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -79.56 -30.14 41.56 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.148 -0.97 . . . . 0.0 109.442 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.452 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -67.38 -27.02 66.76 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 82.0 t80 -68.44 -54.61 15.93 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.652 0.739 . . . . 0.0 109.247 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -63.78 -27.91 69.51 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 87' ' ' GLU . 8.5 t -50.09 -30.1 6.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.48 ' HB2' HD13 ' A' ' 100' ' ' ILE . 87.1 m-85 -98.02 -35.42 10.44 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -90.13 95.71 10.33 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mmmt -89.98 -26.02 20.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.207 -0.933 . . . . 0.0 110.841 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -78.99 5.26 12.12 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.062 -1.024 . . . . 0.0 109.055 179.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 40.94 33.12 0.62 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -75.81 -70.53 0.43 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -1.117 . . . . 0.0 109.081 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.19 -53.98 0.09 OUTLIER Glycine 0 N--CA 1.49 2.245 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.629 ' CE2' ' NE2' ' A' ' 135' ' ' GLN . 9.7 m-30 -107.95 152.15 24.84 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.488 -1.007 . . . . 0.0 109.047 179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 86.0 mt -88.63 128.57 40.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.314 -0.866 . . . . 0.0 109.911 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.9 p -90.36 -176.58 4.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.327 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.664 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -67.51 -50.71 57.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.321 -0.862 . . . . 0.0 109.363 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.74 -29.52 69.43 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.382 -0.824 . . . . 0.0 109.526 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 28.5 mt-10 -73.64 -30.79 63.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.16 -0.962 . . . . 0.0 108.953 179.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 109' ' ' MET . 2.2 tp -91.06 -9.21 46.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.46 -0.775 . . . . 0.0 109.211 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -91.53 -40.24 11.48 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -0.956 . . . . 0.0 109.383 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.579 ' O ' HG22 ' A' ' 110' ' ' THR . 24.4 t60 -54.83 -35.22 63.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.231 -0.918 . . . . 0.0 109.627 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.523 HG21 ' O ' ' A' ' 91' ' ' VAL . 71.1 t -88.85 -44.64 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.118 -0.989 . . . . 0.0 110.056 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.551 ' HB3' HD13 ' A' ' 116' ' ' LEU . 97.1 mmm -68.13 -7.65 31.64 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.179 -0.95 . . . . 0.0 109.188 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 107' ' ' HIS . 6.6 t -98.86 -19.54 17.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.275 -0.891 . . . . 0.0 109.125 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.636 ' O ' HD23 ' A' ' 112' ' ' LEU . 3.3 m120 -89.23 31.3 0.9 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.129 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.636 HD23 ' O ' ' A' ' 111' ' ' ASN . 0.5 OUTLIER 161.03 -19.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.585 -0.697 . . . . 0.0 109.725 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -85.83 20.86 17.38 Favored Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.973 -1.108 . . . . 0.0 110.506 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.529 ' O ' ' O ' ' A' ' 115' ' ' LYS . 13.3 mt-10 62.08 40.61 11.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.112 -1.228 . . . . 0.0 110.125 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 114' ' ' GLU . 3.1 ttpp 50.0 115.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.767 0.794 . . . . 0.0 111.45 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' A' ' 124' ' ' MET . 0.7 OUTLIER -95.36 159.26 15.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 0.0 109.356 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 121' ' ' VAL . 21.7 p -92.41 -171.64 2.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.179 -0.951 . . . . 0.0 109.774 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.87 -47.82 8.3 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.465 -0.772 . . . . 0.0 109.025 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.42 -13.18 62.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 108.838 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.497 ' HB3' ' OG1' ' A' ' 117' ' ' THR . 23.9 tp10 -93.46 -42.23 9.37 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.475 -0.766 . . . . 0.0 109.137 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.664 HG11 ' HB1' ' A' ' 102' ' ' ALA . 6.9 t -53.87 -61.37 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.422 -0.798 . . . . 0.0 109.775 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -48.1 -27.73 2.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.987 . . . . 0.0 109.952 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 126' ' ' ARG . 0.3 OUTLIER -77.33 -39.74 46.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.196 -0.94 . . . . 0.0 109.326 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.553 ' HG3' HD21 ' A' ' 116' ' ' LEU . 25.1 mmm -66.38 -22.3 66.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.872 -1.142 . . . . 0.0 108.586 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.636 HG23 HG23 ' A' ' 136' ' ' VAL . 3.2 mt -86.91 -38.3 12.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.531 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -55.88 -22.82 27.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.636 -0.665 . . . . 0.0 110.062 -179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.488 ' HG2' ' HG3' ' A' ' 126' ' ' ARG . 3.1 mt-10 -90.41 -34.57 15.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 0.0 109.75 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -76.24 -13.49 60.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.201 -0.937 . . . . 0.0 109.917 -179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.844 ' OD1' HG22 ' A' ' 136' ' ' VAL . 7.1 m-20 -94.68 142.45 27.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.178 -0.951 . . . . 0.0 109.696 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.615 HD12 ' OE2' ' A' ' 140' ' ' GLU . 73.2 mt -89.26 -37.15 9.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.324 -0.86 . . . . 0.0 109.22 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.84 -39.09 24.49 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.514 -0.741 . . . . 0.0 109.439 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 90.36 29.94 13.3 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.14 -25.43 42.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -1.072 . . . . 0.0 109.09 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 117.48 5.77 14.01 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.629 ' NE2' ' CE2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -129.27 157.64 41.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.892 -1.357 . . . . 0.0 109.434 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.844 HG22 ' OD1' ' A' ' 129' ' ' ASP . 77.9 t -116.27 165.28 11.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.192 -0.943 . . . . 0.0 108.61 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.567 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -141.39 -164.19 1.71 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.925 -1.109 . . . . 0.0 108.512 179.477 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.501 ' O ' HG23 ' A' ' 142' ' ' VAL . 65.1 t80 -81.45 -42.17 20.73 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.126 -0.984 . . . . 0.0 109.182 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -68.34 -29.43 68.16 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.392 -0.817 . . . . 0.0 109.199 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.615 ' OE2' HD12 ' A' ' 130' ' ' ILE . 1.0 OUTLIER -86.27 -33.91 20.54 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.308 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.418 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 60.1 t80 -70.94 -24.43 62.44 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.561 -0.712 . . . . 0.0 109.293 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.683 HG13 ' OG1' ' A' ' 146' ' ' THR . 3.8 t -66.01 -51.64 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.498 -0.751 . . . . 0.0 109.991 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -59.79 -26.03 65.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.115 -0.991 . . . . 0.0 110.662 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.07 -28.37 19.07 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.854 -1.154 . . . . 0.0 110.742 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.4 tpt -102.57 -61.86 1.34 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.012 -1.055 . . . . 0.0 109.801 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.9 HG23 HG12 ' A' ' 85' ' ' ILE . 0.3 OUTLIER -46.16 -38.68 8.55 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.486 -0.759 . . . . 0.0 109.88 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -97.73 154.69 17.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.142 -0.974 . . . . 0.0 109.407 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.455 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.466 ' CG ' ' O ' ' A' ' 76' ' ' MET . 2.2 ptt? . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.436 ' CB ' ' O ' ' A' ' 76' ' ' MET . 0.9 OUTLIER 71.42 176.98 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.945 . . . . 0.0 109.408 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -114.55 -11.0 12.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.765 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 43.4 m 52.33 91.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.125 -0.984 . . . . 0.0 109.34 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -65.55 110.07 2.58 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.345 -0.847 . . . . 0.0 109.766 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.11 18.39 21.78 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.313 -0.867 . . . . 0.0 109.105 179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -82.16 -28.76 31.94 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.415 -0.803 . . . . 0.0 109.486 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.42 -20.94 62.05 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.56 -0.712 . . . . 0.0 109.202 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 87' ' ' GLU . 2.2 tm-20 -65.73 -35.8 81.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.416 -0.802 . . . . 0.0 109.531 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.603 HG21 ' HA ' ' A' ' 142' ' ' VAL . 2.8 mp -80.3 -37.65 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.271 -0.893 . . . . 0.0 110.026 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.483 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 5.7 ttp180 -48.53 -39.72 24.33 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.062 -1.024 . . . . 0.0 109.715 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 11.3 pt-20 -82.26 -50.74 8.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.111 -0.993 . . . . 0.0 109.875 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -45.59 -27.23 0.73 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.002 -1.061 . . . . 0.0 108.922 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.416 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 91.4 t80 -63.51 -56.99 11.66 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.419 -0.8 . . . . 0.0 109.753 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.443 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -62.03 -32.07 72.53 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.529 -0.732 . . . . 0.0 109.112 -179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 55.1 t -44.56 -30.41 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -99.44 -35.48 9.89 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.457 ' HB2' HG12 ' A' ' 100' ' ' ILE . 10.1 t0 -91.55 98.88 11.93 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.505 -0.747 . . . . 0.0 109.377 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.418 ' HE3' ' CD2' ' A' ' 107' ' ' HIS . 0.0 OUTLIER -90.32 -23.61 21.1 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.245 -0.909 . . . . 0.0 110.262 -179.487 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.468 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -79.01 3.68 16.54 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.237 -0.915 . . . . 0.0 109.337 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.61 31.76 0.09 OUTLIER Glycine 0 N--CA 1.495 2.57 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 95' ' ' ASP . 11.4 p-10 -80.47 -24.03 39.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.071 -1.252 . . . . 0.0 109.87 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.509 ' O ' ' ND2' ' A' ' 137' ' ' ASN . . . 126.33 -44.64 1.23 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 52.3 m-85 -110.4 145.03 38.27 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.495 -1.003 . . . . 0.0 109.629 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 136' ' ' VAL . 71.6 mt -90.43 94.31 4.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.453 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 p -66.58 158.61 29.38 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.106 -0.996 . . . . 0.0 109.208 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.552 ' HA ' HG11 ' A' ' 121' ' ' VAL . . . -45.49 -42.38 10.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.108 -0.995 . . . . 0.0 109.266 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.31 -43.26 99.17 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.241 -0.912 . . . . 0.0 109.311 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.455 ' OE1' ' HB2' ' A' ' 95' ' ' ASP . 1.5 mm-40 -64.47 -24.15 67.52 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.246 -0.909 . . . . 0.0 109.199 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.481 HD23 HG13 ' A' ' 121' ' ' VAL . 34.7 tp -88.83 -16.83 31.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.747 ' O ' HG22 ' A' ' 110' ' ' THR . 5.6 ttt-85 -83.44 -35.23 25.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.505 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.418 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 23.3 t60 -42.24 -49.9 4.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 0.0 110.667 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.7 t -95.59 -24.77 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.987 -1.071 . . . . 0.0 110.717 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.521 ' HB2' ' HA ' ' A' ' 106' ' ' ARG . 8.3 mmt -64.17 -23.49 67.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.05 -1.031 . . . . 0.0 109.758 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.747 HG22 ' O ' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -82.1 -31.13 30.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 109.795 -179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.405 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 22.5 t-20 -56.88 92.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 0.0 109.456 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.466 HD23 ' N ' ' A' ' 112' ' ' LEU . 1.5 mt 56.92 24.11 8.98 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.241 -0.912 . . . . 0.0 109.478 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -117.67 51.94 0.71 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 57.4 178.87 0.05 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.219 -1.165 . . . . 0.0 109.346 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -112.98 79.79 1.27 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.331 -0.856 . . . . 0.0 109.215 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.584 HD11 HG22 ' A' ' 121' ' ' VAL . 1.0 OUTLIER -94.21 133.84 37.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.144 -0.972 . . . . 0.0 109.378 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.901 ' O ' HG23 ' A' ' 121' ' ' VAL . 5.3 t -92.08 -146.14 0.21 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.363 -0.836 . . . . 0.0 109.237 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.778 ' N ' HG23 ' A' ' 117' ' ' THR . 3.9 m-20 -78.63 -48.85 14.28 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.224 -0.923 . . . . 0.0 109.552 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.409 ' H ' HG23 ' A' ' 117' ' ' THR . 20.8 mt-10 -54.48 -24.99 22.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.865 . . . . 0.0 109.709 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.597 ' HG2' HG22 ' A' ' 117' ' ' THR . 18.1 mm-40 -86.96 -47.98 8.52 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 117' ' ' THR . 92.5 t -54.81 -26.15 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.72 -0.613 . . . . 0.0 109.568 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -68.36 -34.89 76.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.124 -0.985 . . . . 0.0 109.555 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -79.95 -19.0 49.01 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.948 -1.095 . . . . 0.0 108.598 179.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 15.2 mmt -88.91 -20.78 24.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.681 HG23 HG23 ' A' ' 136' ' ' VAL . 7.6 mt -92.43 -45.6 14.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-O 121.73 0.776 . . . . 0.0 109.718 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -43.7 -26.35 0.23 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.682 -0.636 . . . . 0.0 110.723 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -90.35 -37.15 14.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.985 -1.072 . . . . 0.0 109.749 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.43 ' HB2' ' CE ' ' A' ' 144' ' ' MET . . . -80.09 -4.36 52.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.885 . . . . 0.0 109.852 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 130' ' ' ILE . 0.0 OUTLIER -96.67 176.75 5.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 -179.749 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.497 ' N ' ' OD1' ' A' ' 129' ' ' ASP . 3.7 mt -69.92 -69.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.362 -0.836 . . . . 0.0 109.437 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' HB3' ' O ' ' A' ' 130' ' ' ILE . 3.0 p-10 -179.24 32.95 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.44 -0.788 . . . . 0.0 110.533 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 146.93 49.75 0.03 OUTLIER Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.068 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 129' ' ' ASP . 2.2 p30 -112.55 -24.65 9.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -1.119 . . . . 0.0 109.035 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.29 -10.2 55.2 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.448 ' HG3' ' CD1' ' A' ' 99' ' ' TYR . 4.3 pt20 -144.91 -170.35 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -1.154 . . . . 0.0 109.133 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.681 HG23 HG23 ' A' ' 125' ' ' ILE . 53.6 t -126.33 160.4 33.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.607 ' HB3' ' OE1' ' A' ' 140' ' ' GLU . 3.9 t-20 -141.53 -166.48 2.21 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.755 ' O ' HG23 ' A' ' 142' ' ' VAL . 88.4 t80 -78.19 -31.07 49.31 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.563 -1.336 . . . . 0.0 112.106 -178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.15 -15.43 60.07 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.462 -1.399 . . . . 0.0 110.321 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.607 ' OE1' ' HB3' ' A' ' 137' ' ' ASN . 3.8 mp0 -100.57 -34.64 9.82 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.416 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 50.9 t80 -71.88 -25.28 61.87 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 138' ' ' TYR . 9.9 t -60.43 -55.27 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.7 mm100 -65.44 -21.05 66.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.099 -1.001 . . . . 0.0 109.762 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.43 ' CE ' ' HB2' ' A' ' 128' ' ' ALA . 3.1 tpt -85.16 -20.55 30.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.16 -0.963 . . . . 0.0 109.726 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.27 -39.64 20.58 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.141 -0.975 . . . . 0.0 109.482 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.5 p -74.2 -57.85 3.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.0 109.477 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -92.81 -179.34 5.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 0.0 109.72 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.301 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.475 ' CG ' ' O ' ' A' ' 76' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -113.49 66.99 0.66 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.948 . . . . 0.0 109.404 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 79' ' ' THR . 6.6 m-20 179.94 -88.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.839 . . . . 0.0 109.42 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 174.93 131.65 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.276 -0.89 . . . . 0.0 109.501 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -136.26 -92.78 0.26 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.183 -0.948 . . . . 0.0 109.527 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.98 7.14 3.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.11 -0.994 . . . . 0.0 109.763 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -90.05 -64.0 1.2 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.363 -0.836 . . . . 0.0 109.55 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 86' ' ' ARG . 15.9 tt0 -88.31 -9.17 53.69 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.646 -0.659 . . . . 0.0 109.807 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -46.38 -27.52 1.08 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.27 -0.894 . . . . 0.0 110.095 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.826 HG21 HG22 ' A' ' 142' ' ' VAL . 5.1 mm -77.4 -47.45 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.17 -0.956 . . . . 0.0 110.446 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.476 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 5.3 mmm180 -47.73 -45.07 28.44 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.101 -0.999 . . . . 0.0 109.908 -179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.539 ' HG3' ' N ' ' A' ' 88' ' ' ALA . 10.4 pt-20 -79.99 -39.79 29.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 110.059 -179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.539 ' N ' ' HG3' ' A' ' 87' ' ' GLU . . . -57.88 -19.54 30.23 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.912 -1.117 . . . . 0.0 108.48 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 82.4 t80 -71.53 -55.44 7.82 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.451 -0.78 . . . . 0.0 109.326 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -63.77 -27.45 69.2 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.513 HG12 HG21 ' A' ' 108' ' ' VAL . 24.3 t -50.14 -30.72 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.6 ' CE2' ' HB ' ' A' ' 108' ' ' VAL . 65.1 m-85 -96.88 -33.91 11.45 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.467 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 23.3 t0 -97.83 91.94 5.6 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.773 -0.58 . . . . 0.0 109.649 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 94' ' ' LYS . 19.4 mmmt -90.19 -19.34 24.32 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.285 -0.884 . . . . 0.0 110.013 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -77.94 2.43 17.53 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.344 -0.848 . . . . 0.0 109.386 -179.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 39.57 37.54 0.86 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -85.86 -25.65 26.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -1.194 . . . . 0.0 109.556 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 132.18 -48.1 0.98 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.487 ' HB3' ' O ' ' A' ' 136' ' ' VAL . 13.5 m-30 -112.85 178.4 4.3 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.564 -0.962 . . . . 0.0 108.786 179.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.467 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 54.2 mt -113.04 128.29 69.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.471 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.49 ' OG ' ' N ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -87.37 -178.96 6.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.36 -0.838 . . . . 0.0 109.8 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.596 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -67.4 -47.28 70.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 0.0 109.181 179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.81 -31.76 72.82 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.368 -0.832 . . . . 0.0 109.027 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 65.2 mm-40 -70.67 -23.1 62.44 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 1.05 HD22 ' CE ' ' A' ' 109' ' ' MET . 0.5 OUTLIER -82.64 -36.43 26.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.474 -0.766 . . . . 0.0 109.324 179.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -9.61 58.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 0.0 109.117 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -75.99 -34.65 59.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.83 . . . . 0.0 110.392 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.6 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 52.2 t -111.36 -42.79 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.919 -1.113 . . . . 0.0 110.582 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 1.05 ' CE ' HD22 ' A' ' 105' ' ' LEU . 4.4 mtm -55.03 -16.57 2.95 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.165 -0.959 . . . . 0.0 110.111 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.35 -34.84 23.56 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.851 -1.155 . . . . 0.0 108.938 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.782 ' HB3' HD23 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -56.26 -55.86 28.1 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.297 -0.877 . . . . 0.0 109.829 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.782 HD23 ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -135.47 7.74 3.33 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.968 . . . . 0.0 110.025 -179.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.483 ' CA ' ' O ' ' A' ' 109' ' ' MET . . . -103.23 36.79 4.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.56 ' O ' HD23 ' A' ' 116' ' ' LEU . 41.0 mt-10 64.85 114.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.439 -1.036 . . . . 0.0 108.789 -179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.63 88.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 110.447 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.701 ' H ' HD23 ' A' ' 116' ' ' LEU . 0.9 OUTLIER -93.97 174.12 7.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.218 -0.926 . . . . 0.0 108.779 179.093 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 121' ' ' VAL . 1.4 t -120.32 171.89 8.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 0.0 108.588 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 119' ' ' GLU . 1.1 m-20 -48.67 -48.35 40.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.073 -1.017 . . . . 0.0 110.615 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.41 ' C ' ' O ' ' A' ' 118' ' ' ASP . 0.6 OUTLIER -41.81 -38.78 1.58 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.24 -0.912 . . . . 0.0 110.332 -179.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 121' ' ' VAL . 3.0 mt-10 -87.72 -46.6 9.34 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.391 -0.818 . . . . 0.0 110.086 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.596 HG11 ' HB1' ' A' ' 102' ' ' ALA . 71.1 t -32.83 -50.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.668 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.7 -50.78 72.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.761 -1.212 . . . . 0.0 109.418 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -66.58 -13.4 61.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 108.794 179.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.432 ' HG3' HD13 ' A' ' 116' ' ' LEU . 5.8 mmt -89.35 -22.42 22.62 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.932 HG21 ' O ' ' A' ' 134' ' ' GLY . 4.0 mt -80.1 -42.99 22.23 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -57.19 -19.12 18.8 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.659 -0.651 . . . . 0.0 109.98 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 123' ' ' GLU . 20.4 mm-40 -90.6 -24.56 20.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.133 -0.979 . . . . 0.0 110.018 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.41 -59.82 2.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.18 -0.95 . . . . 0.0 109.359 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.47 ' HA ' ' HB3' ' A' ' 140' ' ' GLU . 43.5 p30 -47.46 154.86 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 109.467 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 52.7 mt -102.05 -40.58 7.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.187 -0.946 . . . . 0.0 109.754 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.27 -40.77 36.01 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.52 -0.737 . . . . 0.0 109.641 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 100.53 33.37 5.11 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.07 -23.04 44.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.357 -1.084 . . . . 0.0 109.099 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.932 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 117.21 -30.06 6.45 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.75 167.51 10.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.162 -1.199 . . . . 0.0 109.277 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 99' ' ' TYR . 68.6 t -119.98 160.57 20.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.2 -0.938 . . . . 0.0 108.666 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.5 ' ND2' ' HG3' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -135.99 -164.41 1.55 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.63 -1.294 . . . . 0.0 108.648 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.547 ' O ' HG23 ' A' ' 142' ' ' VAL . 64.9 t80 -75.66 -42.07 52.32 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.973 -1.079 . . . . 0.0 109.817 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -65.15 -47.8 75.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.117 -0.989 . . . . 0.0 109.432 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.5 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 55.8 mt-10 -69.84 -36.77 75.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.281 -0.887 . . . . 0.0 109.126 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.52 ' CZ ' ' CG ' ' A' ' 145' ' ' MET . 44.0 t80 -64.72 -27.62 69.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.844 . . . . 0.0 109.081 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.826 HG22 HG21 ' A' ' 85' ' ' ILE . 4.6 t -61.28 -47.83 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.837 . . . . 0.0 109.859 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -53.23 -37.75 62.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.135 -0.978 . . . . 0.0 110.482 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.11 -23.31 30.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.055 -1.028 . . . . 0.0 110.022 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.52 ' CG ' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -86.08 -11.06 53.75 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.092 -1.005 . . . . 0.0 109.849 -179.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 147' ' ' ALA . 1.1 p -81.99 -44.11 17.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.129 -0.982 . . . . 0.0 109.615 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 146' ' ' THR . . . -44.8 130.73 7.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.139 -0.976 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.515 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.462 ' O ' ' O ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 76' ' ' MET . 0.0 OUTLIER 56.64 161.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.369 -0.832 . . . . 0.0 109.69 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -95.81 -92.29 0.21 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 0.0 109.379 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.99 125.17 6.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.0 109.641 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -115.93 -26.17 7.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.386 -0.821 . . . . 0.0 109.56 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 11.1 m -76.7 7.17 4.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.495 -0.753 . . . . 0.0 110.35 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.581 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 1.1 pt-20 -88.22 -31.45 19.06 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.095 -1.003 . . . . 0.0 108.88 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.581 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 1.4 tt0 -91.72 -12.77 33.06 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.59 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 6.7 tt0 -79.17 7.96 6.69 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.536 -0.728 . . . . 0.0 109.612 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 5.5 mm -117.89 -42.98 2.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.111 -0.993 . . . . 0.0 109.722 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.451 ' HG3' ' OH ' ' A' ' 138' ' ' TYR . 4.6 mtp180 -66.83 -33.32 75.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.131 -0.981 . . . . 0.0 109.08 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.689 ' O ' HG23 ' A' ' 91' ' ' VAL . 18.5 pt-20 -96.57 -26.77 15.12 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.24 -0.913 . . . . 0.0 109.106 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -67.64 -29.52 68.85 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.489 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 84.6 t80 -62.07 -56.05 22.84 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.568 -0.708 . . . . 0.0 109.196 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -33.35 74.98 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.253 -179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.751 ' O ' HG21 ' A' ' 108' ' ' VAL . 23.7 t -47.91 -33.77 3.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.499 ' CD1' ' HB ' ' A' ' 108' ' ' VAL . 66.7 m-85 -92.33 -30.9 15.58 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.496 ' HB2' HG12 ' A' ' 100' ' ' ILE . 26.2 t0 -100.33 83.04 2.58 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -73.32 -21.12 60.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 0.0 110.248 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -77.87 0.52 23.68 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.251 -0.906 . . . . 0.0 109.012 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.42 50.68 1.78 Allowed Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 99' ' ' TYR . 7.8 p-10 -107.49 -14.26 14.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.177 -1.19 . . . . 0.0 109.802 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.39 -26.48 11.05 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.671 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.2 m-85 -121.12 146.66 46.51 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.377 -1.072 . . . . 0.0 109.262 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.496 HG12 ' HB2' ' A' ' 93' ' ' ASP . 76.6 mt -103.54 120.85 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.429 -0.794 . . . . 0.0 109.54 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.6 p -81.96 170.78 15.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.065 -1.022 . . . . 0.0 109.095 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.829 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -59.55 -45.8 90.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.046 -1.034 . . . . 0.0 109.475 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.37 83.45 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.219 -0.926 . . . . 0.0 109.462 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -73.28 -20.9 60.72 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.18 -0.95 . . . . 0.0 108.586 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 105' ' ' LEU . 15.4 tp -87.21 -23.69 24.67 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.47 -0.769 . . . . 0.0 109.534 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.488 ' HA ' ' HB2' ' A' ' 109' ' ' MET . 23.3 ttt180 -82.97 -39.5 21.28 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.167 -0.958 . . . . 0.0 109.975 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -50.1 -30.51 11.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.301 -0.874 . . . . 0.0 110.403 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.751 HG21 ' O ' ' A' ' 91' ' ' VAL . 98.9 t -110.17 -26.12 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.001 -1.062 . . . . 0.0 110.173 -179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.659 ' HB3' HD21 ' A' ' 116' ' ' LEU . 2.3 mmt -61.95 -14.39 34.33 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.339 -0.851 . . . . 0.0 109.656 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -82.6 -35.26 27.22 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.283 -0.886 . . . . 0.0 109.655 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 110' ' ' THR . 10.7 m120 -43.43 -59.14 2.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.461 ' C ' HD12 ' A' ' 112' ' ' LEU . 0.6 OUTLIER -144.29 16.8 1.7 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.407 -0.808 . . . . 0.0 109.134 179.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.487 ' O ' HD23 ' A' ' 116' ' ' LEU . . . -94.97 30.84 7.53 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.431 ' HG2' ' C ' ' A' ' 113' ' ' GLY . 23.9 mm-40 71.1 167.28 0.31 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.196 -1.179 . . . . 0.0 109.703 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -90.6 73.33 6.8 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.263 -0.898 . . . . 0.0 109.379 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.659 HD21 ' HB3' ' A' ' 109' ' ' MET . 0.7 OUTLIER -97.97 153.55 18.29 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.398 -0.814 . . . . 0.0 109.584 -179.732 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.896 ' O ' HG23 ' A' ' 121' ' ' VAL . 1.7 p -101.05 -150.03 0.39 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.141 -0.974 . . . . 0.0 109.776 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.456 ' O ' ' HB ' ' A' ' 121' ' ' VAL . 4.1 m-20 -77.86 -54.07 6.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.0 109.853 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.432 ' HG3' ' OE1' ' A' ' 120' ' ' GLU . 10.9 pt-20 -48.98 -38.23 22.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 0.0 109.125 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.56 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 2.6 mm-40 -71.5 -46.64 59.2 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.896 HG23 ' O ' ' A' ' 117' ' ' THR . 21.3 t -37.64 -51.82 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.105 0.479 . . . . 0.0 110.109 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.406 ' OD1' ' C ' ' A' ' 122' ' ' ASP . 37.7 t0 -54.26 -46.9 72.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.109 -0.995 . . . . 0.0 109.844 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.516 ' O ' ' HG3' ' A' ' 126' ' ' ARG . 0.8 OUTLIER -63.37 -31.69 72.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.979 . . . . 0.0 109.75 -179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 18.2 mmt -73.06 -26.17 61.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.93 -1.106 . . . . 0.0 108.293 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.477 HG12 ' CD2' ' A' ' 105' ' ' LEU . 7.1 mt -76.28 -37.14 31.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.516 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -57.07 -14.28 3.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.845 -0.534 . . . . 0.0 110.206 -179.636 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -89.37 -30.14 18.59 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 0.0 109.277 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 140' ' ' GLU . . . -102.96 -0.69 30.61 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.565 -0.71 . . . . 0.0 109.624 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.446 ' CG ' HG22 ' A' ' 125' ' ' ILE . 7.5 m-20 -82.72 143.72 30.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.336 -0.852 . . . . 0.0 110.01 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.529 HG12 ' CG ' ' A' ' 140' ' ' GLU . 33.0 mm -108.66 -32.9 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.323 -0.861 . . . . 0.0 109.139 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -97.6 -33.91 11.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.608 -0.683 . . . . 0.0 109.23 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 92.11 26.41 18.97 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -80.06 -28.25 39.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -1.142 . . . . 0.0 109.219 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 112.11 33.96 2.07 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.438 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -154.31 150.82 28.39 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.425 -1.044 . . . . 0.0 109.361 -179.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.621 HG12 ' N ' ' A' ' 137' ' ' ASN . 89.6 t -112.86 167.1 6.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.186 -0.946 . . . . 0.0 109.318 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.671 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 7.5 p30 -150.6 -172.5 4.2 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.762 ' O ' HG23 ' A' ' 142' ' ' VAL . 51.7 t80 -68.53 -48.78 63.46 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.413 -1.429 . . . . 0.0 110.804 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.521 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 7.0 mp0 -54.86 -55.51 29.62 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.986 -1.071 . . . . 0.0 110.845 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.536 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 22.4 mt-10 -63.3 -41.91 99.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.863 -1.148 . . . . 0.0 109.904 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.441 ' CG ' ' HD1' ' A' ' 89' ' ' PHE . 51.8 t80 -64.68 -23.05 67.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.323 -0.861 . . . . 0.0 109.978 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 138' ' ' TYR . 43.2 t -76.37 -44.08 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.355 -0.841 . . . . 0.0 110.47 -178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.846 ' HA ' ' HB3' ' A' ' 147' ' ' ALA . 1.6 mt-30 -64.47 -32.36 73.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.129 -0.982 . . . . 0.0 110.605 -179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -88.5 -21.74 24.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.927 -1.108 . . . . 0.0 110.283 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 2.3 tpt -98.59 -6.63 29.61 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 120.897 -1.127 . . . . 0.0 110.649 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.575 ' CG2' ' N ' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -154.74 -52.25 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.678 -1.264 . . . . 0.0 110.733 -179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.846 ' HB3' ' HA ' ' A' ' 143' ' ' GLN . . . -86.72 80.61 8.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.042 . . . . 0.0 110.328 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.279 179.473 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.271 0.558 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.4 ttpt 68.7 86.86 0.13 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 0.0 109.771 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -77.21 141.43 40.06 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.285 -0.885 . . . . 0.0 109.079 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.1 m -122.83 110.56 15.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.952 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.485 ' O ' ' CB ' ' A' ' 81' ' ' SER . 4.8 t70 -93.29 -60.65 1.73 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.321 -0.862 . . . . 0.0 108.991 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 80' ' ' ASP . 0.1 OUTLIER 166.67 115.11 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.469 -0.769 . . . . 0.0 109.308 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.41 -22.44 63.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.298 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -90.31 -1.23 57.9 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.55 -0.718 . . . . 0.0 109.738 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -57.65 -30.14 65.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.973 . . . . 0.0 109.639 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.3 mt -83.88 -40.72 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.916 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.8 mtt85 -58.64 -35.29 72.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.155 -0.965 . . . . 0.0 109.608 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' OE2' ' N ' ' A' ' 88' ' ' ALA . 0.8 OUTLIER -87.08 -31.68 20.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.577 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -63.5 -28.94 70.29 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.152 -0.967 . . . . 0.0 108.443 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.451 ' HD1' ' CG ' ' A' ' 141' ' ' PHE . 87.6 t80 -66.9 -53.0 36.42 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.408 -0.807 . . . . 0.0 109.507 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.415 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 1.8 mtp180 -66.2 -25.07 66.76 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 -179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 2.7 t -52.7 -24.6 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.501 ' CE1' ' HB ' ' A' ' 108' ' ' VAL . 75.5 m-85 -108.34 -30.08 8.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.415 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 39.0 t0 -95.25 76.06 3.42 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.447 ' HB2' ' OE1' ' A' ' 104' ' ' GLU . 11.3 mmmt -79.86 -16.75 54.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.465 ' O ' ' C ' ' A' ' 96' ' ' GLY . 18.8 m-20 -78.32 5.5 10.33 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.433 -0.792 . . . . 0.0 109.984 -179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.465 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.14 38.11 0.32 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -93.66 -69.2 0.76 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.401 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 176.9 -50.85 0.11 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.625 ' CD2' ' NE2' ' A' ' 135' ' ' GLN . 11.3 m-30 -109.66 155.37 21.57 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.413 -1.051 . . . . 0.0 108.784 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.497 HD13 ' CB ' ' A' ' 92' ' ' PHE . 94.1 mt -90.51 122.37 41.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.259 -0.901 . . . . 0.0 109.597 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 63.2 p -85.38 174.14 9.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.401 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.548 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -66.0 -33.04 74.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.132 -0.98 . . . . 0.0 109.447 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.17 -34.4 68.44 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.228 -0.92 . . . . 0.0 109.565 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 60.3 mm-40 -78.71 -20.96 48.87 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.578 HD22 HG12 ' A' ' 125' ' ' ILE . 3.2 tp -93.25 -17.49 23.59 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.581 -0.699 . . . . 0.0 109.277 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.429 ' O ' ' OG1' ' A' ' 110' ' ' THR . 15.1 ttt-85 -80.58 -21.99 41.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.198 -0.939 . . . . 0.0 109.251 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -70.55 -27.79 64.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.307 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.501 ' HB ' ' CE1' ' A' ' 92' ' ' PHE . 79.4 t -111.07 -21.52 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.917 -1.114 . . . . 0.0 110.122 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.502 ' HB3' HD21 ' A' ' 116' ' ' LEU . 10.5 mmt -67.48 -41.04 85.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.016 -1.052 . . . . 0.0 109.18 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 0.2 OUTLIER -73.69 -15.99 61.22 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.377 -0.827 . . . . 0.0 109.867 -179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.838 ' C ' HD23 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -59.09 87.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.894 . . . . 0.0 109.899 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.838 HD23 ' C ' ' A' ' 111' ' ' ASN . 1.4 pt? 36.29 29.2 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.637 -0.664 . . . . 0.0 110.835 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.564 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -96.03 -12.57 52.1 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 1.025 ' HG3' HD23 ' A' ' 116' ' ' LEU . 0.4 OUTLIER 151.27 -167.64 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.84 65.2 0.77 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.007 . . . . 0.0 109.167 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.025 HD23 ' HG3' ' A' ' 114' ' ' GLU . 1.7 pp -105.77 121.76 44.69 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.583 -0.698 . . . . 0.0 109.431 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.81 HG23 ' N ' ' A' ' 118' ' ' ASP . 4.5 t -86.5 -146.89 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.623 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.81 ' N ' HG23 ' A' ' 117' ' ' THR . 1.2 m-20 -73.4 -57.58 3.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.334 -0.853 . . . . 0.0 109.873 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.4 -20.41 2.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.847 . . . . 0.0 110.014 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.675 ' HG2' HG22 ' A' ' 117' ' ' THR . 27.4 mm-40 -89.77 -39.79 12.9 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 117' ' ' THR . 22.4 t -47.67 -61.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.185 0.517 . . . . 0.0 109.652 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 121' ' ' VAL . 49.4 t0 -41.75 -34.0 0.57 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.293 -0.879 . . . . 0.0 109.878 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.27 -45.14 49.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.219 -0.926 . . . . 0.0 108.96 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.549 ' HE2' HD22 ' A' ' 116' ' ' LEU . 65.7 mmm -60.87 -20.67 62.27 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.18 -0.95 . . . . 0.0 108.723 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.578 HG12 HD22 ' A' ' 105' ' ' LEU . 3.0 mt -87.47 -38.81 12.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -19.22 4.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.816 -0.552 . . . . 0.0 109.657 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -89.29 -31.95 17.6 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.254 -0.904 . . . . 0.0 109.049 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.403 ' HA ' ' HG2' ' A' ' 144' ' ' MET . . . -90.08 -5.0 57.03 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.409 -0.807 . . . . 0.0 109.255 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.495 ' OD1' ' CG2' ' A' ' 125' ' ' ILE . 1.8 m-20 -95.18 133.72 38.72 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.313 -0.867 . . . . 0.0 109.382 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.493 HG13 ' OE1' ' A' ' 140' ' ' GLU . 41.3 mm -83.78 -49.74 16.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.142 -0.974 . . . . 0.0 109.383 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.45 -45.09 23.04 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.571 -0.706 . . . . 0.0 109.168 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.62 31.95 3.79 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.47 -27.36 41.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.436 -1.038 . . . . 0.0 109.429 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.501 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 121.72 -16.21 8.97 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.847 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.625 ' NE2' ' CD2' ' A' ' 99' ' ' TYR . 0.7 OUTLIER -109.18 164.59 12.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.739 -1.448 . . . . 0.0 109.587 -179.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.559 HG23 HG23 ' A' ' 125' ' ' ILE . 53.8 t -121.87 163.65 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.257 -0.902 . . . . 0.0 108.707 179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.567 ' ND2' ' HG2' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -135.1 -168.72 2.23 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.928 -1.108 . . . . 0.0 108.707 179.603 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.895 ' O ' HG23 ' A' ' 142' ' ' VAL . 73.0 t80 -80.47 -36.59 33.24 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.089 -1.007 . . . . 0.0 110.146 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -68.26 -34.26 75.86 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.567 ' HG2' ' ND2' ' A' ' 137' ' ' ASN . 4.1 mm-40 -83.52 -34.75 25.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.305 -0.872 . . . . 0.0 108.921 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.576 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 14.3 t80 -72.26 -23.17 61.16 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.45 -0.781 . . . . 0.0 109.158 179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 138' ' ' TYR . 48.4 t -74.99 -59.51 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 0.0 109.694 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.445 ' HG3' ' O ' ' A' ' 139' ' ' GLU . 12.4 mt-30 -53.34 -24.11 11.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.825 . . . . 0.0 110.538 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -90.7 -37.08 13.95 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.036 -1.04 . . . . 0.0 110.96 -178.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -84.8 -8.68 58.72 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.978 -1.077 . . . . 0.0 110.838 -178.641 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -92.68 -35.01 13.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.912 -1.118 . . . . 0.0 109.061 179.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 148' ' ' LYS . . . -98.56 98.93 10.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.0 109.371 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 118.097 -0.954 . . . . 0.0 109.572 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.31 64.98 1.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.179 -0.951 . . . . 0.0 109.448 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -156.16 92.39 1.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.5 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -142.64 91.18 2.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.298 -0.876 . . . . 0.0 109.424 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -157.1 -77.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.198 -0.939 . . . . 0.0 109.644 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 t 62.08 26.63 16.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.387 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -84.74 -23.54 29.23 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.297 -0.877 . . . . 0.0 109.802 -179.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -89.19 -17.85 28.29 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.432 -0.792 . . . . 0.0 109.485 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -60.94 -19.51 60.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.361 -0.837 . . . . 0.0 109.716 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.47 HG21 ' HA ' ' A' ' 142' ' ' VAL . 3.5 mt -97.74 -38.13 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.185 -0.947 . . . . 0.0 110.047 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.535 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 2.9 ttt-85 -49.58 -32.13 12.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.041 -1.037 . . . . 0.0 109.49 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 88' ' ' ALA . 5.1 mt-10 -91.01 -53.94 4.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 109.735 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -43.98 -27.03 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.195 -0.941 . . . . 0.0 108.79 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 138' ' ' TYR . 70.3 t80 -62.37 -58.08 8.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.411 -0.806 . . . . 0.0 109.141 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.446 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.1 OUTLIER -60.04 -37.49 79.97 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.385 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.629 ' O ' HG21 ' A' ' 108' ' ' VAL . 59.5 t -42.9 -32.87 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.495 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 56.0 m-85 -95.93 -35.12 11.56 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.477 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 28.3 t0 -91.06 88.89 7.16 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.4 mmtt -77.53 -21.16 53.08 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.313 -0.867 . . . . 0.0 110.229 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 96' ' ' GLY . 67.2 m-20 -78.21 0.4 25.24 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.164 -0.96 . . . . 0.0 109.133 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 35.47 49.25 0.94 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -106.79 -22.82 12.59 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.076 -1.249 . . . . 0.0 109.666 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 125.36 -27.97 5.15 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.638 ' CE1' ' HB3' ' A' ' 137' ' ' ASN . 1.7 m-85 -121.61 145.46 47.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.412 -1.052 . . . . 0.0 108.985 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.477 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 56.8 mt -96.17 133.94 35.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.236 -0.915 . . . . 0.0 109.358 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.59 170.9 9.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.295 -0.878 . . . . 0.0 109.466 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.41 94.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 0.0 109.281 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.89 -35.83 77.67 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.391 -0.818 . . . . 0.0 109.703 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.57 ' O ' ' CE1' ' A' ' 107' ' ' HIS . 64.6 mm-40 -71.61 -21.86 61.79 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.174 -0.954 . . . . 0.0 108.495 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.505 ' HG ' ' CG ' ' A' ' 109' ' ' MET . 1.6 tp -99.73 4.49 45.49 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.585 -0.697 . . . . 0.0 109.212 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -96.92 -30.89 12.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.127 -0.983 . . . . 0.0 109.978 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.95 ' CD2' HG23 ' A' ' 108' ' ' VAL . 45.5 p-80 -88.07 -53.3 4.79 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.244 -0.91 . . . . 0.0 111.802 -178.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.95 HG23 ' CD2' ' A' ' 107' ' ' HIS . 18.9 t -68.43 -54.14 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.168 -0.957 . . . . 0.0 110.968 -178.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.505 ' CG ' ' HG ' ' A' ' 105' ' ' LEU . 1.5 mmt -35.98 -45.33 0.41 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.611 -0.681 . . . . 0.0 110.786 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.658 HG21 ' HA ' ' A' ' 115' ' ' LYS . 0.6 OUTLIER -88.88 -33.31 17.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.992 -1.067 . . . . 0.0 109.994 -179.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.459 ' C ' ' HG ' ' A' ' 112' ' ' LEU . 0.5 OUTLIER 41.19 51.49 3.46 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.275 -0.891 . . . . 0.0 109.864 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 112' ' ' LEU . 0.8 OUTLIER 56.33 41.26 29.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.351 -0.843 . . . . 0.0 110.115 179.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.55 ' O ' ' CB ' ' A' ' 114' ' ' GLU . . . -141.63 8.1 2.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.55 ' CB ' ' O ' ' A' ' 113' ' ' GLY . 0.3 OUTLIER 155.1 57.1 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.752 -0.852 . . . . 0.0 108.999 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.658 ' HA ' HG21 ' A' ' 110' ' ' THR . 3.1 ptpt -46.6 97.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.35 -0.844 . . . . 0.0 110.318 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.664 ' H ' HD23 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -70.59 156.81 38.96 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.146 -0.971 . . . . 0.0 108.794 179.266 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.978 ' O ' HG23 ' A' ' 121' ' ' VAL . 2.0 t -82.0 -174.78 5.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.131 -0.981 . . . . 0.0 109.486 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.16 -57.65 3.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.25 -0.906 . . . . 0.0 109.281 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.56 -24.04 4.86 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 108.887 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.429 ' CB ' HG22 ' A' ' 117' ' ' THR . 16.0 tp10 -81.11 -40.88 23.36 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.978 HG23 ' O ' ' A' ' 117' ' ' THR . 58.0 t -54.73 -48.39 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -31.54 29.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.842 . . . . 0.0 109.249 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 26.1 mm-40 -73.92 -39.58 63.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.376 -0.828 . . . . 0.0 109.042 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 2.9 mtt -67.33 -23.91 65.68 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.041 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.08 -40.03 15.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.441 -0.787 . . . . 0.0 109.805 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -15.41 6.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.511 -0.743 . . . . 0.0 110.359 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 123' ' ' GLU . 4.1 mt-10 -90.16 -27.41 19.6 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.009 -1.057 . . . . 0.0 109.582 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.09 -58.45 2.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.23 -0.918 . . . . 0.0 109.6 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 129' ' ' ASP . 40.2 p-10 -45.25 123.94 4.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.244 -0.91 . . . . 0.0 109.645 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 67.2 mt -91.89 -38.32 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.27 -0.894 . . . . 0.0 109.476 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -76.23 -37.3 57.86 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.454 -0.779 . . . . 0.0 109.722 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 103.88 32.32 4.46 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.46 ' OD1' ' HG2' ' A' ' 135' ' ' GLN . 2.3 p30 -79.54 -24.56 42.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.372 -1.075 . . . . 0.0 109.638 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.2 28.87 5.94 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.46 ' HG2' ' OD1' ' A' ' 133' ' ' ASP . 3.1 pt20 -160.23 -169.28 2.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.192 -1.181 . . . . 0.0 108.993 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.619 HG12 ' N ' ' A' ' 137' ' ' ASN . 57.5 t -136.47 169.07 20.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.989 -1.07 . . . . 0.0 110.129 -179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.638 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -143.63 -167.92 2.7 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 178.252 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.888 ' O ' HG23 ' A' ' 142' ' ' VAL . 50.6 t80 -74.5 -38.36 62.87 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 120.805 -1.184 . . . . 0.0 109.497 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -49.68 68.02 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.308 -0.87 . . . . 0.0 109.701 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.508 ' HG3' ' ND2' ' A' ' 137' ' ' ASN . 50.2 mt-10 -68.23 -36.92 80.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 109.678 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.566 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 34.6 t80 -69.21 -26.91 65.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.227 -0.921 . . . . 0.0 109.686 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 138' ' ' TYR . 48.1 t -68.12 -43.3 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.619 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.452 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 14.8 mt-30 -72.44 -21.99 61.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.178 -0.951 . . . . 0.0 109.878 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.43 -22.32 22.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.566 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 1.6 tpt -92.34 -59.15 2.16 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.078 -1.014 . . . . 0.0 109.787 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.514 ' CG2' ' N ' ' A' ' 147' ' ' ALA . 4.8 t -59.82 -44.78 93.86 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.367 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.514 ' N ' ' CG2' ' A' ' 146' ' ' THR . . . -99.81 157.84 16.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.463 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.383 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 78' ' ' ASP . 2.6 mtmt -146.1 160.02 42.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.704 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 77' ' ' LYS . 35.8 t70 44.9 87.85 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.32 -0.863 . . . . 0.0 109.646 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -52.19 141.74 18.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.377 179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.46 ' O ' ' O ' ' A' ' 79' ' ' THR . 0.8 OUTLIER -45.41 -96.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.326 -0.859 . . . . 0.0 109.848 -179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 48.9 m -167.05 21.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 110.081 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.42 ' CG ' ' N ' ' A' ' 83' ' ' GLU . 15.3 pt-20 -90.07 -41.66 11.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.022 -1.049 . . . . 0.0 109.477 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.42 ' N ' ' CG ' ' A' ' 82' ' ' GLU . 5.2 mt-10 -90.54 -14.67 32.13 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.49 -47.56 81.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.307 -0.871 . . . . 0.0 110.109 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.679 ' CG2' HG22 ' A' ' 142' ' ' VAL . 3.2 mt -65.07 -36.85 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.155 -0.965 . . . . 0.0 110.159 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.587 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.4 mtp85 -50.67 -34.29 25.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.112 -0.992 . . . . 0.0 109.372 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 88' ' ' ALA . 3.4 mt-10 -87.73 -52.73 5.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 109.742 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 91' ' ' VAL . . . -44.64 -26.83 0.41 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.112 -0.992 . . . . 0.0 108.635 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.54 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 88.0 t80 -62.77 -57.64 10.22 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.43 -0.794 . . . . 0.0 109.572 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.467 ' HA ' ' HB3' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -61.06 -31.66 71.32 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.447 -0.783 . . . . 0.0 109.04 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 70.4 t -46.66 -35.48 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.933 ' CZ ' HG11 ' A' ' 108' ' ' VAL . 28.0 m-85 -87.29 -47.71 8.6 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 90' ' ' ARG . 57.5 t0 -72.97 116.75 13.85 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.69 -25.29 21.29 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.142 -0.973 . . . . 0.0 110.125 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.471 ' O ' ' C ' ' A' ' 96' ' ' GLY . 0.9 OUTLIER -78.94 2.61 19.65 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.161 -0.962 . . . . 0.0 108.983 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.471 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.04 47.56 1.35 Allowed Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -108.26 -38.63 5.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -1.202 . . . . 0.0 109.748 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 143.14 -10.44 2.27 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.606 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 0.6 OUTLIER -130.26 151.06 51.18 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.165 -1.197 . . . . 0.0 109.946 -179.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.417 ' CG1' ' HB2' ' A' ' 93' ' ' ASP . 62.9 mt -114.0 141.18 31.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.24 -0.913 . . . . 0.0 109.339 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 p -100.44 -178.29 3.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.8 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.456 ' HB1' HG11 ' A' ' 121' ' ' VAL . . . -67.76 -46.17 72.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.338 -0.851 . . . . 0.0 109.242 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.49 ' HA ' ' HG3' ' A' ' 106' ' ' ARG . . . -56.47 -47.12 79.86 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.373 -0.829 . . . . 0.0 109.343 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.451 ' OE2' ' OD2' ' A' ' 95' ' ' ASP . 97.7 mt-10 -65.75 -22.88 66.63 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.587 ' CD2' ' CG ' ' A' ' 109' ' ' MET . 0.6 OUTLIER -77.86 -25.19 48.51 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.521 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.835 ' HG2' HG21 ' A' ' 121' ' ' VAL . 8.9 mtm-85 -77.74 -45.71 23.9 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.216 -0.928 . . . . 0.0 108.55 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -48.09 -27.22 2.19 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.454 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.933 HG11 ' CZ ' ' A' ' 92' ' ' PHE . 98.8 t -112.82 -39.26 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.612 -1.305 . . . . 0.0 111.309 -178.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.587 ' CG ' ' CD2' ' A' ' 105' ' ' LEU . 10.6 mmt -61.76 -15.89 44.9 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 109.727 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.7 t -85.53 -25.12 26.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.129 -0.982 . . . . 0.0 109.34 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -54.75 -34.77 62.99 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.282 -0.886 . . . . 0.0 109.38 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.47 ' H ' HD12 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -135.15 1.95 3.0 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.911 . . . . 0.0 109.795 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 114' ' ' GLU . . . -110.74 30.52 8.05 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 113' ' ' GLY . 2.2 mt-10 59.06 -95.53 0.06 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.329 -1.1 . . . . 0.0 109.304 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.45 ' O ' HD22 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -139.94 136.21 33.59 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.07 -1.019 . . . . 0.0 109.601 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.72 HD13 ' HG2' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -115.04 108.76 17.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.205 -0.935 . . . . 0.0 109.544 179.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.769 ' O ' HG23 ' A' ' 121' ' ' VAL . 0.6 OUTLIER -72.53 -170.21 0.64 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.078 -1.014 . . . . 0.0 108.294 179.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -80.49 -54.96 5.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.915 -1.116 . . . . 0.0 108.882 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.04 -22.62 65.89 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 108.838 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.72 ' HG2' HD13 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -77.61 -47.07 20.25 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.835 HG21 ' HG2' ' A' ' 106' ' ' ARG . 44.2 t -52.7 -46.5 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.488 -0.757 . . . . 0.0 110.087 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -48.64 -33.91 10.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 0.0 109.871 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -71.83 -37.96 70.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.17 -0.956 . . . . 0.0 109.404 -179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.428 ' SD ' HD11 ' A' ' 116' ' ' LEU . 2.6 mtt -68.54 -27.53 66.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.091 -1.006 . . . . 0.0 108.98 179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 134' ' ' GLY . 6.0 mt -78.19 -37.47 22.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.546 ' HG3' ' N ' ' A' ' 127' ' ' GLU . 0.1 OUTLIER -57.82 -27.08 62.84 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.83 -0.544 . . . . 0.0 110.235 -179.417 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 126' ' ' ARG . 3.5 mt-10 -91.24 -16.95 26.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.021 -1.049 . . . . 0.0 109.859 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.534 ' O ' ' HE2' ' A' ' 144' ' ' MET . . . -99.15 -66.36 0.91 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.114 -0.991 . . . . 0.0 109.794 -179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.411 ' C ' ' O ' ' A' ' 128' ' ' ALA . 6.8 t70 -46.12 154.74 0.24 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.37 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 37.5 mm -88.89 -65.22 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.715 0.769 . . . . 0.0 109.268 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.6 t0 -176.91 57.09 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.564 -0.71 . . . . 0.0 109.342 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -104.32 -89.63 2.12 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 109.331 -1.507 . . . . 0.0 109.331 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -129.46 -19.54 3.41 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.73 -0.865 . . . . 0.0 110.128 -179.75 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.558 ' O ' HG21 ' A' ' 125' ' ' ILE . . . 125.81 16.75 2.67 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.466 ' HB3' ' CD2' ' A' ' 99' ' ' TYR . 1.6 tt0 -112.56 163.38 14.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.23 -1.159 . . . . 0.0 108.674 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.576 HG12 ' N ' ' A' ' 137' ' ' ASN . 96.5 t -106.18 165.85 3.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 O-C-N 120.923 -1.11 . . . . 0.0 109.492 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.606 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 0.2 OUTLIER -149.62 -171.31 3.86 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.893 ' O ' HG23 ' A' ' 142' ' ' VAL . 62.9 t80 -69.0 -37.7 78.86 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.607 -1.308 . . . . 0.0 111.337 -177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.41 ' H ' ' ND2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -68.88 -40.38 79.27 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.053 . . . . 0.0 110.377 -179.153 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.517 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 26.8 mt-10 -81.04 -23.04 38.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.933 -1.105 . . . . 0.0 109.192 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.481 ' O ' ' HB2' ' A' ' 145' ' ' MET . 28.4 t80 -84.28 -23.62 30.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.38 -0.825 . . . . 0.0 109.607 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 138' ' ' TYR . 52.2 t -73.97 -63.13 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -0.866 . . . . 0.0 110.312 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.832 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 2.4 mm100 -56.58 -24.54 48.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.29 -0.881 . . . . 0.0 110.753 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.534 ' HE2' ' O ' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -90.23 -31.8 16.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.906 -1.121 . . . . 0.0 110.029 -179.506 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 141' ' ' PHE . 2.1 ttp -77.04 -16.87 59.13 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.223 -0.923 . . . . 0.0 110.189 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.517 HG23 ' N ' ' A' ' 147' ' ' ALA . 5.8 t -127.64 -43.72 1.55 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.086 -1.009 . . . . 0.0 109.784 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -85.33 74.71 10.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 109.501 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.419 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 15.5 mmm . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.04 179.76 0.13 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.257 -0.902 . . . . 0.0 109.489 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.73 16.88 6.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.852 . . . . 0.0 110.024 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.15 178.65 4.55 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.043 -1.036 . . . . 0.0 109.597 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -71.88 -69.28 0.4 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 0.0 109.853 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.481 ' HB2' ' OE1' ' A' ' 84' ' ' GLU . 0.4 OUTLIER 176.83 114.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.226 -0.921 . . . . 0.0 109.08 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -52.78 -22.24 5.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.366 -0.834 . . . . 0.0 110.298 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -89.71 27.76 1.46 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.922 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.611 ' O ' ' HB2' ' A' ' 88' ' ' ALA . 0.2 OUTLIER -100.22 -18.65 16.77 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.748 HG21 HG13 ' A' ' 142' ' ' VAL . 2.7 mp -83.5 -35.11 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.595 -0.691 . . . . 0.0 109.665 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -59.37 -45.89 90.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.111 -0.993 . . . . 0.0 109.344 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -84.67 -31.66 24.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.14 -0.975 . . . . 0.0 109.069 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 84' ' ' GLU . . . -61.57 -24.01 66.36 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 138' ' ' TYR . 73.6 t80 -66.31 -55.47 15.84 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.418 -0.801 . . . . 0.0 109.279 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -28.84 70.05 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.223 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 4.8 t -48.18 -29.04 2.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.586 ' CE2' ' HB ' ' A' ' 108' ' ' VAL . 78.6 m-85 -100.32 -35.94 9.43 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.437 ' HB2' HG12 ' A' ' 100' ' ' ILE . 41.5 t0 -90.36 87.16 6.69 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -77.25 -18.48 57.6 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.338 -0.851 . . . . 0.0 109.836 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 97' ' ' ASN . 10.3 t70 -78.02 2.32 18.11 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.405 -0.81 . . . . 0.0 109.252 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.464 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 37.39 29.92 0.05 OUTLIER Glycine 0 N--CA 1.495 2.629 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 95' ' ' ASP . 4.0 t30 -88.93 -36.94 15.63 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.089 -1.242 . . . . 0.0 109.467 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.54 -14.17 4.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.598 ' CE1' ' HB2' ' A' ' 137' ' ' ASN . 0.7 OUTLIER -128.37 146.55 50.74 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.25 -1.147 . . . . 0.0 109.746 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 93' ' ' ASP . 87.0 mt -105.05 131.63 53.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.566 -0.709 . . . . 0.0 109.448 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.51 172.25 8.05 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.189 -0.944 . . . . 0.0 109.574 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -57.78 -47.85 81.36 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 109.399 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.89 -35.89 75.8 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.362 -0.836 . . . . 0.0 109.332 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 92' ' ' PHE . 66.1 mm-40 -70.64 -23.41 62.52 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.151 -0.968 . . . . 0.0 108.861 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.947 HD23 HG13 ' A' ' 121' ' ' VAL . 55.8 tp -83.9 -25.15 30.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.546 -0.722 . . . . 0.0 109.301 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.03 -24.95 43.28 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.246 -0.909 . . . . 0.0 108.967 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -59.91 -29.61 68.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 110.297 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.586 ' HB ' ' CE2' ' A' ' 92' ' ' PHE . 95.5 t -111.23 -46.62 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.887 -1.133 . . . . 0.0 110.203 -179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -52.69 -58.98 5.08 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.451 -0.78 . . . . 0.0 109.241 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.743 HG22 ' HA ' ' A' ' 114' ' ' GLU . 0.1 OUTLIER -91.16 13.09 18.0 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.412 -0.805 . . . . 0.0 110.137 -179.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.517 ' HB3' ' HA ' ' A' ' 108' ' ' VAL . 3.0 p-10 -43.41 -48.44 7.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 0.0 109.785 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 111' ' ' ASN . 20.1 mt -152.53 14.67 0.58 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.079 -1.013 . . . . 0.0 109.94 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -106.3 -14.51 20.11 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.743 ' HA ' HG22 ' A' ' 110' ' ' THR . 37.1 mt-10 54.55 30.43 13.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.412 -1.052 . . . . 0.0 109.24 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.513 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -79.31 161.01 26.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -0.896 . . . . 0.0 109.437 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.763 HD13 HG23 ' A' ' 121' ' ' VAL . 3.6 pp 31.95 -157.36 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.499 0.666 . . . . 0.0 111.391 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.881 ' O ' HG23 ' A' ' 121' ' ' VAL . 4.0 t -152.19 -161.79 1.38 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.189 -0.945 . . . . 0.0 108.913 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.57 ' N ' HG23 ' A' ' 117' ' ' THR . 1.0 OUTLIER -79.73 -50.15 11.01 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.065 -1.022 . . . . 0.0 110.14 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -67.56 -13.1 61.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 0.0 109.618 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 116' ' ' LEU . 5.5 tt0 -97.5 -34.77 10.87 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.27 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.947 HG13 HD23 ' A' ' 105' ' ' LEU . 11.6 t -49.5 -51.75 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 121' ' ' VAL . 0.1 OUTLIER -41.14 -37.65 0.93 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 109.805 -179.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.522 ' HG2' ' HD2' ' A' ' 126' ' ' ARG . 0.7 OUTLIER -68.25 -57.51 5.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.158 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.533 ' SD ' HD22 ' A' ' 116' ' ' LEU . 0.4 OUTLIER -49.86 -22.73 1.58 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.139 -0.976 . . . . 0.0 109.158 179.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.682 HG23 HG23 ' A' ' 136' ' ' VAL . 3.4 mt -84.66 -38.65 13.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.63 0.729 . . . . 0.0 109.741 179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.522 ' HD2' ' HG2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -62.02 -31.16 71.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.508 -0.745 . . . . 0.0 110.035 -179.303 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -88.02 -9.51 53.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.106 -0.996 . . . . 0.0 109.113 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -100.57 -14.0 18.38 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.442 -0.786 . . . . 0.0 109.047 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.592 ' OD1' HG22 ' A' ' 136' ' ' VAL . 9.8 m-20 -92.63 164.27 13.47 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.433 -0.792 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 40.9 mt -86.16 -53.48 10.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.271 -0.893 . . . . 0.0 109.562 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -73.52 -46.58 46.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.495 -0.753 . . . . 0.0 109.673 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 106.79 30.71 4.17 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 135' ' ' GLN . 0.7 OUTLIER -79.85 -24.79 41.03 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.256 -1.144 . . . . 0.0 109.596 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.39 16.91 9.77 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.561 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 0.4 OUTLIER -128.65 147.53 50.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -1.088 . . . . 0.0 109.205 -179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.682 HG23 HG23 ' A' ' 125' ' ' ILE . 71.9 t -115.0 165.54 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.079 -1.013 . . . . 0.0 109.574 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.606 ' N ' HG12 ' A' ' 136' ' ' VAL . 0.3 OUTLIER -140.56 -168.05 2.48 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 178.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.975 ' O ' HG23 ' A' ' 142' ' ' VAL . 38.2 t80 -65.67 -52.64 50.05 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.715 -1.24 . . . . 0.0 110.689 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.465 ' N ' ' OD1' ' A' ' 137' ' ' ASN . 2.6 mt-10 -58.44 -60.56 3.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.051 -1.03 . . . . 0.0 110.155 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 129' ' ' ASP . 13.5 mt-10 -52.14 -38.67 58.31 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.161 -0.962 . . . . 0.0 110.275 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.463 ' CE2' ' HA ' ' A' ' 89' ' ' PHE . 38.5 t80 -69.65 -29.22 66.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.981 -1.074 . . . . 0.0 109.81 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.975 HG23 ' O ' ' A' ' 138' ' ' TYR . 59.7 t -67.34 -39.36 82.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.444 -0.785 . . . . 0.0 109.875 -179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.749 ' O ' ' HB2' ' A' ' 147' ' ' ALA . 9.3 mm100 -64.06 -32.09 73.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.6 tmm? -90.2 -21.47 22.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.019 . . . . 0.0 110.029 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -57.94 3.5 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.08 -1.012 . . . . 0.0 109.913 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.653 ' O ' HG22 ' A' ' 146' ' ' THR . 1.4 m -105.98 12.99 29.89 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.191 -0.943 . . . . 0.0 109.229 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.749 ' HB2' ' O ' ' A' ' 143' ' ' GLN . . . -19.87 100.99 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 CA-C-O 121.401 0.62 . . . . 0.0 111.36 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mttt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.587 -179.885 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -120.94 62.64 0.88 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 109.355 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -83.04 -12.86 56.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.36 -0.838 . . . . 0.0 109.422 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 79' ' ' THR . 14.5 t -168.24 49.42 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.146 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -41.99 108.13 0.09 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.451 -0.781 . . . . 0.0 109.664 -179.694 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.464 ' O ' ' CD1' ' A' ' 85' ' ' ILE . 3.7 m -135.02 35.34 3.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.485 -0.759 . . . . 0.0 109.672 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -57.41 -88.73 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.232 -0.918 . . . . 0.0 108.836 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -89.32 -5.24 57.69 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.687 -0.633 . . . . 0.0 109.296 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 81' ' ' SER . 0.7 OUTLIER -61.31 -13.29 18.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.213 -0.929 . . . . 0.0 109.687 -179.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.533 ' CG2' HG22 ' A' ' 142' ' ' VAL . 8.4 mt -86.71 -49.54 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.128 -0.983 . . . . 0.0 109.207 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.614 ' HA ' ' CE1' ' A' ' 138' ' ' TYR . 1.2 ttp180 -47.97 -29.26 3.27 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.254 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 88' ' ' ALA . 46.5 mt-10 -93.46 -53.25 4.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.362 -0.836 . . . . 0.0 109.92 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 87' ' ' GLU . . . -45.82 -25.5 0.52 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.999 -1.063 . . . . 0.0 109.0 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CE1' ' C ' ' A' ' 137' ' ' ASN . 87.2 t80 -65.61 -56.25 13.24 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.441 -0.787 . . . . 0.0 109.604 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -62.08 -32.43 72.96 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.673 -0.642 . . . . 0.0 109.272 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.403 ' HB ' ' O ' ' A' ' 88' ' ' ALA . 32.5 t -47.41 -31.08 2.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 64.4 m-85 -96.9 -33.71 11.52 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.453 ' HB2' ' CG1' ' A' ' 100' ' ' ILE . 25.8 t0 -92.57 108.15 19.76 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.539 ' HD3' ' CE1' ' A' ' 107' ' ' HIS . 0.1 OUTLIER -80.1 -26.56 39.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.113 -0.992 . . . . 0.0 110.128 -179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 97' ' ' ASN . 47.3 m-20 -79.15 2.67 20.09 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.3 -0.875 . . . . 0.0 108.934 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.48 ' C ' ' O ' ' A' ' 95' ' ' ASP . . . 34.53 34.56 0.04 OUTLIER Glycine 0 N--CA 1.496 2.66 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 95' ' ' ASP . 3.5 t30 -87.32 -59.15 2.33 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.158 -1.201 . . . . 0.0 109.836 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 137' ' ' ASN . . . 166.39 -24.15 0.14 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.647 ' CE2' ' HB3' ' A' ' 137' ' ' ASN . 15.4 m-85 -122.42 139.88 53.34 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.257 -1.143 . . . . 0.0 109.791 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.528 HG23 ' HB2' ' A' ' 104' ' ' GLU . 63.1 mt -100.47 141.98 16.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.447 ' OG ' ' HG3' ' A' ' 104' ' ' GLU . 88.9 p -109.91 -178.67 3.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.052 -1.03 . . . . 0.0 109.153 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 105' ' ' LEU . . . -62.38 -45.33 93.66 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 109.284 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.4 -46.43 88.71 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.37 -0.831 . . . . 0.0 109.539 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.528 ' HB2' HG23 ' A' ' 100' ' ' ILE . 28.5 mt-10 -62.97 -24.26 67.82 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.839 HD23 HG13 ' A' ' 121' ' ' VAL . 57.8 tp -71.28 -38.47 71.83 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.514 ' O ' ' CG ' ' A' ' 109' ' ' MET . 0.5 OUTLIER -70.92 -11.06 60.75 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.539 ' CE1' ' HD3' ' A' ' 94' ' ' LYS . 11.9 t-160 -57.82 -47.09 83.65 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.42 -0.8 . . . . 0.0 110.037 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' ' C ' ' A' ' 109' ' ' MET . 10.6 t -106.55 -5.66 10.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.243 -0.91 . . . . 0.0 110.103 -178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.525 ' HB2' ' HB2' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -39.12 -38.58 0.49 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 110.806 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.527 ' HA ' ' CA ' ' A' ' 114' ' ' GLU . 7.2 t -94.69 -34.65 12.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.869 -1.144 . . . . 0.0 110.226 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.433 ' HB2' HG13 ' A' ' 108' ' ' VAL . 15.6 m-80 -58.14 -18.54 26.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.194 -0.941 . . . . 0.0 109.929 -179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.6 mt -145.39 -20.37 0.48 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.043 -1.036 . . . . 0.0 111.222 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' MET . . . -124.14 18.54 7.41 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.203 -179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.527 ' CA ' ' HA ' ' A' ' 110' ' ' THR . 22.5 mt-10 58.1 179.65 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -1.223 . . . . 0.0 109.601 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HA ' ' SD ' ' A' ' 109' ' ' MET . 0.3 OUTLIER -54.64 133.57 46.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.912 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 109' ' ' MET . 0.4 OUTLIER -108.89 -164.8 0.97 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.198 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.516 ' OG1' ' HG3' ' A' ' 120' ' ' GLU . 3.0 p -149.47 -150.09 0.33 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.398 -0.814 . . . . 0.0 108.85 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.51 -49.31 7.27 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.44 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 123' ' ' GLU . 0.0 OUTLIER -68.96 -15.72 63.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -0.913 . . . . 0.0 109.889 -179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.516 ' HG3' ' OG1' ' A' ' 117' ' ' THR . 0.1 OUTLIER -94.52 -37.1 11.55 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.109 -0.994 . . . . 0.0 108.996 -179.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.839 HG13 HD23 ' A' ' 105' ' ' LEU . 29.3 t -72.0 -70.38 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.819 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -50.76 -27.65 7.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 0.0 109.434 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 119' ' ' GLU . 79.1 tt0 -75.2 -39.15 60.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 0.0 108.703 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . 0.641 ' HB2' HD21 ' A' ' 105' ' ' LEU . 23.1 mtp -61.83 -29.84 70.44 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.8 mt -77.08 -40.81 30.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.5 mtp85 -57.77 -33.15 68.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.624 -0.672 . . . . 0.0 109.931 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.478 ' HG3' ' N ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -81.38 -20.09 41.27 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.116 -0.99 . . . . 0.0 108.9 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.478 ' N ' ' HG3' ' A' ' 127' ' ' GLU . . . -97.46 -6.54 33.61 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.514 -0.741 . . . . 0.0 109.469 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -89.82 131.21 35.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 109.31 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.463 HD12 ' CD ' ' A' ' 140' ' ' GLU . 47.5 mt -104.9 -32.42 2.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.157 -0.965 . . . . 0.0 109.745 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.53 -41.86 6.45 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.854 . . . . 0.0 109.767 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.23 36.21 2.0 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 2.3 p30 -79.16 -26.65 42.73 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.324 -1.104 . . . . 0.0 108.885 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.411 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 119.42 -40.75 2.15 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.47 ' HG3' ' CD2' ' A' ' 99' ' ' TYR . 15.3 pm0 -110.05 -177.39 3.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -1.164 . . . . 0.0 109.454 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.615 HG12 ' N ' ' A' ' 137' ' ' ASN . 99.5 t -122.64 171.83 10.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.343 -0.848 . . . . 0.0 108.852 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.647 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 1.4 p-10 -148.57 -175.04 4.77 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.795 -1.191 . . . . 0.0 108.828 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.662 ' O ' HG23 ' A' ' 142' ' ' VAL . 52.5 t80 -71.75 -39.8 69.79 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.804 -1.185 . . . . 0.0 110.721 -178.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -64.42 -48.5 75.13 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.992 -1.067 . . . . 0.0 109.985 -179.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.482 ' HG3' ' OD1' ' A' ' 137' ' ' ASN . 1.3 mm-40 -71.83 -32.6 67.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.495 ' CZ ' ' HG3' ' A' ' 145' ' ' MET . 37.4 t80 -72.76 -25.78 61.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.274 -0.891 . . . . 0.0 109.868 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 138' ' ' TYR . 39.6 t -74.01 -51.16 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.197 -0.94 . . . . 0.0 109.59 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.522 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 51.6 mt-30 -59.81 -30.67 69.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -0.901 . . . . 0.0 110.185 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 8.1 tpp -84.46 -29.98 25.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.009 -1.057 . . . . 0.0 109.924 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.495 ' HG3' ' CZ ' ' A' ' 141' ' ' PHE . 3.1 tmm? -91.41 -5.14 54.86 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.184 -0.947 . . . . 0.0 110.217 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 142' ' ' VAL . 1.2 t -140.43 -43.9 0.41 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.98 -1.075 . . . . 0.0 110.206 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 143' ' ' GLN . . . -84.62 163.37 19.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.12 -0.987 . . . . 0.0 109.671 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.493 ' OXT' ' CG ' ' A' ' 148' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.318 179.907 . . . . . . . . 2 2 . 1 stop_ save_